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PREFACE 
 
This cumulative doctoral thesis is divided into two main sections, chapter 1 and 
chapters 2 to 11. The first chapter comprises an introduction into the topic by giving 
an overview on the scientific knowledge. A strong focus was laid on terpene natural 
products and their biosynthetic machinery. Nonribosomal peptide/polyketide 
biosynthesis, the isotope tracer technique and an introduction into volatile natural 
products is also given.  
 
The following second section contains the scientific results obtained during the 
course of this doctoral thesis. It is comprised of ten chapters, each representing one 
scientific publication. In every chapter, an introduction and a summary are given, 
explaining the relationship between the individual parts and their scientific 
significance. Chapters 2 to 6 contain publications revolving around the identification 
and biosynthesis of terpenes and other volatile natural products from 
microorganisms. A focus is made on the in vivo application of synthetic isotopically 
labeled precursors. Chapters 7 to 10 comprise publications revolving around the 
design, synthesis and application of isotopically labeled substrates for in vitro studies 
with recombinant enzymes. The publications in Chapter 7, 8 and 9 are already 
included in cumulative doctoral theses from Dr. Christian A. Citron 
(TU Braunschweig, Chapter 7) and Dr. Patrick Rabe (University of Bonn, Chapter 7, 
8, and 9) and are only supplementary to this thesis. A statement on my contribution 
to the work is given priorly to every chapter. The last chapter (chapter 11) describes 
a method for the synthesis of a tetrasubstituted, pseudosymmetric cyclobutane 
derivative, which was developed during studies towards a total synthesis for a fungal 
sesquiterpene. Reprints of all mentioned publications are given in the appendix of 
this thesis.   
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1 State of Scientific Knowledge 
1.1 Terpene Natural Products 
Terpenes make up the biggest class of natural products, with over 50.000 known 
structures isolated from all kingdoms of life.[1] They all share a common biosynthetic 
origin and are composed of 2-methyl-1,3-butadiene, so called isoprene units. This 
concept was firstly recognized by Otto Wallach in 1887 and later described by 
Leopold Ruzicka as the “isoprene rule”.[2,3] According to the number of C5 units, the 
terpenoids are subdivided into (C5) hemi-, (C10) mono-, (C15) sesqui-, (C20) di-, (C25) 
sester-, (C30) tri-, and (C40) tetraterpenes. Important and interesting examples for 
each subdivision are discussed in the following section.  
 
Only about 25 naturally occurring hemiterpenoids are known from nature.[4] One 
prominent example is isoprene (1), released by plants with an annual rate of 500 – 
750 Tg, one of the most abundant volatile natural product on earth (Figure 1).[5]  
 
 
Figure 1. Selection of known hemi-, mono-, sesqui-, di-, tri- and tetraterpenes. 
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Geraniol (2) is an acyclic, linear monoterpene consisting of two isoprene building 
blocks and can be found as an ingredient in rose oil (Rosa damascene) inhabiting a 
characteristic flowery smell.[1] (R)-(+)-limonene (3) is an example for a monocyclic 
monoterpene and can be found in essential oils from citrus fruits, exhibiting a 
characteristic smell of oranges.[1] The methylated monoterpene 2-methylisoborneol 
(2-MIB, 4) and the degraded sesquiterpene geosmin (5) are together responsible for 
the characteristic smell of forest earth and both terpenes are produced by soil-
dwelling bacteria of the genus Streptomyces.[6,7] The terpene hydrocarbon 
backbones often occur as highly decorated terpenoids, carrying various functional 
groups, as can be seen for the guaiane sesquiterpenoid englerine A (6). Englerin A 
was isolated from the African plant Phyllanthus engleri, indigenous to Tanzania and 
Zimbabwe and exhibits high activity against renal cancer cells.[8] The tetracyclic 
diterpene spiroviolene (7), isolated from Streptomyces violens[9] and the fungal 
sesterterpene asperterpenoid A (8) are recent examples for highly complex polycyclic 
terpenoids.[10] Interestingly, an oxidation product of 7 was recently isolated from the 
deep-sea-derived fungus Penicillium granulatum.[11] Cholesterol (9) is a triterpene 
steroid, a constituent of all cell membranes in animal tissues. It is also a precursor for 
human steroid hormones, bile acids and vitamine D.[12] Another biologically important 
terpene is the tetraterpene -carotene (10). Due to the extended π-system, strong 
red-orange coloration is observed and 10 and analogues are widely used in the food 
industry as coloring agents. -Carotene is the precursor of retinol (11), also known as 
vitamine A1, the universal chromophore essential for the mammalian process of 
sight.[13] Lastly, polyisoprenes (12, n>8) exist in nature and are known as natural 
rubber. This polymer is harvested from the Brazilian rubber tree (Hevea brasiliensis) 
and is used to manufacture a wide range of products, for example tires for 
automobiles or aircrafts.[14] 
1.2 Biosynthesis of Terpenes 
The biosynthesis of terpenoid natural products can be sectioned into four general 
steps. The first step comprises the generation of the central biological C5-units 
dimethylallyl pyrophosphate (DMAPP, 13) and isopentenyl pyrophosphate (IPP, 14). 
They either arise from the mevalonate pathway (MV pathway) or the deoxyxylulose 
phosphate pathway (DOX pathway). In bacteria, algae and protozoen, the DOX 
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pathway is employed, whereas in higher eukaryotes like fungi and animals the 
mevalonate pathway is utilized. In plants both metabolic pathways co-occur: the 
mevalonate pathway is localized in the cytosol, whereas the DOX pathway is found in 
the chloroplasts.[15] The subsequent second step involves coupling of the C5-
monomers 13 and 14 to linear oligoprenyl diphosphates. The chain length is thereby 
controlled by the operating synthase, yielding geranyl diphosphate (15, GPP, n = 1), 
farnesyl diphosphate (16, FPP, n = 2), geranylgeranyl diphosphate (17, GGPP, n = 3) 
or geranylfarnesyl diphosphate (18, GFPP, n = 3). In the third step, the linear achiral 
precursors are converted by designated terpene synthases into linear or (poly)cyclic 
terpenes. In a subsequent fourth step, the obtained terpenes can be further 
functionalized by one or more tailoring enzymes, like P450-monooxygenases, 
NAD(P)+ and flavin dependent oxidoreductases, acetyltransferases or 
methyltransferases. This final step often introduces the specific bioactivity into the 
metabolite (Figure 2).[4,15]  
 
 
Figure 2. Overview of the biogenetic steps during terpene biosynthesis. 
 
The linear precursor for all triterpenes, squalene (19) is produced by dimerization of 
two FPP units, catalyzed by a squalene synthase. Similarly, condensation of two 
GGPP units gives phytoene (20), the precursor of all tetraterpenes (Figure 3). The 
biosynthetic details of tri- and tetraterpenes are not covered in this thesis.  
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Figure 3. Structure of squalene (19) and phytoene (20). 
 
1.2.1 Biosynthesis of DMAPP and IPP 
1.2.1.1 The Mevalonate Pathway 
The discovery of the mevalonate pathway was achieved in the course of investigating 
steroid metabolism and was awarded with a Nobel Prize to Feodor Lynen and 
Konrad Bloch in 1964 and John Cornforth in 1975.[16,17] This essential metabolic 
pathway links the primary metabolism to isoprenoid biosynthesis by the central 
metabolite acetyl coenzyme A (acetyl-CoA, 21). Overall, six enzymes convert three 
units of 21 firstly to IPP (14) and a seventh enzyme can isomerize 14 into DMAPP 
(13) (Figure 4).  
 
Figure 4. Depiction of the mevalonate pathway. AAC: acetyl-CoA synthase; HMGS: 
hydroxymethylglutaryl-CoA synthase; HMGR: hydroxymethylglutaryl-CoA reductase; MK: mevalonate 
kinase; PMK: phosphomevalonate kinase, MDD: diphosphomevalonate decarboxylase; IDI: 
isopentenyl diphosphate isomerase; NADPH: nicotinamide adenine dinucleotide phosphate; ATP: 
adenosine triphosphate.    
 
The first reaction is catalyzed by the enzyme acetoacetyl-CoA synthase (AAC), which 
connects two acetyl-CoA (21) units in a biological Claisen reaction to form 
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-ketothioester 22. A third acetyl-CoA (21) is attached to 22 in a stereospecific aldol 
addition by the 3-hydroxy-3-methylglutaryl-CoA synthase (HMGS),[18] followed by 
reduction to the central metabolite mevalonic acid (24), catalyzed by the 3-hydroxy-3-
methylglutaryl-CoA reductase (HMGR).[19] The stereochemical course of the aldol 
reaction was firstly studied by Theodor Lynen by growing Mycobacterium spp. on 
media containing rac-24 as a single carbon source. He was able to show that only 
(+)-(R)-24 was consumed by the organism, observed from enrichment of the 
antipodal (−)-(S)-24 in the culture.[20] Two subsequent phosphorylation steps of the 
primary alcohol function of 24 by a mevalonate kinase (MK) and phosphomevalonate 
kinase (PMK) yield diphosphate 26.[21] Subsequently, IPP (14) is generated by an 
ATP assisted decarboxylative-elimination reaction, catalyzed by the mevalonate 5-
diphosphate decarboxylase (MDD).[22,21b] At last, IPP (14) is isomerized to DMAPP 
(13) by the isopentenyl diphosphate isomerase (IDI) (Figure 4).[23]  
The stereochemical details of the MDD catalyzed decarboxylation-elemination 
reaction were analyzed by isotopic labeling experiments, employing (2R)- and (2S)-
(2-2H)-24. Determination of the label incorporation into 14 demonstrated that the pro-
R proton (HR) in 26 is turned into HZ in 14 and the pro-S proton (HS) into HE.[24] Here, 
ATP assists the anti-elimination of H2O without covalently binding to 26 (Figure 5A).  
 
Figure 5. Stereochemical details of A) the MDD mediated reaction; B) the IDI-reaction. MDD: 
diphosphomevalonate decarboxylase; IDI: isopentenyl diphosphate isomerase.   
The enzyme IDD converts IPP (14) into DMAPP (13) by a protonation-deprotonation 
sequence. The HR proton in 14 is thereby selectively abstracted (Figure 5B). 
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1.2.1.2 The Deoxyxylulose Phosphate Pathway 
An alternative pathway for isoprenoid biosynthesis was subsequently discovered, 
which also gave an explanation for observed inconsistencies in labeling patterns after 
feeding experiments, like in the biosynthesis of ubiquinones in Escherichia coli.[25] 
Key experiments have been conducted by Michel Rohmer and Duilio Arigoni in the 
1990s.[26] The deoxyxylulose phosphate pathway starts with pyruvic acid (27) and D-
glyceraldehyde-3-phosphate (28), which are converted under decarboxylation into 1-
deoxy-D-xylulose-5-phosphate (29) in a thyamine pyrophosphate mediated reaction, 
which is catalyzed by the 1-deoxy-D-xylulose-5-phosphate synthase (DXPS) 
(Figure 6).[27]  
Figure 6. The deoxyxylulose phosphate pathway. DXPS: 1-deoxy-D-xylulose-5-phosphate synthase; 
IspC: 1-deoxy-D-xylulose 5-phosphate reductoisomerase; IspD: 4-diphosphocytidyl-2-C-methyl-D-
erythritol synthase; IspE: 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase; IspF: 2-C-methyl-D-
erythritol-2,4-cyclodiphosphate synthase; IspG: 4-hydroxy-3-methylbut-2-enyl diphosphate synthase; 
IspH: 4-hydroxy-3-methylbut-2-enyl diphosphate reductase.   
 
In the next step, the branched-chain structure, equivalent to the isoprene unit, is 
introduced by a reductoisomerase (IspC), generating 2-C-methyl-D-erythritol-4-
phosphate (30).[28] The primary phosphate group in 30 is substituted with a cytidine 
diphosphate, catalyzed by the 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase 
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(IspD),[29] followed by phosphorylation of the tertiary alcohol by the 4-
diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE).[30] Intermediate 32 is 
transformed into a highly unusual 8-membered cyclic phosphoanhydride (33), the 
only known cyclic diphosphate from nature, by the 2-C-methyl-D-erythritol-2,4-
cyclodiphosphate synthase (IspF).[31] By elimination of water and transfer of two 
electrons, 4-hydroxy-3-methyl-but-2-enyl diphosphate (34) is generated by IspG.[32] 
The final step is catalyzed by the 4-hydroxy-3-methylbut-2-enyl diphosphate 
synthase (IspH), yielding DMAPP (13) and IPP (14) in a ratio of 5:1 by elimination of 
water and reduction.[33]  
The second step in the DOX-pathway is catalyzed by the reductoisomerase IspC and 
involves a complex rearrangement to aldehyde intermediate 35 prior to reduction. For 
this transformation, two possible mechanisms are discussed in the literature: a 
concerted -ketol rearrangement consisting of initial deprotonation of the C3 hydroxyl 
group, followed by 1,2-alkyl migration from C4 to C2 (Figure 7A), or a stepwise 
mechanism by a retroaldol/aldol sequence (Figure 7B). A study by LIU, employing 
deuterated isotopologues of 29 and determination of secondary kinetic isotope 
effects, points to the occurrence of a stepwise mechanism via the bimolecular 
intermediate A.[34]  
 
 
Figure 7. Possible mechanisms for IspC-reaction. 
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1.2.1.3 Pharmacological Implications 
Knowledge about the details of early terpenoid biosynthetic pathways is not only 
indispensable for the design of feeding experiments, but also offers opportunities for 
the development of pharmaceutical therapeutics.[35] The differing biogenesis of 
terpenes in mammalian cells to that in prokaryotes, like the tuberculosis pathogen 
Mycobacterium tuberculosis or the protozoan malaria parasite Plasmodium 
falciparum, opens up possibilities for a selective inhibition of these pathogens without 
disturbing the human metabolism. Fosmidomycin (36) and its derivative FR-900098 
(37) were found to be highly potent inhibitors of the reductoisomerase IspC of the 
deoxyxylulose phosphate pathway[36], which was shown for M. tuberculosis[37] in vitro 
and for P. falciparum in vitro and in vivo.[38] A lack of acute toxicity and genotoxicity 
further supports pre-clinical and clinical development (Figure 8).[39]  
 
Figure 8. Structures of isoprenoid biosynthesis inhibitors (36-39) and mevaldyl-CoA (40). 
 
A second pharmacologically important example is the use of statins for the treatment 
of hypocholesterolemia, a major risk for the development of coronary heart disease. 
High levels of cholesterol (9), a steroid produced via the mevalonate pathway in 
mammals, can be lowered by inhibition of the HMG-CoA reductase (HMGR).[40] The 
first highly potent HMG-CoA reductase inhibitor was the polyketide compactin (38), 
isolated from Penicillium citrinum in 1977.[41] The related lovastatin (39), isolated from 
Aspergillus terreus,[42] was the first cholesterol-lowering agent approved for clinical 
use.[40] Its structural similarity to mevaldyl-CoA (40), an intermediate towards 
mevalonic acid (24), is shown in Figure 8.   
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1.2.2 Biosynthesis of Polyisoprenoid Chains 
The linear oligoprenyl diphosphates are synthesized by prenyltransferases, also 
called polyisoprenoid diphosphate synthases, catalyzing consecutive prenyl chain 
elongations. These enzymes mediate the coupling between DMAPP (13) and IPP 
(14) via a nucleophilic substitution reaction. Thereby, the allylic diphosphate in 
DMAPP is abstracted and the allylic cation is attacked by the terminal, electron-rich 
double bond in IPP, followed by a stereoselective deprotonation of the HR-proton at 
C2 (Figure 9).  
 
Figure 9. Mechanism of the oligoprenyl chain formation from DMAPP (13) and IPP (14).  
 
In the course of this reaction, one DMAPP (13) is extended by IPP (14) to form GPP 
(15), the linear precursor for all monoterpenes. A second elongation by addition of 
another IPP-extender unit following the same mechanism yields FPP (16), the 
universal sesquiterpene, and a third addition of 14 yields GGPP (17), the diterpene 
precursor. The actual chain length and structure of the enzyme product depends on 
the nature of the catalyzing prenyltransferase. The first enzyme structurally and 
chemically characterized was the FPP-synthase, a prototypal representative for 
regular chain elongating oligoprenyl diphosphate synthases.[43] 
 
1.2.3 Terpene Cyclization 
The final terpene carbon backbone is constructed from the linear oligoprenyl 
diphosphates by a carbocation-mediated cyclization cascade. The responsible 
enzymes catalyzing these reactions are called terpene synthases, often referred to 
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as terpene cyclases. Terpene cyclases can be subdivided into two classes, type I 
and type II cyclases.[44] On amino acid level, terpene cyclases of type I can be 
identified from their conserved motifs DDxx(D,E) and the NSE-triad 
(ND(L/I/V)xSxxxE). This aspartate-rich sequences effectuate binding of a cationic co-
factor, in most cases a trinuclear magnesium metal cluster, responsible for 
coordination of the diphosphate moiety, present in all type I terpene cyclase 
substrates. The binding initiates pyrophosphate abstraction accompanied by 
formation of a reactive allylic cation, the starting point for the subsequent domino 
reaction. Recently, a new effector triad, including a highly conserved pyrophosphate 
sensor, an effector and a linker, was recognized during crystallographic studies on 
the bacterial selina-4(15),7(11)-diene synthase.[45] 
In contrast, terpene cyclases of type II initiate cyclization by protonation of a double 
bond or a previously formed epoxide and share the conserved DxDD motif. After 
formation of the initial reactive cation, the subsequent conformationally and 
stereochemically precise cyclization reaction is guided by amino acid residues inside 
the active center of a terpene cyclase, which confer an overall shape to the cavity, 
serving as a template for the precursor conformation. The mechanistic reaction steps 
resemble the reactivity of carbocation chemistry such as nucleophilic attack of double 
bonds, proton transfer reactions, hydride shifts and alkyl shifts. In the terminating 
step, a carbocation is either quenched by deprotonation or attack of an exogenous 
nucleophile, in most cases water.[46,4] 
In 2017 LIU and coworkers discovered a new family of diterpene cyclases, closely 
related to the UbiA superfamily of intramembrane prenyltransferases, which usually 
catalyze the formation of ubiquinones, menaquinones, plastoquinones, hemes, 
chlorophylls, vitamin E and structural lipids. Analysis of their protein sequences led to 
the identification of two highly conserved motifs: Nxxx(G/A)xxxD and DxxxD.[47] A 
detailed analysis of the mechanism and function of this new class of terpene 
cyclases remains to be conducted.      
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1.2.3.1 Mechanistic Details - Taxadiene Synthase 
Important insights into the structural and chemical features of terpene cyclases were 
obtained from X-ray crystallographic data. The first reported terpene cyclase 
structure was the pentalenene synthase from Streptomyces UC5319, published by 
CHRISTIANSON in 1997.[48] In this chapter, the mechanistic details of a type I terpene 
cyclase are exemplary illustrated by the taxadiene synthase (TXS), catalyzing the 
formation of taxa-4(5),11(12)diene (41) from GGPP (17), reported by CHRISTIANSON 
in 2011.[49]  
The TXS was co-crystallized with substrate analogue 2-fluorogeranylgeranyl 
diphosphate (FGP). The active site with bound substrate is shown in Figure 10A and 
a detailed view of the molecular recognition site is shown in Figure 10B.[49] The active 
center of TXS exhibits conserved motifs typical for class I terpene cyclases with the 
amino acid sequences D613DMAD617 and N757DTKT761YQAE765. Cofactor ions Mg2+A 
and Mg2+C are coordinated by D613 and D617, whereas N757, T761 and E765 
complex Mg2+B, building up the binding site for the diphosphate moiety of GGPP 
(Figure 10B). 
A)                                                                 B) 
 
Figure 10. X-ray crystal structure of taxadiene synthase. A) Active site with bound substrate analogue 
and B) close-up view of the phosphate binding site (FGP is shortened to one carbon (grey)). Metal 
coordination is shown as thin solid lines, hydrogen bond interactions are indicated by thin dashed 
lines. Atoms are colored as follows: carbon=yellow, nitrogen=blue, oxygen=red, phosphorus=orange. 
Mg2+-ions (A, B, C)=purple spheres, water=red spheres.[49] 
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Coordination of the diphosphate is also assisted by hydrogen bonds to R754 and 
N757, as well as hydrogen bonds with Y688, E691, Y835, S713, R768 and Q770 
mediated by water. The overall shape of the enzyme pocket determines the fate of 
the activated substrate and in case of the TXS, taxadiene (41) is formed.  
The cyclization mechanism of GGPP to 41 can be explained by the following reaction 
cascade: attack of the terminal C14/C15-double bond in GGPP (17) to the allylic 
cation, generated after pyrophosphate-abstraction, yields an isopropyl cation, which 
is subsequently attacked by the neighboring double bond C10/C11 to form bicyclic 
intermediary verticillen-12-yl cation A (Scheme 1). 
 
 
Scheme 1. Cyclization mechanism of GGPP (17) to taxa-4(5),11(12)diene (41). 
 
Via a proton transfer reaction, verticillen-8-yl cation B is formed, from which a 
transannular attack of double bond C2/C3 generates taxen-4-yl cation C. The 
reaction cascade is terminated by deprotonation, mediated by a basic residue in the 
enzyme pocket, thereby generating the final product 41. Different polar amino acid 
residues or the extruded PPi are discussed to assist this terminating deprotonation.[49]  
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1.3 NRPS/PKS-Derived Natural Products 
Nonribosomal peptides are oligopeptides with a linear, circular or branched structure, 
often consisting of less than 20 amino acids. Besides DNA-encoded regular amino 
acids, highly modified building blocks are frequently observed carrying additional 
acyl-, methyl- or glycosyl groups, exhibiting epimerized stereocenters or are 
condensed to heterocycles.[50] Many bioactive NRPS-derived natural products are 
known and used for medicinal purposes. A prominent example is the antibiotic 
vancomycin (42), isolated from Amycolatopsis orientalis (Figure 11).[51]  
Figure 11. Examples for NRPs, PKs and NRPs/PKs hybrid natural products. 
 
Nonribosomal peptides are biosynthetically generated by nonribosomal peptide 
synthases (NRPS), large megaenzymes functioning as assembly lines on a 
molecular level.[52] They have a modular architecture, in which every module is 
responsible for the assembly and modification of one building block. The first module 
initiates the assembly line by loading of the starter unit. All subsequent modules 
extend this starter by one further building block and the last module terminates the 
assembly line and releases the product from the enzyme. Each extender module 
comprises at least three functional domains, an adenylation- (A), thiolation- (PCP) 
and condensation (C) domain. The loading module usually contains only an A and a 
PCP domain. The adenylation domain is responsible for selection and activation of 
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the respective building block by converting the amino acid into aminoacyl adenylates 
using ATP. The activated amino acid is then transferred to the peptidyl carrier protein 
(PCP), forming an aminoacyl thioester. The PCP domain carries a 
phosphopantetheine residue, resembling a flexible arm and enabling the growing 
chain to reach the active sites of the enzyme. The condensation domain then 
catalyzes the transpeptidation between the PCP-loaded amino acid of module n and 
module n+1 (Figure 12A).[50]  
 
Figure 12. Schematic representation of A) a NRPS and B) a PKS assembly line. 
 
The modules often do not only consist of these core domains, but can have 
additional specialized domains, like epimerization, methylation, cyclization, reduction 
or oxidation domains, enabling production of highly specialized bioactive natural 
products. The termination step is usually catalyzed by a thioesterase, breaking the 
bond of the oligopeptide to the NRPS, often under intramolecular cyclization by 
nucleophilic attack of an amino group in the assembled amino acid chain.[53]  
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The biosynthesis of polyketide natural products follows the same modular logic but 
differs in the employed building blocks. Instead of amino acids, short carboxylic acids 
like malonyl-CoA are sequentially condensed. The responsible multifunctional 
megaenzymes are called polyketide synthases (PKS). Similar to NRPSs, three core 
domains exist within each module of a PKS. Selection of the incorporated building 
block is catalyzed by an acyltransferase (AT), selecting a distinct building block and 
transferring it onto the acyl carrier protein (ACP). The ACP domain is also comprised 
of a flexible phosphopantetheine moiety. The condensation of two building blocks is 
catalyzed by a ketoacyl synthase (KS), which connects the building block with the 
extender unit under decarboxylation (Figure 12B). Similar to NRPS, PKS modules 
can also contain additional tailoring domains, like a ketoreductase, dehydratase, an 
enoyl reductase or O- and C-methylation domains. The off-loading of the polyketide 
chain is also achieved by a thioesterase for most cases.[50,52,53] Many clinically used 
drugs are PKS-derived natural products, like the antibiotic erythromycin (43) (Figure 
11).[54]  
Additional diversification in nature was achieved by the evolutionary combination of 
NRPS and PKS biosynthetic machineries to NRPS/PKS hybrids.[50,52] An important 
example for a natural product originating from such a hybrid machinery is the 
clinically used anticancer agent epothilone B (44) isolated from Sorangium 
cellulosum (Figure 11).[55]  
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1.4 Isotope Tracer Technique 
“The single most important technical advance that transformed biochemistry in the 
20th century was the isotope tracer technique. Without it, the rapid growth of our 
knowledge of biosynthesis would be simply inconceivable.” (E. P. Kennedy)[56] 
The investigation of biochemically processes on a molecular level strongly relies on 
appropriate tracer techniques, enabling to follow the fate of specific atoms or 
molecules through complex metabolic processes. The first idea of tracing a 
metabolite through a biochemical transformation was exemplified by Franz Knoop in 
1904, who studied the fate of fatty acids in metabolism by introducing a phenylring in 
the -position of even and uneven fatty acids.[57] Such a “chemical labeling” of 
metabolites can however affect the overall chemistry of a compound and therefore 
alter its biochemical processing. The groundbreaking discovery of isotopes by 
Frederik Soddy and Francis Aston, awarded with a Nobel Prize in 1921 and 1922, 
paved the way for the development of the isotope tracer technique.[58] Isotopes of 
one element differ in their number of neutrons and therefore in their physical 
properties. However, their overall chemical behavior is not altered or only to a limited 
extent (kinetic isotope effect). In the 1940s and 1950s Rudolf Schoenheimer, Konrad 
Bloch, John Cornforth and Georg Papják were pioneers in biochemistry and the 
discovery of metabolic pathways by using isotope tracer techniques. They employed 
heavy water (2H2O) and radioactive 14C-labeled isotopomers to study metabolic 
pathways.[56] The invention of pulsed Fourier-transform nuclear magnetic resonance 
spectroscopic methods in the 1970s revolutionized the applicability and scope of 
stable isotope tracer techniques[59] and continous to be of great importance for 
studying biochemical processes.[60]  
1.4.1 In Vivo Labeling – Siphonazole Biosynthesis 
Siphonazole (45) was isolated from the Gram-negative gliding bacterium 
Herpetosiphon sp., belonging to the phylum Chloroflexi. It exhibits a linear 
arrangement of unusual building blocks, pointing to a PKS/NRPS-derived natural 
product (Figure 13).[61] 
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Figure 13. Structure of Siphonazole (45). 
 
Building block I consists of an aromatic benzene ring and a C3-side chain, with an 
additional C1-element at one of the aromatic hydroxyl functions (Building block VI). 
The two presumably threonine-derived oxazole rings (II and IV) are connected via a 
C2-unit (III) and an additional C5N-group, carrying an unusual terminal diene 
structure, is incorporated (Figure 13). The biogenetic origin of these building blocks 
was hypothesized to arise from phenylalanine-derived cinnamic acid for I, threonine-
derived oxazole moieties II and IV and acetate for the linkage III. Building block V 
was hypothesized to arise either from a lysine precursor, resembling a C5N-building 
block, or by condensation of propionate and glycine. To address this hypothesis, 
feeding experiments using 13C- and 15N-labeled precursors were conducted. 
Feeding of (1-13C)acetate, which is transformed into the central metabolite (1-
13C)acetyl-CoA, revealed incorporation into C4, C9, C11, C2’ and C4’ of 45 (Figure 
14A).  
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Figure 14. Label incorporation into siphonazole (45) after feeding of A) (1-13C)acetate; B) (1,2-
13C2)acetate; C) (1-13C)glycine; D) (1,2-13C2,15N)glycine; E) (methyl-13C)methionine. Black dots 
indicate 13C-incorporation; asteriks indicate 15N-incorporation.   
 
The observed labeling in building block I (C9 and C11) clearly ruled out a cinammic 
acid origin, since only labeling of C9 would be expected. Cinammic acid is derived 
from phenylalanine, which itself is build up from two phosphoenolpyruvate units and 
D-erythrose-4-phosphate via the shikimate pathway. (1-13C)Acetyl-CoA is 
transformed into (1-13C)phosphoenolpyruvate, which would lead to labeling of only 
C9 since one 13C-label is lost during a decarboxylation step from prephenic acid to 
phenylpyruvic acid, the precursor to phenylalanine. The findings also rule out an 
acetate-derived origin of the aromatic ring, since no labeling in the benzene ring of 45 
was detected. The results therefore point to a benzoic acid building block, connected 
to an acetate unit. The incorporation into C4 is in line with an acetyl-CoA-derived 
linkage of the oxazole building blocks. Incorporation into the homodiene side chain 
was detected in C2’ and C4’ position. A complementing experiment was conducted 
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using (1,2-13C2)acetate, which was in line with feeding of the singly labeled acetyl-
CoA (Figure 14B). Interestingly, an intact C2-unit was detected in position C3’-C4’.  
To further analyze the biogenetic origin of the side chain, labeled (1-13C)glycine and 
(1,2-13C2,15N)glycine were fed to Herpetosiphon, both leading to incorporation 
resembling a glycine-derived moiety for C1’ and C2’ (Figure 14C and D).  
The remaining three carbon atoms in the side chain were thought to arise from 
propionyl-CoA, but surprisingly (1-13C)propionate was not incorporated into the 
carbon backbone of 45. Taking into account, that labeling of C2’ and C4’ had been 
detected after feeding of (1-13C)acetate (labeling of the glycine-derived C2’ position 
can be explained by an intensive metabolism via (1-13C)oxaloacetate (tca cycle) and 
(1-13C)-3-phosphoglycerate (gluconeogenesis) to (1-13C)glycine) and that C3’ and 
C4’ resemble an intact acetate unit, it was concluded, that the side chain must have 
been composed of glycine and two acetate units, from which one carbon is lost by 
decarboxylation.  
Lastly, feeding of (methyl-13C)methionine proved that C20 originates from S-
adenosylmethionine, the universal biological methylation agent (Figure 14E).    
 
1.4.2 In Vitro Labeling – Corvol Ether Biosynthesis 
The detailed understanding of the underlying mechanism of terpene cyclases 
resembles an important field in terpene natural product research. The product scope 
of these enzymes is up to now highly difficult to predict solely on their protein- or 
nucleic acid sequence. Besides the evaluation of structural biology data by 
computational studies using quantum chemical calculations, the investigation of 
terpene cyclization mechanisms, using isotope tracer techniques can further 
contribute to this research field.[62] Corvol ethers A (47) and B (46) were recently 
characterized as the enzyme products of a sesquiterpene cyclase from Kitasatospora 
setae and are produced in a 1:3 ratio, respectively (Figure 15).[63]  
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Figure 15. Structures of corvol ether A (47) and B (46). 
Their biosynthesis was intensively investigated by in vitro incubation of isotopically 
labeled FPP isotopomers with the recombinant enzyme obtained by heterologous 
expression in E. coli. The formation of corvol ether can be envisaged by the following 
cyclization mechanism. After initial pyrophosphate abstraction from FPP (16) 
nerolidol diphosphate (48) is generated, enabling 1,10-cyclization towards isopropyl 
cation A. A subsequent 1,3-hydride shift to allylic cation B, followed by a double bond 
shift and attack of water gives neutral intermediate germacrene D-4-ol (49) (Figure 
16).  
 
Figure 16. Biosynthesis of corvol ether A (44) and B (43). 
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The transannular second ring closer mediated by protonation opens up two possible 
pathways for the generation of central intermediate F towards corvol ether A or B. 
Formation of C would require two subsequent suprafacial 1,2-hydride shifts, whereas 
formation of stereoisomer E necessitates one suprafacial 1,3-hydride shift to explain 
the stereochemical outcome in 46 and 47. The main product of the corvol ether 
synthase, 46 is formed from F by a Wagner-Meerwein rearrangement (WMR) to 
cationic intermediate G, followed by intramolecular attack of the hydroxyl group. The 
formation of the second product 47 can be explained by a 1,2-hydride shift instead of 
the WMR to cation H also followed by an intramolecular attack of the alcohol moiety. 
To verify the proposed cyclization mechanism and experimentally prove the 
postulated steps, three labeling experiments were designed and conducted.[64] The 
presence of neutral intermediate 49 was investigated by incubation of synthetic (2-
13C)-16 with corvol ether synthase in D2O (Scheme 2A).  
 
 
Scheme 2. Labeling experiments for corvol ether biosynthesis studies. 
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Since neutral intermediates require a reprotonation step to regenerate a cationic 
reactive center in the carbon backbone, this proton gets 2H-labeled, when the 
reaction is carried out in D2O. The position of deuterium can be detected by a triplet 
signal for the bound carbon atom in the corresponding 13C-NMR spectrum caused by 
1H,13C heteronuclear coupling. When the respective carbon atom is additionally 13C-
labeled, the 13C-NMR signal is strongly enhanced, allowing for analysis of only 
minute amounts of material. The outcome of the incubation experiment indeed 
revealed a triplet signal for the respective carbon atom, giving evidence for the 
presence of 49. Additionally, labeling experiments were designed to distinguish 
between the two possible pathways from 49 to F. By incubation of (6-13C,1,1-2H2)-16 
the fate of the proton in C5 position can be followed (Scheme 2B). Pathway A should 
lead to 2H-labeling of C1, which is also 13C-labeled, whereas in pathway B the 
deuterium is shifted in the C10 position. The outcome was analyzed by 13C-NMR 
spectroscopy and revealed a strong triplet signal for C1, which demonstrates the 
occurrence of two subsequent 1,2-hydride shifts instead of one 1,3-hydride shift. This 
finding was further supported by the complementary experiment with (7-13C,1,1-2H2)-
16 leading to a strong triplet for C10 (Scheme 2C).  
 
1.5 Volatile Natural Products 
Volatile compounds are typically small (up to C20) and have therefore a low molecular 
mass (100-500 Daltons), high vapour pressure and a low boiling point. Volatiles are 
produced by nearly all living organisms and can exhibit diverse functions for the 
producing organism.[65]  
The sulfur volatile dimethyl sulfide (DMS, 50) is produced by marine bacteria of the 
Roseobacter clade by degradation of the algal metabolite dimethylsulfoniopropionate. 
DMS is released from the ocean into the atmosphere by 2 x 107 tons per year. Its 
oxidation products dimethylsulfate and sulfate influence the planets climate by acting 
as cloud condensation nuclei and participate in the global sulfur cycle. DMS is also 
the main contributor for the typical smell of the seaside and is a potent 
chemoattractant for birds (Figure 17).[66]  
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Figure 17. Examples of bioactive volatile metabolites from bacteria, fungi, plants and insects.  
 
Another interesting volatile metabolite is the sesquiterpene ( )-thujopsene (51), 
produced by the ectomycorrhizal fungus Laccaria bicolor. L. bicolor is a mutualistic 
fungus associated with the roots of plants e.g. Populus or Arabidopsis. It was shown, 
that 51 is the key signaling compound emitted by the fungus to initiate plant lateral 
root production, prior to direct contact pre-colonization.[67] Volatiles are also produced 
by almost all plants and often act as chemical defense compounds against 
herbivores.[68] In many cases, not only a single compound exhibits a certain 
bioactivity, but a whole set of different chemicals. Recently, the semiochemicals 52-
55 have been identified from the spider orchid Caladenia crebra and were shown to 
attract the male thynnine wasp Campylothynnus flavopictus for pollination by 
mimicking the female wasps pheromone cocktail.[69]  
 
1.5.1 Capturing Volatile Natural Products from Microorganisms 
Besides their biological importance, the analysis of volatile natural products is 
associated with certain obstacles. Classical extraction-isolation techniques employed 
for natural product isolation require concentration steps to remove the employed 
solvent during which volatiles are easily lost. Therefore, special techniques are 
necessary for compound sampling. Additionally, volatiles often occur as complex 
mixtures and in rather low yields, demanding for elaborate chromatographic and 
highly sensitive analytical methods.[70] For the sampling of biogenic volatiles, two 
main techniques have evolved: the closed-loop-stripping apparatus (CLSA)[71] and 
the use of a solid phase micro extraction fibre (SPME) (Figure 18).[72] 
 24 
 
A) B) 
 
 
Figure 18. Sampling techniques for the trapping of volatiles: A) CLSA; B) SPME. 
 
A CLSA is a closed glass vessel, in which a grown agar plate culture can be 
introduced. A connected pump blows a constant airflow over the culture and through 
a charcoal filter on which the emitted volatiles get trapped and concentrated. This 
filter is subsequently extracted with suitable solvents (e.g. dichloromethane) and the 
amounts of material are sufficient for GC/MS analysis. Alternatively, a SPME-fibre 
can be employed for trapping of emitted volatiles. The fibre is coated with 
poly(dimethylsiloxane), acting as an adsorber medium, and can be held directly 
above a biological sample. The adsorbed compounds can be analyzed by GC/MS, 
thereby making use of thermal desorption inside the injector chamber.  
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2 Pogostol Biosynthesis by the Endophytic Fungus 
Geniculosporium  
Lena Barra, Dr. Barbara Schulz and Prof. Dr. Jeroen S. Dickschat*  
ChemBioChem 2014, 15, 2379-2383. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reprinted from ChemBioChem 2014, 15, 2379-2383 with kind permission from John 
Wiley and Sons. 
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Introduction 
Fungi are prolific producers of volatile terpenes with hundreds of identified 
compounds from various fungal genera like Aspergillus, Penicillium, Trichoderma or 
Fusarium.[65c] The homomonoterpenoid 2-methylisoborneol (2-MIB, 4), firstly isolated 
from a Streptomycete, as already discussed in the introduction (Chapter 1.1),[7] was 
found to be also produced by Aspergillus[73] and Penicillium.[74] The sesquiterpene -
caryophyllene (56) is produced by Talaromyces wortmannii and shows plant growth 
promoting properties.[75] Besides terpenes with direct effects in their environments, 
the terpene carbon backbone is often used as a precursor towards highly 
functionalized bioactive compounds like the aristolochene (57) derived toxin PR-
Toxin (58) from Penicillium roqueforti (Figure 19).[76] 
 
 
Figure 19. Examples of volatile terpenes from fungi. 
 
The GC/MS based identification of volatile terpenes relies on comparison of the 
measured respective mass spectra and retention indices to electronic mass spectral 
libraries and tabulated literature data. This approach is limited by incomplete 
published data, the occurrence of stereoisomers, which can exhibit highly similar 
mass spectra and retention indices, or completely unknown terpenes. Alternatively, a 
mass spectrum deviated reference compound could be used as a standard, but only 
a few compounds are commercially available and the development of a total 
synthesis for complex organic molecules like terpenes is highly laborious. In those 
cases, access to 13C-NMR data is desirable to gain additional structural information 
of the analyte. The sampling of volatile metabolites by CLSA usually yields material 
in the sub-microgram range, too little for NMR spectroscopic methods. Additionally, 
terpenes often occur in a complex mixture with other volatile organic compounds 
from various classes, further preventing the sufficient application of NMR techniques. 
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To circumvent these problems, a suitable 13C-labeled biosynthetic precursor can be 
fed to the organism, leading to selective labeling of distinct carbon atoms in the final 
natural product. These 13C-labeled atoms appear with strongly enhanced intensities 
in the respective 13C-NMR spectrum enabling access to 13C-NMR data with only 
minute amounts of material as obtained from CLSA headspace extracts. The 
CLSA/NMR technique was firstly employed in the analysis of the stereochemical 
course in 2-MIB biosynthesis in Micromonospora olivasterospora by feeding of (1-
13C)-1-deoxy-D-xylulose.[77]  
 
Summary 
The CLSA/NMR technique was systematically developed for the identification of 
volatile terpenes from fungal sources. Fungi employ the mevalonate pathway for the 
generation of the isoprenoid monomers DMAPP and IPP (Chapter 1.2.1), enabling 
feeding experiments with mevalonolactone, the -lactone of mevalonic acid, leading 
to sufficient incorporation into the produced terpenes.[78] Therefore, a robust 
synthesis starting from commercially available 13C-labeled ethyl acetoacetate 
developed by ZAMIR et al.[79] was tested and employed for the generation of singly 
and doubly 13C-labeled mevalonolactone isotopomers 59a-59d (Figure 20). 
Synthesis of (2,6-13C2)-59e was achieved by a previously developed route in our 
workgroup[80] and (4-13C)-59f was synthesized by a procedure developed by CANE.[81] 
 
 
Figure 20. Synthesized 13C-labeled mevalonolactone isotopomers 59a-59f and structure of the 
identified sesquiterpene pogostol (60). Black dots indicate 13C-label,  
 
Feeding of labeled precursors to the endophytic fungus Geniculosporium sp. isolated 
from Cistus monspeliensis and analyses of the headspace extracts obtained from 
CLSA sampling by GC/MS revealed high incorporation into a sesquiterpene alcohol. 
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The structure of the terpene was analyzed by sequential feeding of all six 
mevalonolactone isotopomers, collection of the emitted volatile bouquet by CLSA, 
extraction of the charcoal filter with CDCl3 and direct analyses of the extracts by 13C-
NMR spectroscopy. The results gave access to the complete 13C-NMR data of the 
sesquiterpene alcohol, which could be identified and distinguished from its 
stereoisomers as pogostol (60) by comparison to literature data. The results 
additionally gave insight into the cyclization mechanism of 60, including 
stereochemical aspects. 
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3 Structural Revision and Elucidation of the Biosynthesis 
of Hypodoratoxide by 13C,13C COSY NMR Spectroscopy 
 
Lena Barra, Dr. Kerstin Ibrom and Prof. Dr. Jeroen S. Dickschat* 
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Reprinted from Angew. Chem. Int. Ed. 2015, 54, 6637-6640 with kind permission 
from John Wiley and Sons. 
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Introduction 
The CLSA/NMR technique is a highly useful method for the identification of volatile 
terpenes produced by microorganisms. The access to 13C-NMR data of only little 
amounts of material based on in vivo 13C-labeling of the natural product gives 
valuable information about the analyte. However, a direct access to the connectivity 
of the labeled carbon atoms can not be obtained, rendering a direct approach to the 
structure. Alternatively, isolation of the natural product in preparative amounts and 
standard NMR spectroscopic methods can be established. Isolation is often highly 
laborious for volatile organic compounds like mono- or sesquiterpenes, due to low 
yields and material loss during concentration steps. Additionally, interpration of NMR 
and 2D NMR data of complex (poly)cyclic hydrocarbons is often difficult due to strong 
overlapping of chemical shifts. Direct access to the connectivity of a carbon 
backbone can be obtained from 13C,13C-INADEQUATE experiments, but for that high 
amounts of material are necessary.  
 
Summary 
The mycophylus fungus Hypomyces odoratus produces a sesquiterpene, which was 
isolated by ABRAHAM and shown to have phytotoxic and antifungal activity.[82] Its 
structure was analyzed by various 2D NMR methods leading to the eremophilane 
ether 61 (Figure 21).  
Figure 21. Structure of (2,3,4,5,6-13C5)-59g and volatile terpenes from H. odoratus: initial structure of 
hypodoratoxide (61), protoillud-6-ene (62), cis-dihydroagarofuran (63), revised structure of 
hypodoratoxide (64). Black dots indicate 13C-label. 
 
During our analysis of the volatiles of H. odoratus three terpenes were detected, from 
which the two minor compounds could be identified as protoillud-6-ene (62) and cis-
dihydroagarofuran (63) based on their GC/MS data. The major compound was 
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identified by feeding of (2,3,4,5,6-13C5)mevalonolactone (59g), which was 
synthesized from ethyl (1,2,3,4-13C4)acetoacetate and (2-13C)ethyl acetate.[79] Label 
incorporation by 16% to [13C15]hypodoratoxide allowed the measurement of a 
13C,13C-COSY-NMR spectrum, from which the planary structure could be deduced by 
one-bond 13C,13C-homonuclear coupling. The obtained structure of hypodoratoxide 
was different to the previously reported structure showing a 5,6,5-tricyclic ringsystem, 
a spirocenter and a cyclic ether moiety (64) (Figure 21). In order to support the 
structural revision of hypodoratoxide, 64 was isolated in preparative amounts and 2D 
NMR analysis was conducted. It could be shown, that the false structure elucidation 
of 64 was caused by misinterpretation of HMBC correlations, due to the strong 
overlapping of proton signals. This demonstrates, that 13C-labeling not only assists 
structure elucidation but can be even superior to standard methods. The relative 
configuration of 64 could be established by NOESY interpretation and the absolute 
configuration was tentatively deduced from identification and isolation of the 
biosynthetically related cis-dihydroagarofuran (63). Additionally, the complex 
biosynthetic cyclization mechanism of hypodoratoxide was analyzed by feeding of (3-
13C)-59a and (4,6-13C2)-59c, proving the occurrence of a Wagner-Meerwein 
rearrangement (WMR) and a methyl shift. 
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Reprinted from ChemBioChem, 2017, 18, DOI: 10.1002/cbic.201700462 with kind 
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Introduction 
As illustrated in the previous chapters, many interesting volatile natural products can 
be isolated from microbial sources and isotopically labeled biosynthetic precursors 
can help to elucidate their structures and give valuable insights into their 
biosynthesis. Fungi of the genus Trichoderma are opportunistic, avirulent plant 
symbionts common in soil and wood habitats. They are used in agriculture as 
biocontrol agents where they are able to increase crop productivity due to their 
mycoparasitic and antibiotic potential against different plant pathogens.[83] Identified 
volatiles from Trichoderma spp.[84] include 6-pentyl--pyrone (65), which was recently 
shown to improve pathogen resistence in Arabidopsis,[85] the sesquiterpene alcohol 
-acorenol (66), along with acorenone (67) and related acorane sesquiterpenes 68, 
69 and 70 (Figure 22).[86] 
 
   
Figure 22. Examples of known volatiles from Trichoderma. 
 
The biosynthesis of the acorane sesquiterpenes has been studied by feeding 
experiments with deuterated mevalonolactone isotopomers and analysis of the 
resulting GC/MS data.[86b,87] Accompanied by the presented volatiles, an oxidated 
diterpene was observed in the analyzed Trichoderma strains, which could not be 
identified in the course of these studies.   
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Summary 
The observed volatile diterpene was detected during the analysis of all seven 
Trichoderma strains (Trichoderma sp. 34, T. asperellum, T. citrinoviride, T. 
harzianum, T. longibrachiatum, T. viride, T. reesei QM6a) and identified by a 
combination of 13C,13C-COSY-NMR spectroscopy of in vivo [13C15]labeled diterpene 
and classic NMR spectroscopic methods. The deduced structure was identical to the 
literature known harzianone (71), previously isolated from Trichoderma. It consists of 
a unique tetracyclic 4,7,5,6-membered ring system and is known to exhibit 
antibacterial and cytotoxic activity.[88] A series of related harziane diterpenes (72-76) 
has also been reported (Figure 23).[89] 
 
Figure 23. Structures of the identified diterpene harzianone (71) and related harziane diterpenes 72-
76 reported in the literature. 
 
The cyclization mechanism of 71 was studied by feeding of a series of 13C-labeled 
mevalonolactone isotopologues and a 1,2-hydride shift was followed by feeding of 
2H-labeled isotopologues of 50. The results revealed a concise biosynthesis for 71, 
sharing similarities to taxadiene (41) biosynthesis of early cyclization steps (Chapter 
1.2.3.1). The common production of 71 in all analyzed Trichoderma strains indicates 
a conserved occurrence of the respective terpene synthase within the genus 
Trichoderma. 
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5 Volatiles from the Fungal Microbiome of the Marine 
Sponge Callyspongia cf. flammea 
Lena Barra, Paul Barac, Prof. Dr. Gabriele M. König, Dr. Max Crüsemann and Prof. 
Dr. Jeroen S. Dickschat*  
Org. Biomol. Chem. 2017, 15, 7411-7421. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reprinted from Org. Biomol. Chem. 2017, 15, 7411-7421 with kind permission from 
The Royal Society of Chemistry. 
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Introduction 
As illustrated in chapter 1.5 volatile metabolites are of great importance for all living 
organisms and can have many different functions for signalling, chemical defense or 
pathogen control. They are particular important for communication among microbes 
and between microbes and their eukaryotic hosts, where they can have antimicrobial 
properties, effects on bacterial quorum sensing, motility, gene expression and 
antibiotic resistance.[90] Marine sponges, the most ancient living animals on our 
planet, are sessile filter feeding organisms, occurring in almost any aquatic habitat. 
They are known to inhabit highly complex dense microbial communities consisting of 
bacteria, fungi and archaea.[91] Many bioactive natural products have been isolated 
from sponges or their microbes[92] but only little is known about volatiles from these 
animals or their associated microbial communities. The bread-crumb sponge 
(Halichondria panicea) from the North Sea (Clever Bank) emits a strong stench, 
causing sickness and nausea among fisherman. The olfactory source was traced 
back to three volatile sulfur compounds, dimethyl disulfide (77), dimethyl trisulfide 
(78) and methylbenzylsulfide (79) (Figure 24).[93] A similar study was conducted on 
volatiles from the stinker-sponge (Ircinia felix), emitting a sulfur-garlic stench. Among 
59 detected volatile compounds, the three metabolites DMS (50), methyl isocyanide 
(80) and methyl isothiocyanate (81) were identified as the odour source. Metabolites 
50, 80 and 81 are continuously released by the sponge and the concentration 
drastically increases after tissue wounding.[94] The released volatiles are discussed to 
act as chemical defense compounds, protecting the sponge from predators. 
However, their metabolic origin is unknown. 
 
 
Figure 24. Volatiles from sponges. 
 
A series of studies on volatiles emitted by Antarctic sponge-associated bacteria is 
reported in the literature and the volatile boquet was shown to be active against the 
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human pathogen Burkholderia.[95] The volatiles from sponge-associated fungi have 
not been investigated so far. 
 
Summary  
The volatile metabolites from five fungal strains, previously isolated from the 
Australian marine sponge Callyspongia cf. flammea[96] were investigated. A closed-
loop-stripping apparatus was used for sampling and the obtained headspace extracts 
were analyzed by GC/MS. In total 48 compounds were identified from various 
compound classes e.g. alkanes, alcohols, ketones and aldehydes, terpenes and 
aromatic compounds. The highly methylated isotorquatone (82) along with two 
desmethyl analogues (83 and 84) were identified by synthesis of reference 
compounds. The para-O-desmethyl derivative 84 is a new natural product and was 
named dichotomone (Figure 25).  
 
 
Figure 25. Selection of identified bioactive volatiles from the analyzed sponge-associated fungi. 
 
The absolute configuration of 82 was deduced by an asymmetric synthesis and 
revealed the natural occurrence of 82 as a mixture of enantiomers (40% ee) with (R)-
(−)-82 as the major component. The biosynthetic origin of 82 was addressed by 
feeding experiments with isotopically labeled (2-13C)acetate and (methyl-
2H3)methionine, pointing to a polyketide biosynthetic machinery and S-
adenosylmethionine-derived methylgroups. The obtained synthetic compounds were 
tested for activity against Gram-positive bacteria (Bacillus megaterium), Gram-
negative bacteria (E. coli) and algae (Chlorella fusca). Racemic isotorquatone 
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showed algicidal activity but not the synthesized (S)-(+)-enantiomer, pointing to (R)-
(−)-82 as being the bioactive enantiomer. The algicidal activity of isotorquatone hints 
at a possible ecological function in the sponge-microbiome community. Other 
interesting identified volatiles are the quorum sensing inhibitor protoanemonine (85), 
the phytopathogenic lactone 86, kairomone 87 and the sesquiterpene (1(10)E,5E)-
germacradien-11-ol (88).   
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6 Volatiles from Nineteen Recently Genome Sequenced 
Actinomycetes 
Dr. Christian A. Citron, Lena Barra, Dr. Joachim Wink, Prof. Dr. Jeroen S. Dickschat* 
Org. Biomol. Chem. 2015, 13, 2673-2683. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reprinted from Org. Biomol. Chem. 2015, 13, 2673-2683 with kind permission from 
The Royal Society of Chemistry. 
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Introduction 
Actinomycetes are Gram-positive filamentious actinobacteria, occurring in both soil 
and marine ecosystems. They are known for their tremendous production of bioactive 
substances, reflected by their large genomes, containing numerous genes for 
secondary metabolism.[97] They are used in agriculture, biotechnology and medicine 
and two-thirds of all known antibiotics originate from these bacteria.[98] Many 
actinomycetes have been studied in regard of their volatile metabolites[65a,99] leading 
to the identification of new interesting natural products, like the antibacterial 
butenolide (89),[100] the unusual - and (-3)-methyl branched fatty acid 90,[101] the 
antimycin derived blastmycinone 91[102] or streptopyridine (92) (Figure 26).[103] 
However, the most abundant and widespread volatile compounds from 
actinomycetes are the terpenoids geosmin (5) and 2-methylisoborneol (4), already 
introduced in chapter 1.1.[6] 
 
 
Figure 26. Selection of volatiles identified from actinomycetes.   
 
Summary 
The volatile constituents of 19 actinomycetes were investigated by trapping with a 
CLSA and analyses of the headspace extracts by GC/MS. In total 178 compounds 
were identified from different compound classes. Two particularly interesting 
metabolites, the insect pheromone frontalin (93) and the plant compound 1-nitro-2-
phenylethane (94) were identified (Figure 27).  
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Figure 27. Frontalin (93) identified from S. varsoviensis and 1-nitro-2-phenylethane (94) from S. 
afghaniensis and S. prunicolor and structure of epi-isozizaene (95) and albaflavenone (96).  
  
The occurrence of insect pheromones in bacteria, as can also be seen for 
conophtorin and chalcogran identified from streptomycetes, suggests that the true 
origin of pheromones, at least in some cases, could be the metabolism of insect-
associated bacteria.[104] Nitrocompound 94, sofar only known from different plants 
e.g. tomato,[105] has interesting bioactivities and antifungal, antinociceptive, 
bradicardiac, vasorelaxant, anti-inflammatory, anticonvulsant and anxiolytic activity 
has been reported.[106] Its biosynthetic origin was studied by feeding experiments with 
isotopically labeled precursors, pointing to a phenylalanine-derived metabolite. 
Formation of 94 could be explained by a PLP assisted decarboxylation of 
phenylalanine and subsequent oxidation of the amino group in phenylethylamine. 
Also, a series of terpenes were identified from the analyzed organisms, e.g. epi-
isozizaene (95), the carbon precursor towards the antibiotic albaflavenone (96). 
Since all 19 analyzed strains were recently genome sequenced and the genetic 
information is available from public databases, a correlation between the encoded 
terpene cyclases and the identified produced terpenes was conducted.   
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Diphosphates and Their Application in Mechanistic 
Investigations of Terpene Cyclases 
 
Dr. Christian A. Citron, Dr. Patrick Rabe, Lena Barra, Prof. Dr. Chiaki Nakano, Prof. 
Dr. Tsutomu Hoshino and Prof. Dr. Jeroen S. Dickschat* 
Eur. J. Org. Chem. 2014, 7684-7691. 
 
 
 
This publication was also part of a cumulative dissertation by Dr. Patrick Rabe at the 
University of Bonn and Dr. Christian A. Citron, Technical University of Braunschweig 
and only supplements this thesis. My contribution to this work comprises the 
synthesis of a few unlabeled substrates for completion of the systematic table of 
isolated yields.  
 
 
 
 
 
 
 
 
Reprinted from Eur. J. Org. Chem. 2014, 7684-7691 with kind permission from John 
Wiley and Sons. 
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Introduction 
Classic isotopic labeling experiments in combination with modern NMR spectroscopic 
methods remain a powerful tool for the investigation of molecular biochemical 
processes (Chapter 1.4). Terpene cyclases are remarkable enzymes in terms of the 
structural complexity they create from one achiral linear precursor in only one 
enzymatic reaction. To study the mechanism underlying these transformations, 
labeling experiments, which enable the tracking of specific atoms, with stable 
isotopes can be carried out (Chapter 1.4.2). Therefore, robust, flexible and reliable 
synthetic methodologies have to be developed, which enable the synthesis of 
isotopically labeled compounds from commercially available building blocks. 
 
Summary 
A systematic synthetic route towards oligoprenyl diphosphates, based on the 
employment of three simple building blocks, acetone, triethyl phosphonoacetate and 
ethyl acetoacetate was developed. The synthesis enables selective labeling of every 
position of the linear terpene precursor. Isotopomers of the required building blocks 
are either commercially available or can be easily generated thereof. The synthesis 
makes use of a cyclic sequence, resembling subsequent elongation by five carbon 
atoms in every cycle (Scheme 3).  
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Scheme 3. Schematic representation of the developed synthetic route.  
 
The scope of this synthetic route was demonstrated by the synthesis of 
[14-2H]GGPP, which was used for incubation experiments with the tuberculosinyl 
diphosphate synthase from Mycobacterium tuberculosis. The experiments allowed 
for following of the stereochemical course of the initial protonation step, revealing 
attack from the Si face.   
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EI-MS Fragmentation Mechanism of (1(10)E,4E,6S,7R)-
Germacradien-6-ol by 13C-Labeling Experiments 
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Tim A. Klapschinski, Aron Janusko and Prof. Dr. Jeroen S. Dickschat* 
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This publication was also part of a cumulative dissertation by Dr. Patrick Rabe at the 
University of Bonn and only supplements this thesis. My contribution to this work 
comprises the synthesis of (13C15)-labeled FPP and a series of (13C1)-labeled 
isotopomers.   
Reprinted from Angew. Chem. Int. Ed. 2015, 54, 13448-13451 with kind permission 
from John Wiley and Sons. 
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9 A Method for Investigating the Stereochemical Course 
of Terpene Cyclisations 
 Dr. Patrick Rabe, Jan Rinkel, Tim A. Klapschinski, Lena Barra, Prof. Dr. Jeroen S. 
Dickschat* 
Org. Biomol. Chem. 2016, 14, 158-164. 
 
This publication was also part of a cumulative dissertation by Dr. Patrick Rabe at the 
University of Bonn and Dr. Christian A. Citron, Technical University of Braunschweig 
and only supplements this thesis. My contribution to this work comprises the 
synthesis of one labeled substrate, employed for in vitro experiments in this study.  
Reprinted from Org. Biomol. Chem. 2016, 14, 158-164 with kind permission from The 
Royal Society of Chemistry. 
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Introduction 
Biotechnological methods and the next generation sequencing technologies have 
revolutionized natural products research, with thousands of genome sequences 
available from public databases. The identification of genes encoding for terpene 
synthases can be achieved by utilizing a Basic Local Alignment Search Tool 
(BLAST), enabling the identification of genes by their homology.[107] The targeted 
genes can be amplified by polymerase chain reaction and cloned into heterologous 
expression hosts, like E. coli. After purification, the recombinant proteins can be used 
for in vitro experiments and the substrate scope can be tested by incubation with 
suitable substrates e.g. GPP, FPP or GGPP. The obtained enzyme products have to 
be purified and their structure has to be identified or elucidated. By 2016 over 600 
bacterial terpene cyclases have been identified from genome sequencing data, from 
which about 50 have been biochemically characterized. By phylogenetic analyses of 
known genes to predicted terpene cyclase genes, resulting in grouping of closely 
related families, round about 300 further enzymes could be identified in regard of 
their product specificity.[46,108] 
 
Summary 
Five terpene cyclase genes are encoded in the genome of the actinomycete 
Streptomyces pratensis, from which a geosmin,[109] 2-methylisoborneol,[110] 7-epi--
eudesmol,[111] and epi-cubenol[112] synthase has been characterized before. The 
product of the terpene cyclase from the fifth gene was identified in this publication 
and its chemical properties were thoroughly investigated by isotopic labeling 
experiments. Therefore the gene was cloned into the heterologous expression host 
E. coli and incubation of the purified expressed enzyme with the sesquiterpene 
precursor FPP led to the production of (1(10)E,4E)-germacradien-6-ol (97), identified 
from GC/MS data. Analysis of the respective 1H- and 13C-NMR data, measured at 
room temperature, showed unclear and broad signals for the terpenoid. When 
measured at −50 °C or 0 °C, two sets of clearly resolved signals were observed, 
resembling the occurrence of two conformers (97a and 97b), also known from 
literature data (Figure 28).[113] In order to fully elucidate the NMR data, all singly 
labeled (13C)FPP isotopomers and the fully 13C-labeled (13C15)FPP were synthesized 
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by the route described in Chapter 7.[114] By incubation of singly labeled (13C)FPP with 
the recombinant germacradien-6-ol synthase and analysis of the resulting singly 
labeled terpene by 13C-NMR spectroscopy, two sharp signals, belonging to 97a and 
97b were obtained. By sequential incubation of all 15 isotopomers of FPP, all 13C 
signals in the NMR spectrum belonging to one carbon atom of 97 could be deduced. 
To differentiate between the two conformers, incubation with fully labeled (13C15)FPP 
was conducted. The resulting fully 13C-labeled terpene (13C15)-97 was subjected to 
13C,13C-COSY-NMR spectroscopy. The results enabed the assignment of the 13C 
signals to the corresponding conformer 97a or 97b by analysis of the 
C,C-connectivities deduced from the obtained cross peaks.   
    
 
Figure 28. Structure of the identified sesquiterpene (1(10)E,4E)-germacradien-6-ol (97) from S. 
pratensis and its interconvertible conformers 97a and 97b. Thermal rearrangement products 98a and 
98b.  
 
Apart from the interesting NMR properties, (1(10)E,4E)-germacradien-6-ol (97) also 
showed reactivity for undergoing a thermal Cope-rearrangement, as was observed 
from two sideproducts in the respective gaschromatogram, caused by the high 
temperature impact in the GC/MS injector. Their structures were elucidated after 
microwave assisted synthesis from 97 and were identified as shyobunol (98a) and 
5,10-di-epi-shyobunol (98b). Additionally, the EI-MS (electron ionization mass 
spectrometry) fragmentation mechanism of 97 was studied by GC/MS and GC/MS2 
experiments employing all enzymatically generated (13C)-97 isotopomers.  
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Additionally, three putative terpene cyclase genes from S. scabei, S. venezuelae and 
S. clavuligerus were identified and cloned into the expression host E. coli. The 
expressed purified enzymes were incubated with GPP, FPP and GGPP and revealed 
in all three cases the conversion of FPP into a sesquiterpene. The three terpenes 
were isolated and their structures were elucidated by NMR spectroscopic methods, 
leading to the identification of the two new natural products neomeranol B (99) from 
S. scabei and isodauc-8-en-11-ol (100) for S. venezuelae. The terpene cyclase from 
S. clavuligerus produced the known terpene (+)-(4S,5S,7R,10S)-intermedeol (101) 
(Figure 29).[115]  
 
     
Figure 29. Structures of the identified terpenes neomeranol B (99), isodauc-8-en-11-ol (100) and 
intermedeol (101). 
 
The cyclization mechanisms of 99, 100 and 101 were studied by incubation 
experiments with 13C-labeled FPP isotopomers. The biosyntheses of 99 and 101 
proceed via neutral intermediates, requiring reprotonation prior to subsequent attack 
of an olefinic double bond. A highly sensitive method to follow the stereochemical 
course of these reprotonation steps was developed. Therefore, a 13C-label was 
introduced in the reprotonated carbon position by employing a (13C)FPP isotopomer 
labeled in the appropriate position. The enzyme reaction was carried out in D2O, 
leading to a stereoselective deuteration of the respective carbon atom. The outcome 
of the experiment was analyzed by recording a 1H,13C-HSQC spectrum, revealing 
which of the diastereotopic protons got deuterated by a missing crosspeak.   
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Reprinted from Angew. Chem. Int. Ed. 2016, 55, 13611-13614 with kind permission 
from John Wiley and Sons.  
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Introduction 
The identification of the biosynthetic gene cluster (BGC) responsible for the assembly 
of a certain natural product is nowadays a key step in natural product research. 
Access to the BGC provides the opportunity for high-level overproduction in 
heterologous hosts to improve isolatable yields, the genetic manipulation to generate 
novel derivatives or detailed mechanistic investigations by expression of recombinant 
enzymes. This research is particularly important in terms of the quest for new 
bioactive compounds, which can be exploited for therapeutic uses.[116] Compared to 
well studied bacteria genera like streptomycetes or myxobacteria, Herpetosiphon 
spp. belonging to the phylum Chloroflexi have not been thoroughly investigated 
before. The PKS/NRPS-derived natural product siphonazole (45), isolated from 
Herpetosiphon sp. C060 is one recent example and is already introduced in Chapter 
1.4.1 (Figure 30).[61]  
 
   
Figure 30. Structure of siphonazole (45). 
 
Summary 
The gene cluster from Herpetosiphon sp. B060, responsible for the biosynthesis of 
siphonazole (45) was identified by genome-mining in combination with imaging mass 
spectrometry (IMS). By bioinformatic screening of the draft genome, two candidate 
NRPS/PKS hybrid gene clusters were discovered, from which one could be excluded 
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based on the substrate specificity of the encoded adenylation domains. The second 
cluster carries adenylation domains predicted to be specific for glycine and threonine, 
both building blocks in siphonazole biosynthesis. Additionally, oxidation domains are 
encoded within this cluster, essential for oxazole formation. In total 10 genes spha to 
sphJ consisting of 12 core modules were identified and linked to siphonazole 
biosynthesis by activity tests. Besides the mosaic-like assembly line, the termination 
step in the biosynthesis of this natural product is highly unusual and the mechanism 
of the decarboxylative release mechanism was studied by in vitro experiments. 
Therefore, recombinant enzymes SphJ, the thioesterase domain and SphHCterm, the 
C-terminal hydrolase domain, were incubated with substrate mimic 102. The resulting 
enzyme product, the volatile pentadiene (104), was trapped by using the SPME-
technique and detected by GC/MS. The results demonstrate that SphHCterm alone is 
responsible for product release and SphJ acts as a proof-reading function, which is 
further supported from bioinformatic predictions. The mechanism of the 
decarboxylation-dehydration sequence was studied by a labeling experiment, 
pointing to an initial thioesterase hydrolysis to acid 103 catalyzed by SphHCterm 
followed by spontaneous or concerted dehydration and decarboxylation (Scheme 4).   
 
 
Scheme 4. Possible mechanism for product  off-loading in siphonazole biosynthesis. 
 
The bioactivity of siphonazole (45) was studied and activity against the malaria 
pathogen Plasmodium falciparum was detected. The evolutionary background of the 
encoded gene cluster is discussed, as well as the possible application of SphHCterm 
for synthetic biology. 
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Introduction 
The cyclobutane skeleton is a highly strained and yet widespread structural motif in 
nature and can be found in almost all classes of natural products, namely terpenes, 
alkaloids, fatty acids, nucleosides or polyketides.[117] A particularly intriguing group 
among them are the cyclobutane-centered symmetric or often rather pseudo-
symmetric natural products. They can be seen as dimers formed by an 
intermolecular [2+2] cycloaddition, either by homo- or heterodimerization. The 
sponge-derived pyrrole-imidazole alkaloid Sceptrin (105) was isolated in 1981 by 
FAULKNER and CLARDY from the marine sponge Agelas sceptrum.[118] Its structure 
consists of two hymenidin (106) subunits which are connected in a head-to-head 
manner with an all-trans configured cyclobutane core. Sceptrin exhibits antimicrobial 
activity by disrupting cell membranes of eukaryotic and prokaryotic cells, anti-
muscarinic and anti-histaminic activities and inhibits cell motility of cancer cell lines 
without showing cytotoxicity at comparable concentrations.[119] Apart from sceptrin 
(105) a series of related compounds can be isolated from different Agelas species, 
for example nakamuric acid[120] (107) and ageliferin[121] (108), which can be 
rationalized as the [4+2] cycloaddition product of 106 (Figure 31).  
 
Figure 31. Structures of sceptrin (105), hymenidin (106), nakamuric acid (107) and ageliferin (108). 
Revised structures (2014) are shown. 
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From a synthetic point of view chiral cyclobutane centered natural products are 
challenging targets since methods for asymmetric construction of cyclobutane 
scaffolds are limited.[122] The first total synthesis of rac-sceptrin was developed by 
BARAN in 2004 and was based on the formation of a tetrasubstituted cyclobutane 
skeleton containing suitable reactive side chains, which subsequently were 
transformed into 105 in 12 linear steps. The cyclobutane ring was synthesized by an 
intramolecular [2+2] photocycloaddition of oxo-bridged compound 109, which can be 
obtained from a Diels-Alder reaction of dimethyl acetylenedicarboxylate and 2,5-
dimethylfuran, to the highly reactive oxaquadricyclane species 110, followed by an 
acid induced fragmentation and epimerization to all-trans cyclobutane rac-111.[123] An 
asymmetric variation of this reaction could be achieved by the desymmetrization of 
meso-compound 109 to acid 112 using pig liver esterase (PLE) in quantitative yield 
and 75% ee. Subsequent esterification, selective saponification and amidation with 
benzylamine to 113 allowed for the conservation of the implemented stereo 
information to obtain (+)-111 after irradiation, acid induced fragmentation and 
methanolysis under simultaneous epimerization. The enantiomeric excess was 
increased to 95% by recrystallization after photolysis. Thus, (+)-111 was synthesized 
over 7 steps with an overall yield of 20% (Scheme 5).[124]  
 
Scheme 5. Synthesis of rac-all-trans cyclobutane 111 and asymmetric approach to (+)-111 developed 
by BARAN. The absolute configuration of (+)-111 is shown according to the revised structure of sceptrin 
(105). 
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The opposite enantiomer (−)-111 could be synthesized analogously after direct 
amidation of 112 with benzylamine. The absolute configurations of cyclobutanes (−)-
111 and (+)-111 were assigned by conversion to sceptrin and comparison of CDI-
spectra and optical rotary powers to the natural sample. Since the absolute 
configuration of 105 was wrongly assigned in 1981, which was shown in 2014 by 
CHEN and BARAN, also the configurations of (−)-111 and (+)-111 should be 
incorrect.[125] This finding stands in disagreement with a crystal structure, which was 
obtained to determine the absolute configuration of 112. However, as concluded by 
the authors, the desymmetrization of 109 could only be achieved with an ee of 75%, 
therefore a single-crystal of the minor enantiomer could have been obtained and 
subjected to X-ray analysis. In addition, the fragmentation mechanism of 110 to 111 
has not been elucidated, therefore the absolute configurations of (+)-111 and (−)-111 
have not been unambiguously assigned yet.  
 
Summary 
During studies towards the total synthesis of the cyclobutane containing volatile 
terpene koraiol,[126] an alternative synthesis for both enantiomers of 111 was 
discovered. Irradiation of photoactive valine-derived enone 114, originally developed 
for stereoselective cyclopropanations and cyclobutanolations by MEYERS,[127] led to 
the formation of two major (115a and 115b) and one minor photodimer (115c) 
(Scheme 6).  
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Scheme 6. Alternative approach to key intermediate (+)- and (−)-111.  
 
Their structures were elucidated by 2D NMR spectroscopy, symmetry considerations 
and analyses of their methanolysis products. Additionally, a crystal structure could be 
obtained for the major photodimer 115a. Methanolyses of the chiral auxiliary yielded 
cyclobutane (+)-111 for 115a, two achiral compounds (116a and 116b) for 115b and 
(-)-111 for 115c. Their formation can be explained by cleavage of the chiral auxiliary 
and fast epimerization in -position to the methyl ketones, instead of the methyl 
esters. This observation was supported from a deuterium exchange experiment and 
the occurrence of a high enantiomeric excess of 98% for 111. The absolute 
configuration of (+)-111 can thus be delineated from the prearrangement in 115a and 
was additionally shown by X-ray diffraction analysis.  
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Six 13C-labelled isotopomers of mevalonolactone were synthes-
ised and used in feeding experiments with the endophytic
fungus Geniculosporium. The high incorporation rates of 13C-
label into a sesquiterpene that was found in headspace
extracts of the fungus enabled unambiguous identification of
this volatile as pogostol without the need for compound purifi-
cation, simply by collecting the volatile fraction with a closed-
loop stripping apparatus followed by direct 13C NMR analysis
(CLSA-NMR). The feeding experiments also gave insights into
the biosynthesis of pogostol, including stereochemical aspects
of the terpene cyclisation reaction. The possible biological
function of pogostol is discussed.
Volatiles that are emitted by living organisms can be efficiently
captured on charcoal filters by the use of a closed-loop strip-
ping apparatus (CLSA). The experimental setup consists of
a chamber containing a biological sample, and an air stream
maintained by a pump and directed over the sample and then
through the charcoal filter. The filter can then simply be ex-
tracted with an organic solvent, and the extract can be ana-
lysed by GC/MS.[1] This technique was originally developed in
1973 by Grob and Zrcher for trace analysis of volatile contam-
inants in water samples,[2, 3] and has since been successfully ap-
plied in studies on volatile natural products, for example, those
from insects,[4] bacteria[5, 6] and fungi.[7] Unambiguous com-
pound identification by GC/MS requires knowledge of the ana-
lyte’s mass spectrum. For automated database searches, the
mass spectra of thousands of compounds are collected in
large electronic libraries.[8, 9] In cases where several constitution-
al or stereoisomers of a compound have very similar mass
spectra, the analyte can only be identified by additional com-
parison of its retention index to published retention indices.
Ideally, positive compound identification in such cases requires
knowledge of the retention indices of all eligible isomers. If
this is not the case, synthesis of all isomers for direct compari-
son is a solution,[10,11] but this is highly laborious and impracti-
cal, especially with highly complex volatile natural products,
such as most sesquiterpenes. An alternative approach is to
purify the compound from culture extracts for structure eluci-
dation by NMR spectroscopy. However, with volatiles signifi-
cant losses in concentration steps can render the purification
process unsuccessful. The major advantage of the CLSA tech-
nique is non-invasive detection of trace components in com-
plex mixtures that cannot be analysed by NMR. Thus, to obtain
NMR data from compounds in CLSA headspace extracts, we
recently reported a new method; this combines feeding with
13C-labelled precursors and CLSA headspace extraction for
13C NMR analysis (CLSA-NMR).[12–15] The fed precursor must be
one that is only incorporated into volatiles from a certain com-
pound class (e.g. , mevalonolactone or deoxyxylulose, only into
terpenes). If incorporation rates are high, 13C NMR analysis of
the CLSA headspace extract results in a set of strongly en-
hanced 13C NMR signals, and only of compounds from a partic-
ular class. By using this method, the volatiles 2-methylisobor-
neol (1),[12] isoafricanol (2),[13] eudesma-11-en-4a-ol (3)[14] and
koraiol (4)[15] were identified in headspace extracts of different
actinomycetes and ascomycete fungi (Scheme 1A), and stereo-
chemical aspects of their biosynthesis were elucidated. Here,
we report the synthesis of 13C-labelled mevalonolactone iso-
topomers, their use in feeding experiments with the endophyt-
ic fungus Geniculosporium sp. , the identification of pogostol in
headspace extracts and investigation of its biosynthesis by
CLSA-NMR.
In previous investigations, we identified a series of structur-
ally related lactones (5–7; Scheme 1B) and two chlorinated
veratrole derivatives (8 and 9) by GC/MS in headspace extracts
of Geniculosporium sp. , an endophytic fungus that had been
Scheme 1. A) Volatiles identified from actinomycetes and ascomycete fungi
by CLSA-NMR. B) Previously identified volatiles from Geniculosporium sp.
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isolated from Cistus monspeliensis and was grown on potato–
carrot medium for three weeks at 20 8C (Figure 1A).[7,10] A few
other unidentified compounds and traces of a sesquiterpene
alcohol “X” were also detected. The mass spectrum of the alco-
hol was most similar to that of pogostol (10) in the database,
but as the quality of the mass spectrum of the trace com-
pound X was poor, the next best matches, globulol (13) and
epi-globulol (14), could not be excluded (Scheme 2 and Fig-
ure S1 in the Supporting Information). The structures of their
stereoisomers, ledol (15) and viridiflorol (16), were excluded
based on their mass spectra (data not shown). Also, the reten-
tion index of X (I=1659) matched best that of 10 (I=1651),
whereas the retention indices of 13–16 deviated significantly.[9]
Unfortunately, published mass spectra and retention indices
for all other stereoisomers of pogostol and of globulol were
not available, so these compounds were also candidate struc-
tures for X. The 13C NMR data for all five compounds[16–20] and
the two pogostol stereoisomers (11 and 12)[21] have been re-
ported, and therefore we strived to confirm the identities of X
and 10 by obtaining 13C NMR data for X by CLSA-NMR (note:
the originally published structure of 10[22] was later found to
be incorrect[21] and then corrected;[23] in ref. [17] the wrong
structure is shown for 13). Therefore, we had to find culture
conditions under which the production of X was significantly
enhanced. The production of X was much higher after five
weeks of incubation with feeding of mevalonolactone (5 mm)
after four weeks (Figure 1B), thus suggesting that the availabil-
ity of terpenoid monomers was limiting.
For further investigations on the structure of X by CLSA-
NMR, a series of 13C-labelled isotopomers of mevalonolactone
was synthesised from commercially available 13C-labelled ethyl
acetoacetate isotopomers by a known route (Zamir and Ngu-
yen;[24] Scheme 3A). The route was first tested with unlabelled
material, thus revealing that the reported yields were accessi-
ble. Ethyl acetoacetate (17) was converted into ketal 18 by
reaction with neopentyl glycol and trimethylchlorosilane. Sub-
sequent reduction with LiAlH4 to alcohol 19 and protection of
the hydroxy function gave the benzyl ether 20, which was
transformed into ketone 21 by acid deprotection. Aldol reac-
tion with the ester enolate of ethyl acetate yielded ester 22,
which upon catalytic hydrogenation and treatment with p-tol-
uenesulfonic acid provided mevalonolactone in 19% yield via
six steps. This reliable protocol allowed us to convert commer-
cially available isotopomers of ethyl acetoacetate 17a–d into
the corresponding mevalonolactones 23a–d. For the synthesis
of 23e we used a route that we previously developed for the
synthesis of deuterated isotopomers of mevalonolactone
(Scheme 3B).[25] Starting from the aldehyde 24, reaction with
[13C]methylmagnesium iodide yielded the alcohol 25, which
was oxidised with IBX to ketone 21e. This was transformed
into mevalonolactone 23e (as above). Finally, [4-13C]mevalono-
lactone (23 f) was synthesised by a reported procedure (Cane
and Levin).[26]
All six mevalonolactone isotopomers (23a–f) were fed to
agar plate cultures of Geniculosporium sp., and the volatiles
emitted by these agar plate cultures were trapped on charcoal
by CLSA. The charcoal filter was extracted with CDCl3 daily for
one week. The extracts were collected in an NMR tube and
subjected to 13C NMR analysis (13C NMR and DEPT spectra; re-
sults in Figure 2). Each feeding experiment resulted in the in-
corporation of labelling at three or six carbons of X, depending
on whether a singly or doubly labelled mevalonolactone isoto-
pomer was fed. This resulted in a set of strongly enhanced
13C NMR signals. These signals perfectly matched the chemical
shifts of 10, whereas the chemical shifts of its known stereoiso-
mers revealed significant differences (Table S1). The 13C NMR
shifts of 13 and its known stereoisomers also did not match. In
Figure 1. Total ion chromatograms of headspace extracts from Geniculospori-
um sp. cultured on potato-carrot agar medium at 20 8C, A) after three weeks
of incubation, and B) after five weeks of incubation with feeding of mevalo-
nolactone (5 mm) after four weeks. Peak numbers refer to compounds in
Scheme 2. The intensity scales of chromatograms A and B are directly com-
parable.
Scheme 2. Pogostol (10) and structurally related isomers. The retention
index I for commercially available 14 (Sigma–Aldrich; analysed by GC-MS
under the same conditions as the headspace extracts, vide infra) was deter-
mined on a HP5-MS fused silica capillary column. Retention indices of the
other compounds are for a BP5 column and were taken from ref. [9] .
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particular, the presence of signals for olefinic carbons in the
experiments with 23a and 23c–e clearly ruled out 13–16 and
their unknown stereoisomers. Based on these data, the identity
of X as pogostol was unequivocally established. The full bio-
synthetic pathway for the incorporation of label from 23 into
10 is presented in Scheme S1.
The obtained data were also used to investigate the biosyn-
thesis of 10 (Scheme 4). The conversion of farnesyl diphos-
phate (FPP) into 10 proceeds most likely first through a 1,10-
cyclisation to the (E,E)-germacradienyl cation (26), which might
proceed via nerolidyl diphosphate (not shown), and deproto-
nation to germacrene A (27). Its reprotonation initiates a
second cyclisation to cation 28, which is trapped with water to
yield 10. Feeding of 23 f resulted in labelling of FPP at C-2, C-6
and C-10 (converted into C-5, C-1 and C-7 of 10). A CC single
bond between C-5 and C-1 is formed by the second ring clo-
Scheme 3. Synthesis of 13C-labelled isotopomers of mevalonolactone. A) Syn-
thesis of isotopomers 23a–d starting from ethyl acetoacetate according to
Zamir and Nguyen.[24] The yields are those obtained in the synthesis of unla-
belled 23. (For yields with labelled compounds see the Supporting Informa-
tion.) B) Synthesis of 23e by a route that was previously developed in our
laboratories.[25] Black dots indicate 13C-labelled carbons.
Figure 2. Results of feeding experiments with synthetic mevalonolactone
isotopomers 23a–f. The 13C NMR spectra were obtained in CLSA-NMR ex-
periments from crude extracts. Chemical shifts of 13C signals, multiplicities
and coupling constants for nJ(C,C) couplings are summarised in Table S1.
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sure, thus resulting in doublets in the respective 13C NMR sig-
nals (coupling constant 1J(C,C)=33.1 Hz), thereby confirming
the biosynthesis of 10 as shown in Scheme 4. Feeding experi-
ments with 23c and 23e gave insights into the stereochemical
course of the terpene cyclisation. The methyl group of mevalo-
nolactone that is labelled in these two isotopomers is convert-
ed into the terminal (Z)-methyl group of FPP (C-13). Both feed-
ing experiments showed that the deprotonation step of the
terpene cyclisation to the neutral intermediate 27 proceeds
with stereospecific deprotonation of C-13 and not C-12 of FPP,
thus ending up as the olefinic C-13 of 10. This suggests that
free rotation around the C-10/C-11 single bond in cation 26 is
not possible, as similarly observed in the biosynthesis of 2-
methylisoborneol.[12] A possible explanation is cation–p stabili-
sation[27] of cation 26 with an adjacent aromatic amino acid
residue in the active centre of the terpene cyclase, similarly to
other terpene cyclisation reactions.[28–31]
Stereochemical questions in terpene biosynthesis have fre-
quently been solved by isotopic labelling.[32] Other compound
classes can be investigated by related methods; for example,
Bode and co-workers recently presented a combined strategy
of gene knockout and cultivation in D2O to identify d-amino
acids in nonribosomally synthesised peptides.[33] Pogostol was
first isolated from patchouli (Pogostemon cablin),[34] and was
recently reported in the endophytic fungus Biscogniauxia num-
mularia from the plum yew Cephalotaxus harringtonia, where it
co-occurs with its oxidation product xylaranone (xylaranone
arises by oxidation at C-3 of 10 to the corresponding
ketone).[23] Both 10 and xylaranone were shown to inhibit seed
germination by Raphanus sativus (radish)—the particularly
strong activity of xylaranone is comparable to that of glypho-
sate. Intrigued by this we reanalysed our Geniculosporium
headspace extracts for the presence of oxidation products of
10. We observed traces of candidate compounds, but the
amounts were too small for detection by CLSA-NMR in the
13C NMR spectra, and the mass spectra did not match database
spectra in our mass spectral libraries. In an ecological context,
both sesquiterpenoids 10 and xylaranone secreted by the en-
dophytes might be directed towards the endophyte’s host. In
particular, endophytic fungi produce herbicidal metabolites
that are assumed to play a role in maintaining a balance of an-
tagonisms between host and endophyte.[35–37] Seed germina-
tion inhibiting metabolites such as 10 and xylaranone might
also benefit the host plant by inhibiting the proliferation of
other species in the area. Currently, the toxic effects of glypho-
sate towards humans have become a concern and have
prompted discussion as to whether glyphosate should be sub-
stituted. Natural germination inhibitors such as 10 and xylara-
none might be suitable alternatives and could be made avail-
able by biotechnological approaches in the near future.
Experimental Section
Culture conditions and feeding experiment: The endophytic
fungus Geniculosporium sp. 9910, isolated from the leaves of Cistus
monspeliensis, was cultivated for three weeks (without feeding) or
four weeks (feeding experiment) on potato-carrot agar medium[38]
(20 mL) in glass petri dishes at 20 8C. For the feeding experiments,
cultures were supplemented with an aqueous solution of mevalo-
nolactone isotopomer (23a–f, 10 mg in sterile-filtered water
(200 mL)). The resulting solution was injected with a syringe (10 mL)
into the agar. The cultures were incubated at 20 8C for a further
day, and collection of the volatiles was by use of a closed-loop
stripping apparatus as described previously.[39] For the feeding ex-
periments, collection of volatiles was continued for the next seven
days. The charcoal filter was extracted every 24 h with of CDCl3
(50 mL). The extracts were combined and analysed by 13C NMR and
DEPT spectroscopy. Spectra were recorded on an AV II-600 spec-
trometer (150 MHz; Bruker) and referenced to TMS.
GC-MS analysis of headspace extracts: CLSA headspace extracts
were obtained from Geniculosporium, with or without feeding of
mevalonolactone isotopomers, and analysed by GC-MS (total ion
chromatograms in Figure 1). GC-MS analyses were carried out an
HP7890A GC system (Agilent) connected to an HP5975C Mass
Selective Detector equipped with a HP-5 MS fused silica capillary
column (30 m0.22 mm, 0.25 mm; Agilent): inlet pressure 67 kPa,
He 23.3 mLmin1, injection volume 1 mL, injector 250 8C, transfer
line 300 8C, electron energy 70 eV. The GC was programmed as
follows: 50 8C (5 min isothermic), then increasing (5 8C min1) to
320 8C, operated in splitless mode (60 s valve time), He
1.2 mLmin1.
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 Figure 1. Mass spectra of X, pogostol (10), globulol (13), and epi-globulol (14). 
  
 Table 1. Results of CLSA-NMR experiments and comparison to 13C-NMR data of 10 and structurally related known compounds. 
23a[a] 23b[a] 23c[a] 23d[a] 23e[a] 23f[a] 10[b] 11[b] 12[b] 13[b] 14[b] 15[b] 16[b] 
  
16.2 
CH3, d 
2J=1.7 
 
16.2 
CH3, s 
 
16.1 
CH3 
C-15 
14.6 
CH3 
15.4 
CH3 
16.4 
CH3 
15.8 
CH3 
15.2 
CH3 
16.1 
CH3 
C-15 
    
19.9 
CH3, d 
2J=3.1 
 
19.9 
CH3 
C-12 
20.8 
CH3 
20.5 
CH3 
16.6 
CH3 
16.6 
CH3 
15.7 
CH3 
16.3 
CH3 
C-12 
 
26.2 
CH2, s 
 
26.2 
CH2, s 
  
26.1 
CH2 
C-2 
25.2 
CH2 
25.9 
CH2 
19.5 
CH2 
19.1 
CH2 
19.2 
Cq 
18.4 
Cq 
C-11 
 
28.53 
CH2, s 
 
28.52 
CH2, s 
  
28.5 
CH2 
C-8 
28.0 
CH2 
26.1 
CH2 
20.7 
CH3 
20.6 
Cq 
20.1 
CH2 
18.9 
CH2 
C-8 
 
28.55 
CH2, s 
 
28.53 
CH2, s 
  
28.5 
CH2 
C-6 
30.0 
CH3 
31.1 
CH3 
20.7 
CH3 
26.6 
CH2 
23.1 
CH 
22.5 
CH 
C-7 
  
29.8 
CH3, s 
 
29.8 
CH3, d 
2J=2.3 
 
29.7 
CH3 
C-14 
34.1 
CH2 
33.6 
CH2 
26.0 
CH2 
27.1 
CH 
24.4 
CH2 
25.9 
CH2 
C-3 
    
31.1 
CH2, s 
 
31.1 
CH2 
C-3 
37.8 
CH2 
33.8 
CH2 
26.7 
CH 
28.7 
CH3 
24.7 
CH 
28.7 
CH3 
C-13 
    
36.1 
CH2, d 
2J=2.3 
 
36.0 
CH2 
C-9 
38.9 
CH 
38.3 
CH 
 
28.9 
CH 
28.9 
CH 
28.4 
CH3 
28.7 
CH 
C-6 
38.9 
CH, d 
3J=3.3 
  
38.9 
CH, d 
3J=3.3 
  
38.9 
CH 
C-4 
41.1 
CH 
38.8 
CH 
29.0 
CH 
31.3 
CH3 
30.3 
CH3 
29.3 
CH2 
C-9 
  
45.8 
CH, dd 
1J=33.3 
2J=1.5 
  
45.8 
CH, d 
1J=33.1 
45.8 
CH 
C-5 
42.8 
CH2 
43.5 
CH2 
34.9 
Cq 
34.6 
CH2 
30.6 
CH2 
32.1 
CH3 
C-14 
  
46.1 
CH, d 
2J=2.1 
  
46.1 
CH, s 
46.1 
CH 
C-7 
50.0 
CH 
45.0 
CH 
36.8 
CH2 
35.8 
CH 
38.2 
CH 
37.9 
CH2 
C-2 
  
55.3 
CH, d 
1J=33.3 
  
55.3 
CH, d 
1J=33.1 
55.3 
CH 
C-1 
52.6 
CH 
53.5 
CH 
 
40.0 
CH 
37.5 
CH 
39.0 
CH2 
38.5 
CH 
C-4 
74.9 
Cq, d 
3J=3.3 
  
74.9 
Cq, d 
3J=3.2 
  
74.9 
Cq 
C-10 
74.1 
Cq 
72.7 
Cq 
45.2 
CH2 
42.9 
CH2 
40.5 
CH 
39.8 
CH 
C-5 
  
107.8 
CH2, d 
2J=2.1 
 
107.8 
CH2, d 
2J=3.1 
 
107.7 
CH2 
C-13 
108.3 
CH2 
108.5 
CH2 
57.1 
CH 
55.9 
CH 
53.5 
CH 
58.4 
CH 
C-1 
152.5 
Cq, s 
  
152.5 
Cq, t 
2J=1.2 
  
152.4 
Cq 
C-11 
151.8 
Cq 
152.1 
Cq 
74.5 
Cq 
72.3 
Cq 
74.7 
Cq 
74.6 
Cq 
C-10 
[a] Observed 13C-NMR signals after feeding of mevalonolactones 23a-f. Multiplicities (s=singlet, d=doublet, t=triplet) and coupling constants (in Hz) are 
for nJ(C,C) couplings. Results of DEPT spectra are indicated by CH3, CH2, CH, and Cq. [b] Assigned 13C-NMR data according to references [1-6]. 
 
  
 Scheme 1. Biosynthetic pathway from mevalonolactone 23 to pogostol 10. The biosynthesis involves three 
stages, i. e. A) mevalonate pathway from 23 to the isoprenoid monomers isopentenyl diphosphate (IPP) and 
dimethylallyl diphosphate (DMAPP), B) polyisoprenoid biosynthesis via geranyl diphosphate (GPP) to farnesyl 
diphosphate (FPP), and C) terpene cyclisation of FPP to 10. 
  
Synthesis of isotopomers of mevalonolactone (23a-f) 
General synthetic methods. 
Chemicals were obtained from Acros Organics (Geel, Belgium) or Sigma Aldrich 
Chemie GmbH (Steinheim, Germany) and used without purification. All non-aqueous 
reactions were performed under an inert atmosphere (N2) in flame-dried flasks. 
Solvents were purified by distillation and dried according to standard methods. In 
case of general procedures, the relative amounts of the reagents are given as 
equivalents (eq) with respect to their molar ratios. Relative amounts of solvents are 
indicated by final concentrations of the transformed starting material (set to 1.0 eq). 
Thin-layer chromatography was performed with 0.2 mm precoated plastic sheets 
Polygram® Sil G/UV254 (Machery-Nagel). Column chromatography was carried out 
using Merck silica gel 60 (70-200 mesh). 1H NMR and 13C NMR spectra were 
recorded on Bruker DRX-400 (400 MHz), AV III-400 (400 MHz) or AV II-600 (600 
MHz) spectrometers, and were referenced against TMS ( = 0.00 ppm) for 1H-NMR 
and CDCl3 ( = 77.01 ppm) for 13C-NMR. IR spectra were recorded with a Bruker 
Tensor 27 ATR (attenuated total reflectance). GC-MS analyses of synthetic 
compounds were carried out with a HP 6890 gas chromatograph connected to a HP 
5973 inert mass detector fitted with a BPX-5 fused silica capillary column (25 m, 0.25 
mm i. d., 0.25 m film). Instrumental parameters were (1) inlet pressure, 77.1 kPa, 
He 23.3 mL min-1, (2) injection volume, 2 L, (3) transfer line, 300 °C, and (4) 
electron energy 70 eV. The GC was programmed as follows: 5 min at 50 °C 
increasing at 10 °C min-1 to 320 °C, and operated in split mode (20:1, 60 s valve 
time). The carrier gas was He at 1 mL min-1. Retention indices (I) were determined 
from a homologous series of n-alkanes (C8-C38). 
  
Synthesis of mevalonolactones 23a-d 
 
Scheme 22. Synthesis of mevalonolactones 23a-d. The indicated yields were obtained in a test synthesis of the 
unlabelled compound. For yields of labelled compounds vide infra. 
 
The synthesis of the mevalonolactones 23a-d was performed according to the 
procedure of Zamir and Nguyen (Scheme 2).[7] Briefly, the commercially available 
isotopomers of 13C-labelled ethyl acetoacetate (17) were protected with neopentyl 
glycol to give the ketals 18. This was followed by a reduction with LiAlH4 to the 
corresponding alcohols 19 and protection with benzyl bromide to give 20. 
Subsequent removal of the ketale function yielded the ketones 21 which were used in 
aldol reactions with ethyl acetate to give the esters 22. Removal of the benzyl group 
with Pd/C in a hydrogen atmosphere and acidic lactonization yielded the 
mevalonolactones 23. 
General procedure for the synthesis of isotopomers of 18. Freshly distilled 
TMSCl (4.4 eq) was added to a 0.5 M solution of ethyl acetoacetate (17, 1 eq) and 
neopentyl glycol (2.2 eq) in dry dichloromethane. The reaction mixture was heated to 
reflux overnight, followed by neutralisation with an aqueous solution of NaHCO3 (5 wt 
%) and extraction with dichloromethane. The organic phase was dried with MgSO4 
and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography with ethyl acetate-hexane (1:10 v/v, Rf = 0.2) to 
yield the isotopomers of 18 as colourless oils. 
Ethyl [3-13C]-2-(2,5,5-trimethyl-1,3-dioxan-2-yl)acetate (18a). Yield: 1.61 g (7.4 
mmol, 97%). GC (BPX-5): I = 1352. 1H-NMR (400 MHz, CDCl3, TMS):  = 4.15 (q, 
3J(H,H) = 7.1 Hz, 2H, CH2), 3.56 (dd, 2J(H,H) = 11.4 Hz, 3J(C,H) = 3.8 Hz, 2H, 2 
CH2), 3.50 (dd, 2J(H,H) = 11.4 Hz, 3J(C,H) = 4.4 Hz, 2H, 2 CH2), 2.78 (d,  2J(C,H)  =  
5.9  Hz,  2H,  CH2), 1.54 (d, 2J(C,H) = 4.8 Hz, 3H, CH3), 1.26 (t, 3J(H,H) = 7.1 Hz, 3H, 
CH3), 0.98 (s, 3H, CH3), 0.94 (s, 3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 
169.5 (d, 2J(C,C) = 0.7 Hz, Cq), 97.3 (s, 13Cq), 70.6 (d, 2J(C,C) = 1.9 Hz, 2 CH2), 60.5 
(s, CH2), 41.6 (d, 1J(C,C) = 44.3 Hz, CH2), 29.9 (d, 3J(C,C) = 2.2 Hz, Cq), 22.8 (d, 
1JC,C = 47.6 Hz, CH3), 22.6 (s, CH3), 22.5 (s, CH3), 14.2 (s, CH3) ppm. MS (EI, 70 
eV): m/z (%) = 203 (7), 202 (46), 132 (40), 130 (100), 104 (19), 86 (43), 69 (69), 44 
(100). 
Ethyl [1-13C]-2-(2,5,5-trimethyl-1,3-dioxan-2-yl)acetate (18b). Yield: 0.98 g (4.5 
mmol, 59%). GC (BPX-5): I = 1352. 1H-NMR (400 MHz, CDCl3, TMS):  = 4.15 (dq, 
3J(H,H) = 7.2 Hz, 3J(C,H) = 3.2 Hz, 2H, CH2), 3.56 (d, 2J(H,H) = 11.5 Hz, 2H, 2 CH2), 
3.50 (d, 2J(H,H) = 11.5 Hz, 2H, 2 CH2), 2.78 (d, 2J(C,H) = 6.9 Hz, 2H, CH2), 1.54 (s, 
3H, CH3), 1.26 (t, 3J(H,H) = 7.1 Hz, 3H, CH3), 0.97 (s, 3H, CH3), 0.94 (s, 3H, CH3) 
ppm. 13C-NMR (100 MHz, CDCl3):  = 169.7 (s, 13Cq), 97.5 (s, Cq), 70.8 (s, 2 CH2), 
60.7 (d, 2J(C,C) = 2.5 Hz, CH2), 41.7 (d, 1J(C,C) = 58.8 Hz, CH2), 30.0 (s, Cq), 22.8 
(s, CH3), 22.6 (s, CH3), 22.5 (s, CH3), 14.2 (d, 3J(C,C) = 2.0 Hz, CH3) ppm. MS (EI, 
70 eV): m/z (%) = 203 (4), 202 (40), 132 (36), 129 (94), 117 (22), 104 (17), 86 (39), 
69 (61), 43 (100). 
[2-13C]Ethyl 2-(2,5,5-[2-13C]trimethyl-1,3-dioxan-2-yl)acetate (18c). Yield: 1.62 g 
(7.4 mmol, 98%). GC (BPX-5): I = 1350. 1H-NMR (400 MHz, CDCl3, TMS):  = 4.16 
(q, 3J(H,H) = 7.1 Hz, 2H, CH2), 3.57 (d, 2J(H,H) = 11.4 Hz, 2H, 2 CH2), 3.51 (d, 
2J(H,H) = 11.4 Hz, 2H, 2 CH2), 2.79 (dd, 1J(C,H) = 130.1 Hz, 3J(C,H) = 3.2 Hz, 2H, 
CH2), 1.55 (dd, 1J(C,H) = 127.4 Hz, 3J(C,H) = 3.0 Hz, 3H, CH3), 1.27 (t, 3J(H,H) = 7.1 
Hz, 3H, CH3), 0.99 (s, 3H, CH3), 0.95 (s, 3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3): 
 = 169.5 (d, 1J(C,C) = 58.9 Hz, Cq), 97.3 (dd, 1J(C,C) = 44.2 Hz, 1J(C,C) = 47.3 Hz, 
Cq), 70.6 (dd, 3J(C,C) = 1.7 Hz, 3J(C,C) = 1.7 Hz, 2 CH2), 60.5 (s, CH2), 41.6 (d, 
2J(C,C) = 4.0 Hz, 13CH2), 29.9 (s, Cq), 22.8 (d, 2J(C,C) = 4.0 Hz, 13CH3), 22.6 (s, 
CH3), 22.5 (s, CH3), 14.2 (s, CH3) ppm. MS (EI, 70 eV): m/z (%) = 202 (30), 133 (29), 
130 (100), 116 (18), 105 (14), 87 (37), 69 (57), 56 (34), 44 (99), 43 (25), 41 (42). 
[1-13C]Ethyl [2-13C]-2-(2,5,5-trimethyl-1,3-dioxan-2-yl)acetate (18d). Yield: 1.44 g 
(6.6 mmol, 87%). GC (BPX-5): I = 1353. 1H-NMR (400 MHz, CDCl3, TMS):  = 4.15 
(dq, 3J(H,H) = 7.2 Hz, 3J(C,H) = 3.2 Hz, 2H, CH2), 3.56 (dd, 2J(H,H) = 11.4 Hz, 
3J(C,H) = 3.8 Hz, 2H, 2 CH2), 3.50 (dd, 2J(H,H) = 11.4 Hz, 3J(C,H) = 3.8 Hz, 2H, 2 
CH2), 2.78 (dd, 2J(C,H) = 6.3 Hz, 2J(C,H) = 6.3 Hz, 2H, CH2), 1.54 (d, 2J(C,H) = 4.8 
Hz, 3H, CH3), 1.26 (t, 3J(H,H) = 7.2 Hz, 3H, CH3), 0.98 (s, 3H, CH3), 0.94 (s, 3H, 
CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 169.5 (d, 2J(C,C) = 0.7 Hz, 13Cq), 97.3 (d, 
2J(C,C) = 0.7 Hz, 13Cq), 70.6 (d, 2J(C,C) = 2.0 Hz, 2 CH2), 60.5 (d, 2J(C,C) = 2.4 Hz, 
CH2), 41.6 (dd, 1J(C,C) = 59.0 Hz, 1J(C,C) = 44.3 Hz, CH2), 29.9 (d, 3J(C,C) = 2.5 Hz, 
Cq), 22.8 (d, 1J(C,C) = 47.6 Hz, CH3), 22.6 (s, CH3), 22.5 (s, CH3), 14.2 (d, 3J(C,C) = 
2.1 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 203 (67), 133 (64), 130 (100), 117 (42), 
105 (31), 87 (63), 69 (78), 56 (62), 44 (91). 
General procedure for the synthesis of isotopomers of 20.  A 1.5 M solution of 
the respective isotopomer of 18 (1 eq) in dry THF at 0 °C was added to a 1.5 M 
suspension of LiAlH4 (1 eq) in dry THF. The mixture was stirred at room temperature 
for 2 h and then quenched by the addition of water under stirring until a white 
suspension was formed. The mixture was filtered and the obtained filtrate was dried 
over MgSO4. The solvent was removed under reduced pressure and the residue was 
purified by flash chromatography with ethyl acetate-hexane (1:2 v/v, Rf = 0.2). The 
resulting alcohol 19 was used immediately in the next step. The alcohol (1 eq) was 
added dropwise at 0 °C to a 0.5 M suspension of NaH (1.1 eq) in dry DMF. After 
stirring for 15 min benzyl bromide (1 eq) was added dropwise. The reaction mixture 
was stirred at room temperature overnight, quenched by the addition of water, and 
extracted with dichloromethane. The combined organic layers were washed with 
water, dried over MgSO4 and the solvent was removed under reduced pressure. The 
residue was purified by flash chromatography with ethyl acetate-hexane (1:10 v/v, Rf 
= 0.3) to yield the isotopomers of 20 as colourless oils. 
[2-13C]-2-(2-(Benzyloxy)ethyl)-2,5,5-trimethyl-1,3-dioxane (20a). Yield: 1.41 g (5.3 
mmol, 72%). GC (BPX-5): I = 1880. 1H-NMR (400 MHz, C6D6, TMS):  = 7.36-7.05 
(m, 5H, 5 CH), 4.36 (s, 2H, CH2), 3.74 (dt, 3J(H,H) = 7.2 Hz, 3J(C,H) = 2.8 Hz, 2H, 
CH2), 3.33 (dd, 2J(H,H) = 11.3 Hz, 3J(C,H) = 3.1 Hz, 2H, 2 CH2), 3.26 (dd, 2J(H,H) = 
11.3 Hz, 3J(C,H) = 4.8 Hz, 2H, 2 CH2), 2.26 (dt, 3J(H,H) = 7.3 Hz, 2J(C,H) = 5.1 Hz, 
2H, CH2), 1.36 (d, 2J(C,H) = 4.5 Hz, 3H, CH3), 0.83 (s, 3H, CH3), 0.62 (s, 3H, CH3) 
ppm. 13C-NMR (100 MHz, C6D6): = 139.5 (s, Cq), 128.5 (s, 2 CH), 127.7 (s, 2 CH), 
127.5 (s, CH), 98.3 (s, 13Cq), 73.1 (s, CH2), 70.3 (d, 2J(C,C) = 2.0 Hz, 2 CH2), 66.6 (s, 
CH2), 38.6 (d, 1J(C,C) = 46.5 Hz, CH2), 29.8 (d, 3J(C,C) = 2.5 Hz, Cq), 22.8 (s, CH3), 
22.4 (s, CH3), 21.1 (d, 1J(C,C) = 46.2 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 250 
(20), 178 (2), 161 (6), 130 (70), 107 (26), 91 (100), 69 (43), 56 (32), 44 (64). 
[4-13C]-2-(2-(Benzyloxy)ethyl)-2,5,5-trimethyl-1,3-dioxane (20b). Yield: 0.38 g (1.6 
mmol, 35%). GC (BPX-5): I = 1879. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.37-7.23 
(m, 5H, 5 CH), 4.50 (d, 3J(C,H) = 3.9 Hz, 2H, CH2), 3.64 (dt, 1J(C,H) = 141.9 Hz, 
3J(H,H) = 7.3 Hz, 2H, CH2), 3.53 (d, 2J(H,H) = 11.4 Hz, 2H, 2 CH2), 3.45 (d, 2J(H,H) = 
11.4 Hz, 2H, 2 CH2), 2.10 (dt, 3J(H,H) = 7.4 Hz, 2J(C,H) = 5.7 Hz, 2H, CH2), 1.40 (s, 
3H, CH3), 0.97 (s, 3H, CH3), 0.91 (s, 3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 
138.5 (d, 3J(C,C) = 2.9 Hz, Cq), 128.3 (s, 2 CH), 127.7 (s, 2 CH), 127.5 (s, CH), 98.1 
(s, Cq), 73.1 (d, 2J(C,C) = 1.4 Hz, CH2), 70.3 (s, 2 CH2), 66.2 (s, 13CH2), 37.9 (d, 
1J(C,C) = 39.3 Hz, CH2), 29.9 (s, Cq), 22.7 (s, CH3), 22.6 (s, CH3), 21.4 (s, CH3) ppm. 
MS (EI, 70 eV): m/z (%) = 250 (18), 159 (5), 129 (74), 107 (21), 91 (100), 69 (40), 56 
(17), 43 (61). 
2-(2-(Benzyloxy)-[1-13C]ethyl)-2,5,5-[2-13C]trimethyl-1,3-dioxane (20c). Yield: 0.91 
g (3.4 mmol, 53%). GC (BPX-5): I = 1884. 1H-NMR (400 MHz, CDCl3, TMS):  = 
7.37-7.23 (m, 5H, 5 CH), 4.51 (s, 2H, CH2), 3.64 (dt, 2J(C,H) = 2.9 Hz, 3J(H,H) = 7.3 
Hz, 2H, 2 CH2), 3.53 (d, 2J(H,H) = 11.3 Hz, 2H, 2 CH2), 3.45 (d, 2J(H,H) = 11.3 Hz, 
2H, CH2), 2.10 (ddt, 1J(C,H) = 126.9 Hz, 3J(H,H) = 7.4 Hz, 3J(C,H) = 3.0 Hz, 2H, 
CH2), 1.40 (dd, 1J(C,H) = 126.6 Hz, 3J(C,H) = 3.0 Hz, 3H, CH3), 0.97 (s, 3H, CH3), 
0.91 (s, 3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 138.5 (s, Cq), 128.3 (s, 2 
CH), 127.7 (s, 2 CH), 127.5 (s, CH), 98.1 (dd, 1J(C,C) = 46.3 Hz, 1J(C,C) = 46.3 Hz, 
Cq), 73.1 (d, 3J(C,C) = 3.7 Hz, CH2), 70.3 (dd, 3J(C,C) = 1.7 Hz, 3J(C,C) = 1.7 Hz, 2 
CH2), 66.2 (dd, 1J(C,C) = 39.3 Hz, 3J(C,C) = 0.9 Hz, CH2), 37.3 (d, 2J(C,C) = 3.7 Hz, 
13CH2), 29.9 (s, Cq), 22.7 (s, CH3), 22.6 (s, CH3), 21.3 (d, 2J(C,C) = 3.7 Hz, 13CH3). 
MS (EI, 70 eV): m/z (%) = 250 (45), 179 (5), 160 (16), 130 (95), 107 (48), 91 (100), 
69 (71), 56 (32), 44 (85). 
[2-13C]-2-([2-13C]-2-(Benzyloxy)ethyl)-2,5,5-trimethyl-1,3-dioxane (20d). Yield: 
0.71 g (2.7 mmol, 40%). GC (BPX-5): I = 1884. 1H-NMR (400 MHz, d6-DMSO, TMS): 
 = 7.39-7.23 (m, 5H, 5 CH), 4.44 (d, 3J(C,H) = 3.9 Hz, 2H, CH2), 3.54 (ddt, 1J(C,H) = 
141.5 Hz, 3J(H,H) = 7.3 Hz, 3J(C,H) = 2.4 Hz, 2H, CH2), 3.47 (dd, 2J(H,H) = 11.3 Hz, 
3J(C,H) = 2.9 Hz, 2H, 2 CH2), 3.38 (dd, 2J(H,H) = 11.3 Hz, 3J(C,H) = 5.0 Hz, 2H, 2 
CH2), 1.96 (m, 2H, CH2), 1.32 (d, 2J(C,H) = 4.5 Hz, 3H, CH3), 0.91 (s, 3H, CH3), 0.82 
(s, 3H, CH3) ppm. 13C-NMR (100 MHz, d6-DMSO):  = 138.6 (d, 3J(C,C) = 3.0 Hz, 
Cq), 128.2 (s, 2 CH), 127.4 (s, 2 CH), 127.3 (s, CH), 97.5 (s, 13Cq), 71.9 (d, 2J(C,C) = 
1.1 Hz, CH2), 69.2 (d, 2J(C,C) = 1.9 Hz, 2 CH2), 65.5 (s, 13CH2), 37.3 (dd, 1J(C,C) = 
46.0 Hz, 1J(C,C) = 39.2 Hz, CH2), 29.5 (d, 3J(C,C) = 2.4 Hz, Cq), 22.4 (s, CH3), 22.0 
(s, CH3), 21.0 (d, 1J(C,C) = 46.3 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 251 (23), 
143 (24), 130 (100), 107 (49), 91 (84), 79 (59), 69 (57), 57 (50), 44 (79). 
General procedure for the synthesis of isotopomers of 21. A 1 M solution of HCl 
in water (0.5 mL/mmol) was added to a 0.2 M solution of the respective isotopomer of 
20 (1 eq) in MeOH. The reaction mixture was stirred at room temperature for 15 min 
and then neutralized with an aqueous solution of NaHCO3 (5 wt%). The aqueous 
layer was extracted three times with Et2O and the combined extracts were dried over 
MgSO4. The solvent was removed under reduced pressure and the residue purified 
by flash chromatography with ethyl acetate-hexane (1:5 v/v, Rf = 0.2) to yield the 
isotopomers of 21 as colourless oils.   
[2-13C]-4-(Benzyloxy)butan-2-one (21a). Yield: 0.84 g (4.7 mmol, 89%). GC (BPX-
5): I = 1462. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.38-7.24 (m, 5H, 5 CH), 4.51 (s, 
2H, CH2), 3.74 (dt, 3J(H,H) = 6.3 Hz, 3J(C,H) = 4.4 Hz, 2H, CH2), 2.71 (dt, 2J(C,H) = 
5.8 Hz, 3J(H,H) = 6.1 Hz, 2H, CH2), 2.18 (d, 2J(C,H) = 5.9 Hz, 3H, CH3) ppm. 
13C-NMR (100 MHz, CDCl3):  = 207.1 (s, 13Cq), 138.1 (s, Cq), 128.4 (s, 2 CH), 127.7 
(s, 2 CH), 127.6 (s, CH), 73.2 (s, CH2), 65.2 (d, 2J(C,C) = 1.6 Hz, CH2), 43.7 (d, 
1J(C,C) = 40.0 Hz, CH2), 30.4 (d, 1J(C,C) = 40.9 Hz, CH3) ppm. MS (EI, 70 eV): m/z 
(%) = 179 (1), 120 (24), 107 (63), 91 (100), 79 (30), 65 (31), 44 (76). 
[4-13C]-4-(Benzyloxy)butan-2-one (21b). Yield: 0.28 g (1.5 mmol, 98%). GC 
(BPX-5): I = 1461. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.38-7.24 (m, 5H, 5 CH), 
4.51 (d, 3J(C,H) = 4.3 Hz, 2H, CH2), 3.74 (dt, 1J(C,H) = 144.5 Hz, 3J(H,H) = 6.3 Hz, 
2H, CH2), 2.72 (dt, 2J(C,H) = 4.9 Hz, 3J(H,H) = 6.3 Hz, 2H, CH2), 2.18 (s, 3H, CH3) 
ppm. 13C-NMR (100 MHz, CDCl3):  = 207.1 (d, 2J(C,C) = 1.7 Hz, Cq), 138.0 (d, 
3J(C,C) = 2.9 Hz, Cq), 128.4 (s, 2 CH), 127.7 (s, 2 CH), 127.6 (s, CH), 73.2 (d, 
2J(C,C) = 1.3 Hz, CH2), 65.2 (s, 13CH2), 43.7 (d, 1J(C,C) = 39.8 Hz, CH2), 30.4 (s, 
CH3) ppm. MS (EI, 70 eV): m/z (%) = 121 (13), 120 (13), 107 (59), 91 (100), 79 (27), 
65 (27), 43 (67). 
[1,3-13C2]-4-(Benzyloxy)butan-2-one (21c). Yield: 0.61 g (3.4 mmol, 99%). GC 
(BPX-5): I = 1468. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.38-7.24 (m, 5H, 5 CH), 
4.51 (s, 2H, CH2), 3.74 (dt, 3J(H,H) = 6.3 Hz, 2J(C,H) = 2.8 Hz, 2H, CH2), 2.72 (dt, 
1J(C,H) = 126.0 Hz, 3J(H,H) = 6.2 Hz, 2H, CH2), 2.18 (dd, 1J(C,H) = 127.3 Hz, 3J(C,H) 
= 1.5 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 138.1 (s, Cq), 128.4 (s, 2 
CH), 127.7 (s, 2 CH), 127.6 (s, CH), 73.2 (d, 3J(C,C) = 3.9 Hz, CH2), 65.2 (d, 1J(C,C) 
= 39.9 Hz, CH2), 43.7 (d, 2J(C,C) = 13.9 Hz, 13CH2), 30.4 (d, 2J(C,C) = 13.9 Hz, 
13CH3) ppm. MS (EI, 70 eV): m/z (%) = 121 (26), 120 (27), 107 (83), 92 (30), 91 
(100), 79 (50), 65 (50), 58 (27), 44 (88). 
[2,4-13C2]-4-(Benzyloxy)butan-2-one (21d). Yield: 0.39 g (2.2 mmol, 81%). GC 
(BPX-5): I = 1459. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.38-7.25 (m, 5H, 5 CH), 
4.51 (d, 3J(C,H) = 4.3 Hz, 2H, CH2), 3.74 (ddt, 1J(C,H) = 143.0 Hz, 3J(H,H) = 6.3 Hz, 
3J(C,H) = 4.4 Hz, 2H, CH2), 2.72 (m, 2H, CH2), 2.18 (d, 2J(C,H) = 5.9 Hz, 3H, CH3) 
ppm. 13C-NMR (100 MHz, CDCl3):  = 207.1 (d, 2J(C,C) = 1.7 Hz, 13Cq), 138.1 (d, 
3J(C,C) = 2.9 Hz, Cq), 128.4 (s, 2 CH), 127.7 (s, 2 CH), 127.6 (s, CH), 73.2 (d, 
2J(C,C) = 1.6 Hz, CH2), 65.2 (d, 2J(C,C) = 1.7 Hz, 13CH2), 43.7 (dd, 1J(C,C) = 40.0 
Hz,
 
1J(C,C) = 40.0 Hz, CH2), 30.4 (d, 1J(C,C) = 40.7 Hz, CH3) ppm. MS (EI, 70 eV): 
m/z (%) = 121 (15), 120 (15), 107 (66), 91 (100), 79 (31), 74 (21), 65 (35), 59 (15), 51 
(16), 44 (87). 
General procedure for the preparation of the isotopomers of 22. A 1.6 M solution 
of n-butyllithium (2.1 eq) in hexane was added at 0 °C to a 0.2 M solution of 
diisopropylamine (2.1 eq) in dry THF. The mixture was stirred for 1 h and then cooled 
to -78°C. A solution of ethyl acetate (2.1 eq, 0.4 M) in dry THF was added dropwise 
and the reaction was stirred for 30 min. Subsequently, a solution of the respective 
isotopomer of 21 (1 eq, 0.3 M) in dry THF was added dropwise. The reaction mixture 
was stirred for 45 min, quenched by the addition of water and allowed to warm to 
room temperature. The mixture was extracted with ethyl acetate and the combined 
extracts were dried over MgSO4. The solvent was removed under reduced pressure 
and the residue was purified by flash chromatography with ethyl acetate-hexane (1:5 
v/v, Rf = 0.2) to yield the isotopomers of 22 as colourless oils. 
Ethyl [3-13C]-5-(benzyloxy)-3-hydroxy-3-methylpentanoate (22a). Yield: 0.98 g 
(3.7 mmol, 79%). GC (BPX-5): I = 1918. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.38-
7.26 (m, 5H, 5 CH), 4.50 (s, 2H, CH2), 4.14 (dq, 3J(H,H) = 7.1 Hz, 1J(H,H) = 10.8 Hz, 
1H, CH2), 4.13 (dq, 3J(H,H) = 7.1 Hz, 1J(H,H) = 10.8 Hz, 1H, CH2), 3.95 (d, 2J(C,H) = 
2.8 Hz, 1H, OH), 3.69 (m, 2H, CH2), 2.58 (dd, 2J(H,H) = 15.3 Hz, 2J(C,H) = 4.9 Hz, 
1H, CH2), 2.49 (dd, 2J(H,H) = 15.3 Hz, 2J(C,H) = 4.4 Hz, 1H, CH2), 1.91 (m, 2H, CH2), 
1.28 (d, 2J(C,H) = 4.2 Hz, 3H, CH3), 1.25 (dd, 3J(H,H) = 7.2 Hz, 3J(H,H) = 7.2 Hz, 3H, 
CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 172.4 (d, 2J(C,C) = 1.1 Hz, Cq), 138.0 (s, 
Cq), 128.4 (s, 2 CH), 127.7 (s, CH), 127.6 (s, 2 CH), 73.3 (s, CH2), 70.8 (s, 13Cq), 66.9 
(d, 2J(C,C) = 1.1 Hz, CH2), 60.5 (s, CH2), 45.5 (d, 1J(C,C) = 37.3 Hz, CH2), 40.3 (d, 
1J(C,C) = 38.8 Hz, CH2), 27.1 (d, 1J(C,C) = 40.2 Hz, CH3), 14.1 (s, CH3) ppm. MS (EI, 
70 eV): m/z (%) = 180 (2), 161 (27), 143 (18), 131 (11), 107 (9), 91 (100), 65 (16), 44 
(25). 
Ethyl [5-13C]-5-(benzyloxy)-3-hydroxy-3-methylpentanoate (22b). Yield: 0.08 g 
(0.4 mmol, 71%). GC (BPX-5): I = 1917. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.39-
7.26 (m, 5H, 5 CH), 4.50 (d, 3J(C,H) = 4.0 Hz, 2H, CH2), 4.14 (dq, 3J(H,H) = 7.1 Hz, 
2J(H,H) = 10.8 Hz, 1H, CH2), 4.13 (dq, 3J(H,H) = 7.1 Hz, 2J(H,H) = 10.8 Hz, 1H, CH2), 
3.97 (s, 1H, OH), 3.68 (dt, 1J(C,H) = 141.2 Hz, 3J(H,H) = 6.1 Hz, 2H, CH2), 2.58 (d, 
2J(H,H) = 15.3 Hz, 1H, CH2), 2.50 (d, 2J(H,H) = 15.3 Hz, 1H, CH2), 1.91 (m, 2H, CH2), 
1.21 (s, 3H, CH3), 1.18 (dd, 3J(H,H) = 7.1 Hz, 3J(H,H) = 7.1 Hz, 3H, CH3) ppm. 
13C-NMR (100 MHz, CDCl3):  = 172.4 (s, Cq), 138.0 (d, 3J(C,C) = 2.8 Hz, Cq), 128.4 
(s, 2 CH), 127.7 (s, CH), 127.6 (s, 2 CH), 73.2 (d, 2J(C,C) = 1.3 Hz, CH2), 70.7 (d, 
2J(C,C) = 1.3 Hz, Cq), 66.9 (s, 13CH2), 60.5 (s, CH2), 45.5 (d, 3J(C,C) = 2.1 Hz, CH2), 
40.3 (d, 1J(C,C) = 38.8 Hz, CH2), 27.1 (d, 3J(C,C) = 2.2 Hz, CH3), 14.1 (s, CH3) ppm. 
MS (EI, 70 eV): m/z (%) = 180 (2), 161 (28), 143 (17), 131 (9), 112 (9), 91 (100), 65 
(13), 43 (21). 
Ethyl [4-13C2]-5-(benzyloxy)-3-hydroxy-3-[13C]methylpentanoate (22c). Yield: 0.74 
g (2.8 mmol, 82%). GC (BPX-5): I = 1919. 1H-NMR (400 MHz, CDCl3, TMS):  = 
7.38-7.26 (m, 5H, 5 CH), 4.50 (s, 2H, CH2), 4.14 (dq, 2J(H,H) = 10.8 Hz, 3J(H,H) = 7.1 
Hz, 1H, CH2), 4.13 (dq, 2J(H,H) = 10.8 Hz, 3J(H,H) = 7.1 Hz, 1H, CH2), 3.95 (t, 
3J(C,H) = 3.1 Hz, 3J(C,H) = 3.1 Hz, 1H, OH), 3.68 (dt, 3J(C,H) = 6.2 Hz, 2J(C,H) = 2.9 
Hz, 2H, CH2), 2.58 (ddd, 2J(H,H) = 15.3 Hz, 3J(C,H) = 3.2 Hz, 3J(C,H) = 3.2 Hz, 1H, 
CH2), 2.50 (ddd, 2J(H,H) = 15.3 Hz, 3J(C,H) = 3.0 Hz, 3J(C,H) = 3.0 Hz, 1H, CH2), 
1.91 (m, 1J(C,H) = 125.8 Hz, 2H, CH2), 1.29 (dd, 1J(C,H) = 126.2 Hz, 3J(C,H) = 3.7 
Hz, 3H, CH3), 1.25 (dd, 3J(H,H) = 7.2 Hz, 3J(H,H) = 7.2 Hz, 3H, CH3) ppm. 13C-NMR 
(100 MHz, CDCl3):  = 172.4 (dd, 3J(C,C) = 2.1 Hz, 3J(C,C) = 2.1 Hz, Cq), 138.0 (s, 
Cq), 128.4 (s, 2 CH), 127.7 (s, CH), 127.6 (s, 2 CH), 73.3 (d, 3J(C,C) = 3.6 Hz, CH2), 
70.8 (dd, 1J(C,C) = 40 Hz, 1J(C,C) = 38 Hz, Cq), 67.0 (dd, 1J(C,C) = 39.4 Hz, 3J(C,C) 
= 1.7 Hz, CH2), 60.5 (s, CH2), 45.6 (dd, 2J(C,C) = 1.7 Hz, 2J(C,C) = 1.7 Hz, CH2), 40.4 
(d, 2J(C,C) = 1.4 Hz, 13CH2), 27.2 (d, 2J(C,C) = 1.5 Hz, 13CH3), 14.2 (s, CH3) ppm. MS 
(EI, 70 eV): m/z (%) = 181 (2), 162 (28), 144 (18), 132 (11), 113 (9), 91 (100), 65 
(16), 44 (26). 
Ethyl [3,5-13C2]-5-(benzyloxy)-3-hydroxy-3-methylpentanoate (22d). Yield: 0.42 g 
(1.6 mmol, 72%). GC (BPX-5): I = 1912. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.36-
7.25 (m, 5H, 5 CH), 4.50 (d, 3J(C,H) = 4.0 Hz, 2H, CH2), 4.14 (dq, 2J(H,H) = 10.8 Hz, 
3J(H,H) = 7.2 Hz, 1H, CH2), 4.13 (dq, 2J(H,H) = 10.8 Hz, 3J(H,H) = 7.2 Hz, 1H, CH2), 
3.95 (s, 1H, OH), 3.69 (dm, 1J(C,H) = 141.4 Hz, 2H, CH2), 2.58 (dd, 2J(H,H) = 15.4 
Hz, 2J(C,H) = 4.6 Hz, 1H, CH2), 2.50 (dd, 2J(H,H) = 15.4 Hz, 2J(C,H) = 4.4 Hz 1H, 
CH2), 1.91 (m, 2H, CH2), 1.29 (d, 2J(C,H) = 4.2 Hz, 3H, CH3), 1.25 (dd, 3J(H,H) = 7.2 
Hz, 3J(H,H) = 7.2 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 172.4 (d, 
2J(C,C) = 1.1 Hz, Cq), 138.0 (d, 3J(C,C) = 2.7 Hz, Cq), 128.4 (s, 2 CH), 127.7 (s, CH), 
127.6 (s, 2 CH), 73.2 (d, 2J(C,C) = 1.5 Hz, CH2), 70.7 (d, 2J(C,C) = 1.1 Hz, 13Cq), 66.9 
(d, 2J(C,C) = 1.1 Hz, 13CH2), 60.5 (s, CH2), 45.5 (d, 1J(C,C) = 37.3 Hz, CH2), 40.3 (dd, 
1J(C,C) = 38.8 Hz, 1J(C,C) = 38.8 Hz, CH2), 27.1 (dd, 1J(C,C) = 40.2 Hz, 3J(C,C) = 
2.2 Hz, CH3), 14.1 (s, CH3) ppm. MS (EI, 70 eV): m/z (%) = 162 (22), 144 (13), 132 
(10), 113 (7), 107 (8), 98 (8), 91 (100), 86 (12), 77 (13), 65 (20), 44 (30). 
General procedure for the synthesis of isotopomers of 23. Pd/C (5 wt%, 0.05 eq) 
was added to a solution of the respective isotopomer of 22 (1 eq, 0.1 M) in MeOH. 
The mixture was then stirred at 40 °C under a hydrogen atmosphere (40 bar) for 2 h. 
The Pd/C catalyst was filtered off and the solvent was removed under reduced 
pressure. The residue was dissolved in dichloromethane (0.1 M) and a catalytic 
amount (0.01 eq) of p-TsOH was added. The reaction mixture was stirred at room 
temperature overnight. The solvent was removed under reduced pressure and the 
residue was purified by flash chromatography with ethyl acetate-hexane (1:1 v/v, Rf = 
0.1) to yield the isotopomers of 23 as colourless oils. 
[3-13C]Mevalonolactone (23a). Yield: 0.37 g (2.8 mmol, 76%). GC (BPX-5, MSTFA): 
I = 1389. 1H-NMR (400 MHz, CDCl3, TMS):  = 4.61 (m, 1H, CH2), 4.35 (m, 1H, CH2), 
2.67 (m, 2J(H,H) = 17.4 Hz, 2J(C,H) = 5.0 Hz, 1H, CH2), 2.52 (dd, 2J(H,H) = 17.4 Hz, 
2J(C,H) = 5.0 Hz, 1H, CH2), 2.48 (s, 1H, OH), 1.90 (m, 2H, CH2), 1.36 (d, 2J(C,H) = 
4.3 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 170.8 (d, 2J(C,C) = 1.8 Hz, 
Cq), 68.1 (s, 13Cq), 66.4 (d, 2J(C,C) = 2.3 Hz, CH2), 44.6 (d, 1J(C,C) = 36.6 Hz, CH2), 
35.8 (d, 1J(C,C) = 37.0 Hz, CH2), 29.1 (d, 1J(C,C) = 39.6 Hz, CH3) ppm. MS (EI, 70 
eV, MSTFA): m/z (%) = 188 (18), 161 (7), 146 (100), 145 (39), 116 (88), 101 (15), 75 
(77), 73 (50), 45 (36). 
[5-13C]Mevalonolactone (23b). Yield: 0.05 g (0.4 mmol, 74%). GC (BPX-5, MSTFA): 
I = 1389. 1H-NMR (400 MHz, CDCl3, TMS):  = 4.67 (m, 1J(C,H) = 150.6 Hz, 1H, 
CH2), 4.29 (m, 1J(C,H) = 150.6 Hz, 1H, CH2), 2.67 (d, 2J(H,H) = 17.4 Hz, 1H, CH2), 
2.51 (d, 2J(H,H) = 17.4 Hz, CH2), 1.92 (m, 2H, CH2), 1.39 (s, 3H, CH3). 13C-NMR (100 
MHz, CDCl3):  = 170.9 (s, Cq), 68.0 (d, 2J(C,C) = 2.4 Hz, Cq), 66.1 (s, 13CH2), 44.6 
(d, 3J(C,C) = 1.8 Hz, CH2), 35.8 (d, 1J(C,C) = 34.6 Hz, CH2), 29.6 (d, 3J(C,C) = 2.4 
Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 188 (21), 157 (8), 146 (100), 145 (37), 115 
(82), 102 (20), 75 (77), 45 (36). 
[4,6-13C2]Mevalonolactone (23c). Yield: 0.27 g (2.1 mmol, 75%). GC (BPX-5, 
MSTFA): I = 1385. 1H-NMR (400 MHz, CDCl3, TMS):  = 4.61 (m, 1H, CH2), 4.35 (m, 
1H, CH2), 2.67 (m, 2J(H,H) = 17.4 Hz, 1H, CH2), 2.53 (ddd, 2J(H,H) = 17.4 Hz, 
3J(C,H) = 1.9 Hz, 3J(C,H) = 1.9 Hz, 1H, CH2), 2.08 (m, 1H, CH2), 1.76 (m, 1H, CH2), 
1.40 (dd, 1J(C,H) = 126.3 Hz, 3J(C,H) = 4.2 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, 
CDCl3):  = 170.5 (dd, 3J(C,C) = 3.6 Hz, 3J(C,C) = 3.6 Hz, Cq), 68.2 (dd, 1J(C,C) = 
39.8 Hz, 1J(C,C) = 37.2 Hz, Cq), 66.0 (dd, 1J(C,C) = 34.5 Hz, 3J(C,C) = 2.3 Hz, CH2), 
44.7 (d, 2J(C,C) = 2.7 Hz, CH2), 35.9 (d, 2J(C,C) = 1.8 Hz, 13CH2), 29.8 (d, 2J(C,C) = 
1.8 Hz, 13CH3) ppm. MS (EI, 70 eV, MSTFA): m/z (%) = 189 (12), 147 (100), 145 
(39), 117 (47), 116 (48), 75 (51), 73 (45), 45 (24). 
[3,5-13C2]Mevalonolactone (23d). Yield: 0.15 g (1.1 mmol, 73%). GC (BPX-5, 
MSTFA): I = 1389. 1H-NMR (300 MHz, CDCl3, TMS):  = 4.58 (m, 1J(C,H) = 150.6 
Hz, 1H, CH2), 4.34 (m, 1J(C,H) = 150.6 Hz, 1H, CH2), 2.67 (m, 2J(H,H) = 17.4 Hz, 1H, 
CH2), 2.52 (dd, 2J(H,H) = 17.4 Hz, 2J(C,H) = 2.8 Hz, 1H, CH2), 2.08 (s, 1H, OH) 1.90 
(m, 2H, CH2), 1.40 (d, 2J(C,H) = 4.4 Hz, 3H, CH3) ppm. 13C-NMR (75 MHz, CDCl3):  
= 171.9 (s, Cq), 68.2 (d, 2J(C,C) = 2.3 Hz, 13Cq), 66.0 (d, 2J(C,C) = 2.3 Hz, 13CH2), 
44.7 (dd, 1J(C,C) = 36.6 Hz, 3J(C,C) = 1.8 Hz, CH2), 35.6 (dd, 1J(C,C) = 37.1 Hz, 
1J(C,C) = 34.8 Hz, CH2), 29.1 (dd, 1J(C,C) = 40.1 Hz, 3J(C,C) = 2.3 Hz, CH3) ppm. 
MS (EI, 70 eV, MSTFA): m/z (%) = 189 (44), 158 (22), 147 (100), 131 (25), 116 (96), 
102 (37), 75 (80), 45 (44). 
  
Synthesis of [2,6-13C2]mevalonolactone (23e) 
 
Scheme 3. Synthesis of [2,6-13C]mevalonolactone (23e). 
 
The synthesis of [2,6-13C2]mevalonolactone (23e) was performed according to a 
previously published procedure that was developed in our laboratories for the 
synthesis of deuterated isotopomers of mevalonolactone (Scheme 3).[8] Therefore, 
the aldehyde 24 was used in a Grignard reaction with [13C]methyl iodide to yield the 
alcohol 25. Oxidation to the corresponding ketone 21e was performed using IBX. The 
subsequent steps towards 23e were according to those presented in Scheme 1. 
Synthesis of [1-13C]-4-(benzyloxy)-2-butanol (25). Magnesium (185 mg, 7.7 mmol, 
1.1 eq) was covered with dry Et2O (2 mL) and a solution of [13C]methyl iodide (1.10 g, 
7.7 mmol, 1.1 eq) in dry Et2O (5 mL) was added dropwise. The reaction mixture was 
stirred at room temperature for 15 min until the magnesium was consumed and then 
cooled to 0 °C. A solution of the aldehyde 24 (1.03 g, 7.0 mmol, 1.0 eq) in dry Et2O (5 
mL) was added dropwise and the reaction mixture was stirred for 2 h at room 
temperature. The mixture was quenched with a saturated aqueous NH4Cl solution 
(50 mL) and extracted with Et2O (3 x 50 mL). The organic layers were dried over 
MgSO4 and the solvent was removed under reduced pressure. The residue was 
purified by flash chromatography using ethyl acetate-hexane (1:3 v/v, Rf = 0.2) to 
yield 25 as a colourless oil (0.90 g, 5.0 mmol, 72%). GC (BPX-5): I = 1467. 1H-NMR 
(400 MHz, CDCl3, TMS):  = 7.37-7.25 (m, 5H, 5 CH), 4.52 (s, 2H, CH2), 4.05-3.97 
(m, 1H, CH), 3.74 (ddd, 2J(H,H) = 9.3 Hz, 3J(H,H) = 5.8 Hz, 3J(H,H) = 4.8 Hz, 1H, 
CH2), 3.64 (ddd, 2J(H,H) = 9.1 Hz, 3J(H,H) = 8.6 Hz, 3J(H,H) = 4.6 Hz, 1H, CH2), 2.65 
(br s, 1H, OH), 1.83-1.67 (m, 2H, CH2), 1.20 (dd, 1J(C,H) = 125.9 Hz, 3J(H,H) = 6.3 
Hz, 3H, 13CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 137.9 (s, Cq), 128.4 (s, 2 CH), 
127.7 (s, CH), 127.6 (s, 2 CH), 73.2 (s, CH2), 69.0 (d, 3J(C,C) = 3.9 Hz, CH), 67.4 (d, 
1J(C,C) = 39.2 Hz, CH), 38.1 (s, CH2), 23.3 (s, 13CH3) ppm. MS (EI, 70 eV): m/z (%) = 
181 (<1) [M]+, 162 (21), 120 (21), 108 (13), 107 (52), 105 (16), 92 (23), 91 (100), 79 
(39), 78 (11), 77 (24), 65 (30), 57 (19), 51 (13), 46 (22), 44 (16).  
Synthesis of [1-13C]-4-(benzyloxy)-2-butanone (21e). To a solution of IBX (1.54 g, 
5.5 mmol, 1.1 eq) in dry DMSO (55 mL) was added alcohol 25 (0.90 g, 5.0 mmol, 1 
eq). The reaction mixture was stirred for 3 h at room temperature, then quenched by 
the addition of water (250 mL) and extracted with Et2O (3 x 250 mL). The combined 
organic layers were washed with water (3 x 250 mL) and dried with MgSO4. The 
solvent was removed under reduced pressure and the residue was purified by flash 
chromatography with ethyl acetate-hexane (1:5 v/v, Rf = 0.2) to yield 21e (0.71 g, 4.1 
mmol, 82%) as colourless oil. GC (BPX-5): I = 1461. 1H-NMR (400 MHz, CDCl3, 
TMS):  = 7.38-7.25 (m, 5H, 5 CH), 4.51 (s, 2H, CH2), 3.74 (t, 3J(H,H) = 6.3 Hz, 2H, 
CH2), 2.72 (t, 3J(H,H) = 6.3 Hz, 2H, CH2), 2.18 (d, 1J(C,H) = 127.3 Hz, 3H, 13CH3) 
ppm. 13C-NMR (100 MHz, CDCl3):  = 207.1 (d, 1J(C,C) = 40.7 Hz, Cq), 138.0 (s, Cq), 
128.4 (s, 2 CH), 127.7 (s, 2 CH), 127.6 (s, CH), 73.2 (s, CH2), 65.3 (s, CH2), 43.7 (d, 
2J(C,C) = 13.9 Hz, CH2), 30.4 (s, 13CH3) ppm. MS (EI, 70 eV): m/z (%) = 179 (<1) 
[M]+, 120 (19), 107 (55), 91 (100), 79 (30), 77 (29), 65 (33), 44 (81). 
Synthesis of ethyl [2,6-13C2]-5-(benzyloxy)-3-hydroxy-3-methylpentanoate (22e). 
The conversion of 21e into the ester 22e was carried out as described above for the 
synthesis of the isotopomers 22a-d. The labelled ester [2-13C]ethyl acetate was used. 
Yield: 0.90 g (3.5 mmol, 82%). GC (BPX-5): I = 1916. 1H-NMR (400 MHz, CDCl3, 
TMS):  = 7.39-7.25 (m, 5H, 5 CH), 4.50 (s, 2H, CH2), 4.14 (dq, 2J(H,H) = 10.3 Hz, 
3J(H,H) = 7.1 Hz, 1H, CH2), 4.13 (dq, 2J(H,H) = 10.3 Hz, 3J(H,H) = 7.1 Hz, 1H, CH2), 
3.69 (m, 2H, CH2), 2.58 (ddd, 1J(C,H) = 128.9 Hz, 2J(H,H) = 15.4 Hz, 3J(C,H) = 3.7 
Hz, 1H, CH2), 2.50 (ddd, 1J(C,H) = 128.3 Hz, 2J(H,H) = 15.4 Hz, 3J(C,H) = 3.2 Hz, 1H, 
CH2), 1.91 (m, 2H, CH2), 1.28 (dd, 1J(C,H) = 126.2 Hz, 3J(C,H) = 4.1 Hz, 3H, CH3), 
1.25 (dd, 3J(H,H) = 7.1 Hz, 3J(H,H) = 7.1 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, 
CDCl3):  = 172.4 (dd, 1J(C,C) = 56.8 Hz, 3J(C,C) = 2.1 Hz, Cq), 138.0 (s, Cq), 128.4 
(s, 2 CH), 127.7 (s, CH), 127.6 (s, 2 CH), 73.2 (s, CH2), 70.7 (dd, 1J(C,C) = 40.1 Hz, 
1J(C,C) = 37.6 Hz, Cq), 66.9 (dd, 3J(C,C) = 4.2 Hz, 3J(C,C) = 2.1 Hz, CH2), 60.5 (s, 
CH2), 45.5 (d, 2J(C,C) = 2.2 Hz, 13CH2), 40.4 (dd, 2J(C,C) = 1.4 Hz, 2J(C,C) = 1.4 Hz, 
CH2), 27.1 (d, 2J(C,C) = 2.2 Hz, 13CH3), 14.1 (s, CH3). MS (EI, 70 eV): m/z (%) = 180 
(2), 161 (24), 144 (12), 107 (10), 91 (100), 65 (12), 44 (24).  
Synthesis of [2,6-13C2]mevalonolactone (23e). The conversion of 22e into 23e was 
carried out as described above for the isotopomers 23a-d. Yield: 0.95 g (0.72 mmol, 
84%). GC (BPX-5, MSTFA): I = 1381. 1H-NMR (400 MHz, CDCl3, TMS):  = 4.61 
(ddd, 2J(H,H) = 11.2 Hz, 3J(H,H) = 9.2 Hz, 3J(H,H) = 5.5 Hz, 1H, CH2), 4.35 (ddd, 
2J(H,H) = 11.2 Hz, 3J(H,H) = 5.1 Hz, 3J(H,H) = 4.1 Hz, 1H, CH2), 2.69 (m, 1J(C,H) = 
133.0 Hz, 2J(H,H) = 17.3 Hz, 1H, CH2), 2.52 (ddd, 1J(C,H) = 126.6 Hz, 2J(H,H) = 17.3 
Hz, 3J(C,H) = 2.4 Hz, 1H, CH2), 2.20 (br s, 1H, OH), 1.98-1.85 (m, 2H, CH2), 1.40 
(dd, 1J(C,H) = 126.2 Hz, 3J(C,H) = 4.4 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, 
CDCl3):  = 170.7 (dd, 1J(C,C) = 51.6 Hz, 3J(C,C) = 3.6 Hz, Cq), 68.1 (dd, 1J(C,C) = 
36.5 Hz, 1J(C,C) = 40.0 Hz, Cq), 66.0 (dd, 3J(C,C) = 2.0 Hz, 3J(C,C) = 2.0 Hz, 3J(C,C) 
= 2.0 Hz, CH2), 44.7 (d, 2J(C,C) = 2.7 Hz, 13CH2), 35.8 (d, 2J(C,C) = 1.7 Hz, 29.7 (d, 
2J(C,C) = 2.7 Hz, 13CH3) ppm. MS (EI, 70 eV, MSTFA): m/z (%) = 189 (10), 161 (19), 
146 (100), 144 (36), 116 (39), 101 (17), 75 (75), 40 (52).      
  
Synthesis of [4-13C]mevalonolactone (23f) 
 
Scheme 4. Synthesis of [4-13C]mevalonolactone (23f). 
 
The synthesis of [4-13C]mevalonolactone (23f) was performed according to the 
procedure of Cane and Levin (Scheme 4).[9] Briefly, acetoacetaldehyde 
dimethylacetal (29) was used in an aldol reaction with [2-13C]ethyl acetate to yield 
ester 30. Subsequent reduction with LiAlH4 to the corresponding alcohol 31 was 
followed by conversion into the acetate ester 32 with acetic anhydride in pyridine. 
The resulting material was directly converted into 23f with sulfuric acid and hydrogen 
peroxide in formic acid.  
Synthesis of ethyl [2-13C]-3-hydroxy-3-methyl-5,5-dimethoxypentanoate (30). A 
solution of n-butyllithium in hexane (1.6 M, 5.3 mL, 8.4 mmol, 1.1 eq) was added at 
0°C to a solution of diisopropylamine (850 mg, 8.4 mmol, 1.1 eq) in dry THF (2 mL). 
The mixture was stirred for 1 h and then cooled to -78°C. A solution of [2-13C]ethyl 
acetate (750 mg, 8.4 mmol, 1.1 eq) in dry THF (2 mL) was added dropwise and the 
reaction mixture was stirred for 30 min. Subsequently, a solution of 
acetoacetaldehyde dimethylacetal (29, 1.01 g, 7.6 mmol, 1.0 eq) in dry THF (1 mL) 
was added dropwise. The reaction mixture was stirred for 45 min, quenched with sat. 
aqueous NH4Cl solution (50 mL) and allowed to warm to room temperature. The 
aqueous layer was extracted with Et2O (3 x 50 mL) and the combined extracts were 
dried with MgSO4. The solvent was removed under reduced pressure and the residue 
was purified by flash chromatography with ethyl acetate-hexane (1:4 v/v, Rf = 0.2) to 
yield the target compound 30 (1.35 g, 6.1 mmol, 80%) as a colourless oil. GC (BPX-
5): I = 1406. 1H-NMR (400 MHz, C6D6, TMS):  = 4.67 (t, 3J(H,H) = 5.4 Hz, 1H, CH), 
4.03 (d, 3J(C,H) = 2.1 Hz, 1H, OH), 3.87 (q, 3J(H,H) = 7.1 Hz, 2H, CH2), 3.05 (s, 6H, 2 
CH3), 2.56 (dd, 1J(C,H) = 129.4 Hz, 2J(H,H) = 15.5 Hz, 1H, CH2), 2.39 (dd, 1J(C,H) = 
129.0 Hz, 2J(H,H) = 15.5 Hz, 1H, CH2), 1.97 (ddd, 2J(H,H) = 14.1 Hz, 3J(H,H) = 5.3 
Hz, 3J(C,H) = 3.0 Hz, 1H, CH2), 1.94 (ddd, 2J(H,H) = 14.1 Hz, 3J(H,H) = 5.3 Hz, 
3J(C,H) = 3.7 Hz, 1H, CH2), 1.30 (d, 3J(C,H) = 4.1 Hz, 3H, CH3), 0.90 (t, 3J(H,H) = 7.1 
Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, C6D6):  = 172.4 (d, 1J(C,C) = 57.5 Hz, Cq), 
102.5 (d, 3J(C,C) = 1.9 Hz, CH), 69.6 (d, 1J(C,C) = 37.8 Hz, Cq), 60.3 (s, CH2), 52.5 
(s, CH3), 52.4 (s, CH3), 45.7 (s, 13CH2), 43.7 (d, 2J(C,C) = 1.7 Hz, CH2), 28.2 (d, 
2J(C,C) = 2.3 Hz, CH3), 14.1 (s, CH3) ppm. MS (EI, 70 eV): m/z (%) = 188 (3), 174 
(15), 172 (34), 158 (11), 132 (28), 118 (14), 101 (32), 86 (43), 75 (100), 58 (53), 43 
(100). 
Synthesis of [2-13C]-3-methyl-5,5-dimethoxypentane-1,3-diol (31). A 1.5 M 
solution of 30 (1.35 g, 6.1 mmol, 1.0 eq) in dry THF (1 mL) was added at 0 °C to a 
suspension of LiAlH4 (460 mg, 12.2 mmol, 2.0 eq) in dry THF (10 mL). The reaction 
mixture was stirred at room temperature for 2 h and then quenched by the addition of 
water under stirring until a white suspension was formed. The mixture was filtered 
and the obtained filtrate was dried over MgSO4. The solvent was removed under 
reduced pressure and the residue was purified by flash chromatography with ethyl 
acetate-hexane (2:1 v/v, Rf = 0.2) to yield the target compound 31 (0.86 g, 4.8 mmol, 
79%) as colourless oil. GC (BPX-5, MSTFA): I = 1500. 1H-NMR (400 MHz, C6D6, 
TMS):  = 4.53 (t, 3J(H,H) = 5.8 Hz, 1H, CH), 3.84 (d, 3J(C,H) = 3.3 Hz, 1H, OH), 3.82 
(m, 1H, CH2), 3.75 (m, 1H, CH2), 3.32 (br s, 1H, OH), 3.02 (s, 3H, CH3), 3.01 (s, 3H, 
CH3) 1.86 (ddd, 2J(H,H) = 14.4 Hz, 3J(H,H) = 6.4 Hz, 3J(C,H) = 2.3 Hz, 1H, CH2), 1.61 
(ddd, 2J(H,H) = 14.4 Hz, 3J(H,H) = 5.3 Hz, 3J(C,H) = 3.0 Hz, 1H, CH2), 1.66 (ddd, 
1J(C,H) = 125.1 Hz, 2J(H,H) = 14.3 Hz, 3J(H,H) = 4.6 Hz, 1H, CH2), 1.48 (ddd, 1J(C,H) 
= 124.1 Hz, 2J(H,H) = 14.3 Hz, 3J(H,H) = 4.3 Hz, 1H, CH2), 1.13 (d, 3J(C,H) = 3.8 Hz, 
3H, CH3) ppm. 13C-NMR (100 MHz, C6D6):  = 102.6 (d, 3J(C,C) = 2.7 Hz, CH), 71.9 
(d, 1J(C,C) = 38.8 Hz, Cq), 59.5 (d, 1J(C,C) = 36.8 Hz, CH2), 52.6 (s, CH3), 52.3 (s, 
CH3), 43.7 (s, CH2), 43.3 (s, 13CH2), 27.2 (d, 2J(C,C) = 1.5 Hz, CH3) ppm. MS (EI, 70 
eV, MSTFA): m/z (%) = 234 (24), 147 (23), 133 (23), 116 (19), 103 (29), 89 (25), 75 
(100). 
Synthesis of [2-13C]-3-methyl-5,5-dimethoxypentane-1,3-diol-1-acetate (32). The 
diol 31 (0.86 g, 4.8 mmol) was dissolved in dry pyridine (20 mL) and the solution was 
cooled to 4 °C. Ac2O (20 mL) was added and the reaction mixture was stirred 
overnight at 4 °C. The mixture was concentrated under reduced pressure and the 
residue was purified by flash chromatography with ethyl acetate-hexane (1:2 v/v, Rf = 
0.2) to yield the target compound 32 (0.84 g, 3.8 mmol, 80%) as a colourless oil. GC 
(BPX-5): I = 1479. 1H-NMR (400 MHz, C6D6, TMS):  = 4.50 (dd, 3J(H,H) = 5.5 Hz, 
3J(H,H) = 6.1 Hz, 1H, CH), 4.30 (dt, 3J(H,H) = 7.2, 2J(C,H) = 2.7 Hz, 2H, CH2), 3.14 
(br s, 1H, OH), 2.99 (s, 6H, 2 CH3), 1.78 (ddt, 1J(C,H) = 126.3 Hz, 2J(H,H) = 13.9 Hz, 
3J(H,H) = 7.2 Hz, 1H, CH2), 1.75 (ddd, 2J(H,H) = 14.4 Hz, 3J(H,H) = 6.1 Hz, 3J(C,H) = 
2.0 Hz, 1H, CH2), 1.72 (ddt, 1J(C,H) = 126.3 Hz, 2J(H,H) = 13.9 Hz, 3J(H,H) = 7.3 Hz, 
1H, CH2), 1.68 (s, 3H, CH3), 1.63 (ddd, 2J(H,H) = 14.4 Hz, 3J(H,H) = 5.5 Hz, 3J(C,H) 
= 3.2 Hz, 1H, CH2), 1.08 (d, 3J(C,H) = 3.8 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, 
C6D6):  = 170.2 (d, 3J(C,C) = 1.8 Hz, Cq), 102.6 (d, 3J(C,C) = 2.8 Hz, CH), 69.6 (d, 
1J(C,C) = 39.2 Hz, Cq), 61.2 (d, 1J(C,C) = 39.2 Hz, CH2), 52.5 (s, CH3), 52.3 (s, CH3), 
43.3 (d, 2J(C,C) = 1.5 Hz, CH2), 41.3 (s, 13CH2), 27.6 (d, 2J(C,C) = 1.8 Hz, CH3), 20.6 
(s, CH3) ppm. MS (EI, 70 eV): m/z (%) = 174 (2), 132 (9), 114 (9), 101 (34), 75 (89), 
58 (32), 43 (100). 
Synthesis of [4-13C]mevalonolactone (23f). Formic acid (4 mL), an aqueous 
solution of H2O2 (30 wt%, 12 mL) and an aqueous solution of H2SO4 (1%, 4 mL) were 
added to the acetate ester 32 (0.84 g, 3.8 mmol). The reaction mixture was heated to 
reflux for 1 h and then quenched by the addition of anhydrous K2CO3 (200 mg). The 
mixture was concentrated under reduced pressure and the residue was purified by 
flash chromatography with ethyl acetate-hexane (1:1 v/v, Rf = 0.2) to yield the target 
compound 23f (0.28 g, 2.1 mmol, 56%) as colourless oil. GC (BPX-5, MSTFA): I = 
1382. 1H-NMR (400 MHz, CDCl3, TMS):  = 4.61 (dddd, 2J(H,H) = 11.2 Hz, 3J(H,H) = 
9.2 Hz, 3J(H,H) = 5.5 Hz, 2J(C,H) = 2.7 Hz, 1H, CH2), 4.39-4.32 (m, 1H, CH2), 2.67 
(m, 2J(H,H) = 17.4 Hz, 1H, CH2), 2.53 (dd, 2J(H,H) = 17.4 Hz, 3J(C,H) = 1.6 Hz, 1H, 
CH2), 1.90 (m, 1J(C,H) = 127.7 Hz, 2H, CH2), 1.41 (d, 3J(C,H) = 4.2 Hz, 3H, CH3 
ppm. 13C-NMR (100 MHz, CDCl3):  = 170.4 (d, 3J(C,C) = 3.5 Hz, Cq), 68.2 (d, 
1J(C,C) = 37.3 Hz, Cq), 66.0 (d, 1J(C,C) = 34.5 Hz, CH2), 44.7 (s, CH2), 35.9 (s, 
13CH2), 29.8 (d, 2J(C,C) = 1.7 Hz, CH3) ppm. MS (EI, 70 eV, MSTFA): m/z (%) = 188 
(20), 159 7), 146 (100), 115 (51), 102 (15), 75 (51), 45 (19).  
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PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.20
Date_฀฀฀฀฀฀฀฀฀฀20130223
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae119842_od
Current฀Data฀Parameters
EtO
O O O
18a
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1006฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5524178฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8915996฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5635842฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀96
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.28
Date_฀฀฀฀฀฀฀฀฀฀20130223
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae119842_od
Current฀Data฀Parameters
EtO
O O O
18a
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀12.90฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000129฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀295.7฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2.19
Date_฀฀฀฀฀฀฀฀฀฀20130312
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae120069_od
EtO
O O O
18b
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.83฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806648฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.0฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀80.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.39
Date_฀฀฀฀฀฀฀฀฀฀20130312
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae120069_od
EtO
O O O
18b
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806578฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.4฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀96
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.48
Date_฀฀฀฀฀฀฀฀฀฀20130312
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae120069_od
EtO
O O O
18b
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.96฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000140฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.7฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀71.8
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.02
Date_฀฀฀฀฀฀฀฀฀฀20130410
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae120391_od
EtO
O O O
18c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.14฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806641฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀71.8
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3072
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00
Date_฀฀฀฀฀฀฀฀฀฀20130410
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae120391_od
EtO
O O O
18c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806578฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6919063฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.5฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.44
Date_฀฀฀฀฀฀฀฀฀฀20130410
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae120391_od
EtO
O O O
18c
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.91฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8700109฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8724688฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀114
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.45
Date_฀฀฀฀฀฀฀฀฀฀20130822
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae121723_od
Current฀Data฀Parameters
EtO
O O O
18d
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.89฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5473939฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8715995฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5585542฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀300.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀960
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9.06
Date_฀฀฀฀฀฀฀฀฀฀20130822
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae121723_od
Current฀Data฀Parameters
EtO
O O O
18d
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5473888฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8715995฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5585542฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀300.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9195.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀160
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.04
Date_฀฀฀฀฀฀฀฀฀฀20130822
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae121723_od
Current฀Data฀Parameters
EtO
O O O
18d
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.42฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.3999996฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.0฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀57
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀23.44
Date_฀฀฀฀฀฀฀฀฀฀20140120
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122964_od
BnO
O O
20a
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−35.36฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806256฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.5฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀80.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2.21
Date_฀฀฀฀฀฀฀฀฀฀20140121
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122964_od
BnO
O O
20a
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀12.12฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806731฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6919063฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.7฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.41
Date_฀฀฀฀฀฀฀฀฀฀20140121
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122964_od
BnO
O O
20a
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.01฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000200฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.33
Date_฀฀฀฀฀฀฀฀฀฀20130319
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae120166_od
BnO
O O
20b
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.00฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806650฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.5฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀90.5
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.53
Date_฀฀฀฀฀฀฀฀฀฀20130319
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae120166_od
BnO
O O
20b
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806578฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.9฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀96
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀21.02
Date_฀฀฀฀฀฀฀฀฀฀20130319
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae120166_od
BnO
O O
20b
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀180.1฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.68฀Hz
SF฀฀฀฀฀฀฀฀฀฀300.1300137฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀300.1318530฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀12.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀80.600฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀128
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9617012฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126210฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀6203.474฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀49152
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀฀฀฀av300
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.50
Date_฀฀฀฀฀฀฀฀฀฀20130412
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀bae−130412−194108_od
BnO
O O
20c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.45฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806645฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.8฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀80.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3072
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.36
Date_฀฀฀฀฀฀฀฀฀฀20130418
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae120505_od
BnO
O O
20c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806578฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.3฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀96
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.45
Date_฀฀฀฀฀฀฀฀฀฀20130418
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae120505_od
BnO
O O
20c
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.61฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000046฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.8฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀114
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀DMSO
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀18.48
Date_฀฀฀฀฀฀฀฀฀฀20131104
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122468_od
BnO
O O
20d
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀51.24฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6807122฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.1฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀101
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀DMSO
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.08
Date_฀฀฀฀฀฀฀฀฀฀20131104
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122468_od
BnO
O O
20d
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀75.85฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6807369฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6919063฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.3฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀DMSO
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀21.27
Date_฀฀฀฀฀฀฀฀฀฀20131104
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122468_od
BnO
O O
20d
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.19฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8900152฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8924689฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀101.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.09
Date_฀฀฀฀฀฀฀฀฀฀20130304
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae119978_od
Current฀Data฀Parameters
BnO
O
21a
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1006฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5.11฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5524261฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8915996฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5635842฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9195.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀96
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.18
Date_฀฀฀฀฀฀฀฀฀฀20130304
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae119978_od
Current฀Data฀Parameters
BnO
O
21a
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1006฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5524178฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8915996฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5635842฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7298.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀96
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.26
Date_฀฀฀฀฀฀฀฀฀฀20130304
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae119978_od
Current฀Data฀Parameters
BnO
O
21a
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.88฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8900149฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8924689฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀114
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.57
Date_฀฀฀฀฀฀฀฀฀฀20130323
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae120225_od
Current฀Data฀Parameters
BnO
O
21b
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1006฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.61฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5524256฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8915996฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5635842฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀18.34
Date_฀฀฀฀฀฀฀฀฀฀20130323
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae120225_od
Current฀Data฀Parameters
BnO
O
21b
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1006฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀119.09฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5525401฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8915996฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5635842฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4597.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.52
Date_฀฀฀฀฀฀฀฀฀฀20130323
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae120225_od
Current฀Data฀Parameters
BnO
O
21b
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.40฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000194฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀128
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀18.45
Date_฀฀฀฀฀฀฀฀฀฀20130419
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae120533_od
BnO
O
21c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5.13฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806661฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.4฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀90.5
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀96
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀18.54
Date_฀฀฀฀฀฀฀฀฀฀20130419
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae120533_od
BnO
O
21c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806578฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.9฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀96
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.03
Date_฀฀฀฀฀฀฀฀฀฀20130419
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae120533_od
BnO
O
21c
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.15฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8500161฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀143.7
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀23.47
Date_฀฀฀฀฀฀฀฀฀฀20131112
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122541_od
Current฀Data฀Parameters
BnO
O
21d
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.97฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423670฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2.23
Date_฀฀฀฀฀฀฀฀฀฀20131113
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122541_od
Current฀Data฀Parameters
BnO
O
21d
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀122.75฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5424858฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6502
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.42
Date_฀฀฀฀฀฀฀฀฀฀20131113
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122541_od
Current฀Data฀Parameters
BnO
O
21d
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.62฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8500156฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀128
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀23.45
Date_฀฀฀฀฀฀฀฀฀฀20140128
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae123035_od
Current฀Data฀ParametersO
EtO OBn
OH
22a
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.46฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423665฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9195.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3072
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.40
Date_฀฀฀฀฀฀฀฀฀฀20140129
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123035_od
Current฀Data฀ParametersO
EtO OBn
OH
22a
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀24.27฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423873฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9195.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.16
Date_฀฀฀฀฀฀฀฀฀฀20140129
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123035_od
Current฀Data฀ParametersO
EtO OBn
OH
22a
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀18.23฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000182฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.0฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀57
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.11
Date_฀฀฀฀฀฀฀฀฀฀20140404
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae123830_od
22b
O
EtO OBn
OH
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5.31฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806663฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.5฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀101
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3072
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀23.06
Date_฀฀฀฀฀฀฀฀฀฀20140404
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123830_od
22b
O
EtO OBn
OH
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀29.80฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806908฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6919063฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.6฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.43
Date_฀฀฀฀฀฀฀฀฀฀20140405
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123830_od
22b
O
EtO OBn
OH
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀41.71฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8900417฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8924689฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀181
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.12
Date_฀฀฀฀฀฀฀฀฀฀20130422
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae120553_od
Current฀Data฀ParametersO
EtO OBn
OH
22c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1006฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2.27฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5524233฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8915996฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5635842฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀300.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9195.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.31
Date_฀฀฀฀฀฀฀฀฀฀20130422
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae120553_od
Current฀Data฀ParametersO
EtO OBn
OH
22c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1006฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5524178฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8915996฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5635842฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.11
Date_฀฀฀฀฀฀฀฀฀฀20130422
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae120553_od
Current฀Data฀ParametersO
EtO OBn
OH
22c
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀43.88฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8500439฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀161.3
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀18.22
Date_฀฀฀฀฀฀฀฀฀฀20131212
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122796_od
Current฀Data฀Parameters
22d
O
EtO OBn
OH
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.16฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423662฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9195.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.58
Date_฀฀฀฀฀฀฀฀฀฀20131212
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122796_od
Current฀Data฀Parameters
22d
O
EtO OBn
OH
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423598฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.17
Date_฀฀฀฀฀฀฀฀฀฀20131212
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122796_od
Current฀Data฀Parameters
22d
O
EtO OBn
OH
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.37฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8500084฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀128
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.30
Date_฀฀฀฀฀฀฀฀฀฀20140209
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae123137_od
Current฀Data฀Parameters
OO
OH
23a
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5.33฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423683฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀300.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9195.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.06
Date_฀฀฀฀฀฀฀฀฀฀20140209
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123137_od
Current฀Data฀Parameters
OO
OH
23a
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423598฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5.25
Date_฀฀฀฀฀฀฀฀฀฀20140209
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123137_od
Current฀Data฀Parameters
OO
OH
23a
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.88฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000089฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.3฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.48
Date_฀฀฀฀฀฀฀฀฀฀20140424
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae123987_od
OO
OH
23b
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.07฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806681฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.0฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀90.5
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.08
Date_฀฀฀฀฀฀฀฀฀฀20140424
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123987_od
OO
OH
23b
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−45.83฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806152฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6919063฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.4฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.49
Date_฀฀฀฀฀฀฀฀฀฀20140424
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123987_od
OO
OH
23b
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9.86฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8900099฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8924689฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀228.1
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.01
Date_฀฀฀฀฀฀฀฀฀฀20130426
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae120588_od
Current฀Data฀Parameters
OO
OH
23c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1006฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2.95฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5524240฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8915996฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5635842฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀300.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.20
Date_฀฀฀฀฀฀฀฀฀฀20130426
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae120588_od
Current฀Data฀Parameters
OO
OH
23c
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1006฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5524178฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8915996฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5635842฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5792.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀21.00
Date_฀฀฀฀฀฀฀฀฀฀20130426
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae120588_od
Current฀Data฀Parameters
OO
OH
23c
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀180.1฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9.40฀Hz
SF฀฀฀฀฀฀฀฀฀฀300.1300094฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀300.1318530฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀12.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀80.600฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀203
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9617012฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126210฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀6203.474฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀49152
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀฀฀฀av300
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20
Date_฀฀฀฀฀฀฀฀฀฀20131220
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀bae−131220−094451_od
OO
OH
23d
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀754.7฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.50฀Hz
SF฀฀฀฀฀฀฀฀฀฀฀75.4677525฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀300.1312005฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.98฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀฀75.4761254฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9.60฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀25.333฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀19736.842฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀152
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀98304
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀฀฀฀av300
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.35
Date_฀฀฀฀฀฀฀฀฀฀20131220
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀bae−131220−094451_od
OO
OH
23d
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀754.7฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.41฀Hz
SF฀฀฀฀฀฀฀฀฀฀฀75.4677466฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀300.1312005฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.98฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀23.20฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.60฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀฀75.4761254฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.20฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9.60฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀25.333฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1030
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀19736.842฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀76
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀98304
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀฀฀฀av300
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.43
Date_฀฀฀฀฀฀฀฀฀฀20131220
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀bae−131220−094451_od
OO
OH
23d
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.15฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000202฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.7฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀71.8
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.38
Date_฀฀฀฀฀฀฀฀฀฀20131008
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122178_od
BnO
OH
25
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5.37฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806664฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.8฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀90.5
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.16
Date_฀฀฀฀฀฀฀฀฀฀20131008
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122178_od
BnO
OH
25
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806578฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6919063฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.0฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀21.35
Date_฀฀฀฀฀฀฀฀฀฀20131008
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122178_od
BnO
OH
25
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.42฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000194฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.4฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀144
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.32
Date_฀฀฀฀฀฀฀฀฀฀20131008
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122177_od
BnO
O
21e
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.51฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806655฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.3฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀90.5
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.10
Date_฀฀฀฀฀฀฀฀฀฀20131008
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122177_od
BnO
O
21e
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806578฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6919063฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.5฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.29
Date_฀฀฀฀฀฀฀฀฀฀20131008
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122177_od
BnO
O
21e
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀18.63฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000186฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀295.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀71.8
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.48
Date_฀฀฀฀฀฀฀฀฀฀20131010
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122196_odO
EtO OBn
OH
22e
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806662฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.6฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀90.5
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.26
Date_฀฀฀฀฀฀฀฀฀฀20131010
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122196_odO
EtO OBn
OH
22e
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806578฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6919063฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀295.9฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.06
Date_฀฀฀฀฀฀฀฀฀฀20131010
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122196_odO
EtO OBn
OH
22e
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀240.2฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀12.34฀Hz
SF฀฀฀฀฀฀฀฀฀฀400.4000123฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀400.4024726฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.6฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.800฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀101
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9846387฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.125483฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8223.685฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀12.57
Date_฀฀฀฀฀฀฀฀฀฀20130814
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae121642_od
OO
OH
23e
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.91฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806659฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.1฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀90.5
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.16
Date_฀฀฀฀฀฀฀฀฀฀20130814
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae121642_od
OO
OH
23e
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1007฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.6806578฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀400.4016016฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.78฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−4.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.66฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.33฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.6918371฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.50฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5
D12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
D2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.5฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.50฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2050
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀96
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀AVIII400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.26
Date_฀฀฀฀฀฀฀฀฀฀20130814
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae121642_od
OO
OH
23e
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−6.95฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8499931฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀90.5
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.13
Date_฀฀฀฀฀฀฀฀฀฀20131116
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122580_od
Current฀Data฀Parameters
COOEt
OH
MeO OMe
30
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−36.87฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423261฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6502
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3072
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.07
Date_฀฀฀฀฀฀฀฀฀฀20131116
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122580_od
Current฀Data฀Parameters
COOEt
OH
MeO OMe
30
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−7.29฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423557฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7298.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀12.43
Date_฀฀฀฀฀฀฀฀฀฀20131116
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122580_od
Current฀Data฀Parameters
COOEt
OH
MeO OMe
30
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−7.87฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8499921฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀71.8
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.27
Date_฀฀฀฀฀฀฀฀฀฀20131118
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122597_od
Current฀Data฀ParametersOH
MeO OMe
OH
31
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−36.68฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423263฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5792.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀14.30
Date_฀฀฀฀฀฀฀฀฀฀20131118
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122597_od
Current฀Data฀ParametersOH
MeO OMe
OH
31
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−7.22฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423558฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6502
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀18.23
Date_฀฀฀฀฀฀฀฀฀฀20131118
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122597_od
Current฀Data฀ParametersOH
MeO OMe
OH
31
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−6.79฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8499932฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀90.5
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀18.36
Date_฀฀฀฀฀฀฀฀฀฀20131120
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae122630_od
Current฀Data฀ParametersOH
MeO OMe
OAc
32
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−36.71฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423263฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6502
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀21.12
Date_฀฀฀฀฀฀฀฀฀฀20131120
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae122630_od
Current฀Data฀ParametersOH
MeO OMe
OAc
32
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−7.27฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423557฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6502
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.31
Date_฀฀฀฀฀฀฀฀฀฀20131120
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae122630_od
Current฀Data฀ParametersOH
MeO OMe
OAc
32
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀12.11฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8500121฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀203.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.04
Date_฀฀฀฀฀฀฀฀฀฀20140206
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae123108_od
Current฀Data฀Parameters
OO
OH
23f
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3.38฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423664฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9195.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.23
Date_฀฀฀฀฀฀฀฀฀฀20140206
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123108_od
Current฀Data฀Parameters
OO
OH
23f
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.20฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423598฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9195.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9.03
Date_฀฀฀฀฀฀฀฀฀฀20140206
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123108_od
Current฀Data฀Parameters
OO
OH
23f
 
 
Appendix B 
 
Structural Revision and Elucidation of the Biosynthesis of 
Hypodoratoxide by 13C,13C COSY NMR Spectroscopy 
 
German Edition: DOI: 10.1002/ange.201501765Terpene Biosynthesis
International Edition: DOI: 10.1002/anie.201501765
Structural Revision and Elucidation of the Biosynthesis of
Hypodoratoxide by 13C,13C COSY NMR Spectroscopy
Lena Barra, Kerstin Ibrom, and Jeroen S. Dickschat*
Abstract: Feeding of (2,3,4,5,6-13C5)mevalonolactone to the
fungus Hypomyces odoratus resulted in a completely labeled
sesquiterpene ether. The connectivity of the carbon atoms was
easily deduced from a 13C,13C COSY spectrum, revealing
a structure that was different from the previously reported
structure of hypodoratoxide, even though the reported
13C NMR data matched. A structural revision of hypodorat-
oxide is thus presented. Its absolute configuration was tenta-
tively assigned from its co-metabolite cis-dihydroagarofuran.
Its biosynthesis was investigated by feeding of (3-13C)- and
(4,6-13C2)mevalonolactone, which gave insights into the com-
plex rearrangement of the carbon skeleton during terpene
cyclization by analysis of the 13C,13C couplings.
The mountaintop of molecular diversity within secondary
metabolites is represented by the more than 50000 known
terpenes from all kingdoms of life. Their biosynthesis involves
complex reactions that are usually catalyzed by a single
terpene cyclase, which converts a linear precursor, such as
geranyl diphosphate (GPP), farnesyl diphosphate (FPP), or
geranylgeranyl diphosphate (GGPP), into a terpene hydro-
carbon or alcohol. This conversion proceeds via cationic
intermediates in a domino reaction with several elementary
steps, such as cyclizations, hydride and proton shifts, Wagner–
Meerwein rearrangements, and fragmentations, resulting in
(poly)cyclic frameworks with several stereogenic centers.[1]
The initial product can be modified by oxygenases or acyl
transferases, for example, to generate a highly functionalized
terpenoid. The structural complexity of terpenoids renders
their structure elucidation difficult, and although structural
data of terpene cyclases have contributed significantly to our
understanding of terpene biosynthesis,[2–9] it is challenging to
gain insights into the intricate mechanisms of terpene
cyclizations. Herein, we present an approach that addresses
both problems by feeding of 13C-labeled precursors and
13C,13C correlation spectroscopy (COSY).
In our continued research program on the biosynthesis of
bacterial and fungal terpenes, we noticed that the production
of one major sesquiterpene 1 by the fungus Hypomyces
odoratus DSM 11934 was accompanied by traces of other
sesquiterpenes (Figure 1). Two of these co-metabolites were
identified by GC/MS as protoillud-6-ene (2) and cis-dihy-
droagarofuran (3 ; for mass spectra of 1–3, see the Supporting
Information, Figure S1).[10, 11] For the structure elucidation of
1, (2,3,4,5,6-13C5)mevalonolactone was synthesized according
to a known procedure (Scheme S1).[12, 13] In this isotopologue
of mevalonolactone, all five carbon atoms that are incorpo-
rated into terpenes are labeled. The compound was fed to
H. odoratus, from which [13C15]-1 was subsequently isolated
(16% incorporation; the material was mainly a mixture of
unlabeled and completely labeled 1, see Figure S2A). This
allowed for the structure elucidation of 1 by 13C,13C COSY
analysis, which revealed its planar structure (Figure 2).
For the elucidation of the relative configuration, unla-
beled 1 was isolated in a yield of 15 mgL¢1, and a full set of
NMR spectroscopic data, including 1H, 13C, 13C-DEPT-135,
1H,1H COSY, HSQC, HMBC, and NOESY spectra, was
recorded. Comparison of the 13C chemical shifts of 1 (in
CDCl3) to the chemical shifts of previously reported hypo-
doratoxide (in C6D6)
[14] suggested that 1 and hypodoratoxide
are identical, which was confirmed by re-examination of the
13C NMR spectrum of 1 in C6D6 (Table 1) and comparison of
the mass spectra. However, as the 13C,13C COSY spectrum
disagreed with the reported structure 4 of hypodoratoxide,[14]
a structural revision was required. The detected HMBC
correlations were in agreement with the structure delineated
from the 13C,13C COSY spectrum (Figure 3), while the over-
lap of signals from several protons in the 1H NMR spectrum
may have caused misinterpretations of HMBC correlations.
As this is a general problem in the structure elucidation of
structurally complex natural products, our findings demon-
strate the advantage of a 13C,13C-COSY-based structure
elucidation.
The relative configuration of 1 was determined by
NOESY spectroscopy (Figure 4). Key correlations were
observed between H7 (d= 1.57 ppm) and H11 (d= 1.25),
placing these on the same face of 1. This finding was
Figure 1. Total ion chromatogram of a headspace extract from Hypo-
myces odoratus DSM 11934.
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corroborated by a correlation between H6eq (d= 1.47 ppm)
and H15 (d= 1.03 ppm), which are in similar positions on the
opposite face. The equatorial position of H6eq was deduced
from a correlation between H6ax (d= 1.65 ppm) and H14 (d=
1.29 ppm). The configuration of the
spiro center, that is, the counter-
clockwise orientation of the C1, C7,
C8, C9, and C10 carbon atoms
when looking at 1 as depicted in
Figure 4, was evident from a corre-
lation between the axial H5ax atom
(d= 1.43 ppm) and H15 [the equa-
torial orientation of H5eq (d=
1.55 ppm) was delineated from its
correlation to H14].
A proposed mechanism for the
enzymatic conversion of FPP into
1 is shown in Scheme 1. The reac-
tion starts with the cyclization of
FPP to the (E,E)-germacradienyl
cation (A), which is attacked by
water to yield hedycaryol (5). Its
protonation initiates a cyclization
to cation B, which is followed by
a 1,2-hydride migration to yield C.
A subsequent 1,2-methyl shift
results in D, which gives rise to
1 upon Wagner–Meerwein rear-
rangement with ring contraction to
E and intramolecular attack of the
Figure 2. 13C,13C COSY spectrum of [13C15]-1 in CDCl3. All neighboring
carbon atoms along the bold lines of 1 showed cross-peaks, with the
exception of the two neighboring quaternary carbon atoms. The reason
for the missing signal is that spin relaxation of quaternary carbon
atoms is generally slower than for other carbon atoms. The C1¢C2
bond was instead inferred from the multiplicities of the signals
(Figure S3). An enlarged version of this Figure is presented as Fig-
ure S4.
Table 1: 1H NMR data of 1 and comparison of the 13C NMR data of 1 and hypodoratoxide in C6D6.
C[a] 1H[b]
1
13C[c]
1
13C[c]
hypodoratoxide[14]
2 86.7 (Cq) 86.7 (Cq)
12 81.3 (Cq) 81.3 (Cq)
1 51.7 (Cq) 51.8 (Cq)
4 1.64, m 44.0 (CH) 44.0 (CH)
10 2.34, dddd, 2J=13.6, 3J=7.0, 1.9, 4J=1.9
1.05, m
40.5 (CH2) 40.5 (CH2)
3 1.75, ddd, 2J=11.7, 3J=4.6, 4J=2.5
1.62, d, 2J=11.8
39.8 (CH2) 39.9 (CH2)
7 1.57, m 38.9 (CH) 38.9 (CH)
8 1.73, m
1.08, m
38.0 (CH2) 37.9 (CH2)
6 1.65, m
1.47, m
30.9 (CH2) 30.9 (CH2)
13 1.18, s 30.8 (CH3) 30.7 (CH3)
5 1.55, m
1.43, m
26.8 (CH2) 26.8 (CH2)
9 1.47, m
1.23, ddddd, 2J=12.0, 3J=12.0, 12.0, 7.1, 6.1
25.9 (CH2) 25.8 (CH2)
11 1.25, s 23.9 (CH3) 23.9 (CH3)
14 1.29, s 23.2 (CH3) 23.1 (CH3)
15 1.03, d, 3J=6.8 17.8 (CH3) 17.8 (CH3)
[a] Carbon numbering as shown in Figure 3. [b] Chemical shifts d in ppm; multiplicity m: s= singlet,
d=doublet, m=multiplet; coupling constants nJ refer to couplings via n bonds and are given in Hertz.
[c] Chemical shifts d in ppm; carbon assignments (CH3, CH2, CH, and Cq) were delineated from a DEPT
spectrum.
Figure 3. Key HMBC correlations of hypodoratoxide and their interpre-
tation for the revised (1) and reported structure (4). Carbon atom
numbering of 1 is based on IUPAC systematic nomenclature, whereas
carbon numbering of 4 followed the reported assignment of 13C NMR
signals (Table 1). Note that some of the interpretations of HMBC
correlations in the original work involve different hydrogen atoms than
in this work (e.g., the correlation H9/C2 is now interpreted as H6/C2;
the 1H NMR signals of H9 and H6 overlap).
Figure 4. Key NOESY correlations of hypodoratoxide (1).
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hydroxy group at the cationic center with inversion of
configuration. The formation of side product 3 is explained
by intramolecular attack of the hydroxy group at the cationic
center in C with retention of configuration (Figure 1). The
relative configuration of 3 is in line with that of 1. Knowledge
of the absolute configuration of 3 would point to the absolute
configuration of C, from which the absolute configuration of
1 could be inferred. Therefore, 18 mg of 3 were isolated from
H. odoratus with a yield of 3 mgL¢1. Its 13C NMR spectro-
scopic data matched those reported for cis-dihydroagarofuran
(3),[15] confirming the GC/MS-based identification. The
optical activity of isolated (+)-3 pointed to the absolute
configuration that is shown in Scheme 1, which is opposite to
that of (¢)-3 from Prostanthera ovalifolia (Lamiaceae),[16]
while this is the first report of (+)-3 from a natural source.
Consequently, the absolute configuration of hypodoratoxide
is (1R,2S,4S,7S)-1. This assignment is tentative because
a biosynthesis of 1 and 3 by two different terpene cyclases
cannot be ruled out.
The proposed cyclization mechanism for 1 was investi-
gated in two feeding experiments with the mevalonolactone
isotopologues (3-13C)-6a and (4,6-13C2)-6b.
[12] Feeding of 6a
resulted in the incorporation of the 13C label at the C3, C7,
and C11 positions of FPP (68% incorporation, Figure S2B)
and allowed for interesting insights into the terpene cycliza-
tion. The proposed ring contraction from D to E was directly
evident from the occurrence of doublets for the neighboring
labeled carbon atoms C1 and C7 in the 13C NMR spectrum
(Figure 5A). Feeding of 6b gave incorporation of labeling at
the C2, C6, C10, C13, C14, and C15 positions of FPP (10%
incorporation; see Figure S2C, for the carbon numbering of
FPP, see Scheme 1). The 13C NMR spectrum of the terpene
cyclization product showed doublets for the neighboring
labeled carbon atoms C2 and C11, which is indicative of the
1,2-methyl migration from intermediate C to D (Figure 5B).
The incorporation of labeling almost only at the C13 position
(ca. 90% of labeling from C13 of FPP) and only to a low
extent at the C14 position of 1 (ca. 10%) revealed a strict
stereochemical course for the attack of water at cation A. A
similar control of the stereochemical course of terpene
cyclizations in terms of the fate of the geminal methyl
groups of linear terpene precursors was previously observed
for other terpene cyclases.[1, 12, 17–19]
The strategy of labeling a natural product by feeding of
13C-labeled precursors for structure elucidation by advanced
NMR spectroscopic methods has been applied before in the
cases of the diterpene miltiradiene from the lycophyte
Selaginella moellendorfii,[20] solwaric acids A and B from the
Scheme 1. Biosynthesis of hypodoratoxide (1). Gray and black circles indicate 13C-labeled carbon atoms from two individual feeding experiments.
PP=diphosphate, WMR=Wagner–Meerwein rearrangement.
Figure 5. Investigation of the terpene cyclization mechanism by feed-
ing experiments. A) 13C NMR spectrum of [1,7,12-13C3]-1 obtained after
feeding of (3-13C)-6a. B) 13C NMR spectrum of [2,4,10,11,13,15-13C6]-
1 obtained after feeding of (4,6-13C2)-6b. The signals for C2 and C11
are also shown in enlarged versions (width: 800%). Some of the
additional 13C signals are due to incorporation into the minor product
3 of the hypodoratoxide synthase (labeled with asterisks). The signal at
d=23.1 ppm, which was assigned to a minor incorporation into the
C14 position of 1, may also partially account for incorporation into
C13 of 3.
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marine actinomycete Solwaraspora sp. WMMB-329,[21] and
the polyketide forazoline A from marine Actinomadura sp.
WMMB-499.[22] Herein, we provide an example that this
strategy makes structure elucidation not only easier, but can
also be superior because misinterpretations of HMBC
correlations are avoided.
Carefully designed feeding experiments with 13C-labeled
precursors can give detailed insights into rearrangements of
the carbon skeleton during the biosynthesis of a natural
product. Whereas rearrangement-induced 13C,13C couplings
have only very rarely been used to prove skeleton rearrange-
ments,[23] the feeding of multiply 13C-labeled precursors,
usually (1,2-13C2)acetate, and the loss of
13C,13C couplings
owing to bond cleavages in rearrangements has historically
been widely used.[24] An interesting complementary approach
to study the mechanisms of natural-product biosyntheses is
the usage of deuterium labeling, as recently performed to
follow epimerization reactions in the biosynthesis of non-
ribosomal peptides.[25, 26] Another study that combines the
usage of 13C and 2H labeling in mechanistic investigations of
a terpene cyclization has recently been reported from our
laboratories.[27] These and many other previous examples
demonstrate how isotopes can successfully be used to solve
special problems in natural-products chemistry.
Keywords: biosynthesis · isotopic labeling · NMR spectroscopy ·
structure elucidation · terpenoids
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Strain, culture conditions and feeding experiments. Hypomyces odoratus DSM 
11934 was obtained from the Deutsche Sammlung für Mikroorganismen und 
Zellkulturen (DSMZ) and cultured on agar plates containing oat agar medium (30.0 g 
oat flakes, boiled for 10 min in 1 L water, and then charged with 15.0 g agar before 
autoclavation). The fungus was incubated for 4 d at 22 °C and directly subjected to 
headspace analysis using a closed-loop stripping apparatus (CLSA).[1] Feeding 
experiments were conducted by distributing a solution of the 13C-labelled 
mevalonolactone isotopomers [2,3,4,5,6-13C5]mevalonolactone (SI-7) or 6a (10 mg in 
0.5 mL sterile water) with a syringe over a grown agar plate culture. To increase the 
incorporation rates in the experiment with 6a the agar medium was charged with 
lovastatin (100 mg L-1) after autoclavation. The feeding experiment with 6b was 
conducted by incubation of H. odoratus in liquid oat medium (100 mL) for 4 d at 22 
°C. After growth the culture was charged with labelled material (10 mg of 6b) and 
lovastatin (100 mg L-1). The fed agar plate and liquid cultures were immediately 
subjected to a CLSA for the collection of volatiles and the charcoal filters were 
extracted daily with 70 L of CDCl3 or C6D6 for 1 week. The combined extracts were 
directly subjected to NMR analysis. 
 
Collection of volatiles by CLSA. The volatiles emitted by H. odoratus grown on 
agar plate cultures were collected by use of a closed loop stripping apparatus (CLSA) 
as described previously.[1] A circulating air flow was directed over the grown agar 
plate culture and through a charcoal filter (Chromtech GmbH, Idstein, Precision 
Charcoal Filter, 5 mg) in a closed apparatus for 1 week. The charcoal filter was 
extracted daily with 70 L of either CDCl3 or C6D6 and the obtained extracts were 
combined and analyzed by NMR spectroscopy and GC-MS. 
 
GC/MS analysis of headspace extracts. GC-MS analyses for the headspace 
extracts were carried out on a HP 1890B GC system connected to a HP 5977 Mass 
Selective Detector fitted with a HP5-MS fused silica capillary column (30 m x 0.25 
mm i.d., 0.50 µm film). Measurement conditions: inlet pressure: 77.1 kPa, He 23.3 
mL/min; injection volume: 1 µL; injector: 250 °C; transfer line: 250 °C; electron 
energy: 70 eV. The GC was programmed as follows: 50 °C (5 min isothermic), 
increasing at 5 °C/min to 320 °C, and operated in split mode (10:1); carrier gas (He): 
1.0 mL/min. Retention indices were determined from a homologous series of n-
alkanes (C8 – C32).The identification of compounds was performed by comparison of 
mass spectra to data base spectra of commercially available libraries. 
 
Structure elucidation of 1 by 13C,13C-COSY. The volatile material emitted by a H. 
odoratus agar plate culture in the feeding experiment with [2,3,4,5,6-
13C5]mevalonolactone (SI-7) was collected as described above and subjected to 
13C,13C-COSY. 
 
Preparative scale isolation of (+)-hypodoratoxide (1) and (+)-cis-
dihydroagarofuran (3). H. odoratus was cultured on oat agar medium (2 L) using 
large petri dishes (20 cm diameter) for 4 d. The cultures were cut in small pieces and 
extracted with pentane (3 x 500 mL). The combined extracts were dried with MgSO4. 
After removal of the solvent the crude material (1.78 g) was purified by column 
chromatography using Merck silica gel 60 (0.040–0.063 mm) and pentane/diethyl 
ether (50:1) as eluent. Pure hypodoratoxide (30 mg) was obtained as a colourless oil. 
For isolation of the minor component cis-dihydroagarofuran H. odoratus was cultured 
on oat agar medium (6 L). The same extraction and workup procedure as described 
above yielded cis-dihydroagarofuran as a colourless oil (18 mg). Both compounds 
were subjected to NMR spectrocopy for full structure elucidation. 
(+)-Hypodoratoxide (1). IR (ATR): ˜ = 2936 (s), 2868 (m), 1456 (m), 1377 (m), 
1197 (w), 1140 (w), 1114 (w), 971 (w), 885 (s), 547 (w) cm-1. []D20 = +63.7 (c = 14.0, 
CHCl3). GC (HP5-MS): I = 1512. MS (EI, 70 eV): m/z (%) = 222 (7), 164 (9), 149 (5), 
111 (100), 95 (14), 82 (15), 67 (13), 55 (10), 43 (32). 
(+)-cis-Dihydroagarofuran (3). []D20 = +61.9 (c = 1.5, CHCl3), the reported optical 
rotary power for (–)-cis-dihydroagarofuran is []D25 = –87.6 (neat).[2] GC (HP5-MS): I 
= 1520. MS (EI, 70 eV): m/z (%) = 222 (9), 207 (100), 189 (38), 179 (5), 164 (17), 
149 (32), 137 (61), 123 (18), 109 (43), 95 (25), 81 (25), 69 (27), 55 (29), 43 (32). 1H-
NMR (400 MHz, CDCl3):  = 1.94 (m, 1H, CH), 1.93 (m, 1H, CH2), 1.80 (m, 1H, CH), 
1.72 (m, 1H, CH2), 1.64 (m, 1H, CH2), 1.62 (m, 1H, CH2), 1.61 (m, 1H, CH2), 1.55 (m, 
1H, CH2), 1.54 (m, 1H, CH2), 1.53 (m, 1H, CH2), 1.38 (m, 1H, CH2), 1.32 (s, 3H, 
CH3), 1.17 (m, 1H, CH2), 1.15 (m, 1H, CH2), 1.14 (s, 3H, CH3), 0.97 (m, 1H, CH2), 
0.89 (s, 3H, CH3), 0.83 (d, 3JH,H = 6.7 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3): 
 = 88.5 (Cq), 81.2 (Cq), 43.0 (CH), 39.7 (Cq), 36.8 (CH2), 35.3 (CH2), 33.2 (CH2), 
32.6 (CH), 30.7 (CH2), 30.1 (CH3), 25.9 (CH2), 23.1 (CH3), 22.5 (CH3), 21.6 (CH2), 
15.0 (CH3) ppm. 
 
NMR spectroscopy of isolated natural products. NMR (Nuclear magnetic 
resonance) spectra were recorded at 20 °C on a Bruker Avance II 600 spectrometer 
equipped with a TCI cryo probehead (Bruker BioSpin, Rheinstetten, Germany) 
operating at 600.1 MHz (1H) and 150.9 MHz (13C). Chemical shifts  were referenced 
to internal tetramethylsilane (1H,  = 0.00 ppm), C6D6 (13C,  = 128.0 ppm) or CDCl3 
(13C,  = 77.0 ppm), respectively.  
The techniques used to assign the 1H and 13C spectra were 13C-DEPT-135, 1H,1H-
COSY, 1H,1H-NOESY (mixing time 1s), 1H,13C-HSQC, 1H,13C-HMBC (optimised for 
JC,H = 8 Hz), and 13C,13C-COSY (relaxation delay 2 s, proton decoupled). Bruker 
standard pulse programs were applied throughout and with  the exception of the 
13C,13C-COSY experiment pulse sequences with gradient selection were applied for 
the two-dimensional spectra. Digital resolutions in the two-dimensional spectra were 
chosen small enough to distinguish cross peaks with similar chemical shifts (if 
possible). 
 
General Synthetic Methods. Chemicals were purchased from Acros Organics 
(Geel, Belgium) or Sigma-Aldrich Chemie GmbH (Steinheim, Germany). Solvents 
were purified by distillation, and dried according to standard methods. Oxygen and/or 
moisture sensitive reactions were carried out under inert atmosphere (N2) in vacuum-
heated flasks with dried solvents. Thin-layer chromatography (SiO2, TLC) was 
performed on 0.20 mm Macherey-Nagel silica gel plates (Polygram SIL G/UV254). 
Column chromatography was performed on Merck silica gel 60 (0.040–0.063 mm) 
using standard flash chromatographic methods. The NMR spectra of synthetic 
compounds were recorded on Bruker DRX-400 (400 MHz), AV III-400 (400 MHz) or 
AV II-300 (300 MHz) spectrometers, and were referenced against TMS ( = 0.00 
ppm) for 1H-NMR and CHCl3 ( = 77.01 ppm) for 13C-NMR. GC-MS analyses were 
performed on a HP 1890B GC system connected to a HP 5977 Mass Selective 
Detector fitted with a HP5-MS fused silica capillary column (30 m x 0.25 mm i.d., 0.50 
µm film). Measurement conditions: inlet pressure: 77.1 kPa, He 23.3 mL/min; 
injection volume: 1 µL; injector: 250 °C; transfer line: 250 °C; electron energy: 70 eV. 
The GC was programmed as follows: 50 °C (5 min isothermic), increasing at 5 
°C/min to 320 °C, and operated in split mode (50:1); carrier gas (He): 1.0 mL/min. 
Retention indices were determined from a homologous series of n-alkanes (C8 – C32). 
 
Synthesis of (2,3,4,5,6-13C5)mevalonolactone. This compound was synthesised via 
a reported procedure by Zamir and Nguyen using the labelled building blocks ethyl 
(1,2,3,4-13C4)acetoacetate (SI-1) and ethyl (2-13C)acetate (Scheme 1 of SI).[3,4] 
 
 
 
Scheme 1. Synthesis of (2,3,4,5,6-13C5)mevalonolactone (SI-7). 
 
Ethyl (1,2-13C2)-2-(2-(13C)methyl-5,5-dimethyl-(2-13C)-1,3-dioxan-2-yl)acetate (SI-
2). Yield: 1.63 g (7.4 mmol, 99%). GC (HP5-MS): I = 1342. 1H-NMR (400 MHz, 
C6D6):  = 3.98 (dq, 3JH,H = 7.2 Hz, 3JC,H = 3.2 Hz, 2H, CH2), 3.38 (dd, 2JH,H = 11.4 Hz, 
3JC,H = 3.7 Hz, 2H, 2 x CH2), 3.28 (dd, 2JH,H = 11.4 Hz, 3JC,H = 4.6 Hz, 2H, 2 x CH2), 
2.78 (dddd, 1JC,H = 129.8 Hz, 2JC,H = 6.9 Hz, 2JC,H = 6.4 Hz, 3JC,H = 3.5 Hz, 2H, CH2), 
1.68 (ddd, 1JC,H = 127.4 Hz, 2JC,H = 4.9 Hz, 3JC,H = 2.9 Hz, 3H, CH3), 0.96 (t, 3JH,H = 
7.1 Hz, 3H, CH3), 0.76 (s, 3H, CH3), 0.67 (s, 3H, CH3) ppm. 13C-NMR (100 MHz, 
C6D6):  = 169.1 (d, 1JC,C = 59.2 Hz, Cq), 97.7 (dd, 1JC,C = 48.0 Hz, 1JC,C = 44.3 Hz, 
Cq), 70.5 (dd, 2JC,C = 1.9 Hz, 3JC,C = 1.8 Hz, 2 x CH2), 60.2 (d, 2JC,C = 2.1 Hz, CH2), 
41.7 (ddd, 1JC,C = 59.3 Hz, 1JC,C = 44.2 Hz, 2JC,C = 3.8 Hz, CH2), 29.7 (d, 3JC,C = 2.3 
Hz, Cq), 23.3 (dd, 1JC,C = 47.9 Hz, 2JC,C = 3.9 Hz, CH3), 22.6 (s, CH3), 22.4 (s, CH3), 
14.2 (d, 3JC,C = 2.0 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 204 (32), 135 (35), 131 
(100), 118 (16), 107 (12), 89 (28), 69 (39), 56 (16), 45 (38).  
 
(1,2-13C2)-2-(2-(13C)methyl-5,5-dimethyl-(2-13C)-1,3-dioxan-2-yl)ethanol (SI-3). 
Yield: 1.18 g (6.73 mmol, 90%). GC (HP5-MS): I = 1238. 1H-NMR (400 MHz, C6D6):  
= 3.94 (dm, 1JC,H = 142.2 Hz, 2H, CH2), 3.28 (d, 2JH,H = 11.1 Hz, 2H, 2 x CH2), 3.11 
(dm, 2JH,H = 11.1 Hz, 2H, 2 x CH2), 2.81 (m, 1H, OH), 1.87 (dm, 1JC,H = 125.7 Hz, 2H, 
CH2), 1.17 (dm, 1JC,H = 126.1 Hz, 3H, CH3), 0.96 (s, 3H, CH3), 0.40 (s, 3H, CH3) ppm. 
13C-NMR (100 MHz, C6D6):  = 100.1 (ddd, 1JC,C = 46.3 Hz, 1JC,C = 46.3 Hz, 2JC,C = 
1.9 Hz, Cq), 70.2 (d, 2JC,C = 1.9 Hz, 2 x CH2), 58.8 (ddd, 1JC,C = 36.3 Hz, 2JC,C = 1.8 
Hz, 3JC,C = 1.8 Hz, CH2), 42.4 (ddd, 1JC,C = 46.8 Hz, 1JC,C = 36.3 Hz, 2JC,C = 3.8 Hz, 
CH2), 29.7 (d, 3JC,C = 2.4 Hz, Cq), 22.8 (s, CH3), 22.0 (s, CH3), 19.1 (ddd, 1JC,C = 45.9 
Hz, 2JC,C = 3.7 Hz, 3JC,C = 1.7 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 162 (84), 131 
(100), 93 (44), 76 (55), 69 (67), 56 (37), 45 (71). 
 
2-((1,2-13C2)-2-(benzyloxy)ethyl)-2-(13C)methyl-5,5-dimethyl-(2-13C)-1,3-dioxane 
(SI-4). Yield: 1.17 g (4.4 mmol, 65%). GC (HP5-MS): I = 1871. 1H-NMR (400 MHz, 
[2H6]DMSO):  = 7.37 - 7.25 (m, 5H, 5 x CH), 4.44 (d, 3JC,H = 3.9 Hz, 2H, CH2), 3.54 
(dm, 1JC,H = 141.6 Hz, 2H, CH2), 3.47 (dd, 2JH,H = 11.3 Hz, 3JC,H = 3.1 Hz, 2H, 2 x 
CH2), 3.35 (m, 2H, 2 x CH2), 1.96 (dm, 1JC,H = 126.2 Hz, 2H, CH2), 1.31 (ddd, 1JC,H = 
126.3 Hz, 2JC,H = 4.5 Hz, 3JC,H = 3.0 Hz, 3H, CH3), 0.91 (s, 3H, CH3), 0.82 (s, 3H, 
CH3) ppm. 13C-NMR (100 MHz, [2H6]DMSO):  = 138.6 (d, 3JC,C = 2.9 Hz, Cq), 128.2 
(s, 2 x CH), 127.4 (s, 2 x CH), 127.3 (s, CH), 97.5 (dd, 1JC,C = 46.2 Hz, 1JC,C = 46.2 
Hz, Cq), 71.9 (d, 2JC,C = 3.2 Hz, CH2), 69.2 (d, 2JC,C = 1.8 Hz, 2 x CH2), 65.5 (d, 1JC,C 
= 39.2 Hz, CH2), 37.3 (ddd, 1JC,C = 46.1 Hz, 1JC,C = 42.9 Hz, 2JC,C = 3.6 Hz, CH2), 
29.5 (d, 3JC,C = 2.4 Hz, Cq), 22.4 (s, CH3), 22.0 (s, CH3), 20.9 (dd, 1JC,C = 46.4 Hz, 
3JC,C = 3.5 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 252 (16), 164 (11), 131 (100), 
107 (21), 91 (84), 76 (16), 69 (32), 45 (33). 
 
(1,2,3,4-13C4)-4-(benzyloxy)butan-2-one (SI-5). Yield: 0.72 g (4.0 mmol, 92%). GC 
(HP5-MS): I = 1445. 1H-NMR (400 MHz, CDCl3):  = 7.38 - 7.24 (m, 5H, 5 x CH), 
4.51 (d, 3JC,H = 4.3 Hz, 2H, CH2), 3.74 (dm, 1JC,H = 143.1 Hz, 2H, CH2), 2.72 (dm, 
1JC,H = 126.0 Hz, 2H, CH2), 2.18 (ddd, 1JC,H = 127.2 Hz, 2JC,H = 5.9 Hz, 3JC,H = 1.3 Hz, 
3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 207.2 (ddd, 1JC,C = 40.4 Hz, 1JC,C = 
40.0 Hz, 2JC,C = 1.7 Hz, Cq), 138.1 (d, 3JC,C = 2.8 Hz, Cq), 128.4 (s, 2 x CH), 127.7 (s, 
2 x CH), 127.6 (s, CH), 73.2 (dd, 2JC,C = 3.8 Hz, 3JC,C = 1.4 Hz, CH2), 65.2 (d, 1JC,C = 
39.6 Hz, CH2), 43.7 (ddd, 1JC,C = 39.3 Hz, 1JC,C = 39.3 Hz, 2JC,C = 13.8 Hz, CH2), 30.4 
(d, 1JC,C = 40.6 Hz, 2JC,C = 14.1 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 121 (34), 
107 (100), 91 (86), 79 (26), 76 (21), 65 (12), 45 (38). 
 
Ethyl (2,3,4,5-13C4)-5-(benzyloxy)-3-hydroxy-3-(13C)methylpentanoate (SI-6). 
Yield: 0.74 g (2.7 mmol, 68%). GC (HP5-MS): I = 1907. 1H-NMR (400 MHz, CDCl3):  
= 7.38 - 7.25 (m, 5H, 5 x CH), 4.51 (d, 3JC,H = 4.0 Hz, 2H, CH2), 4.14 (m, 2H, CH2), 
3.94 (m, 1H, OH), 3.69 (dm, 1JC,H = 141.9 Hz, 2H, CH2), 2.53 (dm, 1JC,H = 129.2 Hz, 
2H, CH2), 1.91 (dm, 1JC,H = 126.4 Hz, 2H, CH2), 1.28 (dddd, 1JC,H = 126.3 Hz, 2JC,H = 
4.2 Hz, 3JC,H = 3.9 Hz, 3JC,H = 3.9 Hz, 3H, CH3), 1.25 (t, 3JH,H = 7.2 Hz, 3H, CH3) ppm. 
13C-NMR (100 MHz, CDCl3):  = 172.4 (d, 1JC,C = 55.0 Hz, Cq), 138.0 (d, 3JC,C = 2.9 
Hz, Cq), 128.4 (s, 2 x CH), 127.7 (s, CH), 127.6 (s, 2 x CH), 73.2 (dd, 2JC,C = 3.6 Hz, 
3JC,C = 1.5 Hz, CH2), 70.7 (dddd, 1JC,C = 38.5 Hz, 1JC,C = 38.5 Hz, 1JC,C = 38.5 Hz, 
2JC,C = 1.0 Hz, Cq), 66.9 (dd, 1JC,C = 38.7 Hz, 2JC,C = 1.4 Hz, CH2), 60.5 (s, CH2), 45.5 
(dd, 1JC,C = 37.4 Hz, 2JC,C = 2.2 Hz, CH2), 40.3 (dd, 1JC,C = 38.4 Hz, 1JC,C = 38.4 Hz, 
CH2), 27.1 (d, 1JC,C = 40.2 Hz, 2JC,C = 1.8 Hz, CH3), 14.1 (s, CH3) ppm. MS (EI, 70 
eV): m/z (%) = 183 (2), 164 (29), 147 (21), 134 (9), 107 (21), 101 (11), 91 (100), 79 
(9), 45 (16). 
 
(2,3,4,5,6-13C5)Mevalonolactone (SI-7). Yield 0.23 g (1.7 mmol, 62%). GC (HP5-MS, 
MSTFA): I = 1375. 1H-NMR (300 MHz, CDCl3):  = 4.61 (dm, 1JC,H = 150.9 Hz, 1H, 
CH2), 4.36 (dm, 1JC,H = 150.3 Hz, 1H, CH2), 2.67 (ddm, 1JC,H = 132.8 Hz, 2JH,H = 17.8 
Hz, 1H, CH2), 2.52 (ddm, 1JC,H = 126.8 Hz, 2JH,H = 17.5 Hz, 1H, CH2), 2.35 (br s, 1H, 
OH), 1.92 (dm, 1JC,H = 130.4 Hz, 1H, CH2), 1.33 (dddd, 1JC,H = 126.3 Hz, 2JC,H = 4.3 
Hz, 3JC,H = 4.3 Hz, 3JC,H = 4.3 Hz, 3H, CH3) ppm. 13C-NMR (75 MHz, CDCl3):  = 
170.7 (d, 1JC,C = 51.6 Hz, Cq), 68.2 (dddd, 1JC,C = 38.1 Hz, 1JC,C = 38.1 Hz, 1JC,C = 
38.1 Hz, 2JC,C = 2.4 Hz, Cq), 66.1 (dd, 1JC,C = 34.6 Hz, 2JC,C = 2.0 Hz, CH2), 44.6 (ddd, 
1JC,C = 36.5 Hz, 2JC,C = 2.3 Hz, 2JC,C = 2.3 Hz, CH2), 35.8 (ddd, 1JC,C = 35.1 Hz, 1JC,C 
= 35.1 Hz, 2JC,C = 2.0 Hz, CH2), 29.7 (dddd, 1JC,C = 39.8 Hz, 2JC,C = 2.3 Hz, 2JC,C = 
2.3 Hz, 3JC,C = 2.3 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 207 (<1), 192 (16), 161 
(11), 149 (100), 133 (6), 118 (86), 103 (20), 75 (78), 45 (32). 
  
  
Figure 1. Mass spectra and retention indices of A) hypodoratoxide (1), B) protoillud-
6-ene (2), and C) cis-dihydroagarofuran (3). Retention index literature data were 
taken from references [5] (compound 2) and [6] (compound 3). 
 
  
Figure 2. Mass spectra of 13C-labelled 1 obtained in feeding experiments with 13C-
labelled isotopologs of mevalonolactone. A) Mass spectrum of [13C15]-1 obtained after 
feeding of (2,3,4,5,6-13C5)mevalonolactone, B) mass spectrum of [13C3]-1 obtained 
after feeding of (3-13C)mevalonolactone, C) mass spectrum of [13C6]-1 obtained after 
feeding of (4,6-13C)mevalonolactone. 
The mass spectrum of Figure 2A shows that the labelled material is mainly a mixture 
of unlabelled 1 (indicated by its molecular ion at m/z = 222) and completely labelled 
[13C15]-1 (indicated by its molecular ion at m/z = 237), while other expected 
isotopologs arising by incorporation of only one or two 13C-labelled isoprene units 
from (2,3,4,5,6-13C5)mevalonolactone are missing. This finding may be explained by 
the special setup of the feeding experiments. First, the H. odoratus agar plates were 
incubated until the fungus was fully grown. At this point the isotopically labelled 
mevalonolactone was fed to the culture. The administration of the mevalonolactone 
may have resulted in high incorporation rates into 1, explaining the formation of 
mainly [13C15]-1. This material was then isolated as a mixture with non-labelled 1 that 
was produced by the fungus before administration of (2,3,4,5,6-
13C5)mevalonolactone. 
A similar observation was made in the feeding experiment with (3-
13C)mevalonolactone (Figure 2B), while the “usual” dilution and statistical distribution 
of administered labelling was observed in the feeding of (4,6-13C)mevalonolactone 
(Figure 2C). These different outcomes were also reflected by a few unsuccessful 
attempts during the feeding experiments. Although the feeding experiments were 
always conducted in the same way, the fungal cultures were obviously in different 
and difficult to control metabolic stages, that result in different incorporation rates and 
distributions of the isotopic labelling. 
  
Figure 3. Detailed analysis of the coupling patterns of 13C-labelled hypodoratoxide 
obtained in the feeding experiment with (2,3,4,5,6-13C5)mevalonolactone. For each 
13C-signal the coupling constants, multiplicities of the main signal originating from 
(13C5)hypodoratoxide, and the neigbouring carbons are given. The structural formula 
shows the three isoprene units in different colours (cf. discussion of biosynthesis in 
main text). 
 
As indicated by the mass spectrum (Figure 2A of SI), the hypodoratoxide isolated 
from the feeding experiment with (2,3,4,5,6-13C5)mevalonolactone is mainly 
composed of unlabelled and (13C5)hypodoratoxide. While the unlabelled material 
leads to sharp singlets (e. g. at  = 87.2 ppm for C-2, note that the difference to the 
chemical shift in Table 1 of main text is due to a different solvent, CDCl3 instead of 
C6D6), the completely labelled material shows broad multipletts from which the 
number of directly neighbouring carbons can be inferred (e. g. the quartet for C-2 
indicated 3 neighbouring carbons, C-1, C-3 and C-11). The mass spectrum in Figure 
2A of SI also shows that very little of the material is composed of only one or two 13C-
labelled isoprene units. Thus, in rare cases two neigbouring carbons from different 
isoprene units may not both be labelled. This leads to additional small signals with 
lower multiplicities at the borders of isoprene units, shown in red boxes, e. g. for C-3 
(doublet due to coupling with C-2 from the same, but not with C-4 from a different 
isoprene unit) and C-4 (triplett due to coupling with C-5 and C-12 from the same, but 
not with C-3 from a different isoprene unit). The observed pattern is in full agreement 
with the biosynthetic mechanism as discussed in the main text. 
  
  
Figure 4. Enlargement of Figure 2 of main text. All relevant crosspeaks for the fifteen 
13C-13C-connections are shown in red (only shown for the north-western half of the 
13C,13C-COSY spectrum). The expected crosspeak for the 16th bond between the 
quarternary carbons is missing (cf. discussion in main text). 
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Date_฀฀฀฀฀฀฀฀฀฀20140204
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123065_od
Current฀Data฀Parameters
EtO
O O O
SI-2
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−8.12฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423549฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.49
Date_฀฀฀฀฀฀฀฀฀฀20140204
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123065_od
Current฀Data฀Parameters
EtO
O O O
SI-2
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−5.60฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8499944฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀298.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀114
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.59
Date_฀฀฀฀฀฀฀฀฀฀20140204
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae123070_od
Current฀Data฀Parameters
HO
O O
SI-3
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−36.57฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423264฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4597.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.18
Date_฀฀฀฀฀฀฀฀฀฀20140204
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123070_od
Current฀Data฀Parameters
HO
O O
SI-3
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−7.49฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423555฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7298.2
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀C6D6
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.58
Date_฀฀฀฀฀฀฀฀฀฀20140204
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123070_od
Current฀Data฀Parameters
HO
O O
SI-3
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.87฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8500049฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀128
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀DMSO
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.13
Date_฀฀฀฀฀฀฀฀฀฀20140205
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae123090_od
Current฀Data฀Parameters
BnO
O O
SI-4
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀52.18฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5424152฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀DMSO
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.20
Date_฀฀฀฀฀฀฀฀฀฀20140205
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123090_od
Current฀Data฀Parameters
BnO
O O
SI-4
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀56.76฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5424198฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5792.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀฀DMSO
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.12
Date_฀฀฀฀฀฀฀฀฀฀20140205
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123090_od
Current฀Data฀Parameters
BnO
O O
SI-4
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.76฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8500168฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀143.7
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.53
Date_฀฀฀฀฀฀฀฀฀฀20140206
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae123107_od
Current฀Data฀Parameters
BnO
SI-5
O
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.37฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423674฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀300.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1024
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.12
Date_฀฀฀฀฀฀฀฀฀฀20140206
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123107_od
Current฀Data฀Parameters
BnO
SI-5
O
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀145.13฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5425081฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4096
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀512
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.52
Date_฀฀฀฀฀฀฀฀฀฀20140206
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123107_od
Current฀Data฀Parameters
BnO
SI-5
O
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀239.9฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.87฀Hz
SF฀฀฀฀฀฀฀฀฀฀399.8500159฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
F2฀−฀Processing฀parameters
SFO1฀฀฀฀฀฀฀฀399.8524687฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.20฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀60.400฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀143.7
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9584243฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126314฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀8278.146฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀64
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀17.22
Date_฀฀฀฀฀฀฀฀฀฀20140212
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀฀฀bae123190_od
Current฀Data฀Parameters
SI-6
O
EtO OBn
OH
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2.77฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423658฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀1.89999998฀sec
d11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀300.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8192
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3072
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀21.16
Date_฀฀฀฀฀฀฀฀฀฀20140212
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀฀฀bae123190_od
Current฀Data฀Parameters
SI-6
O
EtO OBn
OH
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀1005฀Hz/cm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀23.34฀Hz
SF฀฀฀฀฀฀฀฀฀฀100.5423863฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
F2฀−฀Processing฀parameters
SFO2฀฀฀฀฀฀฀฀399.8515994฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.06฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
p4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀20.00฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀100.5535241฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−3.00฀dB
p2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀22.00฀usec
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
DELTA฀฀฀฀฀฀฀฀0.00001401฀sec
d12฀฀฀฀฀฀฀฀฀฀0.00002000฀sec
d2฀฀฀฀฀฀฀฀฀฀฀0.00344828฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
CNST2฀฀฀฀฀฀฀145.0000000
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀299.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀7.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀19.000฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀5792.6
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀26315.789฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2048
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀131072
PULPROG฀฀฀฀฀฀฀฀฀dept135
PROBHD฀฀฀5฀mm฀QNP฀1H/13
INSTRUM฀฀฀฀฀฀฀฀฀฀drx400
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀23.52
Date_฀฀฀฀฀฀฀฀฀฀20140212
F2฀−฀Acquisition฀Parameters
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀3
NAME฀฀฀฀฀฀฀bae123190_od
Current฀Data฀Parameters
SI-6
O
EtO OBn
OH
12 11 10 9 8 7 6 5 4 3 2 1 0 ppm
Scale:฀0.6฀ppm/cm,฀180.1฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀฀−0.800฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀฀13.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀8.12฀Hz
SF฀฀฀฀฀฀฀฀฀฀300.1300081฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32768
SFO1฀฀฀฀฀฀฀฀300.1318530฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀12.00฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D1฀฀฀฀฀฀฀฀฀฀฀1.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀296.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀80.600฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀161
AQ฀฀฀฀฀฀฀฀฀฀฀฀3.9617012฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.126210฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀฀6203.474฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀32
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀49152
PULPROG฀฀฀฀฀฀฀฀฀฀฀฀zg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀฀฀฀av300
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀10.57
Date_฀฀฀฀฀฀฀฀฀฀20140214
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
NAME฀฀฀฀฀bae−140214−104957_od
OO
OH
SI-7
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀754.7฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4.24฀Hz
SF฀฀฀฀฀฀฀฀฀฀฀75.4677532฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀300.1312005฀MHz
PL13฀฀฀฀฀฀฀฀฀฀฀฀฀฀16.00฀dB
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.98฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
NUC2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1H
CPDPRG2฀฀฀฀฀฀฀฀฀waltz16
========฀CHANNEL฀f2฀========
SFO1฀฀฀฀฀฀฀฀฀75.4761254฀MHz
PL1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
P1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀9.60฀usec
NUC1฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀13C
========฀CHANNEL฀f1฀========
TD0฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
D11฀฀฀฀฀฀฀฀฀฀0.03000000฀sec
D1฀฀฀฀฀฀฀฀฀฀฀2.00000000฀sec
TE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀297.2฀K
DE฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀6.00฀usec
DW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀25.333฀usec
RG฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀362
AQ฀฀฀฀฀฀฀฀฀฀฀฀2.4904180฀sec
FIDRES฀฀฀฀฀฀฀฀฀0.200774฀Hz
SWH฀฀฀฀฀฀฀฀฀฀฀19736.842฀Hz
DS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀4
NS฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀152
SOLVENT฀฀฀฀฀฀฀฀฀฀฀CDCl3
TD฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀98304
PULPROG฀฀฀฀฀฀฀฀฀฀zgpg30
PROBHD฀฀฀5฀mm฀PABBO฀BB−
INSTRUM฀฀฀฀฀฀฀฀฀฀฀av300
Time฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.12
Date_฀฀฀฀฀฀฀฀฀฀20140214
PROCNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1
EXPNO฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀2
NAME฀฀฀฀฀bae−140214−104957_od
OO
OH
SI-7
220 210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
Scale:฀10฀ppm/cm,฀754.7฀Hz/cm
F2P฀฀฀฀฀฀฀฀฀฀฀฀฀−10.000฀ppm
F1P฀฀฀฀฀฀฀฀฀฀฀฀฀230.000฀ppm
PC฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.40
GB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
LB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀1.00฀Hz
SSB฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀0
WDW฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀EM
SR฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−2.41฀Hz
SF฀฀฀฀฀฀฀฀฀฀฀75.4677466฀MHz
SI฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀65536
SFO2฀฀฀฀฀฀฀฀300.1312005฀MHz
PL12฀฀฀฀฀฀฀฀฀฀฀฀฀฀15.98฀dB
PL2฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀−1.00฀dB
PCPD2฀฀฀฀฀฀฀฀฀฀฀฀฀80.00฀usec
P4฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀23.20฀usec
P3฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀฀11.60฀usec
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Harzianone Biosynthesis by the Biocontrol Fungus Trichoderma 
Lena Barra[a] and Jeroen S. Dickschat*[a] 
 
Abstract: Analysis of the volatile terpenes produced by seven fungal 
strains of the genus Trichoderma by use of a closed-loop stripping 
apparatus (CLSA) revealed a common production of harzianone, a 
bioactive, structurally unique diterpenoid consisting of a fused 
tetracyclic 4,5,6,7-membered ring system. The terpene cyclization 
mechanism was studied by feeding experiments using selectively 
13C- and 2H-labeled synthetic mevalonolactone isotopologues, 
followed by analysis of the incorporation patterns by 13C-NMR 
spectroscopy and GC/MS. The structure of harzianone was further 
supported from a 13C,13C-COSY experiment of the in vivo generated 
fully 13C-labeled diterpene.  
Introduction 
Fungi of the genus Trichoderma are widespread in soil and 
wood habitats and are known for their opportunistic avirulent 
plant beneficial attributes.[1] They are used as environmentally 
friendly biocontrol agents, because of their positive effect on root 
growth and development, crop productivity and nutrient uptake.[2] 
One aspect in the complex mechanisms of Trichoderma-plant-
pathogen interaction is the ability of Trichoderma to parasitize 
other fungi, thereby protecting the plant from harmful 
phytopathogens.[3] This ability can be attributed to the production 
of cellulose and chitin degrading enzymes and the production of 
diverse bioactive secondary metabolites.[4] A well-known 
example is the diketopiperazine gliotoxine (1, Scheme 1) that 
was first isolated from Gliocladium fimbriatum, a fungus that was 
later reclassified as T. virens.[5] Gliotoxine is an 
immunosuppressive, toxic, antimicrobial compound that plays an 
important role in pathogen defense.[6] Fungi are also known as 
producers of volatiles with often distinct functions.[7] A series of 
volatile pyrones such as 2 were isolated from Trichoderma,[8] 
which exhibit growth inhibitory properties against 
phytopathogenic fungi including Aspergillus, Botrytis, 
Rhizoctonia, Sclerotinia and Pyrenochaeta.[9] A volatile 
sesquiterpene alcohol that is frequently released by 
Trichoderma is tricho-acorenol (3) that was first identified from 
culture extracts of Trichoderma koningii.[10] Its absolute 
configuration was deduced by enantioselective synthesis,[11] and 
its biosynthesis was addressed by feeding experiments with 
isotopically labeled precursors.[12] Furthermore, a series of 
structurally unique and biosynthetically related diterpenes 
represented by harzianone (4),[13] harziandione (5)[14] and 
trichodermaerin (6)[15] were isolated from Trichoderma. Notably, 
5 and the related diterpenoids 7 – 9 were recently isolated from 
a Trichoderma symbiont of the taxane producing plant Taxus 
baccata.[16] Diketone 5 is a strong antifungal compound active 
against the plant pathogenic fungus Sclerotium rolfsii,[17] 
whereas ketone 4 lacks such an antifungal activity, but exhibits 
activity against Escherichia coli and Staphylococcus aureus and 
in a brine shrimp (Artemia salina) toxicity assay.[13] The absolute 
configuration of 4 was determined by comparison of 
experimental to calculated ECD spectroscopic data,[13] but so far 
no studies regarding the biosynthesis of this unique tetracyclic 
diterpene have been conducted. We have recently developed a 
method that combines feeding of 13C-labeled mevalonolactones 
and capturing of the resulting labeled volatile terpenes by 
collection with a closed-loop stripping apparatus, that allows for 
a direct analysis of the headspace extracts by 13C-NMR (CLSA-
NMR).[18] This method is especially powerful, if the biosynthesis 
of volatile terpenoids is to be addressed, for which the classical 
method of liquid culture extraction and compound isolation in 
preparative amounts can be significantly hampered because of 
the danger of compound loss during solvent evaporation steps. 
Furthermore, the biosynthetic investigations can be performed 
with only a single agar plate culture and thus require only small 
amounts of the expensive 13C-labeled precursors. Here we 
present our insights into harzianone (4) biosynthesis by 
application of this method to the fungus Trichoderma. 
 
 
Scheme 1. Structures of known secondary metabolites from Trichoderma. 
Results and Discussion 
The volatile terpenes released by seven fungi of the genus 
Trichoderma were analyzed by use of a CLSA (Figure 1A and 
Figure S1).[19] In all headspace extracts tricho-acorenol (3) was 
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found as the main constituent, except for T. atroviride, which 
produces large amounts of 2. Furthermore, all seven strains 
produced a compound with a mass spectrum that suggested the 
structure of an oxidized diterpene hydrocarbon, as indicated by 
the molecular ion at m/z = 286 (Figure 1B), but the mass 
spectrum was not included in our mass spectral libraries, 
preventing instantaneous compound identification. Since 
production of this compound was the highest in Trichoderma sp. 
34, this strain was chosen for all further experiments. 
 
 
Figure 1. A) Representative total ion chromatogram of the headspace extract 
of Trichoderma sp. 34 and B) EI mass spectrum of harzianone (4). 
 
Figure 2. 13C,13C-COSY spectrum of (13C20)-4 in C6D6 and C,C connectivities 
deduced from the cross peaks shown in red (bold lines in structure). 
In order to identify the detected compound, its isolation by 
solvent extraction of agar plate cultures was tried several times, 
but the production was too low to obtain sufficient material for 
structure elucidation by NMR. Therefore, feeding experiments 
with (2,3,4,5,6-13C5)mevalonolactone[18f] ((2,3,4,5,6-13C5)-10) 
were carried out, in which all five carbons ending up in the 
terpene monomers dimethylallyl diphosphate (DMAPP, 11) and 
isopentenyl diphosphate (IPP, 12) are 13C-labeled. In a typical 
experiment 10 mg of the labeled compound were fed to a 
standard agar plate culture (ca. 30 mL of medium), followed by 
collection of volatiles by CLSA for the next seven days. The 
charcoal filter was extracted with 50 L C6D6 every day and the 
collected extracts were directly used for further analysis. GC/MS 
analysis revealed an increased production of the diterpenoid due 
to the administration of the terpene precursor and a high 
incorporation of labeling (91% incorporation rate, Figure S2). 
The content of the labeled diterpene in the sample was sufficient 
for recording a 13C,13C-COSY spectrum that hinted at the 
structure of harzianone (4, Figure 2). Since a few crosspeaks for 
correlations to quaternary carbons were missing, the isolation of 
non-labelled 4 was tried again from a large number of agar 
plates (100 plates), resulting in the isolation of 3.8 mg of pure 4. 
Its structure was confirmed by 1H-, 13C-, 13C-DEPT-135, 1H,1H-
COSY, 1H,13C-HSQC, 1H,13C-HMBC, and 1H,1H-NOESY and 
comparison of recorded to literature data (Figure S4 – S10).[13,16] 
The terpene cyclization mechanism of 4 was studied by feeding 
of a series of synthetic 13C-labeled mevalonolactones (10).[18e] 
Three different possibilities for the fold of the diterpene precursor 
geranylgeranyl diphosphate (GGPP, 13) may explain the 
formation of the harzianone backbone (Scheme 2A), but one of 
these folds as shown in I-4 resembles the most straight forward 
arrangement, while the GGPP cyclization mechanisms for the 
substrate folds as in II-4 and III-4 are more difficult to understand. 
In order to distinguish between these possibilities, (4,5-13C2)-10 
was synthesized from ethyl (1,2-13C2)acetoacetate by a known 
procedure (Scheme S1)[20] and fed to Trichoderma sp. 34, 
resulting in the incorporation of labeling into eight carbons of 4 
with 51% incorporation rate, resulting in two contiguous spin 
systems, C10-11 (1JC,C = 43.0 Hz) and C3-2-15-14-6-7 with 
doublet signals for C7 and C3 (1JC7,C6 = 35.0 Hz, 1JC3,C2 = 34.0 
Hz) and doublets of doublets for the carbons at the internal 
positions (Figure 3A, Table S1). These findings strongly support 
the GGPP fold implied by I-4 for the biosynthesis of 4, which 
was further supported by similar feeding experiments with (6-
13C)-, (2,6-13C2), (3-13C)- and (3,5-13C2)-10 (Figures 3B-E, Table 
S1). 
A plausible cyclization mechanism from GGPP (13) that is in line 
with all feeding experiments with the 13C-labeled 
mevalonolactone isotopomers is illustrated in Scheme 2B. After 
initial abstraction of the pyrophosphate group in 13, the allylic 
cation is attacked by the terminal double bond to build up a 14-
membered ring system under formation of a tertiary cation A, 
which is subsequently attacked by the neighbouring double bond 
to form cation B. Intermediate B then undergoes a 1,2-hydride 
shift to C, followed by two cyclization steps yielding the harzianyl 
cation D. The formation of known 7 can be explained by a 
terminating attack of water to D, whereas its deprotonation may 
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yield 14, which is a so far unknown diterpene. Subsequent allylic 
oxidation at C11 gives harzianone 4, possibly via alcohol 
intermediate 8. The other harzianone derivatives 5, 6 and 9 can 
be explained by additional oxidations of 4. 
 
 
Scheme 2. Biosynthetic considerations for the generation of 4. A) Different 
possibilities for GGPP folds (bold) to explain the formation of the harzianone 
skeleton. The arrow in III-4 indicates a required carbon backbone 
rearrangement. B) biosynthetic mechanism to 4 and related derivatives. 
The stereochemical course of the cyclization mechanism for 
GGPP to 4 in terms of the fate of the stereochemically distinct 
terminal geminal methyl groups could be followed by the feeding 
experiment with (6-13C)-10 that results in the specific 
incorporation of labeling into only one of the geminal methyl 
groups in 4 (C16, no incorporation into C17, Figure 3B). This 
finding suggests that the conformation of the intermediate cation 
A is strictly controlled by the enzyme, allowing no rotation of the 
C1-16-17 group prior to the further cyclization to B, and is in line 
with similar results obtained for various other terpenes including 
2-methylisoborneol, hypodoratoxide or pentalenolactone.[18e,18f,21] 
A scrambling of labeling has so far only been observed in 
combination with 1,2-hydride shifts into an isopropyl group as in 
guaia-6,10(14)-diene and -pinacene biosynthesis.[22] 
 
Figure 3. Results of feeding experiments. 13C-NMR spectra of CLSA extracts 
after feeding of A) (4,5-13C2)-10 (51% incorporation), B) (6-13C)-10 (91% 
incorporation), C) (2,6-13C2)-10 (76% incorporation), D) (3-13C)-10 (70% 
incorporation), E) (3,5-13C2)-10 (93% incorporation). Colored dots indicate 13C 
label. Asterisk indicate signals from solvent contaminations or other terpenoid 
signals. 
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The biosynthesis of 4 was further studied by feeding of 
deuterated mevalonolactones[23] and analysis of the 
incorporation and fragment ions by GC/MS. The advantage of 
using deuterated precursors is the possible gas 
chromatographic separation of the obtained isotopologues of 4 
due to their deuterium content (Figure S3). This allows for the 
interpretation of the mass spectra of the maximum deuterated 
isotopologues that are not overlapped with mass spectra of 
isotopologues with a lower deuterium content that can arise by 
dilution of the fed labeled material with mevalolactone 
synthesized by the fungus. The aim of the feeding experiments 
with the deuterated mevalonolactones was to prove the 1,2-
hydride shift from B to C during the cyclization of GGPP to 14 as 
the precursor to 4. This requires to localize the positions of 
incorporation of deuterium labelings from the EI mass spectra of 
deuterated 4. For this purpose, an EI-MS fragmentation 
mechanism explaining the formation of the fragment ion at m/z = 
229 was developed (Scheme 3). The electron impact ionization 
of 4 may result in radical cation E that can undergo two 
subsequent -cleavage reactions via F to G. A hydrogen atom 
transfer results in H that produces cation J (m/z = 229) in 
another -fragmentation with extrusion of a C4H9 radical (I). 
Scheme 3. EI-MS fragmentation mechanism to fragment ion m/z = 229. 
This hypothetical fragmentation mechanism was supported by 
the results from three feeding experiments. First, feeding of 
(6,6,6-2H3)-10 resulted in the incorporation of up to twelve 
deuterium atoms into 4, as indicated by the molecular ion of m/z 
= 298. Fragment ion J was increased by 9 amu (m/z = 238, 
Figure 4A) which supports the suggested mechanism for its 
formation. Similarly, the feeding experiment with (2,2,6,6,6-2H5)-
10 resulted in an increased molecular ion of deuterated 4 to m/z 
= 306 (Figure 4B), showing the incorporation of up to twenty 
deuterium atoms, fifteen of which end up in J (increased to m/z 
= 244), which is again in line with the mechanism of Scheme 3. 
Finally, feeding of (5,5,6,6,6-2H5)-10 produced deuterated 4 with 
a maximum deuterium content of eighteen deuterium atoms (m/z 
= 304, Figure 4C, two deuterium atoms are lost in the oxidation 
of 14 to 4). Along the fragmentation pathway to J a hydrogen 
atom is suggested to be transferred from radical cation G to H, 
and this hydrogen atom is exchanged by deuterium in the 
feeding experiment with (5,5,6,6,6-2H5)-10. As a consequence, 
fragment ion J is observed at m/z = 241. Taken together, all 
three feeding experiments support the fragmentation mechanism 
for J as shown in Scheme 3.  
 
Figure 4. Results of feeding experiments with deuterated mevalonolactones. 
Mass spectrum of harzianone with highest deuterium incorporation after 
feeding of A) (6,6,6-2H3)-10, B) (2,2,6,6,6-2H5)-10, C) (5,5,6,6,6-2H5)-10, D) 
(4,4,6,6,6-2H5)-10. Colored dots indicate positions of 2H labelings. 
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The critical feeding experiment to follow the 1,2-hydride shift 
from intermediate B to C in the cyclization of GGPP to 4 was 
subsequently performed with (4,4,6,6,6-2H5)-10. The expected 
labeling pattern of 4 with the maximum deuterium content is 
shown in Figure 4D. Notably, the 1,2-hydride shift should cause 
incorporation of labeling at C5 of 4. The molecular ion of 
deuterated 4 was observed at m/z = 301, indicating the 
incorporation of fifteen of the sixteen deuterium atoms from 
GGPP into 4 (one deuterium atom is lost by the final 
deprotonation step from D to 14). The fragment ion m/z = 240 
shows incorporation of eleven of these deuterium atoms into J, 
in other words four deuterium atoms are extruded with fragment 
I. These findings are in line with the 1,2-hydride transfer from B 
to C. 
Conclusions 
In conclusion we analyzed the cyclization mechanism of the 
unique diterpene harzianone (4) by feeding of a series of 
isotopically labeled mevalonolactones. The results reveal a 
concise mechanism, resulting in a so far unknown diterpene, 
which is subsequently oxidized, presumably by a P450 
monooxygenase, to harzianone (4) and related known 
terpenoids. Selective labeling of the Z-methyl group in 
geranylgeranyl diphosphate by feeding of (6-13C)-10 revealed a 
strict stereochemical course for the first cyclization. The 1,2 
hydride shift was monitored by selective labeling and careful 
analysis of EI mass spectrometric data. The early steps in 
harziane cyclization are identical to taxadiene biosynthesis,[24] 
which may point to a shared evolutionary background of the 
respective terpene synthases. In this context it is interesting to 
note that Trichoderma symbionts isolated from Taxus baccata 
reportedly produce harziane diterpenes.[16] Detection of 
harzianone (4) in all seven analyzed Trichoderma strains 
investigated in this study points to a conserved genetic 
occurrence of a harziane terpene synthase within this genus. 
Identification of the respective genes, followed by heterologous 
expression and in vitro testing are part of our ongoing 
investigations.  
Experimental Section 
Strains and growth conditions. Trichoderma sp. 34, T. asperellum 328, 
T. citrinoviride 596, T. harzianum 714, T. longibrachiatum 594 and T. 
viride 54 were obtained from Gabriele König (University of Bonn, 
Germany). T. reesei QM 6a was obtained from USDA. T. asperellum, T. 
citrinoviride, T. reesei and T. viride were cultivated at 28 °C in BM liquid 
medium (20 g malt extract per L of deionised water), and Trichoderma sp. 
34, T. harzianum 714 and T. longibrachiatum were cultivated at 28 °C in 
BM-ASW liquid medium (20 g L-1 malt extract, artificial sea water: 23.5 g 
NaCl, 10.6 g MgCl26H2O, 3.92 g Na2SO4, 1.47 g CaCl22H2O, 0.66 g 
KCl, 0.19 g NaHCO3, 0.10 g KBr, 0.04 g SrCl26H2O, 0.03 g H3BO3) for 
10 – 14 days, then inoculated on agar plates of BM or BM-ASW medium. 
The cultures were grown for 5 to 10 days and then analyzed by CLSA.  
Collection of volatiles. The emitted volatiles were collected by use of a 
closed-loop stripping apparatus (CLSA, Chromtech GmbH, Idstein, 
Precision Charcoal Filter 5 mg). Sampling was conducted for 16 – 20 h 
and the adsorbed volatiles were eluted by extraction with analytically 
pure dichloromethane (40-50 L). 
Feeding experiments.  Feeding experiments were performed with 
Trichoderma sp. 34 and synthetic isotopically labeled mevalonolactones 
(10 mg) were directly added to the medium for agar plate cultures (ca. 30 
mL). Trichoderma sp. 34 was inoculated on the agar plates and grown for 
5 – 10 days, followed by CLSA-sampling. For feeding experiments with 
(2,3,4,5,6-13C5)-, (3-13C)-, (3,5-13C2)-, (4,5-13C2)-, (2,6-13C2)- and (6-13C)-
10 the volatiles were collected for 7 days and daily extraction of the 
charcoal filter, using C6D6 (7 x 50 L) as solvent was conducted. The 
crude extracts were directly analyzed by NMR spectroscopy. For feeding 
of (6,6,6-2H3)-, (2,2,6,6,6-2H5)-, (4,4,6,6,6-2H5) and (5,5,6,6,6-2H5)-10, 
sampling was conducted for 16 – 20 h and analytically pure 
dichloromethane was used for extraction (50 L). 
GC/MS Analysis. The obtained headspace extracts were analyzed by 
use of an Agilent HP7890B gas chromatograph, fitted with a HP-5MS 
silica capillary column (30 m, 0.25 mm i. d., 0.50 m film), connected to a 
HP5977A mass detector. The GC/MS conditions were as follows: (1) inlet 
pressure: 77.1 kPa, He flow 23.3 mL/min; (2) injection volume: 1 μL; (3) 
injection mode: splitless, valve time 60 s; (4) oven temperature ramp: 5 
min at 50 °C increasing at 5 °C/min to 320 °C; (5) carrier gas He at 1 
mL/min; (6) transfer line: 250 °C; (7) electron energy: 70 eV. Retention 
indices (I) were determined from a homologous series of n-alkanes (C8-
C40). 
General Synthetic Methods. All chemicals were obtained from Acros 
Organics (Geel, Belgium), Sigma Aldrich Chemie GmbH (Steinheim, 
Germay) or TCI Deutschland GmbH (Eschborn, Germany). Utilized 
solvents were purified by distillation. Whenever necessary, reactions 
were carried out under inert atmosphere (Ar) using vacuum-heated flasks 
and dry solvents (dried according to standard protocols). Thin layer 
chromatography (TLC) was performed on 0.20 mm silica plates 
(Polygram SIL G/UV254) obtained from Macherey-Nagel (Düren, 
Germany). Column chromatography was performed on Merck silica gel 
(0.040 − 0.063 Mesh). NMR spectra were recorded on Bruker AV I (400 
MHz), AV III HD Prodigy (500 MHz) and AV III HD Cryo (700 MHz) 
spectrometers, and were referenced against CDCl3 ( = 7.26 ppm), C6D6 
( = 7.16 ppm) and d6-DMSO ( = 2.50 ppm) for 1H NMR, and CDCl3 ( = 
77.01 ppm), C6D6 ( = 128.06 ppm) and d6-DMSO ( = 39.52 ppm) for 
13C-NMR. The multiplicities are specified as follows: singlet (s), doublet 
(d), triplet (t), quartet (q), quintet (quin), sextet (sex), septet (sept). 
GC/MS analyses were carried out with an Agilent HP7890B gas 
chromatograph connected to a HP5977A mass detector fitted with a HP-
5MS silica capillary column (30 m, 0.25 mm i. d., 0.50 m film). The GC-
MS conditions were as follows: (1) inlet pressure: 77.1 kPa, He flow 23.3 
mL/min; (2) injection volume: 1 μL; (3) injection mode: split 50:1, valve 
time 60 s; (4) oven temperature ramp: 5 min at 50 °C increasing at 
10 °C/min to 320 °C; (5) carrier gas He at 1 mL/min; (6) transfer line: 
250 °C; (7) electron energy: 70 eV. Retention indices (I) were determined 
from a homologous series of n-alkanes (C8-C40). Optical rotary powers 
were recorded on a P8000 Polarimeter (Krüss).  
Synthetic procedures 
Synthesis of ethyl (1,2-13C2)-2-(2,5,5-trimethyl-1,3-dioxan-2-
yl)acetate (S1). Ethyl (1,2-13C2)acetoacetate (>99% 13C, 1.00 g, 7.68 
mmol, 1.0 equiv.) and neopentyl glycol (1.76 g, 16.9 mmol, 2.2 equiv.) 
were dissolved in dry dichloromethane (35 mL) and freshly distilled 
TMSCl (3.67 g, 33.8 mmol, 4.4 equiv.) was added. The reaction mixture 
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was heated to reflux overnight and neutralized with an aqueous solution 
of NaHCO3 (5 wt %) followed by extraction with dichloromethane (3 x 10 
mL). The organic layers were combined and dried with MgSO4 and the 
solvent was removed under reduced pressure. The crude product was 
purified by column chromatography on silica gel (ethyl acetate/hexane; 
1:10 v/v, Rf = 0.2) to yield S1 as a colorless oil (1.64 g, 7.50 mmol, 98%). 
GC (BPX-5): I = 1349. 1H-NMR (400 MHz, CDCl3):  [ppm] = 4.15 (dq, 
3JH,H = 7.1 Hz, 3JC,H = 3.1 Hz, 2H, CH2), 3.56 (d, 2JH,H = 11.4 Hz, 2H, 
CHH), 3.49 (d, 2JH,H = 11.4 Hz, 2H, CHH), 2.78 (dd, 1JC,H = 130.3 Hz, 
2JC,H = 6.9 Hz, 2H, CH2), 1.53 (d, 3JC,H = 2.9 Hz, 3H, CH3), 1.26 (t, 3JH,H = 
7.1 Hz, 3H, CH3), 0.97 (s, 3H, CH3), 0.94 (s, 3H, CH3). 13C-NMR (100 
MHz, CDCl3):  [ppm] = 169.7 (d, 1JC,C = 58.9 Hz, Cq), 97.3 (d, 
1JC,C = 44.4 Hz, Cq), 70.6 (d, 3JC,C = 1.6 Hz, 2 x CH2), 60.7 (d, 2JC,C = 1.9 
Hz, CH2), 41.7 (d, 1JC,C = 58.9 Hz, CH2), 29.9 (s, Cq), 22.8 (d, 2JC,C = 4.0 
Hz, CH3), 22.6 (s, CH3), 22.5 (s, CH3), 14.2 (d, 3JC,C = 2.0 Hz, CH3). EI-
MS (70 eV): m/z (%) = 203 (36), 133 (29), 129 (100), 117 (18), 105 (12), 
87 (31), 69 (54), 56 (36), 43 (98), 41 (49). 
Synthesis of (1,2-13C2)-2-(2-(benzyloxy)ethyl)-2,5,5-trimethyl-1,3-
dioxane (S2). LiAlH4 (0.29 g, 7.50 mmol, 1.0 equiv.) was suspended in 5 
mL dry THF and cooled to 0 °C. A solution of S1 (1.64 g, 7.50 mmol, 1.0 
equiv.) in 5 mL dry THF was added and the reaction was stirred at room 
temperature for 2 h, followed by addition of water until a white 
suspension was formed. The mixture was filtered and the obtained 
organic phase was dried with MgSO4. The solvent was removed under 
reduced pressure and the crude product was purified by column 
chromatography (ethyl acetate/hexane; 1:2 v/v, Rf = 0.2). The resulting 
alcohol was used immediately in the next step. The alcohol (1.13 g, 6.40 
mmol, 1.0 equiv.) was added dropwise at 0 °C to a suspension of NaH 
(0.17 g, 7.04 mmol, 1.1 equiv.) in 15 mL dry DMF. After stirring for 15 min 
benzyl bromide (1.09 g, 6.40 mmol, 1.0 equiv.) was added dropwise and 
the reaction mixture was stirred at room temperature over night. After 
addition of water, the mixture was extracted with dichloromethane (3 x 10 
mL). The organic layers were combined and washed with water, dried 
over MgSO4 and the solvent was removed under reduced pressure. The 
residue was purified by column chromatography on silica gel (ethyl 
acetate/hexane; 1:10 v/v, Rf = 0.3) to yield product S2 (1.40 g, 5.10 
mmol, 69% over 2 steps) as a colourless oil. GC (BPX-5): I = 1878. 1H-
NMR (400 MHz, d6-DMSO):  [ppm] =  7.36 - 7.23 (m, 5H, C6H5), 4.43 (d, 
3JC,H = 3.9 Hz, 2H, CH2), 3.53 (ddt, 1JC,H = 141.5 Hz, 3JH,H = 7.3 Hz, 
2JC,H = 2.9 Hz, 2H, CH2), 3.46 (d, 2JH,H = 11.3 Hz, 2H, CHH), 3.34 (d, 
2JH,H = 11.3 Hz, 2H, CHH), 1.94 (ddt, 1JC,H = 126.7 Hz, 3JH,H = 6.7 Hz, 
2JC,H = 6.7 Hz, 2H, CH2), 1.30 (d, 3JC,H = 2.9 Hz, 3H, CH3), 0.90 (s, 3H, 
CH3), 0.81 (s, 3H, CH3). 13C-NMR (100 MHz, CDCl3):  [ppm] = 138.6 (d, 
3JC,C = 3.0 Hz, Cq), 128.2 (s, 2 x CH), 127.4 (s, 2 x CH), 127.3 (s, CH), 
97.5 (d, 1JC,C = 46.2 Hz, Cq), 71.9 (dd, 2JC,C = 3.6 Hz, 3JC,C = 1.4 Hz, CH2), 
69.2 (d, 3JC,C = 1.8 Hz, 2 x CH2), 65.6 (d, 1JC,C = 39.3 Hz, CH2), 37.9 (d, 
1JC,C = 39.3 Hz, CH2), 29.5 (s, Cq), 22.4 (s, CH3), 22.1 (s, CH3), 20.9 (d, 
3JC,C = 3.3 Hz, CH3). EI-MS (70 eV): m/z (%) = 251 (26), 179 (2), 162 (7), 
129 (78), 107 (29), 91 (100), 69 (45), 56 (29), 43 (66), 41 (45).  
Synthesis of (3,4-13C2)-4-(benzyloxy)butan-2-one (S3). Compound S2 
(1.40 g, 5.10 mmol, 1 equiv.) was dissolved in 25 mL MeOH and 3 mL of 
a 1.0 M solution of HCl in water was added. The reaction was stirred at 
room temperature for 15 minutes followed by neutralization with an 
aqueous solution of NaHCO3 (5 wt %). The aqueous phase was 
extracted with Et2O (3 x 10 mL) and the combined organic layers were 
dried with MgSO4. The solvent was removed under reduced pressure 
and the residue was purified by column chromatography on silica gel 
(ethyl acetate/hexane; 1:5 v/v, Rf = 0.2) to yield product S3 (0.90 g, 5.00 
mmol, 99%) as a colorless oil. GC (BPX-5): I = 1467. 1H-NMR (400 MHz, 
CDCl3):  [ppm] = 7.37 - 7.25 (m, 5H, C6H5), 4.51 (d, 3JC,H = 4.3 Hz, 2H, 
CH2), 3.74 (ddt, 1JC,H = 143.2 Hz, 3JH,H = 6.3 Hz, 2JC,H = 2.8 Hz, 2H, CH2), 
2.72 (ddt, 1JC,H = 126.0 Hz, 3JH,H = 6.3 Hz, 2JC,H = 4.9 Hz, 2H, CH2), 2.18 
(d, 3JC,H = 1.3 Hz, 3H, CH3). 13C-NMR (100 MHz, CDCl3):  [ppm] = 207.1 
(dd, 1JC,C = 40.6 Hz, 2JC,C = 1.7 Hz, Cq), 138.1 (d, 3JC,C = 2.9 Hz, Cq), 
128.4 (s, 2 x CH), 127.7 (s, 2 x CH), 127.6 (s, CH), 73.2 (dd, 2JC,C = 3.9 
Hz, 3JC,C = 1.4 Hz, CH2), 65.3 (d, 1JC,C = 39.8 Hz, CH2), 43.7 (d, 
1JC,C = 39.8 Hz, CH2), 30.4 (d, 2JC,C = 14.2 Hz, CH3). EI-MS (70 eV): m/z 
(%) = 121 (21), 107 (59), 91 (100), 79 (39), 77 (37), 65 (38), 59 (12), 43 
(90). 
Synthesis of ethyl (4,5-13C2)-5-(benzyloxy)-3-hydroxy-3-
methylpentanoate (S4). Diisopropylamine (1.06 g, 10.5 mmol, 2.1 
equiv.) was dissolved in 50 mL dry THF and a 1.6 M solution of n-
butyllithium (6.56 mL, 10.5 mmol, 2.1 equiv.) in hexane was added at 0 
°C. The reaction mixture was stirred for 1 h at 0 °C and then cooled to 
−78 °C. A solution of ethyl acetate (0.93 g, 10.5 mmol, 2.1 equiv.) in 20 
mL dry THF was added dropwise and the reaction mixture was stirred for 
30 min. A solution of S3 (0.90 g, 5.00 mmol, 1.0 equiv.) in 15 mL dry THF 
was added dropwise and the mixture was stirred for 1 h, quenched by 
addition of water and allowed to warm to room temperature. The reaction 
mixture was extracted with ethyl acetate (3 x 15 mL) and the combined 
organic layers were dried with MgSO4. The solvent was removed under 
reduced pressure and the residue was purified by column 
chromatography on silica gel (ethyl acetate/hexane; 1:5 v/v, Rf = 0.2) to 
yield product S4 (1.10 g, 4.10 mmol, 82%) as a colorless oil. GC (BPX-5) 
= 1916. 1H-NMR (400 MHz, CDCl3):  [ppm] = 7.33 - 7.17 (m, 5H, C6H5), 
4.43 (d, 3JC,H = 4.0 Hz, 2H, CH2), 4.11 - 4.02 (m, 2H CH2), 3.90 (d, 
3JC,H = 2.4 Hz, 1H, OH), 3.62 (ddt, 1JC,H = 141.9 Hz, 3JH,H = 6.2 Hz, 2JC,H 
= 2.8 Hz, 2H, CH2), 2.52 (dd, 2JH,H = 15.2 Hz, 3JC,H = 2.9 Hz, 1H, CHH), 
2.43 (dd, 2JH,H = 15.2 Hz, 3JC,H = 2.9 Hz 1H, CHH), 1.85 (ddt, 1JC,H = 
126.3 Hz, 3JH,H = 6.2 Hz, 2JC,H = 4.6 Hz, 2H, CH2), 1.21 (d, 3JC,H = 3.7 Hz, 
3H, CH3), 1.18 (t, 3JH,H = 7.1 Hz, 3H, CH3). 13C-NMR (100 MHz, CDCl3):  
[ppm] = 172.6 (d, 3JC,C = 2.3 Hz, Cq), 138.1 (d, 3JC,C = 2.6 Hz, Cq), 128.5 
(s, 2 x CH), 127.8 (s, CH), 127.8 (s, 2 x CH), 73.4 (dd, 2JC,C = 3.9 Hz, 
3JC,C = 1.4 Hz, CH2), 70.9 (dd, 1JC,C = 38.5 Hz, 2JC,C = 1.33 Hz, Cq), 67.1 
(d, 1JC,H = 38.8 Hz, CH2), 60.6 (s, CH2), 45.5 (dd, 2JC,C = 1.9 Hz, 3JC,C = 
1.9 Hz, CH2), 40.3 (d, 1JC,C = 38.5 Hz, CH2), 27.1 (dd, 2JC,C = 1.9 Hz, 
3JC,C = 1.9 Hz, CH3), 14.1 (s, CH3). EI-MS (70 eV): m/z (%) = 181 (1), 162 
(21), 144 (13), 132 (8), 113 (7), 91 (100), 65 (20), 43 (38).  
Synthesis of (4,5-13C2)mevalonolactone ((4,5-13C2)-10). Compound S4 
(1.10 g, 4.10 mmol, 1 equiv.) was dissolved in 40 mL MeOH and Pd/C (5 
wt %, 0.05 equiv.) was added. The mixture was stirred at 40 °C under a 
hydrogen atmosphere (40 bar) for 2 h. The Pd/C catalyst was removed 
by filtration over celite and the organic phase was concentrated under 
reduced pressure. The residue was dissolved in 40 mL dichloromethane 
and catalytic amounts of p-TsOH were added. The reaction mixture was 
stirred at room temperature over night followed by removal of the solvent 
under reduced pressure and purification of the residue by column 
chromatography (ethyl acetate/hexane; 1:1 v/v, Rf = 0.1) to yield (4,5-
13C2)-10 (0.33 g, 2.50 mmol, 62%) as a colorless oil. GC (BPX-5, 
MSTFA): I = 1390. 1H-NMR (400 MHz, CDCl3):  [ppm] = 4.53 (dm, 
1JC,H = 150.4 Hz, 1H, CHH), 4.32 (dm, 1JC,H = 150.4 Hz, 1H, CHH), 2.65 
(ddd, 2JH,H = 17.4 Hz, 3JC,H = 3.5 Hz, 4JH,H = 1.7 Hz, 1H, CHH), 2.53 (dd, 
2JH,H = 17.4 Hz, 3JC,H = 1.5 Hz, 1H, CHH), 1.87 (dm, 1JC,H = 130.6 Hz, 2H, 
CH2), 1.32 (d, 3JC,H = 4.2 Hz, 3H, CH3). 13C-NMR (100 MHz, CDCl3):  
[ppm] = 170.8 (s, Cq), 68.3 (dd, 1JC,C = 37.1 Hz, 2JC,C = 2.3 Hz, Cq), 66.2 
(d, 1JC,C = 34.9 Hz, CH2), 44.5 (d, 2JC,C = 1.7 Hz, CH2), 35.0 (d, 
1JC,C = 34.9 Hz, CH2), 29.9 (dd, 2JC,C = 1.9 Hz, 3JC,C = 1.9 Hz, CH3). EI-
MS (70 eV, MSTFA): m/z (%) = 189 (12), 147 (100), 145 (39), 117 (47), 
116 (48), 75 (51), 73 (45), 45 (24).  
Isolation of harzianone (4). Trichoderma sp. 34 was precultured at 28 
°C in liquid BM-ASW medium for 10 – 14 days and then inoculated on 
100 agar plates using 3 L BM-ASW medium. The cultures were grown for 
21 days, cut in small pieces and extracted with pentane. After removal of 
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the solvent under reduced pressure the residue was purified by column 
chromatography on silica gel (diethyl ether/pentane; 20:1 to 5:1 v/v, Rf = 
0.3) to yield harzianone (4) (3.8 mg, 0.01 mmol). GC (HP-5MS) = 2280. 
1H-NMR (700 MHz, C6D6):  [ppm] = 2.33 (d, 2J = 15.8 Hz, 1H, CHH), 
2.24 (d, 2J = 15.8 Hz, 1H, CHH), 2.20 (dd, 3J = 7.8 Hz, 2J = 7.8 Hz, 1H, 
CH), 2.06 (s, 3H, CH3), 2.04 (m, 1H, CHH), 1.97 (dd, 3J = 11.4 Hz, 3J = 
8.9 Hz, 1H, CH), 1.92 (m, 1H, CHH), 1.86 (m, 1H, CHH), 1.60 (m, 1H, 
CHH), 1.51 (m, 1H, CH), 1.49 (m, 1H, CHH), 1.42 (m, 1H, CHH), 1.24 (s, 
3H, CH3), 1.21 (m, 1H, CHH), 1.12 (m, 1H, CHH), 1.11 (m, 1H, CHH), 
1.03 (m, 1H, CHH), 0.94 (s, 3H, CH3), 0.86 (d, 3J = 7.5 Hz, 3H, CH3), 
0.70 (s, 3H, CH3). 13C-NMR (175 MHz, C6D6):  [ppm] = 197.0 (Cq), 150.8 
(Cq), 144.3 (Cq), 60.2 (CH2), 52.6 (CH), 50.9 (Cq), 46.2 (Cq), 43.2 (CH), 
40.9 (Cq), 30.5 (CH2), 29.5 (CH), 29.1 (CH2), 27.6 (CH2), 26.2 (CH3), 25.7 
(CH2), 25.6 (CH2), 22.7 (CH3), 22.4 (CH3), 21.7 (CH3), 20.7 (CH3). []D21 
= +21.0 (c 0.1, MeOH). EI-MS (70 eV): m/z (%) = 286 (23), 271 (34), 257 
(40), 243 (60), 229 (30), 215 (40), 202 (46), 189 (51), 173 (34), 159 (57), 
149 (100), 136 (66), 121 (89), 105 (71), 91 (94), 79 (89), 55 (60), 41 (86). 
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1. CLSA HEADSPACE EXTRACTS OF TRICHODERMA STRAINS 
 
 
Figure S1. Total ion chromatograms of the headspace extracts of A) T. citrinoviride, 
B) T. longibrachiatum, C) T. viride, D) T. asperellum, E) T. reesei and F) T. 
harzianum. Numbers at peaks refer to compound numbers in main text. 
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2. RESULTS OF FEEDING EXPERIMENTS WITH 13C-LABELED 10  
 
 
Figure S2. Result of feeding experiment with (2,3,4,5,6-13C5)-10. A) Total ion 
chromatogram of headspace extract, B) mass spectrum of (13C20)-4. 
 
 
 
 
 
 
 
 
 
 
 
4 
 
Table S1. 1H NMR data of 4 and comparison of 13C-NMR data of 4 and feeding experiments in C6D6.    
C[a] 1H (, m, J)[b] 
4
 
13C ()[c] 
4 
13C () 
(2,3,4,5,6-13C5)-10 
13C () 
 (3-13C)-10 
13C () 
(3,5-13C2)-10 
13C () 
(6-13C)-10 
13C () 
(2,6-13C2)-10 
13C () 
(4,5-13C2)-10 
11 - 197.0 (Cq) 197.0, dd, 1JC,C=43.0, 1JC,C=34.0 - 197.0, s - - 197.0, d, 1JC,C=43.0 
10 - 150.8 (Cq) 150.8, ddd, 1JC,C=70.0, 1JC,C=43.0, 1JC,C=35.0 - - - - 150.7, d, 1JC,C=43.0 
9 - 144.3 (Cq) 144.3, ddd, 1JC,C=70.0, 1JC,C=40.0, 1JC,C=40.0 144.3 144.3, d, JC,C=2.1  - - - 
12 2.33, d, 2J=15.8 
2.24, d, 2J=15.8 
60.2 (CH2) 60.2, dd, 1JC,C=30.0, 1JC,C=30.0 - - - 60.2, s - 
14 1.97, dd, 3J=11.4, 3J=8.9 52.6 (CH) 52.6, ddd, 1JC,C=33.0, 1JC,C=33.0, 1JC,C=33.0 - - - - 52.6, ddd, 1JC,C=33.0, 
1JC,C=33.0, 3JC,C=5.3  
6 - 50.9 (Cq) 50.9, dddd, 1JC,C=35.0, 1JC,C=35.0, 1JC,C=35.0, 
1JC,C=35.0 
- - - - 50.9, dd, 1JC,C=35.0, 
1JC,C=35.0 
1 - 46.2 (Cq) 46.2, dddd, 1JC,C=35.0, 1JC,C=35.0, 1JC,C=35.0, 
1JC,C=35.0 
46.2, d, 3JC,C=2.7 46.1, d, 3JC,C=3.1 - - - 
2 1.51, m 43.2 (CH) 43.2, ddd, 1JC,C=34.0, 1JC,C=34.0, 1JC,C=34.0 - - - - 43.2, dd, 1JC,C=34.0, 
1JC,C=34.0 
13 - 40.9 (Cq) 40.9, dddd, 1JC,C=35.0, 1JC,C=35.0, 1JC,C=35.0, 
1JC,C=35.0 
40.9, d, 3JC,C=2.7 40.9, d, 3JC,C=3.1 - - - 
7 1.49, m  
1.03, m 
30.5 (CH2) 30.5, dd, 1JC,C=35.0, 1JC,C=35.0 - - - - 30.5, d, 1JC,C=35.0 
5 2.20, dd, 3J=7.8, 3J=7.8 29.5 (CH) 29.5, ddd, 1JC,C=34.0, 1JC,C=34.0, 1JC,C=34.0  29.5, s 29.5, d, 2JC,C=0.9 - -  
8 2.04, m 
1.42, m 
29.1 (CH2) 29.1, dd, 1JC,C=36.0, 1JC,C=36.0 - - - 29.1, d, 2JC,C=2.8 - 
15 1.60, m 
1.12, m 
27.6 (CH2) 27.6, dd, 1JC,C=32.0, 1JC,C=32.0 - 27.6, d, 3JC,C=2.9 - - 27.6, dd, 1JC,C=32.0, 
1JC,C=32.0 
16 0.70, s 26.2 (CH3) 26.2, d, 1JC,C=37 - - 26.2, s 26.2, d, 2JC,C=1.4 - 
3 1.86, m 
1.21, m 
25.7 (CH2) 25.7, dd, 1JC,C=34.0, 1JC,C=34.0 - 26.1, s - - 26.1, d, 1JC,C=34.0 
4 1.92, m 
1.11, m 
25.6 (CH2) 25.6, dd, 1JC,C=33.0, 1JC,C=33.0 - - - 25.6, s - 
17 0.94, s 22.7 (CH3) 22.7, d, 1JC,C=37.0 - - - 22.7, br - 
20 2.06, s 22.4 (CH3) 22.4, d, 1JC,C=39.0 - - 22.4, s 22.4, d, 2JC,C=2.8 - 
19 1.24, s 21.7 (CH3) 21.7, d, 1JC,C=37.0 - - 21.7, s 21.7, s - 
18 0.86, d, 3J=7.5 Hz 20.7 (CH3) 20.7, d, 1JC,C=35.0 - - 20.7, s 20.7, s - 
[a] Carbon numbering as shown in Figure 4A. [b] Chemical s hifts  in ppm, multiplicity m: s=singlet, d=doublet, m=multiplett; coupling constants nJ are via n bonds and given in Hertz. [c] Carbon assignments (CH3, CH2, CH and Cq) were delineated from a DEPT spectrum. 
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3. SYNTHESIS OF (4,5-13C2)-10 
 
 
Scheme S1. Synthesis of (4,5-13C2)-10. a) TMSCl, neopentyl glycol, reflux, 16 h, 
98%; b) LiAlH4, THF, 0 °C to rt, 2 h; c) NaH, BnBr, 0 °C to rt, 69% (2 steps); d) 
HCl/MeOH, rt, 15 min, 99%; e) LDA, ethyl acetate, −78 °C, 82%; f) Pd/C, H2, 2 h, 
40 °C, then p-TsOH, DCM, 68%.  
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4. RESULTS OF FEEDING EXPERIMENTS WITH 2H-LABELED 10  
 
Figure S3. Extracted ion traces of isotopomers of 4 after feeding of A) (6,6,6-2H3)-10, 
B) (2,2,6,6,6-2H5)-10, C) (5,5,6,6,6-2H5)-10, D) (4,4,6,6,6-2H5)-10. Colored dots 
indicate positions of 2H labelings. 
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5. NMR SPECTRA FOR HARZIANONE (4) AND SYNTHETIC COMPOUNDS  
 
Figure S4. 1H-NMR spectrum of 4 (700 MHz, C6D6). 
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Volatiles from the fungal microbiome of the
marine sponge Callyspongia cf. flammea†
Lena Barra,a Paul Barac,b Gabriele M. König,b Max Crüsemannb and
Jeroen S. Dickschat *a
The volatiles emitted by five fungal strains previously isolated from the marine sponge Callyspongia cf.
flammea were captured with a closed-loop stripping apparatus (CLSA) and analyzed by GC-MS. Besides
several widespread compounds, a series of metabolites with interesting bioactivities were found, including
the quorum sensing inhibitor protoanemonin, the fungal phytotoxin 3,4-dimethylpentan-4-olide, and the
insect attractant 1,2,4-trimethoxybenzene. In addition, the aromatic polyketides isotorquatone and char-
tabomone that are both known from Eucalyptus and a new O-desmethyl derivative were identified. The
biosynthesis of isotorquatone was studied by feeding experiments with isotopically labeled precursors
and its absolute configuration was determined by enantioselective synthesis of a reference compound.
Bioactivity testings showed algicidal activity for some of the identified compounds, suggesting a potential
ecological function in sponge defence.
Introduction
Marine sponges (Porifera) belong to the most ancient living
animals that have evolved during the Cryogenian period (>635
Myr ago), well before the Cambrian explosion.1 They are
sessile, filter-feeding organisms, that occur in almost any
aquatic habitat from tropical reefs to the polar regions, and
from the deep sea to fresh water lakes and rivers.2 They exhibit
highly variable and complex microbiomes consisting of bac-
teria, fungi and archaea3 that can account for up to 40% of the
sponge tissue volume.4 This microbial diversity requires
complex interactions between the symbionts and their host
that are mediated by secondary metabolites with often strong
biological activities and remarkable structural architectures.5 A
well-known example is the pyrrole-imidazole alkaloid sceptrin
(1) from the Caribbean sponge Agelas sceptrum6 that shows
antimicrobial, anti-muscarinic and anti-histaminic activities,
besides a strong inhibition of cancer cell motility,7 but the
function of this compound in its ecological context remains
elusive.8 Calyculin A (2) from the marine sponge Discodermia
calyx is a highly cytotoxic compound and a potent inhibitor of
the protein phosphatases 1 and 2A.9 Notably, this polyketide is
produced by the symbiotic bacterium Entotheonella and gener-
ated enzymatically from the pro-toxin phosphocalyculin (3)
upon tissue wounding (Fig. 1).10 The fungus Stachylidium
sp. 293 K04 that was isolated from the marine sponge
Callyspongia cf. flammea produces the human leukocyte elas-
tase inhibitor mariline A (4) as a mixture of enantiomers.11
The tetrapeptide endolide A (5) containing an unusual 3-furyl-
alanine subunit was isolated from the same fungus and
showed affinity to the vasopressin receptor 1A.12
In contrast to such natural products that are typically iso-
lated by classical extraction–isolation techniques, volatile
metabolites are often overlooked, because these compounds
are easily lost during concentration steps.13 Still, knowledge
about these compounds is desirable, because volatiles can
exhibit antibiotic properties or can be of critical importance
e.g. for interspecies communication, cell-to-cell signaling, or
control of pathogens14 which is of particularly high relevance
in complex microbial communities as they occur in sponges.
Despite these considerations studies on volatiles from sponges
or their microbiomes are surprisingly rare and so far limited
to investigations on bacterial symbionts. Among the few
examples is a report on the North Sea sponge Halichondria
panacea that emits a strong nauseating odour that can be
traced back to a mixture of the sulfur compounds dimethyl di-
sulfide, dimethyl trisulfide and methyl benzyl sulfide.15
Sponges of the genus Ircinia were found to release dimethyl
sulfide, methyl isocyanide and methyl isothiocyanate that may
act as chemical defense compounds.16 A series of studies on
symbiotic bacteria from Antarctic sponges demonstrated the
†Electronic supplementary information (ESI) available: Table of identified vola-
tiles, mass spectra, gas chromatograms for headspace extracts from Sporomiella
and Botrytis, NMR spectra of synthetic compounds. See DOI: 10.1039/
c7ob01837a
aKekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn,
Gerhard-Domagk-Straße 1, D-53121 Bonn, Germany. E-mail: dickschat@uni-bonn.de
bInstitute of Pharmaceutical Biology, University of Bonn, Nußallee 6, D-53115 Bonn,
Germany
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production of volatiles with activity against Burkholderia.17
Here we present the first study on volatile metabolites pro-
duced by sponge associated fungi that were previously iso-
lated18 from Callyspongia cf. flammea.
Results and discussion
The volatile metabolites released by Dichotomomyces cejpii
293 K09, Stachylidium sp. 293 K04, Botrytis sp. 293 K02,
Emericella sp. 293 K10, and Sporormiella sp. 293 K05 that were
all isolated from the marine sponge Callyspongia cf. flammea18
were collected on a charcoal filter by use of a closed-loop strip-
ping apparatus (CLSA).19 Sampling was conducted for 16–24 h
and the adsorbed volatiles were eluted with dichloromethane.
The obtained headspace extracts were analyzed by GC-MS and
compounds were identified by comparison of their mass spectra
to electronic mass spectral libraries20 and comparison of their
measured retention indices to reported data, with additional
verification by comparison to synthetic or commercially available
authentic standards in most cases. A summary of all 48 identi-
fied compounds is given in Table S1.† Two of the examined
fungi, Sporormiella and Botrytis, did not show a significant emis-
sion of volatiles (Fig. S1 and S2†). The results obtained from the
other three isolates are discussed here in detail.
Dichotomomyces cejpii 293 K09
The ascomycete D. cejpii 293 K09 has been intensively investi-
gated for its rich secondary metabolism, which resulted in the
identification of indoloditerpenes,21 unusual steroids, aro-
matic isocyanides,22 gliotoxins and heveadrides.23 Analysis of
the headspace extracts obtained from this fungus also revealed
a rich production of structurally diverse volatiles (Fig. 2). The
most abundant compound was identified as the sesquiterpene
alcohol (1(10)E,5E)-germacradien-11-ol (14), a known inter-
mediate in geosmin biosynthesis, found in Streptomyces
spp.,24 myxobacteria25 and liverworts.26 Other identified terpe-
noids are dauca-4(11),8-diene (13), which was previously iso-
lated from the liverwort Bazzania trilobata27 and the acyclic ter-
penoid geranylacetone (12). The acrid plant defense com-
pound protoanemonin (6) was found in minor amounts and
has previously been described from plants of the buttercup
family (Ranunculaceae) where it is enzymatically generated
from the glucoside ranunculin upon lesion of plant tissue.28
Protoanemonin was also found as a catabolite of the xeno-
Fig. 2 Volatiles from Dichotomomyces cejpii. Total ion chromatogram
of the headspace extract, structures of the identified volatiles and of tor-
quatone (18) and of C-desmethyl isotorquatone (19). Peak numbers in
the chromatogram refer to compound numbers. The absolute configur-
ations of 13, 14, 16 and 17 have not been determined, cf. main text for
the absolute configuration of 15.
Fig. 1 Secondary metabolites from sponges and sponge associated
bacteria and fungi. Structures of sceptrin (1), calyculin A (2), phosphoca-
lyculin (3), mariline A (4) and endolide A (5).
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biotic 4-chlorocatechol in Pseudomonas.29 Recently, 6 was
shown to act as a quorum sensing inhibitor towards N-acyl-
L-homoserine lactones (AHLs) in Pseudomonas sp. B13.30 The
production of 6 by D. cejpii is interesting, as AHLs were shown
to play a key role in the interaction between sponge symbiotic
bacteria and their host.31 Additionally, protoanemonin exhi-
bits antifungal and antibacterial properties.32
Other detected metabolites included the unbranched long-
chain aldehydes nonanal (7), decanal (8) and dodecanal (9),
and the benzene derivatives benzyl cyanide (10) and 3,4-
dimethoxystyrene (11) which are all frequently observed fungal
volatiles.14c A particularly interesting compound, detected as
the second most abundant volatile in the headspace extract of
D. cejpii, was the highly methylated aromatic polyketide 15
along with its O-desmethyl derivatives 16 and 17. Comparison
of the mass spectrum of 15 to data base spectra returned the
two possible structures of torquatone (18) and isotorquatone
(15). Since the mass spectra and retention indices of both com-
pounds are nearly identical (Fig. S3†), a synthesis for both
isomers was performed to allow for an unambiguous structural
assignment. Two successive methylations of 1,3,5-trimethoxy-
benzene (20) with methyl iodide gave access to 22 that was bro-
minated with NBS to yield 23.33 Subsequent lithiation,
addition to 2-methylbutyraldehyde, and oxidation with Dess–
Martin periodinane resulted in 15 (Scheme 1). Compound 18
was prepared analogously from 23 and isovaleraldehyde.
Both synthetic compounds 15 and 18 were compared to the
volatile emitted by D. cejpii, revealing the identity of 15 and the
natural material by GC-MS analysis (Fig. S4†). To determine
the absolute configuration of natural 15, a stereoselective syn-
thesis was performed using the same synthetic route as
described above and employing enantiomerically pure (S)-2-
methylbutyraldehyde.34 The obtained material (S)-(+)-15 (98% ee)
and the racemate of 15 were used to determine the absolute
configuration of natural isotorquatone by HPLC on a
homochiral stationary phase, indicating that natural 15 is a
mixture of enantiomers ((40% ee in favour of (R)-(−)-15),
Fig. S5†). Isotorquatone is a known constituent of the essential
oils of various Eucalyptus species,35 but the absolute configu-
ration of the plant-derived isotorquatone is unknown.
The headspace extract of D. cejpii contained two additional
trace compounds whose mass spectra showed a molecular ion
at m/z = 266 and a base peak ion at m/z = 209 (Fig. S6†),
suggesting the structures of desmethyl analogs of 15 with a
missing methyl group at one of the oxygens or ring carbons.
For an unambiguous structural assignment all three possible
derivatives were synthesized. The C-desmethyl analog 19 was
prepared from 21 via the same strategy as described for torqua-
tone and isotorquatone, by omission of the methylation step
to 22. Treating (rac)-15 with BBr3 yielded the O-desmethyl
analog 16, in addition to the doubly O-demethylated com-
pound 25, but no O-demethylation of the methoxy group in
para-position to the ketone side chain was observed.
Therefore, a published synthesis for 17 over 9 steps starting
from 1,3,5-trimethoxybenzene was conducted (Scheme 2).33
Comparison of the three synthetic compounds to the natural
volatiles by GC-MS resulted in the identification of 16 and 17,
but not of 19 as headspace constituents of D. cejpii. The isotor-
quatone derivative 16 (chartabomone) is known from
Eucalyptus chartaboma and E. miniata,35b while 17 is a new
natural product that we wish to name dichotomone.
The biosynthesis of 15 was addressed in feeding experi-
ments with isotopically labeled (2-13C)acetate and (methyl-2H3)-
L-methionine. Feeding of (2-13C)acetate resulted in the incor-
poration of five labeled C2-units into 15 as indicated by the
resulting mass spectrum, and feeding of (methyl-2H3)-L-meth-
ionine gave incorporation of labeling into six methyl groups
(Fig. S7†). These findings are in line with a biosynthesis of 15
Scheme 1 Synthesis of isotorquatone (15) and torquatone (18). (a)
s-BuLi, 40 °C, 2 h; then MeI, −78 °C to rt, 70%; (b) s-BuLi, 40 °C, 2 h;
then MeI, −78 °C to rt, 82%; (c) NBS, rt, 82%; (d) t-BuLi, −78 °C to
−10 °C; then aldehyde RCHO, −78 °C, 30 min; (e) DMP, rt, 63% for 15,
50% for 18 (2 steps). BuLi butyllithium, MeI methyl iodide, NBS
N-bromosuccinimide, DMP Dess–Martin periodinane.
Scheme 2 Synthesis of (A) C-desmethyl isotorquatone (19), (B) charta-
bomone (16), and (C) dichotomone (17). (a) NBS, 0 °C to rt, 97%; (b)
t-BuLi, −78 °C to −10 °C, then 2-methylbutyraldehyde, −78 °C, 30 min;
(c) IBX, rt, 28% (2 steps); (d) BBr3 (1.1 equiv.), −78 °C to rt, 35% of 16 and
52% of 25. IBX 2-iodoxybenzoic acid.
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by a polyketide synthase (PKS) from an acetate starter unit by
four extension steps with malonyl-CoA, with full reduction of
the 3-oxo function during the first and no reduction during
the following chain extensions, and C-methylation during the
first, third and last chain elongation (Scheme 3). Product
release by a Claisen condensation and three O-methylations
yield 15. The presence of minor amounts of 16 and 17 suggests
that the O-methyltransferase does not convert the complete
material released from the PKS. In contrast to this finding, the
polyketide synthase acts in a highly programmed fashion, as
indicated by the absence of 19 which would represent a PKS
product formed through an omitted C-methylation step.
Stachylidium sp. 293 K04
Besides mariline A (4) and endolide A (5),11,12 a variety of other
bioactive natural products has been isolated from Stachylidium
sp. 293 K04, including the marilones A–C and the stachylines
A–D.36–38 Analysis of the volatiles from Stachylidium resulted in
the identification of 14 compounds (Fig. 3). The most abun-
dant compound was 1,2,4-trimethoxybenzene (44) that is a
known constituent of the bouquet of orchid flowers39 and
Cucurbita blossoms where it acts together with indole and (E)-
cinnamaldehyde as an attractant for rootworm beetles.40 The
related compound 1,2-dimethoxybenzene (41) is only found in
traces and is also known from Aspergillus clavatus.41 The
sulphur compound benzothiazole (43), also a minor com-
ponent, has previously been reported from Trichoderma42 and
Aspergillus.41 Among the major components 1-octen-3-ol (38)
was identified that is probably the most widespread fungal
volatile. This compound is frequently accompanied by other
C8 metabolites such as 3-octanone (39).
14c
“Matsutake alcohol”
38 was first isolated from Tricholoma matsutake43 and its role
in chemical denfense is suggested by the triggered emission
upon wounding of fungal fruiting bodies.44
A rather unusual metabolite released by Stachylidium is
furan-3-carbaldehyde (34) whose production may be linked to
the biosynthesis of endolide A (5), a natural product that is
made up from the structurally related uncommon amino acid
3-furylalanine.45 The production of terpenes including nerolidol
(40), 2-methylisoborneol (42) and geranyl acetone (12) was also
observed. 2-Methylisoborneol is a widespread off-flavour with
a characteristic mouldy odor that is commonly found in
various bacteria24c and ascomycete fungi such as Aspergillus46
und Penicillium.47 Other identified compounds are butyl
acetate (35), 2-hydroxy-5-methylhexan-3-one (36), 4-methyl-
γ-butyrolactone (37) and the long chain aldehydes 7 and 8.
Emericella sp. 293 K02
The fungus Emericella sp. 293 K02 has not been investigated
with respect to its secondary metabolism. The headspace
extracts contained a large number of compounds, twelve of
which could be identified including the aldehydes 7, 8, 9 and
the higher homolog dodecanal (48), matsutake alcohol (38)
and its companion 39, and benzothiazole (43, Fig. 4). A unique
compound emitted by Emericella was 3,4-dimethylpentan-4-
Scheme 3 Biosynthetic model for 15 and labeling pattern after feeding
of (2-13C)acetate and (methyl-2H3)-L-methionine. AT = acyl transferase,
C-MT = C-methyltransferase, O-MT = O-methyltransferase, DH = de-
hydratase, KR = ketoreductase, ER = enoylreductase, KS = ketosynthase,
CLC = claisen condensation domain. Asterisks indicate completely
deuterated carbons and black dots indicate 13C-labeling carbons.
The indicated positions for incorporation of labelling are based on
mechanistic considerations for PKS biosynthesis.
Fig. 3 Volatiles from Stachylidium sp. 293 K04. Total ion chromatogram
of the headspace extract of Stachylidium sp. 293 K04 and structures of the
identified volatiles. Asterisks indicate compounds originating from the
medium. Peak numbers in the chromatogram refer to compound numbers.
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olide (47). This lactone was previously described as a phyto-
toxin that is possibly involved in the pathogenicity of the
fungus Hymenoscyphus pseudoalbidus, the causative agent of
European ash dieback. Compound testings in the laboratory
revealed a strong inhibitory activity of lactone 47 against ash
seed germination.48 H. pseudoalbidus produces mainly the
R enantiomer with 80% ee. Notably, the material emitted by
Emericella is also a 1 : 10 mixture of enantiomers, but in this
species (S)-47 is dominant (Fig. 5).
Bioactivity tests
A selection of fungal volatiles identified during the course of
this study were tested for their bioactivities against bacteria
and algae. While all the tested compounds showed no or only
moderate activity against Gram-positive (Bacillus megaterium)
and Gram-negative (Escherichia coli) bacteria (Table S2†),
the racemate of 15 showed growth inhibitory effects towards
the alga Chlorella fusca (Table 1). The S enantiomer was much
less active, suggesting that the growth inhibition is mainly due
to the R enantiomer in the racemate. Notably, the isomer
torquatone (18) was inactive. The O-desmethyl derivative
chartabomone 16 revealed a similarly strong algicidal activity
as (rac)-15, while no activity was observed for the newly
identified dichotomone 17. The strongest bioactivity was
detected for the synthetic derivatives 19 and 25 (Table 1).
Conclusions
In the present study we describe the first analysis of volatiles
released by sponge-associated fungi that were previously iso-
lated from Callyspongia cf. flammea. The analyses revealed the
production of several volatiles with interesting bioactivities,
including a small family of polymethylated polyketides with
the main compound isotorquatone (15). The observed algicical
activity of racemic 15 and its O-desmethyl derivative 16 may
point to their involvement in protecting the sponge from algal
infections, but it is difficult to judge to which extent the
results from laboratory bioactivity experiments can be used to
assign a function to these compounds in a complex ecosystem
such as a sponge and its microbiome in their natural habitat.
The occurrence of compounds such as the quorum sensing
Fig. 4 Volatiles from Emericella sp. 293 K02. Total ion chromatogram
of the headspace extract of Emericella sp. and structures of the ident-
ified volatiles. Peak numbers in the chromatogram refer to compound
numbers.
Fig. 5 Extracted ion chromatograms (m/z = 113) of (A) a pseudoracemic
mixture of synthetic (S)- and (R)-47, (B) synthetic (R)-47, (C) synthetic
(S)-47, (D) a headspace extract from Emericella, (E) headspace extract
spiked with synthetic (S)-47, and (F) headspace extract spiked with
synthetic (R)-47.
Table 1 Algicidal activity of fungal volatiles against Chlorella fusca (80%
inhibition)
Compound MICa [μg mL−1]
(rac)-15 31.3
(S)-15 125.0
16 31.3
17 >125.0
18 >125.0
19 2.0
25 15.6
2,4-Dichlorophenolb 1.0
CuSO4·5H2O
b <31.3
aMinimal inhibitory concentration. b Positive control.
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disruptor protoanemonine (6) is also noteworthy and suggests
a potential involvement of fungal volatiles in the intra- and
interspecies communication between the multiple micro-
organisms in the rich sponge microbiomes. Further research
will be required to deepen our understanding of the role of
fungal volatiles in the complex interactions between sponges
and their microbial symbionts.
Experimental
Fungal strains and growth conditions
The fungal strains investigated in this study (Table 2) were pre-
viously isolated from a marine sample of the sponge
Callyspongia cf. flammea, collected on Bear Island, Sydney,
Australia as reported in ref. 18. In order to obtain the volatiles,
all strains were cultivated on biomalt salt medium, in 100 mm
× 15 mm Petri dishes, for 14 days, at room temperature.
CLSA sampling
The volatiles were collected by use of a closed-loop stripping
apparatus (CLSA).18 Sampling was conducted for 16 to 24 h at
room temperature (20 °C) and under natural day and night
light conditions. The charcoal filter was extracted with di-
chloromethane (50 μL) and the resulting headspace extracts
were directly analyzed by GC-MS. All headspace samplings
were carried out in duplicates.
GC-MS analysis of headspace extracts
The crude headspace extracts were analyzed by use of an
Agilent HP7890B gas chromatograph, fitted with a HP-5MS
silica capillary column (30 m, 0.25 mm i.d., 0.50 μm film), con-
nected to a HP5977A mass detector. The GC-MS conditions
were as follows: (1) inlet pressure: 77.1 kPa, He flow 23.3 mL
min−1; (2) injection volume: 1 μL; (3) injection mode: splitless,
valve time 60 s; (4) oven temperature ramp: 5 min at 50 °C
increasing at 5 °C min−1 to 320 °C; (5) carrier gas He at 1 mL
min−1; (6) transfer line: 250 °C; (7) electron energy: 70 eV.
Retention indices (I) were determined from a homologous
series of n-alkanes (C8–C40).
Feeding experiments
Feeding experiments were performed with D. cejpii and isotopi-
cally enriched (2-13C)acetate and (methyl-2H3)-L-methionine. The
labeled compounds were directly added to the liquid agar
medium (10 mM) and D. cejpii was inoculated for 10 days. The
emitted volatiles of the grown cultures were captured by use of a
CLSA and the crude headspace extracts were analyzed by GC-MS.
General synthetic and analytical methods
All chemicals were obtained from Acros Organics (Geel,
Belgium), Sigma Aldrich Chemie GmbH (Steinheim, Germay)
or TCI Deutschland GmbH (Eschborn, Germany). All solvents
were purified by distillation. Whenever necessary, reactions
were carried out under inert atmosphere (Ar) using vacuum-
heated flasks and dried solvents (dried according to standard
protocols). Thin layer chromatography (TLC) was performed
on 0.20 mm silica plates (Polygram SIL G/UV254) obtained
from Macherey–Nagel (Düren, Germany). Column chromato-
graphy was performed on Merck silica gel (0.040–0.063 Mesh).
NMR spectra were recorded on Bruker AV I (400 MHz), AV III
HD Prodigy (500 MHz) and AV III HD Cryo (700 MHz) spec-
trometers, and were referenced against CDCl3 (δ = 7.26 ppm)
and C6D6 (δ = 7.16 ppm) for
1H-NMR, and CDCl3 (δ =
77.01 ppm) and C6D6 (δ = 128.06 ppm) for
13C-NMR. The
multiplicities are specified as follows: singlet (s), doublet (d),
triplet (t), quartet (q), quintet (quin), sextet (sex), septet (sept).
GC-MS analyses were carried out with an Agilent HP7890B gas
chromatograph connected to a HP5977A mass detector fitted
with a HP-5MS silica capillary column (30 m, 0.25 mm i.d.,
0.50 μm film). The GC-MS conditions were as follows: (1) inlet
pressure: 77.1 kPa, He flow 23.3 mL min−1; (2) injection
volume: 1 μL; (3) injection mode: split 50 : 1, valve time 60 s;
(4) oven temperature ramp: 5 min at 50 °C increasing at 10 °C
min−1 to 320 °C; (5) carrier gas He at 1 mL min−1; (6) transfer
line: 250 °C; (7) electron energy: 70 eV. Retention indices (I)
were determined from a homologous series of n-alkanes
(C8–C40). Optical rotary powers were recorded on a P8000
Polarimeter (Krüss). UV/Vis spectra were recorded on a Cary
100 UV/Vis spectrometer (Agilent). IR Spectra were measured
by use of an Alpha FT-IR spectrometer from Bruker.
Synthetic procedures
1,3,5-Trimethoxy-2-methylbenzene (21). To a solution of
1,3,5-trimethoxybenzene (20) (5.00 g, 29.7 mmol, 1.0 equiv.) in
80 mL dry THF was slowly added a 1.4 M solution of s-butyl-
lithium (31.9 mL, 44.6 mmol, 1.5 equiv.) at room temperature
and stirred for 15 minutes. The reaction was heated to 40 °C
and stirred for 2 h. Afterwards it was cooled to −78 °C and
methyl iodide (7.40 mL, 119 mmol, 4.0 equiv.) was added
slowly. The reaction was allowed to warm to room temperature
and stirred over night. Addition of water was followed by
extraction with Et2O and the combined organic layers were
dried with MgSO4 and the solvent was removed under reduced
pressure. The crude product was purified by column chromato-
graphy on silica gel (cyclohexane/ethyl acetate 30 : 1) and 21
was isolated as a yellowish oil (3.78 g, 20.8 mmol, 70%). Rf =
0.2. GC (HP-5MS): I = 1482. 1H-NMR (500 MHz, CDCl3): δ =
6.15 (s, 2H, CH), 3.81 (s, 9H, CH3), 2.03 (s, 3H, CH3) ppm.
13C-NMR (125 MHz, CDCl3): δ = 159.1 (s, Cq), 158.9 (s, 2 × Cq),
106.9 (s, Cq), 90.7 (2 × CH), 55.8 (2 × CH3), 55.5 (s, CH3), 7.8 (s,
CH3) ppm. IR (ATR): ν˜ = 2997, 2938, 2836, 1594, 1499, 807.
Table 2 Investigated strains from Callyspongia cf. flammea
Strain no. Taxonomy
293 K02 Botrytis sp.
293 K04 Stachylidium bicolor
293 K05 Sporomiella sp.
293 K09 Dichotomomyces cejpii
293 K10 Emericella sp.
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UV/Vis (MeCN): λmax (lg ε): 271 (4.29), 241 (5.63) nm. EI-MS (70
eV): m/z (%) = 182 (100), 167 (21), 153 (23), 151 (25), 139 (17),
121 (22), 109 (15), 91 (14), 77 (14), 69 (14). HR-EIMS calcd for
C10H14O3
+: m/z = 182.0943, found: m/z = 182.0979.
1,3,5-Trimethoxy-2,4-dimethylbenzene (22). To a solution of
21 (2.30 g, 12.6 mmol, 1.0 equiv.) in 15 mL dry THF was slowly
added a 1.4 M solution of s-butyllithium (13.5 mL, 19.0 mmol,
1.5 equiv.) at room temperature and stirred for 15 minutes.
The reaction was heated to 40 °C and stirred for 2 h.
Afterwards it was cooled to −78 °C and methyl iodide
(3.20 mL, 50.5 mmol, 4.0 eq.) was added slowly. The reaction
was allowed to warm to room temperature and stirred over
night. Addition of water was followed by extraction with Et2O
and the combined organic layers were dried with MgSO4 and
the solvent was removed under reduced pressure. The crude
product was purified by column chromatography on silica gel
(cyclohexane/ethyl acetate 30 : 1) and 22 was isolated as a white
crystalline solid (2.04 g, 10.4 mmol, 82%). Rf = 0.2. GC
(HP-5MS): I = 1520. 1H-NMR (500 MHz, CDCl3): δ = 6.28 (s, 1H,
CH), 3.83 (s, 6H, 2 × CH3), 3.69 (s, 3H, CH3), 2.11 (s, 6H, 2 ×
CH3) ppm.
13C-NMR (125 MHz, CDCl3): δ = 158.0 (s, Cq), 156.8
(s, 2 × Cq), 111.7 (s, 2 × Cq), 91.84 (s, CH), 60.3 (s, CH3), 55.9 (s,
2 × CH3), 8.7 (s, 2 × CH3) ppm. IR (ATR): ν˜ = 2985, 2938, 2840,
1593, 1495, 803. UV/Vis (MeCN): λmax (lg ε): 281 (4.45), 235
(4.79) nm. EI-MS (70 eV): m/z (%) = 197 (12), 196 (100), 181
(34), 165 (31), 153 (15), 138 (10), 135 (11), 121 (11), 91 (10), 77
(10). HR-EIMS calcd for C11H16O3
+: m/z = 196.1099, found: m/z
= 196.1121.
1-Bromo-2,4,6-trimethoxy-3,5-dimethylbenzene (23). To a
solution of 22 (0.20 g, 1.02 mmol, 1.0 equiv.) in 6 mL dry DCM
was added NBS (0.20 g, 1.12 mmol, 1.1 equiv.) and the mixture
was stirred for 16 h at room temperature. The reaction was
quenched with water and extracted with Et2O and the com-
bined organic layers were dried with MgSO4. The solvent was
removed under reduced pressure and the crude product was
purified by column chromatography on silica gel (cyclohexane/
ethyl acetate 20 : 1). Product 23 was isolated as a white solid
(0.23 g, 0.84 mmol, 82%). Rf = 0.2. GC (HP-5MS): I = 1704.
1H-NMR (400 MHz, CDCl3): δ = 3.78 (s, 6H, 2 × CH3), 3.69 (3H,
CH3), 2.23 (s, 6H, 2 × CH3) ppm.
13C-NMR (100 MHz, CDCl3):
δ = 157.5 (Cq), 154.5 (2 × Cq), 122.2 (2 × Cq), 108.3 (Cq), 60.5
(2 × CH3), 60.1 (CH3), 10.0 (2 × CH3) ppm. IR (ATR): ν˜ = 3000,
2938, 2866, 2831, 1583, 1559. UV/Vis (MeCN): λmax (lg ε): 231
(4.90) nm. EI-MS (70 eV): m/z (%) = 276 (98), 274 (100), 261
(14), 259 (14), 233 (25), 231 (27), 216 (17), 165 (20), 137 (20), 77
(16). HR-EIMS calcd for C11H15O3Br
+: m/z = 274.0205, found:
m/z 274.0204.
(rac)-Isotorquatone (15). To a solution of 23 (0.23 g,
0.84 mmol, 1.0 equiv.) in 5 mL dry THF was slowly added a 1.7
M solution of t-butyllithium (1.00 mL, 1.67 mmol, 2.0 equiv.)
at −78 °C. The reaction was warmed to −10 °C, stirred for
10 minutes and again cooled to −78 °C. Aldehyde 2-methyl-
butyraldehyde (0.22 g, 2.51 mmol, 3.0 equiv.) was slowly added
and the reaction was stirred for 30 minutes at −78 °C. The
reaction was quenched with water and extracted with Et2O.
The combined organic layers were dried with MgSO4 and the
solvent was removed under reduced pressure. The crude
product was dissolved in 5 mL dry DCM and DMP (0.36 g,
0.84 mmol, 1.0 equiv.) was added. The reaction was stirred
over night at room temperature, quenched with water and
extracted with Et2O. The crude product was purified by
column chromatography on silica gel (cyclohexane/ethyl
acetate 20 : 1). (rac)-Isotorquatone 15 (0.15 g, 0.53 mmol, 63%)
was isolated as a colorless oil. Rf = 0.2. GC (HP-5MS): I = 1810.
1H-NMR (500 MHz, CDCl3): δ = 3.72 (s, 3H, CH3), 3.69 (s, 6H,
2 × CH3), 2.93–2.84 (m, 1H, CH), 2.17 (s, 6H, 2 × CH3),
1.86–1.75 (m, 1H, CHH), 1.45–1.34 (m, 1H, CHH), 1.13 (d, 3H,
3J = 6.8 Hz, CH3), 0.94 (t, 3H,
3J = 7.3 Hz, CH3) ppm.
13C-NMR
(125 MHz, CDCl3): δ = 209.2 (Cq), 159.0 (Cq), 153.9 (Cq),
127.2 (Cq), 121.0 (Cq), 62.5 (2 × CH3), 60.1 (CH3), 49.3 (CH),
25.2 (CH2), 15.2 (CH3), 11.7 (CH3), 9.4 (CH3) ppm. IR (ATR): ν˜ =
2997, 2921, 2856, 1652. EI-MS (70 eV): m/z (%) = 280 (9),
225 (3), 224 (26), 223 (100), 208 (6), 193 (5), 190 (3), 179 (3),
165 (7), 91 (3). HR-EIMS calcd for C16H24O4
+: m/z = 280.1675,
found: m/z = 280.1658.
(S)-Isotorquatone ((S)-15). Synthesis of (S)-15 was conducted
according to the procedure for (rac)-15. Enantiomerically pure
(S)-2-methylbutyraldehyde33 was used for the alkylation of 23.
All recorded spectral data were identical to those for (rac)-15.
[α]20D = +4.3 (c 1, EtOH).
Analysis of the enantiomeric excess of 15. The enantiomeric
excess of natural 15 and synthetic (S)-15 was determined by
analytical HPLC on a homochiral stationary phase (Fig. S2†)
using the following conditions: system: Fa. Knauer GmbH
(Berlin, Germany), 2 pumps P-1 HPLCplus (max. 750 bar),
oven T-1 with 2 integrated 6-Port valves, photodiode array
detector PDA-1 (190–1000 nm); column: Eurocel 03, 3 μm,
4.6 mm × 250 mm; solvent: methanol/water (90/10); flow rate:
1.0 mL min−1; pressure: 209 bar, temperature: 20 °C.
Dichotomomyces cejpii 293 K09 was cultivated on MPY medium
(malt extract 20 g L−1, peptone from meat 2.5 g L−1, yeast
extract 2.5 g L−1, agar 15 g L−1). Cultivation was performed in
1800 mL Fernbach flasks (20 × 250 mL per flask) for 40 days at
room temperature with constant artificial light exposure. Each
Fernbach flask was extracted with pentane (100 mL) and the
combined extracts were concentrated under reduced pressure.
The crude extract was purified by column chromatography on
silica gel (pentane/diethyl ether 20 : 1) and a fraction contain-
ing 15 (8 mg) was isolated and directly analyzed.
Torquatone (18). To a solution of 23 (0.05 g, 0.18 mmol, 1.0
equiv.) in 1 mL dry THF was slowly added a 1.7 M solution of
t-butyllithium (0.22 mL, 0.36 mmol, 2.0 equiv.) at −78 °C. The
reaction was warmed to −10 °C, stirred for 10 minutes and
again cooled to −78 °C. Aldehyde 24 (0.05 g, 0.58 mmol, 3.0
equiv.) was slowly added and the reaction was stirred for
30 minutes at −78 °C. The reaction was quenched with water
and extracted with Et2O. The combined organic layers were
dried with MgSO4 and the solvent was removed under reduced
pressure. The crude product was dissolved in 1 mL dry DCM
and DMP (0.08 g, 0.18 mmol, 1.0 equiv.) was added. The reac-
tion was stirred over night at room temperature, quenched
with water and extracted with Et2O. The crude product was
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purified by column chromatography on silica gel (cyclohexane/
ethyl acetate 20 : 1). Torquatone 18 (0.03 g, 0.09 mmol, 50%)
was isolated as a colorless oil. Rf = 0.2. GC (HP-5MS): I = 1824.
1H-NMR (500 MHz, C6D6): δ = 3.53 (s, 6H, 2 × CH3), 3.34 (s,
3H, 2 CH3), 2.73 (d,
3J = 6.8 Hz, 2H, CH2), 2.42 (tsept,
3J =
6.7 Hz, 3J = 6.7 Hz, 1H, CH), 2.14 (s, 6H, 2 × CH3), 0.97 (d,
3J =
6.7 Hz, 6H, 2 × CH3) ppm.
13C-NMR (125 MHz, C6D6): δ = 204.1
(Cq), 159.3 (Cq), 154.3 (2 × Cq), 128.6 (Cq), 121.1 (2 × Cq), 62.3
(2 × CH3), 59.5 (CH3), 54.4 (CH2), 24.4 (CH), 22.7 (2 × CH3), 9.3
(2 × CH3) ppm. IR (ATR): ν˜ = 2955, 2868, 1696, 1581, 1452,
1397, 1365, 1333, 1324, 1294, 1265, 1221, 1194, 1143, 1071,
1006, 990. EI-MS (70 eV): m/z (%) = 280 (10), 223 (100), 208 (3),
196 (3), 165 (3). HR-ESIMS calcd for C16H25O4
+: m/z =
281.1747, found: m/z = 280.1747 [M + H]+.
2-Bromo-1,3,5-trimethoxy-4-methylbenzene (24). To a solu-
tion of 21 (0.20 g, 1.10 mmol, 1.0 equiv.) in 2 mL dry THF was
added NBS (0.19 g, 1.10 mmol, 1.0 equiv.) at 0 °C. The reaction
was warmed to room temperature and stirred for 14 h.
Afterwards water was added and it was extracted with Et2O.
The combined organic layers were dried with MgSO4 and the
solvent was removed under reduced pressure. The crude
product was purified by column chromatography on silica gel
(cyclohexane/ethyl acetate 20 : 1) and 24 was isolated as a crys-
talline white solid (0.28 g, 1.06 mmol, 97%). Rf = 0.2. GC
(HP-5MS): I = 1724. 1H-NMR (500 MHz, CDCl3): δ = 6.31 (s, 1H,
CH), 3.88 (s, 3H, CH3), 3.83 (s, 3H, CH3), 3.77 (s, 3H, CH3),
2.13 (s, 3H, CH3) ppm.
13C-NMR (125 MHz, CDCl3): δ = 158.3
(Cq), 156.7 (Cq), 155.2 (Cq), 113.8 (Cq), 98.1 (Cq), 92.8 (CH),
60.5 (CH3), 56.7 (CH3), 55.9 (CH3), 9.2 (CH3) ppm. IR (ATR): ν˜ =
2973, 2944, 2858, 1594, 1575, 805. EI-MS (70 eV): m/z (%) = 262
(95), 260 (100), 217 (20), 182 (19), 181 (24), 152 (20), 151 (34),
123 (20), 121 (25), 77 (18). HR-EIMS calcd for C10H13O3Br
+:
m/z = 260.0048, found: m/z = 260.0028.
2-Methyl-1-(2,4,6-trimethoxy-3-methylphenyl)butan-1-one (19).
To a solution of 24 (0.10 g, 0.38 mmol, 1.0 equiv.) in 1 mL dry
hexane was slowly added a 1.7 M solution of t-butyllithium
(0.45 mL, 0.77 mmol, 2.0 equiv.) at −78 °C. The reaction was
warmed to −10 °C, stirred for 10 minutes and again cooled to
−78 °C. 2-Methylbutyraldehyde (0.05 g, 0.58 mmol, 1.5 equiv.)
was slowly added and the reaction was stirred for 30 minutes
at −78 °C. The reaction was quenched with water and extracted
with Et2O. The combined organic layers were dried with
MgSO4 and the solvent was removed under reduced pressure.
The crude product was dissolved in 2 mL dry DMSO and IBX
(0.04 g, 0.15 mmol, 1.2 equiv.) was added at room temperature.
The reaction was stirred over night and quenched with sat. aq.
NaHCO3-solution. The mixture was extracted with Et2O and
the organic layers were dried with MgSO4. Purification of the
crude product was done by flash chromatography (cyclo-
hexane/ethyl acetate 5 : 1) and 19 was isolated as a colorless oil
(0.03 g, 0.94 mmol, 28%). Rf = 0.2. GC (HP-5MS): I = 1877.
1H-NMR (500 MHz, CDCl3): δ = 6.25 (s, 1H, CH), 3.84 (s, 3H,
CH3), 3.78 (s, 3H, CH3), 3.69 (s, 3H, CH3), 2.94–2.86 (m, 1H,
CH), 2.06 (s, 3H, CH3), 1.83–1.74 (m, 1H, CHH), 1.43–1.34 (m,
1H, CHH), 1.11 (d, 3J = 7.0 Hz, 3H, CH3), 0.92 (t,
3J = 7.4 Hz,
3H, CH3) ppm.
13C-NMR (125 MHz, CDCl3): δ = 208.8 (Cq),
159.9 (Cq), 156.7 (Cq), 155.6 (Cq), 118.6 (Cq), 112.2 (Cq), 91.5
(CH), 62.6 (CH3), 56.0 (CH3), 55.8 (CH3), 49.2 (CH), 25.5 (CH2),
15.3 (CH3), 11.8 (CH3), 8.5 (CH3) ppm. IR (ATR): ν˜ = 2964,
2935, 2875, 2837, 1692, 1598, 805. EI-MS (70 eV): m/z (%) = 266
(6), 209 (100), 194 (5), 165 (3), 136 (5). HR-EIMS calcd for
C15H23O4
+: m/z = 266.1518, found: m/z = 266.1501.
1-(2-Hydroxy-4,6-dimethoxy-3,5-dimethylphenyl)-2-methyl-
butan-1-one (16) and 1-(2,6-dihydroxy-4-methoxy-3,5-di-
methylphenyl)-2-methylbutan-1-one (25). To a solution of 15
(0.05 g, 0.16 mmol, 1.0 equiv.) in dry DCM was slowly added
BBr3 (0.04 g, 0.18 mmol, 1.1 equiv.) in 0.1 mL dry DCM at
−78 °C. The reaction was allowed to warm to room tempera-
ture and stirred over night. It was cooled with an ice bath,
quenched with water and extracted with EtOAc. After drying
with MgSO4 the solvent was removed under reduced pressure
and the crude product was purified by column chromato-
graphy on silica gel (cyclohexane/ethyl acetate 15 : 1 to 5 : 1).
Compounds 16 (0.015 g, 0.06 mmol, 35%) and 25 (0.021 g,
0.08 mmol, 52%) were isolated as colorless oils. Analytical data
for 16: Rf = 0.2 (15 : 1). GC (HP-5MS): I = 1855.
1H-NMR
(500 MHz, CDCl3): δ = 12.63 (s, 1H, OH), 3.74 (s, 3H, CH3),
3.72 (m, 1H, CH), 3.69 (s, 3H, CH3), 2.15 (s, 3H, CH3), 2.13 (s,
3H, CH3), 1.82–1.74 (m, 1H, CHH), 1.48–1.38 (m, 1H, CHH),
1.17 (d, 3J = 6.9 Hz, 3H, CH3), 0.89 (t,
3J = 7.5 Hz, 3H, CH3)
ppm. 13C-NMR (125 MHz, CDCl3): δ = 212.2 (Cq), 163.2 (Cq),
160.7 (Cq), 158.6 (Cq), 115.7 (Cq), 115.5 (Cq), 111.6 (Cq), 62.4
(CH3), 60.2 (CH3), 45.9 (CH), 27.4 (CH2), 17.2 (CH3), 12.0
(CH3), 9.3 (CH3), 8.9 (CH3) ppm. IR (ATR): ν˜ = 2961, 2934,
2874, 1776, 1613, 1585, 1452, 1403, 1371, 1358, 1272, 1192,
1132, 1104, 1030, 992, 922, 904, 832, 771, 709, 580, 510. EI-MS
(70 eV): m/z (%) = 266 (M+, 7), 209 (100), 166 (2). HR-ESIMS
calcd for C15H23O4
+: m/z = 267.1591, found: m/z = 267.1592
[M + H]+. Analytical data for 25: Rf = 0.2 (5 : 1). GC (HP-5MS):
I = 1928. 1H-NMR (500 MHz, CDCl3): δ = 13.22 (s, 1H, OH),
5.28 (s, 1H, OH), 3.75–3.68 (m, 1H, CH), 3.69 (s, 3H, CH3), 2.13
(s, 3H, CH3), 2.10 (s, 3H, CH3), 1.83–1.73 (m, 1H, CHH),
1.48–1.38 (m, 1H, CHH), 1.16 (d, 3J = 6.8 Hz, 3H, CH3), 0.89
(t, 3J = 7.5 Hz, 3H, CH3) ppm.
13C-NMR (125 MHz, CDCl3): δ =
211.4 (Cq), 161.2 (Cq), 158.9 (Cq), 158.7 (Cq), 108.7 (Cq), 108.6
(Cq), 106.6 (Cq), 62.5 (CH3), 45.5 (CH), 27.6 (CH2), 17.4 (CH3),
12.1 (CH3), 8.8 (CH3), 7.7 (CH3) ppm. IR (ATR): ν˜ = 3469, 2963,
2933, 2874, 1601, 1453, 1410, 1373, 1288, 1223, 1171, 1142,
1104, 1069, 1024, 989, 937, 901, 812, 773, 732, 689, 508. EI-MS
(70 eV): m/z (%) = 252 (M+, 6), 195 (100), 180 (3), 152 (4).
HR-ESIMS calcd for C14H21O4
+: m/z = 253.1434, found: m/z =
253.1437 [M + H]+.
Dichotomone (17). Compound 17 was synthesized starting
from 1,3,5-trimethoxybenzene (20) according to a literature
known procedure.32 GC (HP-5MS): I = 1885. 1H-NMR
(500 MHz, CDCl3): δ = 4.91 (s br, 1H, OH), 3.68 (s, 6H, 2 ×
CH3), 2.95–2.87 (m, 1H, CH), 2.13 (s, 6H, 2 × CH3), 1.83–1.74
(m, 1H, CHH), 1.43–1.33 (m, 1H, CHH), 1.12 (d, 3J = 7.1 Hz,
3H, CH3), 0.93 (t,
3J = 7.5 Hz, 3H, CH3) ppm.
13C-NMR
(125 MHz, CDCl3): δ = 209.1 (Cq), 154.4 (Cq), 154.0 (Cq), 123.5
(Cq), 113.1 (Cq), 62.9 (2 x CH3), 49.3 (CH), 25.4 (CH2), 15.3
(CH3), 11.8 (CH3), 8.8 (CH3) ppm. IR (ATR): ν˜ = 3463, 2965,
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2936, 2874, 2838, 1682, 1584, 1457, 1406, 1376, 1295, 1227,
1186, 1126, 1102, 1063, 1022, 1001, 986, 932, 877, 844, 501.
EI-MS (70 eV): m/z (%) = 266 (M+, 7), 209 (100), 194 (11).
HR-ESIMS calcd for C15H23O4
+: m/z = 267.1591, found: m/z =
267.1592.
Analysis of the enantiomeric excess of 47. The enantiomeric
excess of natural 47 and synthetic (R)- and (S)-47 47 was deter-
mined by GC-MS on a homochiral stationary phase (Fig. 5)
using the following conditions: system: Agilent HP7890B gas-
chromatograph connected to a HP5977A mass detector fitted
with an Agilent CycloSil-B capillary column (30 m,
0.25–0.32 mm ID, 0.25 μm film); The GC-MS conditions were
as follows: (1) inlet pressure: 77.1 kPa, He flow 23.3 mL min−1;
(2) injection volume: 1 μL; (3) injection mode: splitless, valve
time 60 s; (4) oven temperature ramp: 5 min at 70 °C increas-
ing at 10 °C min−1 to 210 °C; (5) carrier gas He at 1 mL min−1;
(6) transfer line: 250 °C; (7) electron energy: 70 eV.
Bioactivity tests against Chlorella fusca
CP medium (10 mL; yeast extract 10.0 g L−1, D-(+)-glucose
monohydrate 10.0 g L−1, 1000 mL H2O, pH 6.2) was inoculated
with Chlorella fusca, followed by culturing for one week under
constant artificial light exposure and shaking (100 rpm) at
24 °C. The culture was diluted with sterile CP medium to a cell
count of 10 000 cells per mL distributed in 96 well plates.
Solutions of the test compounds (Table 1) in CP medium were
added with a final concentration of 125 μg mL−1, followed by a
1 : 1 dilution series (62.5 μg mL−1, 31.3 μg mL−1, 15.6 μg mL−1,
etc.). All experiments were performed in triplicate, with 3 nega-
tive controls (no compound added) and using 2,4-dichloro-
phenol and CuSO4·5H2O as positive controls. An extra plate was
used as a blank control (no algae) to exclude light absorption
by the medium. The incubation time was 5 days at 24 °C, with
constant artificial light exposure and without shaking. OD
values were measured at 560 nm using a Sunrise Tecan micro-
plate reader plate reader. The minimal inhibitory concen-
tration was considered the lowest concentration that led to at
least 80% growth inhibition compared to the negative control.
Bioactivity tests against B. megaterium and E. coli
NP medium (10 mL; peptone from meat 7.8 g L−1, peptone
from casein 7.8 g L−1, yeast extract 2.8 g L−1, D-(+)-glucose
monohydrate 1.0 g L−1, NaCl 5.6 g L−1, 1000 mL H2O, pH 7.5)
was inoculated with Bacillus megaterium DSM 32 or Escherichia
coli DSM 498 and the cultures were grown overnight under
constant shaking (200 rpm) at 30 °C. Agar plates were prepared
using NP medium (with 12 g L−1 agar) and the plates were
inoculated with 150 μL bacterial suspension which was evenly
distributed on the surface of the agar. With the use of 200 μL
pipette tip, three small agar plugs were taken out from each
agar plate and solutions of the test compounds (50 μL, 1 mg
mL−1) were filled into the hole from the removed agar plugs.
Ertapenem was used as a positive control. Incubation time
was 24 h at 30 °C, with constant artificial light exposure. The
inhibition zones were measured in mm (radii) and compared
to the positive control.
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1. LIST OF IDENTIFIED VOLATILES 
 
Table S1. Identified volatile compounds and their occurrence in the investigated strains. 
Compounda Ib I (Lit.)c Ident.d occurrence (strain)e 
furan-3-carbaldehyde (34) 816  ms, std St 
butyl acetate (35) 819 8141 ms, ri, std St 
furan-2-carbaldehyde 835 8352 ms, ri, std St 
2-furanmethanol 854 8503 ms, ri, std D, St 
ethyl 2-methylbutyrate (45) 856 8614 ms, ri E 
ethylbenzene  860 8585 ms, ri, std E, B 
m-xylene  868 8665 ms, ri, std E, B 
protoanemonin (6) 881 8806 ms, ri D 
cyclohexanol (46) 886 8867 ms, ri, std E 
2-acetylfuran 909 9098 ms, ri, std D, Sp 
2,5-hexanedione 927 9319 ms, ri, std St,  
2-hydroxy-5-methylhexan-3-one (36) 942 94410 ms, ri St 
4-methyl--butyrolactone (37) 954 95811 ms, ri St 
benzaldehyde 959 9528 ms, ri, std B, Sp 
1-octen-3-ol (38) 978 97512 ms, ri, std St, E 
1-ethyl-4-methylbenzene  968 96513 ms, ri, std B 
3-octanon (39) 986 98314 ms, ri, std St, E 
6-methylhept-5-en-2-one (51) 987 9818 ms, ri, std B 
1,3,4-trimethylbenzene 993 9958 ms, ri, std E, B 
2-acetylpyrrole 1058 10548 ms, ri, std D, St, Sp 
3,4-dimethylpentan-4-olid (47) 1064 106315 ms, ri, std E 
acetophenone 1066 10598 ms, ri, std St, Sp 
linalool (40) 1100 10958 ms, ri, std St, B 
nonanal (7) 1104 110116 ms, ri, std D, St, E, B, Sp 
2-phenylethanol 1114 11078 ms, ri, std St, Sp 
phenylacetonitrile (10) 1138 11348 ms, ri, std D 
1,2-dimethoxybenzene (41) 1146 114617 ms, ri, std St 
2-methylisoborneol (42) 1184 11788 ms, ri, std St, B 
decanal (8) 1202 12018 ms, ri, std D, St, E, B, Sp 
4 
 
2-phenyloxyethanol  1219 12218 ms, ri St, B, Sp 
benzothiazole (43) 1224 122318 ms, ri St, E, Sp 
undecanal (9) 1307 130514 ms, ri, std D, E 
3,4-dimethoxystyrene (11) 1364 136819 ms, ri, std D 
1,3,4-trimethoxybenzene (44) 1368 1373 ms, std St 
dodecanal (48) 1418 141120 ms, ri, std E, B 
geranylactone (12) 1454 145521 ms, ri, std D, St, B 
dauca-4(11),8-diene (13) 1539 153722 ms, ri D 
hexadecane (49) 1600 16008 ms, ri, std E 
(1(10)E,5E)-germacradien-11-ol (14) 1649 163823 ms, ri, std D 
tetradecanol (50) 1676 16768 ms, ri, std E 
isotorquatone (15)  1808  ms, std D 
chartabomone (16) 1853  ms, std D 
dichotomone (17) 1884  ms, std D 
aCompound numbers refer to compound numbers in main text. Unidentified compounds and 
artifacts are not listed. Compounds which have also been identified from the medium are 
marked in italics. bRetention index on a HP5-MS fused silica capillary column. cRetention index 
on the same or a similar column from tabulated data in the literature. dIdentification based on 
ms: mass spectrum (mass spectral match factor >850), ri: retention index on same or similar 
column (maximum deviation of 10 points), std: comparison to a synthetic or commercially 
available standard. eLetters refer to fungal strains: D. cejpii (D), Stachylidium sp. (St), 
Emericella sp. (E), Sporormiella sp. (Sp), Botrytis sp. (B). 
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2. HEADSPACE EXTRACT OF Sporormiella sp. 293 K05 
 
A) 
 
B) 
 
Figure S1. Volatiles produced by Sporormiella. A) Gas chromatogram of the headspace 
extract, B) structures of the detected volatiles. Asterisks indicate compounds originating 
from the medium. 
  
7 
 
3. HEADSPACE EXTRACT OF Botrytis sp. 293 K02 
 
A) 
 
B) 
 
Figure S2. Volatiles produced by Botrytis. A) Gas chromatogram of the headspace extract, B) 
structures of the detected volatiles. Asterisks indicate compounds originating from the 
medium. 
  
8 
 
4. MASS SPECTRA OF ISOTORQUATONE (15) AND TORQUATONE (18) 
 
 
 
Figure S3. Mass spectra of A) synthetic isotorquatone (15), B) synthetic torquatone (18), C) 
natural product from D. cejpii (identified as 15). 
9 
 
5. IDENTIFICATION OF ISOTORQUATONE BY GC-MS 
 
 
Figure S4. Total ion chromatograms of A) headspace extract of D. cejpii, B) synthetic 15, C) 
synthetic 18.  
10 
 
6. DETERMINATION OF THE ABSOLUTE CONFIGURATION OF 15 
 
 
Figure S5. Analysis of the absolute configuration of 15 by HPLC on a homochiral stationary 
phase. A) mixture of synthetic (R)-15 and (S)-15, B) synthetic (S)-15, C) natural product from 
D. cejpii.  
 
  
11 
 
7. MASS SPECTRA OF DESMETHYL ANALOGS 16, 17 and 19 
 
 
Figure S6. Mass spectra of A) natural desmethyl analogue 16, B) natural desmethyl analogue 
17, C) synthetic 16, D) synthetic 17, E) synthetic 19.   
 
12 
 
8. RESULTS OF FEEDING EXPERIMENTS  
 
 
Figure S7. Results of feeding experiments in D. cejpii. A) Total ion chromatogram of the 
headspace-extract of D. cejpii after feeding of (methyl-2H3)-L-methionine, B) mass spectrum of 
(2H18)-15 after feeding of (methyl-2H3)-L-methionine, C) mass spectrum of 15 after feeding of 
(2-13C)acetate. 
  
13 
 
9. BIOACTIVITY TESTS AGAINST BACTERIA  
 
Table S2. Bioactivity tests against bacteria. 
Compound B. megaterium DSM 32a E. coli DSM 498a 
15 0 0 
(S)-15 0 0 
16 3 0 
17 3 2b 
18 0 0 
19 2b 1b 
25 2b 0 
pos. control (ertapenem) 10 8 
a
 Radii of inhibition zones in mm, b partial inhibition. 
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Volatiles from nineteen recently genome
sequenced actinomycetes†
Christian A. Citron,a Lena Barra,a Joachim Winkb and Jeroen S. Dickschat*a
The volatiles released by agar plate cultures of nineteen actinomycetes whose genomes were recently
sequenced were collected by use of a closed-loop stripping apparatus (CLSA) and analysed by GC/MS. In
total, 178 compounds from various classes were identified. The most interesting findings were the detec-
tion of the insect pheromone frontalin in Streptomyces varsoviensis, and the emission of the unusual
plant metabolite 1-nitro-2-phenylethane. Its biosynthesis from phenylalanine was investigated in isotopic
labelling experiments. Furthermore, the identified terpenes were correlated to the information about
terpene cyclase homologs encoded in the investigated strains. The analytical data were in line with func-
tionally characterised bacterial terpene cyclases and particularly corroborated the recently suggested
function of a terpene cyclase from Streptomyces violaceusniger by the identification of a functional
homolog in Streptomyces rapamycinicus.
Introduction
The first genome sequence of the bacterium Haemophilus influ-
enzae was completely mapped in 1995.1 Today, the modern
sequencing techniques have enabled the rapid assembly of
thousands of bacterial genome sequences. The accumulated
sequencing data are stored on giant servers and bioinformatic
online tools are available that allow for an efficient screening
of these data for the presence of sequences with high homo-
logy to a probe sequence (basic local alignment search tool,
BLAST).2 The open access to genome data currently revolutio-
nises many scientific fields including natural products chem-
istry. For each secondary metabolite produced by a bacterium
a candidate biosynthetic gene or gene cluster can immediately
be assigned, thus allowing for advanced genetic techniques
such as heterologous gene expressions and DNA sequence
manipulation that can confirm the involvement of genes in
the biosynthesis of a secondary metabolite, may give detailed
mechanistic insights, and can in some cases even result in an
increased production.3 This approach is particularly interest-
ing for high potential secondary metabolite producing bacteria
such as actinomycetes,4 myxobacteria,5 and cyanobacteria.6
Many bacteria particularly of these taxa encode terpene
cyclases such as the synthases for pentalenene (1),7 epi-iso-
zizaene (2),8 geosmin (3),9 2-methylisoborneol (4),10,11 epi-
cubenol (5),12 and caryolan-1-ol (6, Scheme 1),13 but a large
number of putative bacterial terpene cyclases is still not
characterised. We have recently initiated a program to investi-
gate the function of these bacterial terpene cyclases. Since
mono-, sesqui- and diterpene hydrocarbons are volatile, this
can be performed by gene cloning, heterologous expression in
Escherichia coli, direct sampling of volatiles by use of a closed-
loop stripping apparatus (CLSA) and GC/MS analysis of the
obtained headspace extracts.14 For highly efficient cloning by
homologous recombination in yeast we have recently develo-
ped a pET28c-derived expression vector that contains a yeast
replication system and selectable marker.15 Via heterologous
expression the terpene cyclases for germacrene A (7), γ-cadi-
nene (8), α-amorphene (9), 7-epi-α-eudesmol (10), selina-4
(15),7(11)-diene (11), T-muurolol (12), (E)-β-caryophyllene (13),
hedycaryol (14), and epi-cubebol (15) were identified.15–18 As
second part of this work the volatiles of more than 50 bacteria
encoding terpene cyclases were analysed.19–21 If a completed
genome reveals the presence of only one uncharacterised
terpene cyclase, and if the headspace extracts of this organism
contain only one terpene product for which no particular
terpene cyclase has been assigned, the formation of this
terpene by the respective uncharacterised terpene cyclase is a
very plausible suggestion. By this approach the terpene
cyclases for 5,19 13,21 and isoafricanol (16)22 were uncovered.
The function of the putative (E)-β-caryophyllene synthase
and epi-cubenol synthase were subsequently corroborated by
†Electronic supplementary information (ESI) available: Tabulated data of investi-
gated strains and terpene cyclases encoded in their genomes and of results of
headspace analyses, figures of representative total ion chromatograms for each
investigated strain, and phylogenetic tree of bacterial terpene cyclase homologs.
See DOI: 10.1039/c4ob02609h
aKekulé-Institut für Organische Chemie und Biochemie, Universität Bonn,
Gerhard-Domagk-Straße 1, 53121 Bonn, Germany. E-mail: dickschat@uni-bonn.de;
Tel: +49 228 735797
bHelmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstraße 7,
38124 Braunschweig, Germany
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heterologous expression and in vitro incubation experiments
with the purified enzyme.12,15 Here we report on the volatiles
from nineteen recently genome sequenced actinomycetes with
a special focus on terpenes, but compounds from other classes
will also be presented.
Results and discussion
The volatiles released by nineteen actinomycetes (Table 1 of
ESI†) whose genomes were recently sequenced were collected
on charcoal filters using a CLSA. The filters were extracted
with dichloromethane and the headspace extracts were ana-
lysed by GC/MS. All strains were investigated in duplicate in
order to check for reproducibility of the results. The identified
compounds are summarised in Table 2 of ESI† and representa-
tive chromatograms for each strain are shown in Fig. 1 of ESI.†
In total, 178 different compounds were detected, some of
which occurred in multiple samples, while others were specific
for a particular organism. The identified compounds belong to
various compound classes including hydrocarbons, alcohols,
aldehydes, ketones and ketals, carboxylic acids and esters,
lactones, aromatic compounds, furans, nitrogen compounds,
sulfur compounds, and terpenes. The volatiles from these
different classes will be discussed separately.
Hydrocarbons
The identified hydrocarbons were mainly alkylated benzene
derivatives that occurred in the CLSA headspace extracts of a
few strains and generally in minor amounts (Scheme 2). The
most widespread compound was toluene (17), showing up in
five strains, followed by its partially reduced analog 1-methyl-
cyclohexa-1,3-diene (23) that is a new bacterial metabolite and
was observed in four strains. The other alkylated benzene
derivatives 18–22 occurred less frequently. Particularly interest-
ing is the detection of propylbenzene (19) in Streptomyces
cyaneofuscatus NRRL B-2570 that was accompanied by the fully
reduced analog propylcyclohexane (24) in this species. This
organism released also all other hydrocarbons shown in
Scheme 2, apart from 23. Both volatiles 19 and 24 have been
reported before from Chitinophaga pinensis DSM 2588.20
Alcohols
Among the alcohols the two branched compounds 3-methylbu-
tan-1-ol (26) and 2-methylbutan-1-ol (27) that are likely derived
from leucine and isoleucine, respectively, were the most wide-
spread (Scheme 3). For some strains including Pseudonocardia
spinosispora NRRL B-24156, Streptomyces flavochromogenes
NRRL B-2684 and Streptomyces mediolani NRRL WC3934 the
alcohol 26 was the principal compound. The unsaturated
analogs of 26, 3-methylbut-2-en-1-ol (29) and 3-methylbut-3-
en-1-ol (30), were also frequently found. These compounds
may either also be derived from leucine, or by hydrolysis of the
terpene precursors dimethylallyl diphosphate (DMAPP) and
isopentenyl diphosphate (IPP). Hexanol (25) was emitted
in trace amounts only by P. spinosispora, while its isomer
4-methylpentan-1-ol (28) was detected in Streptomyces anulatus
NRRL B-2873. Secondary alcohols were represented by pentan-
2-ol (31) from Streptomyces varsoviensis NRRL B-3589 and
4-methylpentan-2-ol (32) from S. mediolani. Cyclohexanol (33)
occurred in S. cyaneofuscatus and S. varsoviensis. The unusual
compound cyclohept-4-enol (34) that was previously reported
from Streptomyces sviceus20 was found in Amycolatopsis nigres-
cens DSM 44992 and Streptomyces globisporus NRRL B-2293.
Finally, butan-2,3-diol (35) was released by S. cyaneofuscatus
and S. mediolani. This diol is also known from various
Scheme 1 Terpenes from characterised bacterial terpene cyclases.
Scheme 2 Hydrocarbons.
Paper Organic & Biomolecular Chemistry
2674 | Org. Biomol. Chem., 2015, 13, 2673–2683 This journal is © The Royal Society of Chemistry 2015
Pu
bl
ish
ed
 o
n 
13
 Ja
nu
ar
y 
20
15
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f C
ol
og
ne
 o
n 
19
/1
1/
20
17
 1
1:
40
:1
4.
 
View Article Online
actinomycetes20 and from Bacillus, where it was shown to promote
growth and induce systemic resistance in Arabidopsis thaliana.23,24
Aldehydes, ketones and ketals
Aldehydes were rarely found, with decanal (36) and prenal (37)
as only representatives of this class (Scheme 4). In contrast,
ketones ranging from unbranched to branched, saturated to
unsaturated and cyclic compounds, occurred frequently and in
nearly all investigated species, with the only exception of Strep-
tomyces rapamycinicus NRRL 5491. The linear compounds were
pentan-2-one (38) from S. varsoviensis and heptan-2-one (39)
from Streptomyces globisporus NRRL B-2293. The branched
ketones 3-methylpentan-2-one (40) and (E)-3-methylpent-3-en-
2-one (41) were released by many strains, while (E)-4-methyl-
hex-4-en-3-one (42) was only found in Streptomyces afghaniensis
DSM 40228. All three compounds are likely derived from iso-
leucine via the coenzyme A thioester 2-methylbutyryl-SCoA.
The occasionally detected volatiles 6-methylhept-5-en-2-one (43)
and geranylacetone (44) may arise by oxidative degradation of
terpenoids. Hexan-2,4-dione (45) was the only dione and was
emitted by Amycolatopsis alba DSM 44262. Cyclopentanone (46)
was widespread, while its alkylated and unsaturated derivatives
were only found in a few strains and its higher homolog cyclo-
hexanone (49) was only detected in Streptomyces sclerotialus
NRRL ISP-5269. Cyclohept-4-enone (53) that corresponds to the
alcohol 34 was present in many strains. Interestingly, one of
these strains (A. alba) also produced tropone (54), while both 54
and tropone hydrate (55) were produced by S. flavochromogenes.
Tropone was first reported as a natural product from the bacter-
ium Azoarcus evansii where it accumulated in a mutant with a
blocked phenylacetate catabolon.25 Tropone and its hydrate were
later reported from marine bacteria of the Roseobacter clade26,27
and recently described as a biosynthetic shunt products of the
antibiotic tropodithietic acid in Phaeobacter inhibens.28
A widespread compound class in actinomycetes are hydroxy
ketones including acetoin (56) and its derivatives 57–62. The
parent compound itself was found in ten out of the nineteen
investigated strains, while particularly the branched com-
pounds 3-hydroxy-4-methylpentan-2-one (60), 3-hydroxy-5-
methylhexan-2-one (61) and 2-hydroxy-5-methylhexan-3-one
(62) were rare. The complete series of acetoin derivatives, with
the exemption of 2-hydroxyhexan-3-one (59), was observed in
P. spinosispora. As shown in investigations with the yeast Zygo-
saccharomyces bisporus and the actinomycete Corynebacterium
glutamicum these compounds arise in thiamin diphosphate-
dependent reactions from two α-oxoacids, e.g. 56 is generated
from two units of pyruvic acid.29,30
Surprisingly, the headspace extracts from S. varsoviensis
contained the ketal frontalin (63) that is a known insect phero-
mone first identified from the bark beetle Dendroctonus fronta-
lis.31 It was later also reported from many other coleoptera and
even as a pheromone from elephants.32 In a previous study we
have reported the production of other typical insect phero-
mones including conophtorin and chalcogran by strepto-
mycetes. Together with known symbiotic relationships between
streptomycetes and insects33–35 this raises the question,
whether the true producers of insect pheromones may at least
in some cases be bacteria.
Carboxylic acids and esters
Carboxylic acids and esters were only rarely emitted by
the investigated actinomycetes. In fact, only the leucine and
Scheme 3 Alcohols.
Scheme 4 Aldehydes, ketones and ketals.
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isoleucine derived carboxylic acids 3-methylbutyric acid (64)
and 2-methylbutyric acid (65) were found (Scheme 5). Both
compounds occurred in S. flavochromogenes, while only 65 was
present in extracts from P. spinosispora. A series of methyl
esters and α-hydroxy methyl esters (66–72) was released by
Streptomyces prunicolor NBRC 13075 with methyl 2-methylbuty-
rate as one of the main volatiles from this species. Methyl
3-hydroxy-2-methylbutyrate (71) was additionally detected in
S. varsoviensis. The acetate esters butyl acetate (73) and 3-methyl-
butyl acetate (74) both occurred in only one strain, in S. cyaneo-
fuscatus and in S. globisporus, respectively.
Lactones
As representatives of the lactones a series of alkylated butano-
lides (75–82 and 84) and the butenolide 83 was identified
(Scheme 6). The most widespread compounds of this class
were 3-methylbutan-4-olide (76), 2-methylbutan-4-olide (75),
4-methylpentan-4-olide (81) and 4-methylhexan-4-olide (82)
that occurred in multiple strains. In contrast, all other lactones
were found in only one particular strain, i.e. 4-methylhexan-4-
olide (82) in S. cyaneofuscatus, cis- and trans-2-methylpentan-4-
olide (78 and 79) in S. rapamycinicus, and 3-methylpentan-4-
olide (80) and 4-methylpent-2-en-4-olide (83) in S. sclerotialus.
Furthermore, three structurally related lactones with longer
alkyl chains, 10-methyldodec-2-en-4-olide (85), 10-methyldo-
decan-4-olide (86) and 10-methyldodecan-5-olide (87), were
present in Streptomyces anulatus NRRL B-2873 headspace
extracts. The same lactones have been reported before from
other streptomycetes,20,36 while the compounds 78 and 79
were recently reported from the marine bacterium Ruegeria
pomeroyi DSS-3.37 Various biological functions have been
ascribed to lactones. Compounds such as the A-factor are well
known as quorum sensing signals in streptomycetes.38 Recent
investigations showed that lactones with a high structural
similarity to the compounds described here exhibit a signifi-
cant seed germination inhibiting effect on plants,39 or may in
other cases promote seed germination.40 Some lactones from
streptomycetes may just be formed as shunt products of bio-
synthetic pathways to antibiotics,41 but it is also possible that
their biological function has just not been uncovered so far. If
the lactones from actinomycetes identified in this study have a
function as signals in cell-to-cell communication, or affect
other organisms in their ecological context, remains unknown.
Aromatic compounds
Among aromatic compounds 2-phenylethanol (109) and aceto-
phenone (105) were the most widespread volatiles, followed by
benzyl alcohol (94), benzaldehyde (95) and methyl benzoate
(99, Scheme 7). Large quantities of 109 were emitted by Allo-
kutzneria albata NRRL B-24461, A. alba, S. afghaniensis, and
particularly by Streptomyces fulvissimus DSM 40593 and S. pru-
nicolor where it occurred as the main compound. Phenol (88)
was detected only in S. flavochromogenes, while veratrole (89)
was a main compound of A. nigrescens and also found in traces
in three other strains. Its isomer 1,4-dimethoxybenzene (91)
only appeared in S. anulatus. A variety of aromatic compounds
was present in headspace extracts from A. alba, including
1,2,3-trimethoxybenzene (90), 1,2-dimethoxy-4-methylbenzene
(92), 3,4-dimethoxystyrene (93), 2-methoxybenzaldehyde (97),
methyl salicylate (100), methyl 2-methoxybenzoate (101) and
methyl 2,6-dihydroxybenzoate (104). Salicylaldehyde (96) was
released by S. prunicolor, while 4-methylsalicylaldehyde (98)
was produced by P. spinosispora and the structurally related
ester methyl 6-methylsalicylate (103) by Kitasatospora papulosa
NRRL B-16504. The corresponding methyl 2-methylbenzoate
(102) was found in Streptomyces californicus NRRL B-3320. The
free acid 6-methylsalicylic acid is one of the best studied poly-
ketides and the fungal iterative polyketide synthase from Peni-
cillium patulum is long known.42 Heterologous expression of
its coding gene in Streptomyces coelicolor leads to product for-
mation.43 Furthermore, the methyl ester 103 has been reported
before from the actinomycete Saccharapolyspora erythraea,20
but a bacterial PKS for 6-methylsalicylic acid is unknown.
Scheme 5 Aldehydes, ketones and ketals.
Scheme 6 Lactones.
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In S. erythraea 103 may be generated as a side product of the
recently characterised mellein synthase.44
Other occasionally observed compounds included the
acetophenones 2-hydroxyacetophenone (106), 2-methoxyaceto-
phenone (107) and 2-methylacetophenone (108), the esters
2-phenylethyl acetate (110), methyl phenylacetate (111) and
ethyl phenylacetate (112), and the phenylpropanoids 1-phenyl-
propan-2-ol (113), phenylacetone (114) and 1-phenylpropan-
1,2-dione (115).
Furans
A small, but frequently from streptomycetes reported class of
volatiles were furans (Scheme 8).20,45 The representatives 2-furan-
methanol (116), 2-(methoxymethyl)furan (117), (5-methyl-
furan-2-yl)methanol (118), methyl furan-2-carboxylate (119)
and 2-acetylfuran (122) were widespread, while methyl
5-methylfuran-2-carboxylate (120) and 2-acetyl-5-methylfuran
(123) occurred less often, and dimethyl furan-2,4-dicarboxylate
(121) only in S. californicus. It was recently reported that dis-
ruption of a gene coding for a non-ribosomal peptide synthe-
tase (NRPS) involved in azinomycin biosynthesis resulted in
the enhanced formation of 121 in Streptomyces sahachiroi,46
but information about genes or enzymes for the biosynthesis
of any of the volatile furans is lacking.
Nitrogen compounds
The largest class of nitrogen compounds was represented by
pyrazines (124–135, Scheme 9). Most of these volatiles showed
up in many strains, while a few pyrazines were unique for a
particular species, i.e. the parent compound 124 itself was
found only in S. sclerotialus, 2-(1-methylethyl)-5-methylpyra-
zine (131) only in S. mediolani, and 2-(3-methylbutyl)-3,6-
dimethylpyrazine (135) only in P. spinosispora. Gene knockout
and feeding experiments with C. glutamicum demonstrated
that pyrazines arise from acetoin and its derivatives in this
species,30 but an alternative pathway from amino acids is also
known.47
Phenylacetonitrile (139) and 2-acetylpyrrol (142), previously
reported from a few other actinomycetes,20 were also found in
various strains. Other nitrogen compounds occurred less
often, e.g. 4-methoxy-N-methylaniline (136) was only detected
in S. anulatus and pyridine (141) only in S. mediolani. A. alba
and Streptomyces ochraceiscleroticus NRRL ISP-5594 both
emitted 2-aminoacetophenone (137), while 2-methoxybenzo-
nitril (138) was produced by A. albata and A. nigrescens. This
compound has never been reported from bacteria before and
its identity was unequivocally established by comparison to a
commercially available standard.
S. afghaniensis and S. prunicolor emitted the interesting
nitrogen compound 1-nitro-2-phenylethane (140). For un-
ambiguous identification 140 was synthesised according to a
published procedure.48 The synthetic material proved to be
Scheme 7 Aromatic compounds.
Scheme 8 Furans.
Scheme 9 Nitrogen compounds.
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identical to the natural volatile. The volatile 140 was first iso-
lated from Dennettia tripetala fruits.49 The compound is also
known from several other plants such as tomato,50 Aniba cane-
lilla,51 Parinari curatellifolia52 and Cananga odorata,53 but has
never been reported from bacteria. Many interesting bioactiv-
ities have been attributed to 140 including antifungal,51 anti-
nociceptive,54 bradicardiac,55 vasorelaxant,56 antiinflammatory,57
anticonvulsant and anxiolytic58 effects. The biosynthesis of
140 was investigated by feeding of isotopically labelled precur-
sors (Fig. 1). Feeding of [2-13C]phenylalanine to S. prunicolor
resulted in the incorporation of isotopic labelling into 140
with ca. 50% incorporation rate as indicated by the molecular
ion that increased from m/z = 151 to m/z = 152. Since the frag-
ment ions representing the phenyl group (C6H5
+, m/z = 77) and
the benzyl group (C7H7
+, m/z = 91) were not increased, the
incorporation of isotopic labelling could be located at C-1 of
140. Feeding of [ring-2H5]phenylalanine also resulted in the
incorporation of labelling into 140 with high rates (60%). The
molecular ion and the base peak were observed at m/z = 156
and m/z = 109, respectively, indicating the incorporation of all
five deuterium atoms. Feeding of [1-13C]phenylalanine did not
result in the incorporation of labelling into 140 (not shown).
These experiments are in agreement with a biosynthesis of 140
from phenylalanine by decarboxylation to phenylethylamine
and subsequent oxidation of the amino group.
Sulfur compounds
The sulfur volatiles dimethyl disulfide (143), its oxidation
product S-methyl methanethiosulfonate (146), and dimethyl
trisulfide (144) are widespread and also occur in many of the
strains investigated in this study (Scheme 10). Higher polysul-
fides such as dimethyl tetrasulfide (145) are less frequent.
Accordingly, this compound was only found in A. albata and
S. prunicolor. Methyl methylthiomethyl disulfide (147) may be
formed from 143 in a photochemical reaction59 and was only
detected in A. albata. Furthermore, the cultures of P. spino-
sispora emitted 3-methylthiopropan-1-ol (148), 3-methylthio-
propanal (149) and 2-methyldihydrothiophen-3(2H)-one (150).
The compound 150 was previously reported from the bacterium
Chitinophaga Fx7914 and 149 was shown to be a biosynthetic
intermediate from methionine to 150.60
Terpenes
One of the best known volatiles from streptomycetes is the
musty odour drinking water contaminant 2-methylisoborneol
(4).61 Its biosynthesis proceeds by the S-adenosylmethionine
(SAM) dependent methylation of geranyl diphosphate (GPP)
and subsequent terpene cyclisation.62 The genes and enzymes
for the biosynthesis of 4 have been extensively character-
ised.63,64 Recently, a series of additional homomonoterpenes
that are made along the biosynthetic pathway to 4 has been
characterised, including 2-methyl-β-fenchol (151), 2-methyl-2-
bornene (152), 2-methylenebornane (153), 1-methylcamphene
(154), (E)-2-methylgeraniol (155), 2-methyllinalool (156) and
2-methylmyrcene (157) (Scheme 11).65 2-Methylisoborneol, the
principal component of several of the investigated strains, and
different combinations of its biosynthetic side products were
detected in A. albata, K. papulosa, S. flavochromogenes, S. globis-
porus, S. mediolani, S. ochraceiscleroticus, S. rapamycinicus, S.
sclerotialus, S. varsoviensis and Streptomyces violens NRRL
B-3589. Their occurrence correlates nicely with the available
genetic information, showing that genes for 2-methyliso-
borneol biosynthesis are encoded in the genomes of almost
all of these strains (Table 1 of ESI†). Only for K. papulosa and
Fig. 1 Mass spectra of (A) synthetic 140, (B) [1-13C]-140 after feeding of
[2-13C]phenylalanine, and (C) [ring-2H5]-140 after feeding of [ring-
2H5]
phenylalanine. The black asterisk indicates a 13C-labelled carbon and red
asterisks indicated deuterated carbons.
Scheme 10 Sulfur compounds.
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S. mediolani a BLAST search does not show the presence of bio-
synthetic genes for 4, possibly because the available genome
sequence information is incomplete. Besides the homomono-
terpenes a few regular monoterpenes were occasionally found,
represented by limonene (158), α-pinene (159), β-pinene (160),
α-terpineol (161), p-menth-1-en-4-ol (162), linalool (163), cis-
linalool oxide (164), trans-linalool oxide (165) and 1,8-cineol
(166). Although a monoterpene cyclase for 166 has recently
been identified from Streptomyces clavuligerus,66 a phylogenetic
analysis of all bacterial terpene cyclase homologs (Fig. 2 of
ESI†) reveals that no closely related homolog of the 1,8-cineol
synthase is encoded in the strains producing 166 (A. albata,
S. ochraceiscleroticus, S. sclerotialus and S. varsoviensis),
suggesting that a more distantly related enzyme in these
species may have the same function as the characterised
terpene cyclase from S. clavuligerus.
The longest known sesquiterpenoid from streptomycetes is
the earthy odorant geosmin (3, Scheme 12).67 This widespread
volatile is a sesquiterpene degradation product68 that is fre-
quently accompanied by its biosynthetic intermediates
(8S,9R,10S)-8,10-dimethyl-1-octalin (170) and (1(10)E,5E)-ger-
macradien-11-ol (173) and by the shunt products (8S,10R)-8,10-
dimethyl-1(9)-octalin (171), germacrene D (172), 6,11-epoxyiso-
daucane (174) and isodihydroagarofuran (175).19 Within this
study 3 and these biosynthetically related volatiles were
detected in all strains apart from P. spinosispora. The geosmin
synthase is a bifunctional enzyme with two domains that was
thoroughly characterised from Streptomyces coelicolor,9 and a
close homolog of this enzyme was found to be encoded in all
geosmin producing actinomycetes, with the exception of
K. papulosa (Table 1 of ESI†). Three organisms, A. nigrescens,
S. ochraceiscleroticus and S. violens, even encode two geosmin
synthases in their genomes. The decalone derivative 176 that
was released by a few strains is also likely related to the
geosmin biosynthetic pathway.69
Another widespread sesquiterpene in streptomycetes is epi-
isozizaene (2),8,19 the parent hydrocarbon of the antibiotic
albaflavenone and related oxygenated products such as
169.70,71 The epi-isozizaene synthase has been characterised
from S. coelicolor,8 and homologs of this enzyme are encoded
in S. afghaniensis and S. prunicolor, in agreement with the
observed production of 2 and its oxidation product 169 or the
shunt product epi-prezizaene (168).
As indicated by the phylogenetic tree (Fig. 2 of ESI†) the
terpene cyclases for epi-cubenol (5) and caryolan-1-ol (6) are
also very widespread among streptomycetes. These terpene
cyclases have both first been characterised from Streptomyces
griseus,12,13 and interestingly, in most cases both terpene
cyclases co-occur in one organism. No common function e.g.
in the biosynthesis of a secondary metabolite is known and
Scheme 11 Monoterpenes and homomonoterpenes.
Scheme 12 Sesquiterpenes and nor-sesquiterpenes.
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the two genes are usually not clustered, but the generality of
the co-occurrence of the epi-cubenol synthase and the caryo-
lan-1-ol synthase in streptomycetes suggests that their may be
some kind of crosstalk between the two pathways. In this study
genes for both enzymes were found in S. anulatus, S. cyaneofus-
catus, S. fulvissimus and S. mediolani, while in K. papulosa only
a gene for the epi-cubenol synthase was found and in S. califor-
nicus only a caryolan-1-ol synthase gene is present. Some of
these terpene cyclases seemed not to be expressed under labo-
ratory culture conditions, or the enzymes may be unfunc-
tional, since no production of 5 was observed in K. papulosa
and S. mediolani. Furthermore, neither 5 nor 6 was detected in
S. fulvissimus, while on the other hand S. californicus did
indeed release 5, pointing to some missing genetic infor-
mation. In all other cases the available genetic information
matched the observed production of the volatiles 5 and 6. The
sesquiterpene 5 was in three strains found as principal com-
ponent, and in these strong producers including S. anulatus,
S. californicus, S. cyaneofuscatus 5 was accompanied by a few
structurally related sesquiterpenes. These compounds were
α-muurolene (177), δ-cadinene (178), cadina-1,4-diene (179),
trans-cadina-1(6),4-diene (180), zonarene (181), cadina-3,5-
diene (182) and α-cadinol (183). The formation of these com-
pounds can be explained as side products of the epi-cubenol
synthase (Scheme 13).
S. rapamycinicus emitted isoafricanol (16) and african-1-ene
(184). We have recently suggested the function of an unknown
sesquiterpene cyclase from Streptomyces violaceusniger that
also produces both compounds as isoafricanol synthase.22
Although their is no direct evidence e.g. by incubation of farne-
syl diphosphate with the purified enzyme, it is interesting to
note that S. rapamycinicus encodes a terpene cyclase that is
highly homologous to the putative isoafricanol synthase from
S. violaceusniger, thus further corroborating our hypothesis.
The phylogenetic analysis of terpene cyclase homologs (Fig. 2
of ESI†) reveals that S. afghaniensis encodes an α-amorphene
synthase homolog,16 and in agreement with this finding small
amounts of α-amorphene (9) were found in the headspace
extracts from this organism. Similarly, S. prunicolor encodes a
terpene cyclase with close homology to a characterised 7-epi-
α-eudesmol synthase,16 and production of small amounts of
7-epi-α-eudesmol (10) could also be observed. Finally, germa-
crene D-4-ol (185) was found in S. globisporus, nerolidol (186)
was emitted by P. spinosispora, and β-barbatene (187) occurred
in A. albata, but the genetic background for these findings
remained elusive. There are, however, in all three cases
uncharacterised terpene cyclases encoded in the genomes of
these organisms, and one of the respective genes will likely
encode a terpene cyclase for the biosynthesis of these
sesquiterpenes.
Experimental
Strains, culture conditions, and feeding experiments
The bacterial strains Allokutzneria albata NRRL B-24461, Kita-
satospora papulosa NRRL B-16504, Pseudonocardia spinosispora
NRRL B-24156, Streptomyces anulatus NRRL B-2873, Strepto-
myces californicus NRRL B-3320, Streptomyces cyaneofuscatus
NRRL B-2570, Streptomyces flavochromogenes NRRL B-2684,
Streptomyces globisporus NRRL B2293, Streptomyces mediolani
NRRL WC-3934, Streptomyces ochraceiscleroticus NRRL
ISP-5594, Streptomyces slerotialus NRRL ISP-5269, Streptomyces
varsoviensis NRRL B-3589 and Streptomyces violens NRRL
ISP-5597 were obtained from the US department of agriculture
(USDA ARS, Peoria, USA), the strains Streptomyces afghanaensis
DSM 40228, Streptomyces fulvissimus DSM 40593, Streptomyces
prunicolor DSM 40335, Streptomyces rapamycinicus DSM 41530,
Amycolatopsis alba DSM 44262 and Amycolatopsis nigrescens
DSM 44992 were obtained from the Deutsche Sammlung für
Mikroorganismen und Zelllinien (DSMZ, Braunschweig,
Germany). Bacterial strains were pre-cultured at 28 °C in liquid
medium (generally medium 65, only P. spinosispora was grown
in medium 553 and K. papulosa in medium 547). After three
days of growth 1 mL of the liquid culture was transferred ontoScheme 13 Biosynthesis of epi-cubenol (5) and related sesquiterpenes.
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an agar plate containing the same medium. Incubation on
solid medium was continued until sporulation occurred
(usually ∼7 days), then the volatiles were analysed by the CLSA
method. The feeding experiments were performed by the
addition of a sterile filtered aqueous solution of isotopically
labelled precursors to a final concentration of 1 mmol L−1. The
following growth media were used as recommended by the
DSMZ:72
65. Glucose (4.0 g), yeast extract (4.0 g), malt extract (4.0 g),
CaCO3 (2.0 g), agar (12.0 g), H2O (1000 mL), pH = 7.2. CaCO3
and agar were deleted, when liquid medium was used.
553. Glucose (10.0 g), peptone from casein (5.0 g), yeast
extract (5.0 g), beef extract (5.0 g), CaCl2·2H2O (0.74 g), agar
(15.0 g), H2O (1000 mL), pH = 7.2.
547. Solution A: soluble starch (10.0 g), H2O (500 mL); solu-
tion B: CaCO3 (2.0 g), K2HPO4 (1.0 g), MgSO4·7H2O (1.0 g),
NaCl (1.0 g), (NH4)2SO4 (2.0 g), H2O (500 mL), trace salt solu-
tion: FeSO4 (0.1 g), MnCl2·4H2O (0.1 g), ZnSO4·7H2O (0.1 g),
H2O (100 mL), pH = 7.0–7.4. Solutions A and B were mixed,
trace salt solution (1 mL) and agar (20.0 g) were added before
sterilisation.
Collection of volatiles
The volatiles from the agar plate cultures were collected by use
of the closed-loop stripping analysis technique (CLSA). In a
closed vessel an air stream was pumped over the agar plate
and the emitted volatiles were trapped on charcoal filters
(Chromtech GmbH, Idstein, Precision Char Coal Filter 5 mg).
After 24 h the filter was eluted with ∼50 µL dichloromethane
and the extract was immediately analysed by GC/MS.
GC/MS
GC-MS analyses were carried out on an Agilent 7890B con-
nected with an Agilent 5977A inert mass detector fitted with a
HP-5 fused silica capillary column (30 m, 0.25 mm i.d.,
0.25 μm film, Agilent). GC conditions were as follows: inlet
pressure 77.1 kPa, He 23.3 mL min−1, injection volume 1.5 μL,
transfer line 300 °C, electron energy 70 eV. The operation
mode was splitless (60 s valve time) and the carrier gas was He
at 1.2 mL min−1. The GC was programmed as follows: 5 min at
50 °C increasing with 5 °C min−1 to 320 °C. Retention indices
were calculated from retention times of a mixture of n-alkane
standards (C6–C32).
Conclusions
In summary, we have investigated the volatiles released by
nineteen genome sequenced actinomycetes. Many of the
identified compounds have been reported from actinomycetes
or other bacteria before,19–21,45,73,74 while the compounds
1-methylcyclohexa-1,3-diene (23), frontalin (63), 2-methoxyben-
zonitril (138) and 1-nitro-2-phenylethane (140) are new bac-
terial secondary metabolites and 4-methoxy-N-methylaniline
(136) is a new natural product. In the present study we have
shown in feeding experiments with isotopically labelled pre-
cursors that 140 is derived from phenylalanine by decarboxyla-
tion to 2-phenylethylamine and oxidation. Particularly
interesting is the discovery of the insect pheromone frontalin
from bacteria that is in line with our previous report about the
bacterial production of other typical insect pheromones such
as conophthorin and chalcogran.20 Together with the known
symbiotic relationship between insects and streptomycetes
this suggests that insect pheromones may in some cases have
a bacterial origin. Alternatively, this finding may point to a
horizontal gene transfer event between insects and their sym-
biotic bacterial community. Finally, we have shown that all
investigated actinomycetes encode several terpene cyclases in
their genomes. Their phylogenetic analysis was in line with
the production of terpenes, i.e. the production of geosmin,
2-methylisoborneol, epi-cubenol, caryolan-1-ol, epi-isozizaene,
7-epi-α-eudesmol and α-amorphene, for which highly homolo-
gous terpene cyclases from streptomycetes have been charac-
terised, could be nicely correlated to the genomic information.
Based on the finding that S. violaceusniger produces isoafrica-
nol and only one sesquiterpene cyclase of unknown function
is encoded in this organism, we have recently suggested that
this terpene cyclase is likely active as isoafricanol synthase.
This suggestion is now corroborated by the identification of
isoafricanol in S. rapamycinicus that encodes a closely related
terpene cyclase in its genome. There are, however, several
uncharacterised terpene cyclases with unknown products
encoded in the genomes of the actinomycetes investigated in
this study, and several of these do not seem to be expressed
under laboratory conditions. We will address this question by
heterologous expression of the respective terpene cyclase
genes in our future experiments.
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Table 1 Investigated strains and terpene cyclases encoded in their genomes. 
ID Strain Terpene cyclases 
   
1 Allokutzneria albata NRRL B-24461 geosmin: WP_030430635 
2-MIB: WP_030428809 
unknown: WP_030426588 
unknown: WP_030428809 
unknown: WP_030430753 
unknown: WP_030431358 
unknown: WP_030432512 
unknown: WP_030432932 
2 Amycolatopsis alba DSM 44262 geosmin: WP_020631965 
unknown: WP_020635617 
3 Amycolatopsis nigrescens DSM 44992 geosmin: WP_020666924 
geosmin: WP_020667245 
unknown: WP_026359996 
4 Kitasatospora papulosa NRRL B-16504 epi-cubenol: WP_030124319 
5 Pseudonocardia spinosispora NRRL B-24156 unknown: WP_028934612 
unknown: WP_028934660 
unknown: WP_028934903 
6 Streptomyces afghaniensis DSM 40228 geosmin: WP_020273180 
-amorphene: WP_020270655 
epi-isozizaene: WP_020274234 
7 Streptomyces anulatus NRRL B-2873 geosmin: WP_030593937 
epi-cubenol: WP_030584158 
caryolan-1-ol: WP_030581148 
8 Streptomyces californicus NRRL B-3320 geosmin: WP_030116958/59 
caryolan-1-ol: WP_030122040 
9 Streptomyces cyaneofuscatus NRRL B-2570 geosmin: WP_030566077 
epi-cubenol: WP_030573033 
caryolan-1-ol: WP_030568864 
10 Streptomyces flavochromogenes NRRL B-2684 geosmin: WP_030314776 
2-MIB: WP_030312939 
unknown: WP_030314165 
unknown: WP_030319486 
11 Streptomyces fulvissimus DSM 40593 geosmin: YP_007929188 
epi-cubenol: YP_007929843 
caryolan-1-ol: YP_007934038 
12 Streptomyces globisporus NRRL B-2293 geosmin: WP_030688988 
2-MIB: WP_030693045 
unknown: WP_030690542 
unknown: WP_030691789 
13 Streptomyces mediolani NRRL WC3934 geosmin: WP_030809459 
epi-cubenol: WP_030800135 
caryolan-1-ol: WP_030811225 
14 Streptomyces ochraceiscleroticus NRRL ISP-
5594 
geosmin: WP_031055842 
geosmin: WP_031060696 
2-MIB: WP_031053300 
unknown: WP_031051181 
unknown: WP_031064163 
unknown: WP_031067610 
15 Streptomyces prunicolor NBRC 13075 geosmin: WP_019062772 
epi-isozizaene: WP_026150642 
7-epi--eudesmol: WP_019057753 
unknown: WP_019064917 
16 Streptomyces rapamycinicus NRRL 5491 geosmin: WP_020870145 
2-MIB: WP_020873136 
isoafricanol: YP_008795010 
17 Streptomyces sclerotialus NRRL ISP-5269 geosmin: WP_030613120 
2-MIB: WP_030607882 
unknown: WP_030624126 
unknown: WP_030615021 
unknown: WP_030617047 
18 Streptomyces varsoviensis NRRL B-3589 geosmin: WP_030881645 
2-MIB: WP_030891873 
unknown: WP_030874469 
unknown: WP_030877649 
19 Streptomyces violens NRRL ISP-5597 geosmin: WP_030252760 
geosmin: WP_030266576 
2-MIB: WP_030263590 
unknown: WP_030249874 
unknown: WP_030250690 
unknown: WP_030261827 
 
 
 
 
  
Table 2 Identified volatile compounds and their occurrence in the investigated strains. 
Compounda Ib I (Lit.)c Ident.d occurrence in straine 
     
pentan-2-one (38) 692 6821 ms, ri, std 18 
methyl 2-methylpropionate (66) 693 6907 ms, ri, std 15 
pentan-2-ol (31) 698 6891 ms, ri, std 18 
acetoin (56) 706 7099 ms, ri, std 1, 4, 5, 7, 8, 9, 10, 12, 
13, 15 
3-methylbut-3-en-1-ol (30) 722 72011 ms, ri, std 1, 4, 7, 8, 9, 12, 13, 
15, 18, 19 
3-methylbutan-1-ol (26) 724 7337 ms, ri, std 1, 4, 5, 7, 8, 9, 10, 12, 
13, 15, 18, 19 
pyrazine (124) 726 7349 ms, ri, std 17 
2-methylbutan-1-ol (27) 728 7337 ms, ri, std 1, 4, 5, 7, 8, 9, 10, 12, 
13, 18, 19 
pyridine (141) 733 73615 ms, ri std 13 
dimethyl disulfide (143) 739 7479 ms, ri, std 1, 4, 7, 8, 10, 12, 14, 
15, 17 
3-methylpentan-2-one (40) 743 75012 ms, ri 9, 12, 13, 15, 17, 18, 
19 
3-methylpentan-2-ol (32) 747 7451 ms, ri 13 
toluene (17) 759 75611 ms, ri, std 2, 9, 13, 17, 18 
3-methylbut-2-en-1-ol (29) 766 77011 ms, ri, std 1, 2, 5, 12, 13 
butan-2,3-diol (35) 769 77916 ms, ri, std 9, 13 
methyl 2-methylbutyrate (67) 772 7808 ms, ri, std 15 
1-methylcyclohexa-1,3-diene (23) 773 77121 ms, ri 1, 8, 14, 17 
3-methylbut-2-enal (37) 779 78118 ms, ri, std 1 
cyclopentanone (46) 786 79119 ms, ri, std 1, 3, 7, 9, 12, 13, 15, 
17, 18, 19 
3-hydroxypentan-2-one (57) 800 8004 ms, ri, std 1, 2, 5, 7, 9, 10, 12, 
13, 15 
2-hydroxypentan-3-one (58) 807 81037 ms, ri, std 1, 2, 5, 7, 9, 10, 12, 
13, 15 
butyl acetate (73) 814 8071 ms, ri, std 9 
methylpyrazine (125) 820 8191 ms, ri, std 1, 2, 3, 5, 7, 8, 9, 10, 
12, 13, 14, 15, 17, 18, 
19 
2-(methoxymethyl)furan (117) 829 82338 ms, ri 4, 5, 8, 12, 13, 15, 17, 
18 
cyclopent-2-enone (50) 831 83520 ms, ri, std 7, 9, 13 
3-methylbutyric acid (64) 833 8271 ms, ri, std 10 
4-methylpentan-1-ol (28) 834 8301 ms, ri, std 7 
(E)-3-methylpent-3-en-2-one (41) 838 83839 ms, ri 13, 17, 18 
2-methylcyclopentanone (47) 838 8361 ms, ri, std 7, 19 
3-methylcyclopentanone (48) 845 84812 ms, ri 9, 17 
2-methylbutyric acid (65) 845 8468 ms, ri, std 5, 10 
3-hydroxy-4-methylpentan-2-one (60) 848 84937 ms, ri 5, 9 
methyl 2-hydroxy-2-methylbutyrate 
(70) 
850 84937 ms, ri, std 15 
2-furanmethanol (116) 852 85022 ms, ri, std 1, 2, 4, 5, 6, 9, 10, 11, 
12, 15 
ethylbenzene (18) 860 8582 ms, ri, std 9, 18 
hexan-1-ol (25) 868 8631 ms, ri, std 5 
m-xylene (20) 868 8662 ms, ri, std 9, 18 
methyl 2-methylvalerate (68) 870 8711 ms, ri, std 15 
3-methylbutyl acetate (74) 877 8691 ms, ri 12 
cyclohexanol (33) 882 8868 ms, ri, std 9, 18 
hexan-2,4-dione (45) 888 88027 ms, ri 2 
heptan-2-one (39) 889 8911 ms, ri, std 12 
methyl 2-hydroxy-3-methylbutyrate 
(69) 
892 88926 ms, ri, std 15 
cyclohexanone (49) 893 8958 ms, ri, std 17 
2-hydroxyhexan-3-one (59) 901 9004 ms, ri, std 11, 15 
2-methylcyclopent-2-enone (51) 904 90527 ms, ri, std 7, 19 
3-methylthiopropanal (149) 905 9011 ms, ri, std 5 
2,5-dimethylpyrazine (128) 907 9081 ms, ri, std 1, 2, 3, 5, 6, 7, 8, 9, 
10, 11, 12, 13, 14, 15, 
16, 17, 18, 19 
2-acetylfuran (122) 909 9091 ms, ri, std 1, 3, 4, 6, 7, 8, 9, 10, 
12, 13, 15, 18, 19 
ethylpyrazine (126) 913 9121 ms, ri, std 5, 9, 13, 15, 19 
2,3-dimethylpyrazine (127) 917 9151 ms, ri, std 5, 7, 8, 9, 13, 14, 15, 
19 
methyl 3-hydroxy-2-methylbutyrate 
(71) 
925 93024 ms, ri 15, 18 
propylcyclohexane (24) 929 92829 ms, ri, std 9 
-pinene (159) 933 9321 ms, ri, std 1, 2, 9, 14, 17, 18, 19 
frontalin (63) 941 94923 ms, ri 18 
(E)-4-methylhex-4-en-3-one (42) 941 93439 ms, ri 6 
2-hydroxy-5-methylhexan-3-one (62) 943 94437 ms, ri 5 
3-hydroxy-5-methylhexan-2-one (61) 948 94937 ms, ri 5 
2-methylbutan-4-olide (75) 950 9546 ms, ri, std 2, 9, 16, 17, 18 
pentan-4-olide (77) 951 9411 ms, ri 9 
(5-methylfuran-2-yl)methanol (118) 953 95325 ms, ri 1, 6, 10, 12, 13 
4-methylpent-2-en-4-olide (83) 953 95342 ms, ri, std 17 
propylbenzene (19) 953 9542 ms, ri, std 9 
3-methylbutan-4-olide (76) 956 95837 ms, ri 1, 9, 12, 13, 15, 16, 
17, 18, 19 
benzaldehyde (95) 959 9521 ms, ri, std 1, 2, 3, 5, 9, 13, 15 
3-methylcyclopent-2-enone (52) 965 97328 ms, ri 13, 14 
dimethyl trisulfide (144) 968 9675 ms, ri, std 1, 4, 6, 8, 10, 11, 12, 
15, 17, 19 
methyl furan-2-carboxylate (119) 976 9691 ms, ri, std 4, 7, 8, 9, 12, 15 
3-methylthiopropan-1-ol (148) 976 9691 ms, ri, std 5 
-pinene (160) 978 9741 ms, ri, std 14, 17, 18, 19 
1-ethyl-2-methylbenzene (21) 979 9802 ms, ri, std 9 
phenol (88) 980 98319 ms, ri, std 10 
2-methyl-2-bornene (152) 981 97630 ms, ri 4, 14, 17, 18, 19 
cis-2-methylpentan-4-olide (78) 983 n.a. ms, std 16 
4-methylpentan-4-olide (81) 985 99243 ms, ri, std 2, 3, 9, 12, 15, 17 
1-methylcamphene (154) 986 98330 ms, ri 1, 14, 17, 18, 19 
6-methylhept-5-en-2-one (43) 987 9811 ms, ri, std 2, 3, 9, 13 
2-methyldihydrothiophen-3(2H)-one 
(150) 
987 9823 ms, ri, std 5 
trans-2-methylpentan-4-olide (79) 991 n.a. ms, std 16 
mesitylene (22) 993 9942 ms, ri, std 9 
methyl 2-hydroxy-3-methylvalerate 
(72) 
993 9891 ms, ri 15 
2-ethyl-5-methylpyrazine (130) 998 99736 ms, ri 3, 9, 13, 15 
trimethylpyrazine (132) 999 10001 ms, ri, std 1, 2, 5, 6, 8, 10, 12, 
13, 14, 15, 18, 19 
2-ethyl-3-methylpyrazine (129) 1001 10021 ms, ri 7, 8 
cyclohept-4-enol (34) 1002 100237 ms, ri, std 3, 12 
cyclohept-4-enone (53) 1005 100437 ms, ri, std 2, 3, 9, 12, 13, 14, 15, 
17, 19 
2-methylenebornane (153) 1017 101430 ms, ri 1, 4, 12, 14, 16, 17, 
18, 19 
2-acetyl-5-methylfuran (123) 1025 10311 ms, ri 8, 13, 15 
limonene (158) 1028 10241 ms, ri, std 1 
1,8-cineol (166) 1031 10261 ms, ri, std 1, 14, 17, 18 
benzyl alcohol (94) 1034 10261 ms, ri, std 4, 5, 6, 9, 11, 12, 13, 
15 
3-methylpentan-4-olide (80) 1035 103437 ms, ri 17 
4-methylhex-5-en-4-olide (84) 1039 10341 ms, ri, std 9 
salicylaldehyde (96) 1043 10391 ms, ri, std 15 
2-(1-methylethyl)-5-methylpyrazine 
(131) 
1052 105933 ms, ri 13 
2-acetylpyrrole (142) 1057 10541 ms, ri, std 1, 2, 8, 10, 13, 15 
S-methyl methanethiosulfonate (146) 1062 10655 ms, ri, std 1, 2, 9, 10, 11, 12 
acetophenone (105) 1065 10591 ms, ri, std 1, 3, 6, 8, 9, 10, 12, 
13, 14, 15, 17, 18, 19 
cis-linalool oxide (164) 1072 10671 ms, ri 8, 9, 14 
2-ethyl-3,6-dimethylpyrazine (133) 1076 10774 ms, ri 1, 3, 5, 9, 10, 12, 13, 
14 
2-ethyl-3,5-dimethylpyrazine (134) 1078 10824 ms, ri, std 2, 15, 19 
2-methylmyrcene (157) 1081 108030 ms, ri, std 1 
trans-linalool oxide (165) 1088 10841 ms, ri 8, 9 
methyl 5-methylfuran-2-carboxylate 
(120) 
1091 109237 ms, ri, std 9, 12 
4-methylhexan-4-olide (82) 1092 109337 ms, ri, std 9 
methyl benzoate (99) 1092 10881 ms, ri, std 2, 4, 7, 8, 10, 15 
4-methylhexan-4-olide (82) 1094 109337 ms, ri, std 3, 9, 16, 17 
linalool (163) 1098 10951 ms, ri, std 1, 3, 8, 9, 14, 15 
2-phenylethanol (109) 1111 11071 ms, ri, std 1, 2, 4, 5, 6, 7, 8, 9, 
10, 11, 12, 13, 14, 15, 
18 
methyl methylthiomethyl disulfide 
(147) 
1126 11235 ms, ri 1 
phenylacetone (114) 1128 112410 ms, ri, std 6, 7, 15, 18 
1-phenylpropan-2-ol (113) 1135 n.a. ms 15 
2-methylacetophenone (108) 1136 113931 ms, ri, std 7, 8 
phenylacetonitrile (139) 1138 11341 ms, ri, std 3, 5, 6, 17 
tropone hydrate (55) 1143 n.a. ms, std 10 
veratrole (89) 1145 11411 ms, ri 3, 7, 17, 19 
camphor (167) 1146 11411 ms, ri, std 17 
tropone (54) 1152 n.a. ms, std 2, 10 
2-hydroxyacetophenone (106) 1159 11551 ms, ri 3 
4-methylsalicylaldehyde (98) 1161 n.a. ms 5 
1,4-dimethoxybenzene (91) 1163 11611 ms, ri 7 
1-phenylpropan-1,2-dione (115) 1171 117541 ms, ri 15 
methyl phenylacetate (111) 1177 11751 ms, ri, std 1 
methyl 2-methylbenzoate (102) 1178 118132 ms, ri 8 
p-menth-1-en-4-ol (162) 1178 11741 ms, ri 14, 19 
2-methylisoborneol (4) 1180 11781 ms, ri, std 1, 4, 10, 12, 13, 14, 
16, 17, 18, 19 
2-methyl--fenchol (151) 1184 118230 ms, ri, std 1, 4, 14, 16, 18, 19 
-terpineol (161) 1187 11861 ms, ri 14, 16, 17 
methyl salicylate (100) 1190 11901 ms, ri, std 2, 3 
2-methyllinalool (156) 1193 n.a. ms, std 4 
decanal (36) 1202 12011 ms, ri, std 2, 3, 15 
dimethyl tetrasulfide (145) 1218 12135 ms, ri 1, 15 
(8S,9R,10S)-8,10-dimethyl-1-octalin 
(170) 
1223 122330 ms, ri 1, 2, 3, 4, 6, 11, 12, 
14, 15, 16, 17, 19 
(8S,10R)-8,10-dimethyl-1(9)-octalin 
(171) 
1231 123030 ms, ri 1, 3, 6, 11, 14, 15, 16, 
17, 19 
1,2-dimethoxy-4-methylbenzene (92) 1237 123017 ms, ri 2 
ethyl phenylacetate (112) 1246 12431 ms, ri 6, 10, 11 
2-methoxybenzaldehyde (97) 1250 12471 ms, ri 2 
4-methoxy-N-methylaniline (136) 1255 n.a. ms, std 7 
2-phenylethyl acetate (110) 1256 12541 ms, ri 1, 11 
2-methoxybenzonitrile (138) 1278 n.a. ms, std 1, 3 
2-methoxyacetophenone (107) 1289 12901 ms, ri 3 
2-aminoacetophenone (137) 1296 129913 ms, ri, std 2, 14 
1-nitro-2-phenylethane (140) 1298 12941 ms, ri, std 6, 15 
1,2,3-trimethoxybenzene (90) 1310 131514 ms, ri, std 2, 3, 14 
methyl 6-methylsalicylate (103) 1314 131737 ms, ri, std 4 
2-(3-methylbutyl)-3,6-
dimethylpyrazine (135) 
1315 13217 ms, ri, std 5 
(E)-2-methylgeraniol (155) 1327 132530 ms, ri, std 4 
methyl 2-methoxybenzoate (101) 1336 13341 ms, ri 2 
african-1-ene (184) 1349 135644 ms, ri 16 
dimethyl furan-2,4-dicarboxylate (121) 1356 135837 ms, ri, std 8 
3,4-dimethoxystyrene (93) 1364 136834 ms, ri 2 
methyl 2,6-dihydroxybenzoate (104) 1385 138640 ms, ri 2 
geosmin (3) 1403 13991 ms, ri, std 1, 2, 3, 4, 6, 7, 8, 9, 
10, 11, 12, 13, 14, 15, 
16, 17, 18, 19 
epi-isozizaene (2) 1444 144730 ms, ri 6, 15 
geranylacetone (44) 1449 14531 ms, ri, std 2, 3 
epi-prezizaene (168) 1452 144930 ms, ri 15 
-barbatene (187) 1453 144544 ms, ri 1 
cadina-3,5-diene (182) 1453 145135 ms, ri 7 
6,11-epoxyisodaucane (174) 1463 146930 ms, ri 3, 4, 8, 12, 15, 16 
(1R*,6S*,10S*)-6,10-
dimethylbicyclo[4.4.0]decan-3-one 
(176) 
1465 146935 ms, ri, std 3, 12, 14, 19 
-amorphene (9) 1480 14831 ms, ri 6 
trans-cadina-1(6),4-diene (180) 1475 14751 ms, ri 7 
germacrene D (172) 1488 147944 ms, ri, std 1, 3, 6, 8, 11, 12, 13, 
14, 15, 16, 17, 19 
isodihydroagarofuran (175) 1503 150430 ms, ri, std 3, 6, 12, 14, 15, 16, 
17 
-muurolene (177) 1500 15001 ms, ri 7, 8, 9 
-cadinene (178) 1523 15221 ms, ri 7, 8 
isoafricanol (16) 1526 n.a. ms, std 16 
zonarene (181) 1528 15281 ms, ri 7, 8 
cadina-1,4-diene (179) 1534 15331 ms, ri 7, 8 
nerolidol (186) 1566 15611 ms, ri, std 5 
caryolan-1-ol (6) 1570 156435 ms, ri 7, 8, 9, 13 
germacrene D-4-ol (185) 1582 15741 ms, ri 12 
epi-cubenol (5) 1633 162735 ms, ri 4, 7, 8, 9 
(1(10)E,5E)-germacradien-11-ol (173) 1640 163830 ms, ri 3, 4, 6, 8, 9, 11, 12, 
13, 14, 15, 16, 17, 19 
-cadinol (183) 1655 16521 ms, ri 9 
7-epi--eudesmol (10) 1664 16621 ms, ri 15 
4,5-epoxy-2-epi-zizaan-6-ol (169) 1673 167630 ms, ri 6 
10-methyldodec-2-en-4-olide (85) 1729 172837 ms, ri, std 7 
10-methyldodecan-4-olide (86) 1751 n.a. ms, std 7 
10-methyldodecan-5-olide (87) 1782 178037 ms, ri, std 7 
aCompound numbers refer to compound numbers in main text. Unidentified compounds, 
artifacts and medium constituents are not mentioned. bRetention index on a HP5-MS fused 
silica capillary column. cRetention index on the same or a similar column from tabulated data 
in the literature. dIdentification based on ms: mass spectrum (mass spectral match factor 
>850), ri: retention index on same or similar column (maximum deviation of 10 points), std: 
comparison to a synthetic or commercially available standard. For compound identification 
commercially available mass spectral databases (Adams, Joulain & König, Wiley, NIST)1,44-46 
were used. eNumbers refer to strains listed in Table 1 of ESI. 
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A flexible, efficient and robust method for the synthesis of
isotopically labelled oligoprenyl diphosphates was devel-
oped. The method makes use of just a few building blocks
(acetone, triethyl phosphonoacetate, and ethyl acetoacetate)
from which several isotopomers with deuterium or 13C-label-
ling are commercially available or can be easily obtained by
synthesis. Besides these building blocks, a few deuterated
Introduction
The biosynthesis of terpenes starts with the formation of
the universal C5 building block dimethylallyl diphosphate
(DMAPP) and isopentenyl diphosphate (IPP) that arise
either via the mevalonate or the deoxyxylulose phosphate
pathway. These monomers are subsequently fused by oligo-
prenyl diphosphate synthases to yield the linear precursors
geranyl diphosphate (GPP, C10), farnesyl diphosphate (FPP,
C15) and geranylgeranyl diphosphate (GGPP, C20) with all-
E configurations. These linear precursors are then cyclised
by terpene cyclases in complex reaction cascades via cat-
ionic intermediates, usually into terpene hydrocarbons or
terpene alcohols.[1] Isotopomers of the linear terpene pre-
cursors labelled with stable (2H, 13C) or radioactive (3H,
14C) isotopes have been frequently used to follow the stereo-
chemical course of terpene cyclisations,[2,3] the regioselectiv-
ity of deprotonation steps,[4,5] or other mechanistic aspects
of terpene biosynthesis.[6,7] For these purposes, numerous
synthetic approaches to isotopomers of the linear terpene
precursors DMAPP,[8] GPP,[2,4,6,9,10] FPP,[5,7,11] and
GGPP[3] have been described, aiming at the introduction of
isotope labels at specific and well-defined positions. Particu-
larly interesting in addressing stereochemical problems of
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reagents were used for the introduction of deuterium label-
ling. Furthermore, the synthesis of [14-2H]geranylgeranyl di-
phosphate is reported. The material was used for a stereo-
chemical analysis of the cyclisation reaction catalysed by
tuberculosinyl diphosphate synthase from Mycobacterium
tuberculosis.
terpene biosynthesis[12–15] are stereospecifically labelled pre-
cursors such as (1S)- and (1R)-[1-2H]FPP that have been
made available by enzymatic reactions.[12] All these isotopi-
cally labelled terpene precursors can be efficiently used in
incubation experiments with recombinant terpene cyclases.
Alternatively, for feeding experiments with actively growing
cultures, isotopomers of the monomeric building blocks
mevalonolactone or deoxyxylulose, depending on which
pathway to terpenes is present in the particular organism,
can be used, because these molecules are, in contrast to the
oligoprenyl diphosphates, able to pass the cell membrane.
For investigations on various problems of terpene biosyn-
thesis via feeding experiments, we have recently developed
flexible methods for the synthesis of various deuterated and
13C-labelled isotopomers of mevalonolactone[16] and de-
oxyxylulose,[17] including stereospecifically deuterated mev-
alonolactone isotopomers.[18] In an examplary investigation
we have fed isotopically labelled [6,6,6-2H3]mevalono-
lactone to Fusarium fujikuroi. This compound is trans-
formed via the mevalonate pathway into [2H12]GGPP with
deuterated methyl groups as shown in Scheme 1 (a). The
stereochemical course of its conversion into ent-copalyl di-
phosphate 1 by the ent-copalyl diphosphate synthase (CPS)
with respect to the geminal methyl groups was demon-
strated.[19]
A recent example from our Japanese laboratories of
using isotopically labelled oligoprenyl diphosphates for in-
cubation experiments with purified recombinant terpene
cyclases is shown in Scheme 1 (b). Incubation of [16,16,16-
2H3]GGPP with tuberculosinyl diphosphate synthase
(Rv3377c) from Mycobacterium tuberculosis allowed us to
follow the stereochemical course of the cyclisation reaction
to tuberculosinyl diphosphate (2) via a chair-chair transi-
tion state (Scheme 1, b).[3,20] Usually for the synthesis of
Isotopically Labelled Oligoprenyl Diphosphates
Scheme 1. Stereochemical course of cyclisation of GGPP a) to ent-
copalyl diphosphate (1) by Fusarium fujikuroi ent-copalyl diphos-
phate synthase (CPS), and b) to tuberculosinyl diphosphate (2) by
Mycobacterium tuberculosis tuberculosinyl diphosphate synthase
(Rv3377c). Asterisks indicate completely deuterated methyl groups.
isotopically labelled oligoprenyl diphosphates with labelling
in specific positions, a large number of steps is required,
and a different strategy for the introduction of labelling for
each position has to be developed. We now present a gen-
erally applicable approach for the synthesis of deuterium
or 13C-labelled oligoprenyl diphosphates (GPP, FPP, and
GGPP) that can be used for the introduction of labelling
into every position and all combinations of positions from
cost-effective commercially available labelled building
blocks. The compound [14-2H]GGPP was synthesised and
used in an incubation experiment with tuberculosinyl di-
phosphate synthase, giving further insights into the stereo-
chemical course of the reaction.
Results and Discussion
Our strategy for the synthesis of labelled oligoprenyl di-
phosphates with flexible introduction of stable isotope
labelling is shown in Scheme 2. Starting from acetone (1a)
we pursued a sequence of Horner–Wadsworth–Emmons
(HWE) olefination with triethyl phosphonoacetate (2) to
ethyl 3,3-dimethylacrylate (3a), DIBAL reduction to prenol
(4a), transformation with PBr3 into the corresponding
bromide 5a, alkylation with ethyl acetoacetate (6) to the β-
keto ester 7a, and saponification with spontaneous decarb-
oxylation to sulcatone (1b). In summary, this five-step pro-
cedure results in chain elongation by one isoprene unit.
We aimed at the higher homologs of 4a, i.e. geraniol (4b),
farnesol (4c), and geranylgeraniol (4d) by repeated analo-
gous reactions. Their corresponding halides 5 were planned
to be subjected to nucleophilic substitution with tris(tetra-
butylammonium) hydrogen diphosphate to yield the desired
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oligoprenyl diphosphates 8. This route was previously used
by us for the synthesis of unlabelled FPP and GGPP start-
ing from 4b, thus proving its practicability over two elong-
ation cycles with an overall yield of 3% via 12 steps for the
synthesis of GGPP (yields for each step are summarised in
Table 1).[21] A peculiar problem of the HWE reactions with
1c and 1d is the formation of E- and Z-stereoisomers, thus
requiring rigorous product purification by repeated column
chromatography (3c: dr = 4:1, 3d: dr = 11:1, ratios based
on isolated diastereomerically pure material).
Scheme 2. Synthetic strategy towards oligoprenyl diphosphates.
Table 1. Isolated yields of reactions according to Scheme 2.
Compd.[a] a b c d
1 n. a.[b] 18% (2H14) 93%
[c] 88%[c]
93% (2H1) 88% (
2H1)
3 72% (2H7) 45% (
2H15) 55%
[c] 56%[c]
32% (2H1) 46% (
2H1)
4 79% (2H9) 68%
[c] 85%[c]
75% (2H1) 72% (
2H1)
5 (crude product was used without purification)
7 38% (2H13) 78%
[c] 65%[c] n. a.
76% (2H1) 58% (
2H1)
8 83%[c] 76%[c] 38%[c]
30% (2H1)
[a] Alphanumerical compound identifiers are according to bold
numbers in Table lines to be combined with letters in Table col-
umns. [b] n. a.: not applicable. [c] For comparison, the yields for
unlabelled materials as reported previously were taken from refer-
ence.[21]
A major advantage of the route presented in Scheme 2 is
the possibility to incorporate 13C-labellings into every posi-
tion of the oligoprenyl diphosphates from commercially
available building blocks: All three compounds used to
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build the carbon frameworks, i.e. 1a, 2, and 6, can be ob-
tained with a single 13C-labelling in each (incorporated) po-
sition or as multiply labelled compounds with various com-
binations of 13C-labellings (Figure 1). The 13C-labelling at
the ester carbonyl carbon of 6 as it is present in two com-
mercial isotopomers will be lost in the saponification/de-
carboxylation step from intermediates 7 to 1. However, the
respective isotopomers without a labelling of this lost
carbon are not available from standard suppliers of fine
chemicals. Therefore, the usage of the isotopomers as sum-
marised in Figure 1 offers the most practical solution, if a
synthesis aims at an introduction of the additional label-
lings at C-2 or at all three other carbons of 6.
Figure 1. Commercially available deuterated and 13C-labelled isoto-
pomers of acetone (1a), triethyl phosphonoacetate (2), and ethyl
acetoacetate (6).
While the introduction of 13C-labellings, although not
performed in this study, is an obvious possibility, a special
difficulty during the synthesis of analogous deuterated com-
pounds arises by the danger of deuterium losses in 2H,1H-
exchange reactions, e.g. during aqueous workup. Therefore,
we wanted to prove the operability of the route for the syn-
thesis of all kinds of isotopomers of deuterated oligoprenyl
diphosphates by the completion of one cycle from [2H6]-1a
to [2H14]-1b. While [
2H6]-1a is commercially available, the
other two required building blocks [2H2]-2 and [
2H5]-6 were
made available by synthesis (Scheme 3). Deuterated [2H2]-2
with a high deuterium content (99 %) was obtained from
unlabelled 2 by basic 1H,2H-exchange with K2CO3 in
2H2O.
The synthesis of [2H5]-6 was possible from Meldrum’s acid
(9), which can likewise be converted to [2H2]-9 by stirring in
2H2O and K2CO3. Its acylation with commercially available
[2H3]acetyl chloride yielded [
2H4]-10, if
2H2O and
2HCl
were used for aqueous workup of the reaction. The crude
product was stirred in boiling EtO2H (deuterium content
99%) to yield the desired [2H5]-6. All three deuterated
building blocks [2H6]-1a, [
2H2]-2, and [
2H5]-6 were sub-
sequently used to aim at a synthesis of fully deuterated
[2H14]-1b. Starting from [
2H6]-1a, the HWE reaction with
[2H2]-2 to [
2H7]-3a, the reduction with LiAl
2H4 to [
2H9]-4a
and the conversion into [2H9]-5a all resulted in completely
deuterated materials. Surprisingly, the subsequent alkyl-
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Scheme 3. Synthesis of [2H2]-2 and [
2H5]-6.
ation of [2H5]-6 with [
2H9]-5a proceeded with complete loss
of the acidic deuterium at the α-carbon to yield [2H12]-7a
instead of the desired [2H13]-7a, even if the reaction was
performed in deuterated acetone as solvent. The most likely
explanation for this finding is a 2H/1H-exchange with sil-
anol groups of the silica gel in the chromatographic purifi-
cation of deuterated 7a. The lost deuterium could, however,
be reintroduced in the subsequent deethoxycarbonylation
with KO2H in 2H2O/EtO
2H to [2H12]-1b (herein, it is also
crucial to use 2HCl in the acidic workup). The yields for
the overall procedure are summarised in Table 1 (cf. com-
pounds [2H7]-3a, [
2H9]-4a, [
2H13]-7, and [
2H14]-1b). In sum-
mary, this work demonstrated that the route of Scheme 2
can be used to incorporate deuterium into any of the posi-
tions of the oligoprenyl diphosphates with high incorpora-
tion rates. However, in contrast to the HWE reaction from
[2H6]-1a with [
2H2]-2 to [
2H7]-3a, the corresponding conver-
sion of [2H14]-1b into [
2H15]-3b showed a 66% loss of deu-
terium at the olefinic C-2 carbon. This loss of deuterium
was observed even under aqueous workup with 2H2O, dem-
onstrating that the HWE reaction is somewhat unreliable in
terms of deuterium introduction.
A major disadvantage of the transformations from 1a to
1b as shown in Scheme 2 is the volatility of all products
within this first elongation cycle which engenders signifi-
cant losses of isotopically labelled material during product
isolation. To overcome this problem, an easier-to-handle al-
ternative approach for the introduction of labellings into
the C-terminal portion of 4b was developed (Scheme 4; a
similar approach was reported by Stratakis and co-
workers[22]). The synthetic route starts from 4b that was
protected with TBDPSCl to yield the silyl ether 11. Epoxid-
ation to 12 and periodate cleavage resulted in 13,[23] which
was converted with KOH and iodine in methanol into the
methyl ester 14. This reaction proved to be low-yielding on
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Scheme 4. Synthesis of [2H]-4b and [2H7]-4b.
a large scale, and therefore, 13 was converted into 14 in ten
separate ca. 20 mmol portions. Introduction of deuterium
was performed by reduction with LiAl2H4 to the alcohol
[2H2]-15 which was followed by a sequence of tosylation
and two subsequent nucleophilic substitutions with iodide
and triphenylphosphane to the Wittig salt [2H2]-18. A Wit-
tig reaction either with unlabelled 1a or [2H6]-1a gave access
to the TBDPS ethers [2H]-11 and [2H7]-11. A final deprotec-
tion with TBAF yielded the deuterated geraniol isotopo-
mers [2H]-4b and [2H7]-4b in 19% and 16% overall yield,
respectively, via 10 steps. The compound [2H]-4b was sub-
Scheme 5. Stereochemical course of cyclisation of GGPP to tuber-
culosinyl diphosphate (2) by Mycobacterium tuberculosis tuberculo-
sinyl diphosphate synthase (Rv3377c). Incubation of [14-2H]GGPP,
dephosphorylation by potato acid phosphatase, and 1H NMR
analysis of the product (Figure 2) demonstrated that protonation
at C-14 proceeds from the Si side.
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sequently converted into [14-2H]-8d by the methodology of
Scheme 2. The obtained yields of this procedure are also
summarised in Table 1.
The synthetic compound [14-2H]-8d was subsequently
used in an incubation experiment with the tuberculosinyl
diphosphate synthase from M. tuberculosis to investigate
the stereochemical course of the reaction (Scheme ). The
product obtained was dephosphorylated with acid phos-
phatase from potato to tuberculosinol (19) and then ana-
lysed by 1H NMR spectroscopy. In unlabelled 19, the signal
Figure 2. a) 1H NMR spectrum of 19, b) 1H NMR spectrum of
(R)-[3-2H]-19 obtained from the incubation of [14-2H]-8d with tu-
berculosinyl diphosphate synthase and dephosphorylation, and c)
1H NMR spectrum of (S)-[3-2H]-19 obtained from the incubation
of 8d with tuberculosinyl diphosphate synthase in deuterium oxide
and dephosphorylation.
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at δH = 1.39 exhibited a ddd splitting pattern (J = 12.5,
12.5, 5.4 Hz), indicating that this signal can be assigned to
H-3β, while the signal at δH = 1.53 was assignable to H-3α
(Figure 2, a). The latter signal overlapped with that of H-
11, but these assignments were unambiguously confirmed
by the HSQC spectrum. Feeding of [14-2H]-8d resulted in a
missing signal for the 3-pro-R hydrogen (H-3α) in the 1H
NMR spectrum (Figure 2, b), indicating that [14-2H]-8d is
converted into (R)-[3-2H]-19, consistent with a protonation
of the substrate from the Si side at C-14. This result was
corroborated by a complementary experiment in which un-
labelled 8d was incubated with the tuberculosinyl diphos-
phate synthase in deuterium oxide followed by dephosphor-
ylation. The signal for the 3-pro-S hydrogen (H-3β) was
missing in the 1H NMR spectrum of the enzyme product
(Figure 2, c), establishing its structure as (S)-[3-2H]-19
which is in full agreement with the previous finding.
Conclusions
In summary, we have presented an efficient, flexible and
robust protocol for the synthesis of oligoprenyl diphos-
phates with stable isotope labelling from just a few cost-
effective, commercially available building blocks and rea-
gents. Many of the reactions summarised in Table 1 have
been performed several times in our laboratories, but not
always with isotopically labelled material. Since yield op-
timisation with labelled compounds would be too expens-
ive, the optimised yields for each step as they were obtained
with unlabelled material[21] are also included in Table 1.
These data show which yields along the route are possible.
We have shown that deuterium labelling can be efficiently
introduced in any position of the isoprenoid precursors
using the presented chemistry. Only the Horner–Wad-
sworth–Emmons reaction with [2H2]-2 proved to be some-
what unreliable and proceeded in single cases with partial
loss of deuterium labelling. The prepared compound [14-
2H]GGPP was used in an incubation experiment with the
tuberculosinyl diphosphate synthase from M. tuberculosis,
followed by dephosphorylation. The 1H NMR analysis of
the enzyme’s product demonstrated that the substrate was
protonated from the Si face at C-14, which was further cor-
roborated by the complementary experiment of GGPP in-
cubation in deuterium oxide and dephosphorylation. These
and similar experiments using other isotopically labelled
oligoprenyl diphosphates prepared via our route are cur-
rently being performed in our laboratory.
Experimental Section
General Methods: Chemicals were purchased from Acros Organics
(Geel, Belgium) or Sigma Aldrich Chemie GmbH (Steinheim, Ger-
many) and used without further purification. All nonaqueous reac-
tions were performed under an inert atmosphere (N2) in flame-
dried flasks. Solvents were purified by distillation and dried accord-
ing to standard methods. Thin-layer chromatography was per-
formed with 0.2 mm precoated plastic sheets Polygram® Sil G/
UV254 (Machery–Nagel). Column chromatography was carried
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out using Merck silica gel 60 (70–200 mesh). 1H NMR and 13C
NMR spectra were recorded with Bruker DRX-400 (400 MHz) or
AV III-400 (400 MHz) spectrometers, and were referenced against
TMS (δ = 0.00 ppm) for 1H NMR and CDCl3 (δ = 77.01 ppm) for
13C-NMR spectroscopy. IR spectra were recorded with a Bruker
Tensor 27 ATR (attenuated total reflectance) instrument. GC–MS
analyses were carried out with a HP 6890 gas chromatograph con-
nected to a HP 5973 inert mass detector fitted with a BPX-5 (25 m,
0.25 mm i. d., 0.25 µm film) or HP5-MS (30 m, 0.25 mm i. d.,
0.25 µm film) fused silica capillary column. Instrumental param-
eters were (1) inlet pressure, 77.1 kPa, He flow 23.3 mLmin–1, (2)
injection volume, 2 µL, (3) transfer line, 300 °C, and (4) electron
energy 70 eV. The GC was programmed as follows: 5 min at 50 °C
increasing at 10 °C min–1 to 320 °C, and operated in split mode
(20:1, 60 s valve time). The carrier gas was He at 1 mLmin–1. Re-
tention indices (I) were determined from a homologous series of n-
alkanes (C8–C38).
(E)-tert-Butyl[(3,7-dimethylocta-2,6-dien-1-yl)oxy]diphenylsilane
(11): A solution of geraniol (4b) (51.1 g, 331 mmol, 1.0 equiv.) in
DMF (300 mL) was treated with imidazole (49.5 g, 729 mmol,
2.2 equiv.). After the imidazole was dissolved, the solution was co-
oled to 0 °C and TBDPS-Cl (100 g, 365 mmol, 1.1 equiv.) was
added dropwise. The reaction mixture was stirred for 3 h at room
temperature and afterwards quenched by the addition of H2O. The
aqueous layer was extracted three times with Et2O, and the com-
bined organic layers were washed with a satd. aqueous solution
of NaHCO3. After drying with MgSO4 and concentration under
reduced pressure, the product 11 (129 g, 329 mmol, 99 %) was ob-
tained as a yellow oil. Rf = 0.89 [hexane/EtOAc (5:1)]. GC (BPX-
5): I = 2550. 1H NMR (400 MHz, CDCl3, TMS): δ = 7.72–7.69
(m, 4 H, 4  CH), 7.43–7.23 (m, 6 H, 6  CH), 5.40–5.37 (m, 1 H,
CH), 5.12–5.08 (m, 1 H, CH), 4.23 (d, 3JH,H = 6.3 Hz, 2 H, CH2),
2.09–2.04 (m, 2 H, CH2), 1.99–1.96 (m, 2 H, CH2), 1.68 (d,
4JH,H
= 0.6 Hz, 3 H, CH3), 1.60 (s, 3 H, CH3), 1.43 (s, 3 H, CH3), 1.05
(s, 9 H, 3 CH3) ppm.
13C NMR (100 MHz, CDCl3): δ = 137.0
(Cq), 135.6 (4  CH), 134.1 (Cq), 131.5 (2  Cq), 129.5 (2  CH),
127.6 (4 CH), 124.1 (CH), 124.0 (CH), 61.2 (CH2), 39.5 (CH2),
26.8 (3 CH3), 26.4 (CH2), 25.7 (CH3), 19.2 (Cq), 17.7 (CH3), 16.3
(CH3) ppm. MS (EI, 70 eV): m/z (%) = 392 (1) [M]
+, 335 (27),
257 (3), 199 (100), 181 (5), 135 (5), 69 (3), 41 (3). IR (ATR): ν˜ =
3071 (w), 3050 (w), 2961 (w), 2930 (w), 2857 (w), 1428 (w), 1108
(s), 1056 (m), 822 (m), 738 (m), 700 (s), 610 (m) cm–1. UV/Vis
(CH2Cl2): λmax (ε, L mol
–1 cm–1) = 271 (495), 265 (699), 260 (689),
228 (6229) nm.
(E)-tert-Butyl{[5-(3,3-dimethyloxiran-2-yl)-3-methylpent-2-en-1-yl]-
oxy}diphenylsilane (12): Compound 11 (129 g, 329 mmol,
1.0 equiv.) was dissolved in CHCl3 (1000 mL) and cooled to 0 °C.
In one portion, mCPBA (88.9 g, 362 mmol, 1.1 equiv.) was added,
and the reaction mixture was stirred for 1 h at 0 °C. The mixture
was then washed with a satd. solution of NaHCO3, brine, and H2O.
The organic layer was dried with MgSO4 and concentrated under
reduced pressure. Column chromatography with hexane/EtOAc
(10:1) yielded the desired epoxide 12 (80.5 g, 197 mmol, 60 %) as a
colorless oil. Rf = 0.58 [hexane/EtOAc (5:1)]. GC (BPX-5): I =
2675. 1H NMR (400 MHz, CDCl3, TMS): δ = 7.73–7.68 (m, 4 H,
4 CH), 7.43–7.35 (m, 6 H, 6  CH), 5.42 (tq, 3JH,H = 6.4,
4JH,H
= 1.2 Hz, 1 H, CH), 4.23 (d, 3JH,H = 6.3 Hz, 2 H, CH2), 2.70 (t,
3JH,H = 6.3 Hz, 1 H, CH), 2.15–2.03 (m, 2 H, CH2), 1.68–1.57 (m,
2 H, CH2), 1.46 (s, 3 H, CH3), 1.30 (s, 3 H, CH3), 1.26 (s, 3 H,
CH3), 1.04 (s, 9 H, 3  CH3) ppm.
13C NMR (100 MHz, CDCl3):
δ = 136.1 (Cq), 135.6 (4  CH), 133.9 (2  Cq), 129.5 (2  CH),
127.6 (4  CH), 124.6 (CH), 64.0 (CH), 61.0 (CH2), 58.3 (Cq), 36.1
(CH2), 27.1 (CH2), 26.8 (3  CH3), 24.9 (CH3), 19.1 (Cq), 18.7
Isotopically Labelled Oligoprenyl Diphosphates
(CH3), 16.3 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 408 (1) [M]
+, 351 (2), 273 (6), 199 (100), 181 (7), 135 (24), 107 (5), 77 (4). IR
(ATR): ν˜ = 3071 (w), 3049 (w), 2959 (w), 2931 (w), 2891 (w), 2857
(w), 1428 (w), 1110 (m), 821 (m), 739 (m), 701 (s), 608 (m) cm–1.
UV/Vis (CH2Cl2): λmax (ε, L mol
–1 cm–1) = 271 (461), 265 (686), 260
(686), 253 (641), 228 (6823) nm.
(E)-6-[(tert-Butyldiphenylsilyl)oxy]-4-methylhex-4-enal (13): Epox-
ide 12 (80.5 g, 197 mmol, 1.0 equiv.) was dissolved in THF
(400 mL) and cooled to 0 °C. Within 90 min, a solution of H5IO6
(53.9 g, 236 mmol, 1.2 equiv.) in THF (400 mL) was added drop-
wise. After complete addition, the reaction mixture was stirred for
an additional 2 h at 0 °C. The reaction was extracted with Et2O,
dried with MgSO4 and concentrated under reduced pressure to give
aldehyde 13 (69.9 g, 191 mmol, 97 %) as a pale yellow oil. Rf = 0.44
[hexane/EtOAc (5:1)]. GC (BPX-5): I = 2493. 1H NMR (400 MHz,
CDCl3, TMS): δ = 9.73 (t,
3JH,H = 1.8 Hz, 1 H, CHO), 7.73–7.67
(m, 4 H, 4  CH), 7.41–7.35 (m, 6 H, 6  CH), 5.38 (tq, 3JH,H =
6.2, 4JH,H = 1.3 Hz, 1 H, CH), 4.22 (d,
3JH,H = 6.3 Hz, 2 H, CH2),
2.50–2.46 (m, 2 H, CH2), 2.30–2.26 (m, 2 H, CH2), 1.44 (s, 3 H,
CH3), 1.04 (s, 9 H, 3  CH3) ppm.
13C NMR (100 MHz, CDCl3):
δ = 202.1 (CHO), 135.6 (4  CH), 134.8 (Cq), 133.9 (2  Cq), 129.5
(2 CH), 127.6 (4  CH), 125.0 (CH), 60.9 (CH2), 41.8 (CH2),
31.4 (CH2), 26.8 (3  CH3), 19.1 (Cq), 16.4 (CH3) ppm. MS (EI,
70 eV): m/z (%) = 366 (1) [M]+, 309 (9), 231 (24), 213 (6), 199
(100), 183 (10), 139 (14), 105 (4), 77 (9). IR (ATR): ν˜ = 3071 (w),
3049 (w), 2957 (w), 2931 (w), 2891 (w), 2857 (w), 1725 (w), 1428
(w), 1110 (s), 1069 (m), 822 (m), 740 (m), 702 (s), 611 (m) cm–1.
UV/Vis (CH2Cl2): λmax (ε, L mol
–1 cm–1) = 271 (354), 265 (687), 260
(649), 230 (4042) nm.
Methyl (E)-6-[(tert-Butyldiphenylsilyl)oxy]-4-methylhex-4-enoate
(14): Aldehyde 13 (7.3 g, 20.0 mmol, 1.0 equiv.) was dissolved in
MeOH (200 mL) and cooled 0 °C. Subsequently, solutions of KOH
(2.9 g, 52. 0 mmol, 2.6 equiv.) in MeOH (67 mL) and I2 (6.6 g,
26.0 mmol, 1.3 equiv.) in MeOH (34 mL) were added, and stirring
was continued for 90 min at 0 °C. The reaction mixture was diluted
with EtOAc (1 L) and washed three times with satd. aqueous
Na2S2O3 and with brine. The organic layer was dried with MgSO4
and concentrated under reduced pressure. Column chromatography
with hexane/EtOAc (10:1) yielded product 14 (5.6 g, 14.0 mmol,
71 %) as a yellowish oil. Rf = 0.32 [hexane/EtOAc (10:1)]. GC
(BPX-5): I = 2592. 1H NMR (400 MHz, CDCl3, TMS): δ = 7.70–
7.66 (m, 4 H, 4  CH), 7.44–7.35 (m, 6 H, 6  CH), 5.39 (tq, 3JH,H
= 6.5, 4JH,H = 1.3 Hz, 1 H, CH), 4.21 (d,
3JH,H = 6.3 Hz, 2 H,
CH2), 3.66 (s, 3 H, CH3), 2.42–2.38 (m, 2 H, CH2), 2.31–2.27 (m,
2 H, CH2), 1.44 (s, 3 H, CH3), 1.04 (s, 9 H, 3  CH3) ppm.
13C
NMR (100 MHz, CDCl3): δ = 173.7 (CO), 135.6 (4  CH), 135.2
(Cq), 133.9 (2  Cq), 129.5 (2  CH), 127.6 (4  CH), 124.8 (CH),
61.0 (CH2), 51.5 (CH3), 34.3 (CH2), 32.6 (CH2), 26.8 (3  CH3),
19.1 (Cq), 16.2 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 396 (1)
[M]+, 339 (68), 309 (39), 279 (5), 261 (16), 229 (12), 213 (75), 199
(100), 181 (16), 153 (9), 135 (11), 123 (15), 105 (5), 81 (10). IR
(ATR): ν˜ = 3071 (w), 2954 (w), 2932 (w), 2892 (w), 2857 (w), 1739
(m), 1429 (m), 1109 (s), 1056 (m), 822 (m), 740 (m), 701 (s), 609
(m) cm–1. UV/Vis (CH2Cl2): λmax (ε, L mol
–1 cm–1) = 271 (502), 265
(714), 260 (704), 230 (4609) nm.
(E)-[1,1-2H2]-6-[(tert-Butyldiphenylsilyl)oxy]-4-methylhex-4-en-1-ol
(15): A suspension of LiAlD4 (3.6 g, 86 mmol, 1.2 equiv.) in THF
(500 mL) was cooled to 0 °C, and methyl ester 14 (57.0 g,
144 mmol, 1.0 equiv.) was added dropwise. The reaction mixture
was stirred for 2 h at 0 °C and overnight at room temperature. For
workup, H2O was added carefully, and the precipitate was dissolved
by addition of 2  HCl. The aqueous layer was extracted three
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times with EtOAc, and the combined organic layers were dried with
MgSO4 and concentrated under reduced pressure to give com-
pound [1,1-2H2]-15 (48.8 g, 131 mmol, 91 %) as a yellowish oil. Rf
= 0.26 [hexane/EtOAc (3:1)]. GC (BPX-5, MSTFA): I = 2580. 1H
NMR (400 MHz, CDCl3, TMS): δ = 7.71–7.68 (m, 4 H, 4  CH),
7.42–7.34 (m, 6 H, 6  CH), 5.42 (tq, 3JH,H = 6.3,
4JH,H = 1.3 Hz,
1 H, CH), 4.22 (d, 3JH,H = 6.3 Hz, 2 H, CH2), 2.03 (t,
3JH,H =
7.3 Hz, 2 H, CH2), 1.81 (s, 1 H, OH), 1.62 (t,
3JH,H = 7.9 Hz, 2 H,
CH2), 1.45 (d,
4JH,H = 0.8 Hz, 3 H, CH3), 1.05 (s, 9 H, 3  CH3)
ppm. 13C NMR (100 MHz, CDCl3): δ = 136.8 (Cq), 135.5 (4 
CH), 134.0 (2  Cq), 129.5 (3 CH), 127.5 (4  CH), 124.3 (CH),
61.7 (quint., 1JC,D = 21.6 Hz, C
2H2), 61.0 (CH2), 35.6 (CH2), 30.3
(CH2), 26.8 (3 CH3), 19.1 (Cq), 16.1 (CH3) ppm. MS (EI, 70 eV,
MSTFA): m/z (%) = 385 (5) [M]+, 370 (1), 271 (98), 199 (100),
181 (11), 135 (10), 97 (53), 75 (11). IR (ATR): ν˜ = 3358 (br), 3071
(w), 2931 (w), 2857 (w), 1428 (w), 1109 (m), 1050 (m), 822 (w), 700
(s) cm–1. UV/Vis (CH2Cl2): λmax (ε, L mol
–1 cm–1) = 271 (481), 265
(677), 260 (670), 230 (3961) nm.
(E)-[1,1-2H2]-6-[(tert-Butyldiphenylsilyl)oxy]-4-methylhex-4-en-1-yl
4-Methylbenzenesulfonate (16): Alcohol [1,1-2H2]-15 (48.8 g,
131 mmol, 1.0 equiv.) was dissolved in pyridine (165 mL) and co-
oled to 0 °C. TsCl (36.1 g, 190 mmol, 1.5 equiv.) was added in small
portions, and stirring was continued for 3 h at 0 °C. The reaction
mixture was poured onto ice and extracted three times with EtOAc.
The combined organic layers were washed with a satd. solution of
aqueous CuSO4, 2  HCl and H2O. After drying with MgSO4 and
concentration under reduced pressure, tosylate [1,1-2H2]-16 (64.0 g,
122 mmol, 93 %) was obtained as a yellow oil. Rf = 0.56 [hexane/
EtOAc (3:1)]. 1H NMR (400 MHz, CDCl3, TMS): δ = 7.79–7.77
(m, 2 H, 2 CH), 7.69–7.65 (m, 4 H, 4  CH), 7.44–7.35 (m, 6 H,
6 CH), 7.33–7.31 (m, 2 H, 2  CH), 5.30 (tq, 3JH,H = 6.3,
4JH,H
= 1.3 Hz, 1 H, CH), 4.16 (d, 3JH,H = 6.3 Hz, 2 H, CH2), 2.42 (s, 3
H, CH3), 1.97 (t,
3JH,H = 7.1 Hz, 2 H, CH2), 1.71 (t,
3JH,H = 8.1 Hz,
2 H, CH2), 1.37 (s, 3 H, CH3), 1.03 (s, 9 H, 3  CH3) ppm.
13C
NMR (100 MHz, CDCl3): δ = 144.6 (Cq), 135.5 (4  CH), 135.1
(Cq), 133.9 (2  Cq), 133.2 (Cq), 129.8 (2  CH), 129.5 (2  CH),
127.8 (2  CH), 127.6 (4  CH), 125.1 (CH), 69.5 (quint., 1JC,D =
22.9 Hz, C2H2), 60.9 (CH2), 34.9 (CH2), 26.8 (3  CH3), 26.6
(CH2), 21.6 (CH3), 19.1 (Cq), 16.1 (CH3) ppm. IR (ATR): ν˜ = 3070
(w), 2957 (w), 2931 (w), 2891 (w), 2858 (w), 1359 (m), 1175 (m),
1111 (m), 815 (s), 700 (s), 607 (m), 553 (s) cm–1. UV/Vis (CH2Cl2):
λmax (ε, L mol
–1 cm–1) = 265 (1292), 261 (1250), 231 (11676) nm.
(E)-[6,6-2H2]-tert-Butyl[(6-iodo-3-methylhex-2-en-1-yl)oxy]diphenyl-
silane (17): Tosylate [1,1-2H2]-16 (64.0 g, 122 mmol, 1.0 equiv.) was
dissolved in acetone (750 mL) and treated with NaI (34.8 g,
232 mmol, 1.9 equiv.). The reaction mixture was stirred overnight
at room temperature under exclusion of light. The mixture was
diluted with hexane, filtered and concentrated under reduced pres-
sure to give [6,6-2H2]-17 (57.9 g, 121 mmol, 99 %) as a pale red oil.
Rf = 0.79 [hexane/EtOAc (5:1)]. GC (BPX-5): I = 2812.
1H NMR
(400 MHz, CDCl3, TMS): δ = 7.70–7.68 (m, 4 H, 4  CH), 7.44–
7.36 (m, 6 H, 6  CH), 5.42 (tq, 3JH,H = 6.3,
4JH,H = 1.2 Hz, 1 H,
CH), 4.22 (d, 3JH,H = 6.3 Hz, 2 H, CH2), 2.05 (t,
3JH,H = 7.1 Hz,
2 H, CH2), 1.87 (t,
3JH,H = 7.5 Hz, 2 H, CH2), 1.42 (s, 3 H, CH3),
1.04 (s, 9 H, 3  CH3) ppm.
13C NMR (100 MHz, CDCl3): δ =
135.6 (4  CH), 134.9 (Cq), 134.0 (2  Cq), 129.5 (2  CH), 127.6
(4 CH), 125.4 (CH), 61.0 (CH2), 39.8 (CH2), 31.1 (CH2), 26.8
(3  CH3), 19.1 (Cq), 16.1 (CH3), 6.1 (quint.,
1JC,D = 22.8 Hz,
C2H2) ppm. MS (EI, 70 eV): m/z (%) = 480 (1) [M]
+, 423 (40),
309 (18), 249 (4), 199 (100), 181 (9), 135 (4), 97 (12). IR (ATR): ν˜
= 3070 (w), 2931 (w), 2891 (w), 2856 (w), 1427 (w), 1109 (s), 1062
(m), 822 (m), 739 (m), 700 (s), 610 (m) cm–1. UV/Vis (CH2Cl2):
λmax (ε, L mol
–1 cm–1) = 265 (1078), 259 (1157), 229 (5598) nm.
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(E)-[1,1-2H2]-{6-[(tert-Butyldiphenylsilyl)oxy]-4-methylhex-4-en-1-
yl}triphenylphosphonium Iodide (18): Triphenylphosphine (38.0 g,
145 mmol, 1.2 equiv.) was dissolved in toluene (400 mL) and
treated with [6,6-2H2]-17 (57.9 g, 121 mmol, 1.0 equiv.). The reac-
tion was refluxed for 3 h, cooled to room temperature, and filtered.
The resulting solid was washed with toluene and dried under re-
duced pressure to give the Wittig salt [1,1-2H2]-18 (69.5 g, 94 mmol,
78 %) as a colorless solid. Rf = 0.65 [CH2Cl2/MeOH (10:1)].
1H
NMR (400 MHz, CDCl3, TMS): δ = 7.85–7.62 (m, 19 H, 19 
CH), 7.41–7.30 (m, 6 H, 6  CH), 5.38–5.34 (m, 1 H, CH), 4.17
(d, 3JH,H = 6.3 Hz, 2 H, CH2), 2.32 (t,
3JH,H = 7.1 Hz, 2 H, CH2),
1.86–1.72 (m, 2 H, CH2), 1.34 (s, 3 H, CH3), 0.99 (s, 9 H, 3  CH3)
ppm. 13C NMR (100 MHz, CDCl3): δ = 135.3 (4  CH), 135.0 (d,
4JP,C = 3.0 Hz, 3  CH), 134.9 (Cq), 133.6 (2  Cq), 133.5 (d,
3JP,C
= 10.0 Hz, 6  CH), 130.4 (d, 2JP,C = 12.5 Hz, 6  CH), 129.4 (2 
CH), 127.4 (4  CH), 125.9 (CH), 117.8 (d, 1JP,C = 86.1 Hz, 3 
Cq), 60.6 (CH2), 38.9 (d,
2JP,C = 15.7 Hz, CH2), 26.6 (3 CH3),
19.9 (d, 3JP,C = 3.9 Hz, CH2), 18.9 (Cq), 16.0 (CH3) ppm.
31P NMR
(122 MHz, CDCl3): δ = 24.9 ppm. IR (ATR): ν˜ = 3052 (w), 3014
(w), 2930 (w), 2856 (w), 2183 (w), 1437 (m), 1110 (s), 1064 (m), 917
(m), 731 (s), 703 (s), 687 (s), 610 (m) cm–1. UV/Vis (CH2Cl2): λmax
(ε, L mol–1 cm–1) = 229 (33630) nm.
(E)-[6-2H]-tert-Butyl[(3,7-dimethylocta-2,6-dien-1-yl)oxy]diphenyl-
silane (11): Wittig salt [1,1-2H2]-18 (20.0 g, 27 mmol, 1.0 equiv.) was
suspended in THF (250 mL) and cooled to 0 °C. A solution of
nBuLi (1.6 , 18.6 mL, 29.7 mmol, 1.1 equiv.) in hexane was added,
and stirring was continued for 90 min at 0 °C. After cooling to
–78 °C, acetone (1.7 g, 29.7 mmol, 1.1 equiv.) was added dropwise,
and the mixture was stirred overnight at room temperature. The
reaction was quenched by the addition of H2O and extracted three
times with EtOAc. The combined organic layers were dried with
MgSO4 and concentrated under reduced pressure. Column
chromatography with hexane/EtOAc (10:1) yielded [6-2H]-11 (8.1 g,
20.6 mmol, 76 %) as a colorless oil (deuterium atom content: 90 %).
Rf = 0.78 [hexane/EtOAc (10:1)]. GC (BPX-5): I = 2548.
1H NMR
(400 MHz, CDCl3, TMS): δ = 7.71–7.68 (m, 4 H, 4  CH), 7.43–
7.34 (m, 6 H, 6  CH), 5.38 (tq, 3JH,H = 6.3,
4JH,H = 0.9 Hz, 1 H,
CH), 4.23 (d, 3JH,H = 6.3 Hz, 2 H, CH2), 2.08–2.04 (m, 2 H, CH2),
1.99–1.96 (m, 2 H, CH2), 1.68 (s, 3 H, CH3), 1.60 (s, 3 H, CH3),
1.44 (s, 3 H, CH3), 1.05 (s, 9 H, 3  CH3) ppm.
13C NMR
(100 MHz, CDCl3): δ = 137.0 (Cq), 135.6 (4  CH), 134.2 (2  Cq),
131.4 (Cq), 129.5 (2  CH), 127.6 (4  CH), 124.1 (CH), 123.8 (t,
1JC,D = 23.0 Hz, C
2H), 61.2 (CH2), 39.5 (CH2), 26.9 (3  CH3),
26.3 (CH2), 25.6 (CH3), 19.2 (Cq), 17.7 (CH3), 16.3 (CH3) ppm.
MS (EI, 70 eV): m/z (%) = 393 (3) [M]+, 336 (66), 258 (11), 199
(100), 181 (30), 135 (24), 121 (13), 70 (29), 41 (23). IR (ATR): ν˜ =
3071 (w), 2960 (w), 2857 (w), 1428 (w), 1109 (s), 1060 (m), 822 (w),
738 (m), 700 (s) cm–1. UV/Vis (CH2Cl2): λmax (ε, L mol
–1 cm–1) =
271 (426), 265 (628), 259 (703), 230 (3306) nm.
(E)-[6-2H]-3,7-Dimethylocta-2,6-dien-1-ol (4b): Compound [6-2H]-
11 (29.0 g, 73.6 mmol, 1.0 equiv.) was dissolved in THF (360 mL)
and cooled to 0 °C. A solution of TBAF (1.0  , 88.3 mL,
88.3 mmol, 1.2 equiv.) in THF was added and stirred for 3 h at
0 °C. The solution was diluted with Et2O and washed with H2O.
The organic layer was dried with MgSO4 and concentrated under
reduced pressure. Column chromatography with hexane/EtOAc
(5:1) yielded [6-2H]-4b (11.1 g, 71.4 mmol, 97 %) as a colorless oil.
Rf = 0.26 [hexane/EtOAc (5:1)]. GC (BPX-5, MSTFA): I = 1363.
1H NMR (400 MHz, CDCl3, TMS): δ = 5.31 (tq,
3JH,H = 7.0,
4JH,H
= 1.3 Hz, 1 H, CH), 4.15 (d, 3JH,H = 7.0 Hz, 2 H, CH2), 2.12–2.08
(m, 2 H, CH2), 2.05–2.01 (m, 2 H, CH2), 1.68 (s, 3 H, CH3), 1.67
(s, 3 H, CH3), 1.60 (s, 3 H, CH3) ppm.
13C NMR (100 MHz,
CDCl3): δ = 139.5 (Cq), 131.6 (Cq), 123.5 (t,
1JC,D = 22.9 Hz, C
2H),
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59.3 (CH2), 39.5 (CH2), 26.2 (CH2), 25.5 (CH3), 17.6 (CH3), 16.2
(CH3) ppm. MS (EI, 70 eV, MSTFA): m/z (%) = 227 (10) [M]
+, 212
(15), 183 (8), 169 (23), 157 (27), 143 (55), 122 (62), 108 (11), 93
(34), 73 (100), 41 (47). IR (ATR): ν˜ = 3323 (br), 2967 (w), 2912
(m), 2857 (w), 1445 (m), 1375 (m), 1100 (w), 997 (s) cm–1. UV/Vis
(CH2Cl2): λmax (ε, L mol
–1 cm–1) = 227 (262) nm.
Isolation of (R)-[3-2H]-Tuberculosinol, and (S)-[3-2H]-Tuberculosin-
ol: The purified Rv3377c protein was prepared as described pre-
viously.[3] To isolate the product from the incubation of Rv3377c
with [14-2H]-GGPP, the reaction mixture (300 mL) containing Tris-
HCl buffer (pH 7.5, 50 m), MgCl2 (0.1 m), [14-
2H]-GGPP
(6 mg), and purified Rv3377c protein (4 mg), was incubated at
30 °C for 20 h. To hydrolyze the diphosphate moiety of the product,
the phosphatase reaction mixture (900 mL) containing Rv3377c re-
action mixture (300 mL), acetate buffer (0.2 , pH 5.6), 2-PrOH
(20 %, v/v), and acid phosphatase (0.25 mg mL–1, Sigma) was then
further incubated at 37 °C for 12 h. After addition of MeOH
(400 mL), the reaction mixture was extracted with n-hexane
(300 mL  3). The n-hexane layer was dried with Na2SO4 and the
solvents were evaporated to dryness. The crude materials were dis-
solved in a small amount of hexane. The enzymatic product was
purified by SiO2 column chromatography with hexane/ethyl acetate
(100:0 to 100:5) followed by reverse-phase HPLC [CAPCELL PAK
C18 MG S5 column (250  15 mm), SHISEIDO, Tokyo, Japan,
mobile phase CH3CN, flow rate 3 mLmin
–1, detection at 210 nm],
yielding 1.0 mg of (R)-[3-2H]-tuberculosinol (deuterium atom con-
tent: 93 %). To isolate the product from the incubation of Rv3377c
with non-labeled GGPP in deuterium oxide, the reaction mixture
(150 mL) containing Tris-HCl buffer (1 , pH 7.5, 7.5 mL), MgCl2
(0.1 , 0.15 mL), GGPP (3 mg mL–1, 1 mL), purified Rv3377c pro-
tein (0.5 mg mL–1, 4 mL), and D2O (99.9 atom-% D, Aldrich,
137.35 mL) was incubated at 30 °C for 20 h. After the incubation,
EDTA (0.5 , pH 8.0, 3 mL) was added to terminate the reaction.
The phosphatase reaction mixture (total volume 300 mL, same
composition as described above) was incubated at 37 °C for 12 h.
The enzymatic product was extracted with n-hexane and then puri-
fied by reverse-phase HPLC in CH3CN, yielding 1.1 mg of (S)-[3-
2H]-tuberculosinol (deuterium atom 91 %).
Supporting Information (see footnote on the first page of this arti-
cle): Synthetic procedures and spectroscopic data for compounds
[2H2]-2, [
2H2]-9, [
2H5]-6, [
2H7]-3a, [
2H9]-4a, [
2H12]-7a, [
2H14]-1b,
[2H15]-3b, [9-
2H]-1c, [13-2H]-1d, [10-2H]-3c, [14-2H]-3d, [10-2H]-4c,
[14-2H]-4d, [8-2H]-7b, [12-2H]-7c, and [14-2H]-8d. 1H NMR, 13C
NMR, and DEPT spectra of all synthesised compounds.
Acknowledgments
This work was funded by the Deutsche Forschungsgemeinschaft
(DFG) with a Heisenberg fellowship (grant DI1536/4-1, to J. S. D.
and project “Fragrants from Actinomycetes”, grant DI1536/2-1)
and by the Beilstein Institut zur Förderung der Chemischen Wis-
senschaften with a Scholarship (to P. R.).
[1] J. S. Dickschat, Nat. Prod. Rep. 2011, 28, 1917–1936.
[2] M. L. Wise, H.-J. Pyun, G. Helms, B. Assink, R. M. Coates,
R. B. Croteau, Tetrahedron 2001, 57, 5327–5334.
[3] a) C. Nakano, T. Okamura, T. Sato, T. Dairi, T. Hoshino,
Chem. Commun. 2005, 1016–1018; b) C. Nakano, T. Hoshino,
ChemBioChem 2009, 10, 2060–2071.
[4] T. Suga, Y. Hiragara, M. Aihara, S. Izumi, J. Chem. Soc.,
Chem. Commun. 1992, 1556–1558.
[5] D. E. Cane, P. C. Prabhakaran, J. S. Oliver, D. B. McIlwaine, J.
Am. Chem. Soc. 1990, 112, 3209–3210.
Isotopically Labelled Oligoprenyl Diphosphates
[6] D. Arigoni, D. E. Cane, J. H. Shim, R. Croteau, K. Wagschal,
Phytochemistry 1993, 32, 623–631.
[7] D. J. Miller, J. Gao, D. G. Truhlar, N. J. Young, V. Gonzalez,
R. K. Allemann, Org. Biomol. Chem. 2008, 6, 2346–2354.
[8] H. V. Thulasiram, R. M. Phan, S. B. Rivera, C. D. Poulter, J.
Org. Chem. 2006, 71, 1739–1741.
[9] S. Izumi, M. Aihara, Y. Hiraga, T. Hirata, T. Suga, J. Labelled
Compd. Radiopharm. 1991, 29, 591–597.
[10] D. J. Comeskey, D. D. Rowan, A. J. Matich, J. Labelled Compd.
Radiopharm. 2006, 49, 47–54.
[11] T. Subramanian, K. L. Subramanian, M. Sunkara, F. O.
Onono, A. J. Morris, H. P. Spielmann, J. Labelled Compd. Ra-
diopharm. 2013, 56, 370–375.
[12] D. E. Cane, J. S. Oliver, P. H. M. Harrison, C. Abell, B. R.
Hubbard, C. T. Kane, R. Lattman, J. Am. Chem. Soc. 1990,
112, 4513–4524.
[13] J. Jiang, X. He, D. E. Cane, J. Am. Chem. Soc. 2006, 128, 8128–
8129.
[14] W. K. W. Chou, I. Fanizza, T. Uchiyama, M. Komatsu, H.
Ikeda, D. E. Cane, J. Am. Chem. Soc. 2010, 132, 8850–8851.
[15] Y. Hu, W. K. W. Chou, R. Hopson, D. E. Cane, Chem. Biol.
2011, 18, 32–37.
Eur. J. Org. Chem. 2014, 7684–7691 © 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.eurjoc.org 7691
[16] a) J. S. Dickschat, C. A. Citron, N. L. Brock, R. Riclea, H.
Kuhz, Eur. J. Org. Chem. 2011, 3339–3346; b) C. A. Citron,
N. L. Brock, B. Tudzynski, J. S. Dickschat, Chem. Commun.
2014, 50, 5224–5226.
[17] a) C. A. Citron, N. L. Brock, P. Rabe, J. S. Dickschat, Angew.
Chem. Int. Ed. 2012, 51, 4053–4057; b) N. L. Brock, S. R. Rav-
ella, S. Schulz, J. S. Dickschat, Angew. Chem. Int. Ed. 2013, 52,
2100–2104.
[18] C. A. Citron, J. S. Dickschat, Org. Biomol. Chem. 2013, 11,
7447–7450.
[19] N. L. Brock, B. Tudzynski, J. S. Dickschat, ChemBioChem
2011, 12, 2667–2676.
[20] C. Nakano, T. Okamura, T. Sato, T. Dairi, T. Hoshino, Chem.
Commun. 2005, 1016–1018.
[21] P. Baer, P. Rabe, C. A. Citron, C. C. de Oliveira Mann, N.
Kaufmann, M. Groll, J. S. Dickschat, ChemBioChem 2014, 15,
213–216.
[22] C. Raptis, I. N. Lykakis, C. Tsangarakis, M. Stratakis, Chem.
Eur. J. 2009, 15, 11918–11927.
[23] C. Tsangarakis, M. Stratakis, Eur. J. Org. Chem. 2006, 4435–
4439.
Received: July 28, 2014
Published Online: October 24, 2014
Eur. J. Org. Chem. 2014 ·  © WILEY-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2014 ·  ISSN 1099–0690 
 
SUPPORTING INFORMATION 
 
DOI: 10.1002/ejoc.201403002 
Title: Synthesis of Isotopically Labelled Oligoprenyl Diphosphates and Their Application in Mechanistic Investigations 
of Terpene Cyclases 
Author(s): Christian A. Citron, Patrick Rabe, Lena Barra, Chiaki Nakano, Tsutomu Hoshino, and Jeroen S. 
Dickschat* 
 
 
Experimental Procedures for Synthetic Compounds 
Synthesis of triethyl [2H2]phosphonoacetate (2): A solution of triethyl phosphonoacetate (2) (22.4 g, 100 mmol, 1.0 eq.) in 100 mL of 
2H2O was treated with a catalytic amount of K2CO3 (~130 mg) and stirred for 2 d at room temperature. The mixture was then extracted thrice 
with ethyl acetate, dried over MgSO4 and concentrated under reduced pressure. Compound [2H2]-2 (20.4 g, 90.4 mmol, 90%) was obtained as 
colourless oil. Rf = 0.84 (hexane/EtOAc (1:1). GC (BPX-5): I = 1407. 1H NMR (400 MHz, CDCl3, TMS):  = 4.23 – 4.14 (m, 6H, 3x CH2), 
1.37 – 1.27 (m, 9H, 3x CH3) ppm. 13C NMR (100 MHz, CDCl3):  = 165.6 (d, 2JC,P = 6.0 Hz, Cq), 62.5 (d, 2JC,P = 6.2 Hz, 2x CH2), 61.4 
(CH2), 16.2 (d, 3JC,P = 6.2 Hz, 2x CH3), 13.9 (CH3) ppm. 31P NMR (162 MHz, CDCl3):  = 20.3 ppm. MS (EI, 70 eV): m/z (%) = 226 (<1) 
[M]+, 197 (97), 179 (82), 169 (43), 151 (82), 137 (17), 123 (100), 109 (57), 88 (37), 65 (11), 44 (35). IR (ATR): � ̃ = 2984 (w), 2938 (w), 
1732 (m), 1245 (s), 1016 (s), 964 (s) cm-1. 
Synthesis of [2H2]meldrum’s acid (9): A suspension of meldrum’s acid (9) (7.2 g 50.0 mmol, 1.0 eq.) in 30 mL of 2H2O was treated with 
K2CO3 (140 mg) and stirred at room temperature for 2 d. The mixture was then extracted three times with CH2Cl2, dried over MgSO4 and 
concentrated under reduced pressure. Deuterated [2H2]-9 (6.3 g, 43.4 mmol, 87%) was obtained as colourless solid. Rf = 0.30 (hexane/EtOAc 
(2:1). GC (BPX-5): I = 1132. 1H NMR (400 MHz, CDCl3, TMS):  = 1.79 (s, 6H, 2x CH3) ppm. 13C NMR (100 MHz, CDCl3):  = 162.9 (2x 
Cq), 106.2 (Cq), 35.6 (quint., 1JC,D = 20.5 Hz, C2H2), 27.5 (2x CH3) ppm. MS (EI, 70 eV): m/z (%) = 146 (<1) [M]+, 129 (15), 100 (10), 72 (4), 
58 (24), 43 (100). IR (ATR): � ̃ = 2930 (w), 1787 (s), 1747 (s), 1354 (m), 1299 (s), 1280 (s), 1199 (s), 1068 (s), 1012 (s), 975 (s), 954 (s), 
935 (m), 835 (s), 635 (m) cm-1. 
Synthesis of ethyl [2H5]acetoacetate (6): According to Scherling and Pleiß,1 compound [2H2]-9 (6.3 g, 43.3 mmol, 1.01 eq.) was dissolved 
in 90 mL of abs. CH2Cl2 and cooled to 0 °C. Pyridine (7.8 mL, 86.7 mmol, 2.02 eq.) was added, followed by dropwise addition of [2H3]acetyl 
chloride (3.0 mL, 42.9 mmol, 1.0 eq.). The reaction mixture was stirred for 1 h at 0 °C after which a 1 M solution of 2HCl in 2H2O was added. 
The organic phase was separated, washed with 2HCl and with 2H2O, dried with MgSO4, and concentrated under reduced pressure. The 
residue was taken up with 100 mL of EtO2H and refluxed for 4 h. After cooling down to room temperature, the solvent was removed under 
reduced pressure to yield compound [2H5]-6 (4.5 g, 32.9 mmol, 76%) as pale red liquid. Rf = 0.21 (hexane/EtOAc (10:1). GC (BPX-5): I = 
947. 1H NMR (400 MHz, CDCl3, TMS):  = 4.21 (q, 3JH,H = 7.1 Hz, 2H, CH2), 1.29 (t, 3JH,H = 7.1 Hz, 3H, CH3) ppm. 13C NMR (100 MHz, 
CDCl3):  = 200.8 (Cq), 167.1 (Cq), 61.3 (CH2), 49.5 (quint., 1JC,D = 20.0 Hz, C2H2), 29.3 (sept., 1JC,D = 20.2 Hz, C2H3), 14.0 (CH3) ppm. MS 
(EI, 70 eV): m/z (%) = 135 (8) [M]+, 116 (2), 107 (8), 90 (43), 63 (12), 46 (100). IR (ATR): � ̃= 2985 (w), 2941 (w), 1737 (m), 1711 (s), 
1316 (m), 1256 (m), 1150 (s), 1027 (m) cm-1. UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 244 (943) nm. 
Synthesis of ethyl [2H7]-3-methylbut-2-enoate (3a). A solution of diisopropylamine (9.6 g, 94.9 mmol, 1.05 eq.) in 250 mL of abs. THF 
was cooled to 0 °C and treated with n-butyl lithium (1.6 M in hexane, 59.3 mL, 94.9 mmol, 1.05 eq.). The reaction was stirred for 1 h at 0 °C 
and was then cooled to -78 °C. [2H2]-2 (20.4 g, 90.4 mmol, 1.0 eq.) was added and stirring was continued for 1 h at -78 °C. Acetone [2H6]-1a 
(5.79 g, 90.4 mmol, 1.0 eq.) was added dropwise and the reaction mixture was stirred over night at room temperature. The reaction was 
hydrolyzed by addition of distilled water, followed by threefold extraction with diethyl ether. The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. Column chromatography on silica gel with pentane/diethyl ether (10:1) yielded [2H7]-3a 
(8.76 g, 64.9 mmol, 72%) as colorless liquid. Rf = 0.40 (hexane/EtOAc (10:1). GC (HP-5): I = 922. 1H NMR (400 MHz, CDCl3, TMS):  = 
4.14 (q, 3JH,H = 7.1 Hz, 2H, CH2), 1.27 (t, 3JH,H = 7.1 Hz, 3H, CH3) ppm. 13C NMR (100 MHz, CDCl3):  = 166.7 (Cq), 156.1 (Cq), 115.9 (t, 
1JC,D = 25.7 Hz, C2H), 59.4 (CH2), 26.3 (sept., 1JC,D = 20.3 Hz, C2H3), 19.2 (sept., 1JC,D = 20.3 Hz, C2H3), 14.3 (CH3) ppm. MS (EI, 70 eV): 
m/z (%) = 135 (40) [M]+, 107 (20), 90 (100), 62 (23) 42 (6). IR (ATR): � ̃= 2982 (w), 1710 (s), 1632 (m), 1276 (m), 1222 (s), 1104 (s), 1054 
(s) 788 (m) cm-1. UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 230 (5428) nm. 
Synthesis of [2H9]-3-methylbut-2-en-1-ol (4a). LiAl2H4 (2.2 g, 52.7 mmol, 1.0 eq.) was suspended in 50 mL of abs. diethyl ether and cooled 
to 0 °C. The ester [2H7]-3a (7.1 g, 52.7 mmol, 1.0 eq.) was added dropwise and the reaction mixture stirred for 3 h at 0 °C. The reaction was 
quenched by addition of distilled water. The precipitate was dissolved by addition of aqueous hydrochloric acid. After extraction with diethyl 
ether, the combined organic layers were dried over MgSO4 and concentrated under reduced pressure to yield [2H9]-4a (3.95 g, 41.6 mmol, 
79%) as colorless liquid. Rf = 0.10 (hexane/EtOAc (5:1). 1H NMR (400 MHz, CDCl3, TMS):  = 2.15 (br s, 1H, OH) ppm. 13C NMR (100 
MHz, CDCl3):  = 135.8 (Cq), 123.2 (t, 1JC,D = 23.3 Hz, C2H), 58.3 (quint., 1JC,D = 21.7 Hz, C2H2), 24.6 (sept., 1JC,D = 19.1 Hz, C2H3), 16.8 
(sept., 1JC,D = 19.1 Hz, C2H3) ppm. MS (EI, 70 eV): m/z (%) = 95 (31) [M]+, 77 (100), 58 (16), 46 (22). IR (ATR): � ̃ = 3323 (br), 2195 (w), 
1265 (w), 1085 (s), 1041 (s), 961 (s) cm-1 
Synthesis of ethyl [2H12]-2-acetyl-5-methylhex-4-enoate (7a). The allyl bromide [2H9]-5a (prepared from 3.95 g, 41.6 mmol, [2H9]-4a) was 
dissolved in 50 mL of [2H6]acetone and anhydrous K2CO3 (8.6g, 62.4 mmol, 1.5 eq.) and ethyl [2H5]acetoacetate (4.4 g, 32.9 mmol, 0.8 eq.) 
were added. The mixture was refluxed for 4 h, cooled to room temperature, and filtered. The solution was concentrated und reduced pressure. 
Column chromatography on silica gel with hexane/ethyl acetate (5:1) yielded [2H12]-7a (3.3 g, 15.9 mmol, 38%) as colorless oil. Inspection 
by 1H NMR spectroscopy revealed the loss of one deuterium, most likely due to keto-enol tautomerism during column chromatography. 
Reintroduction of this deuterium in the next step was possible (vide infra). Rf = 0.48 (hexane/EtOAc (5:1). GC (HP-5): I = 1317. 1H NMR 
(400 MHz, CDCl3, TMS):  = 4.19 (q, 3JH,H = 7.1 Hz, 2H, CH2), 3.41 (br s, 1H, CH), 1.27 (t, 3JH,H = 7.1 Hz, 3H, CH3) ppm. 13C NMR (100 
MHz, CDCl3):  = 203.2 (Cq), 169.6 (Cq), 119.3 (t, 1JC,D = 23.3 Hz, C2H), 61.2 (CH2), 59.6 (CH), 28.2 (sept., 1JC,D = 20.5 Hz, C2H3), 26.2 
(quint., 1JC,D = 20.5 Hz, C2H2), 24.7 (sept., 1JC,D = 19.1 Hz, C2H3), 16.8 (sept., 1JC,D = 18.4 Hz, C2H3), 14.0 (CH3) ppm. MS (EI, 70 eV): m/z 
(%) = 211 (4) [M]+, 210 (4) [M-2H]+, 191 (3), 165 (63), 137 (29), 118 (100), 90 (40), 78 (34), 58 (9), 46 (63). IR (ATR): � ̃ = 2984 (w), 1738 
(m), 1712 (s), 1313 (m), 1262 (m), 1199 (m), 1030 (m) cm-1. 
Synthesis of [2H14]-6-methylhept-5-en-2-one (1b). To a solution of the -ketoester [2H12]-7a (3.3 g, 15.9 mmol, 1.0 eq.) in 40 mL of 
[2H]ethanol was added KO2H (4.0 g, 70.1 mmol, 4.0 eq.) in 10 mL of 2H2O. The reaction mixture was refluxed for 2 h and then quenched by 
the addition of 2 N 2HCl. The aqueous phase was extracted three times with diethyl ether. The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure. Column chromatography on silica gel with hexane/ethyl acetate (10:1) yielded [2H12]-1b 
(393 mg, 2.81 mmol, 18%) as colorless liquid, with reintroduction of the deuterium that was lost in the preceeding step. Rf = 0.53 
(hexane/EtOAc (5:1). GC (HP-5): I = 980. 1H NMR (400 MHz, CDCl3, TMS):  = no product signals detectable ppm. 13C NMR (100 MHz, 
CDCl3):  = 209.2 (Cq), 132.5 (Cq), 122.2 (t, 1JC,D = 23.6 Hz, C2H), 42.8 (quint., 1JC,D = 19.0 Hz, C2H2), 29.1 (sept., 1JC,D = 19.4 Hz, C2H3), 
24.6 (sept., 1JC,D = 19.9 Hz, C2H3), 21.6 (quint., 1JC,D = 20.2 Hz, C2H2), 16.7 (sept., 1JC,D = 19.0 Hz, C2H3) ppm. MS (EI, 70 eV): m/z (%) = 
140 (11) [M]+, 120 (76), 102 (20), 78 (60), 62 (36), 46 (100). IR (ATR): � ̃ = 2225 (w), 2193 (w), 1708 (s), 1262 (m), 1048 (m) cm-1. 
Ethyl (2E/Z,6E)-[2H15]-3,6-dimethylocta-2,6-dienoate (3b): A solution of HNiPr2 (306 mg, 3.0 mmol, 1.3 eq.) in abs. THF (20 mL) was 
cooled to 0 °C and then treated with n-butyl lithium (1.6 M in hexane, 1.9 mL, 3.0 mmol, 1.3 eq.). After 1 h the reaction mixture was cooled 
to -78 °C and triethyl [2H2]phosphonoacetate (683 mg, 3.0 mmol, 1.3 eq,) was added dropwise. Stirring was continued for 90 min after which 
1b (313 mg, 2.2 mmol, 1.0 eq.) was added dropwise. The reaction mixture was stirred over night at room temperature and was then quenched 
by addition of H2O. The aqueous layer was extracted three times with diethyl ether, the combined organic layers were dried over MgSO4 and 
concentrated under reduced pressure. Column chromatography on silica gel with hexane/ethyl acetate (20:1) yielded 3b (213 mg, 1.0 mmol, 
45%, mixture of isomers) as colourless liquid. NMR inspection revealed loss of 66% deuterium from the alpha position of the ester. Rf = 0.24 
(E-isomer) / 0.21 (E-isomer). (hexane/EtOAc (5:1). GC (HP-5): I = 1348 (Z-isomer), 1389 (E-isomer). 1H NMR (400 MHz, CDCl3, TMS):  
= 5.59 (br s, 0.33 H, CH of E-isomer), 5.57 (br s, 0.33 H, CH of Z-isomer) 4.10 – 4.04 (m, 2H, CH2 of E- and Z-isomer), 1.22 – 1.18 (m, 3H, 
CH3 of E- and Z-isomer) ppm. 13C NMR (100 MHz, CDCl3):  = 166.8 (Cq, E-isomer), 166.3 (Cq, Z-isomer), 159.9 (Cq, Z-isomer), 159.6 
(Cq, E-isomer), 132.2 (Cq, E-isomer), 131.8 (Cq, Z-isomer), 123.2 (t, 1JC,D = 22.4 Hz, C2H, Z-isomer), 122.6 (t, 1JC,D = 23.3 Hz, C2H, E-
isomer), 116.3 (CH, Z-isomer), 115.7 (CH, E-isomer), 59.4 (CH2, E-isomer), 59.3 (CH2, Z-isomer), 40.0 (quint., 1JC,D = 18.7 Hz, C2H2), 25.1 
(quint., 1JC,D = 19.3 Hz, C2H2), 24.6 (sept., 1JC,D = 19.8 Hz, C2H3), 17.9 (sept., 1JC,D = 20.0 Hz, C2H3), 16.7 (sept., 1JC,D = 19.3 Hz, C2H3), 14.3 
(CH3, E- and Z-isomer) ppm. MS (EI, 70 eV, Z-isomer): m/z (%) = 211 (2) [M]+, 210 (5) [M-1]+,192 (2), 165 (14), 134 (33), 117 (13), 106 
(22), 88 (14), 78 (100), 46 (41). MS (EI, 70 eV, E-isomer): m/z (%) = 211 (1) [M]+, 210 (3) [M-1]+,195 (1), 165 (14), 134 (26), 117 (6), 106 
(14), 88 (11), 78 (100), 46 (33) . 
General procedure for the synthesis of methyl ketones. To a solution of -ketoesters [8-2H]-7b and [12-2H]-7c (1.0 eq., 0.5 M in ethanol) 
was added KOH (2.00 eq.) dissolved in distilled water (3 M). The reaction mixture was stirred under reflux for 2 h. After cooling to room 
temperature the solution was acidified with 2 M HCl and extracted three times with ethyl acetate. The combined organic layers were dried 
over MgSO4 and concentrated under reduced pressure. Column chromatography with hexane/ethyl acetate (10:1) yielded the ketones [9-2H]-
1c and [13-2H]-1d as pale yellow oils. 
(E)-[9-2H]-6,10-dimethylundeca-5,9-dien-2-one (1c): Yield: (9.74 g, 50.0 mmol, 93%). Rf = 0.50 (hexane/EtOAc (5:1). GC (BPX-5): I = 
1435. 1H NMR (400 MHz, CDCl3, TMS):  = 5.08 (tq, 3JH,H = 7.2 Hz, 4JH,H = 1.3 Hz, 1H, CH), 2.47 – 2.44 (m, 2H, CH2), 2.29 – 2.23 (m, 2H, 
CH2), 2.13 (s, 3H, CH3), 2.07 – 2.02 (m, 2H, CH2), 1.99 – 1.95 (m, 2H, CH2), 1.67 (s, 3H, CH3), 1.61 (s, 3H, CH3), 1.59 (s, 3H, CH3) ppm. 
13C NMR (100 MHz, CDCl3):  = 208.8 (Cq), 136.3 (Cq), 131.2 (Cq), 123.8 (t, 1JC,D = 22.9 Hz, C2H), 122.5 (CH), 43.7 (CH2), 39.6 (CH2), 
29.9 (CH3), 26.5 (CH2), 25.6 (CH3), 22.4 (CH2), 17.6 (CH3), 15.9 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 195 (4) [M]+, 177 (4), 151 (24), 137 
(22), 125 (25), 107 (40), 93 (16), 70 (77), 55 (12), 43 (100). IR (ATR): � ̃ = 2966 (w), 2914 (w), 2855 (w), 1716 (s), 1445 (w), 1358 (m), 
1157 (w) cm-1. UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 227 (335) nm. 
(5E,9E)-[13-2H]-6,10,14-trimethylpentadeca-5,9,13-trien-2-one (1d): Yield: (1.72 g, 6.5 mmol, 88%). Rf = 0.85 (hexane/EtOAc (5:1). GC 
(BPX-5): I = 1932. 1H NMR (400 MHz, CDCl3, TMS):  = 5.11 – 5.06 (m, 2H, 2x CH), 2.45 (t, 3JH,H = 7.7 Hz, 2H, CH2), 2.26 (q, 3JH,H = 6.7 
Hz, 2H, CH2), 2.13 (s, 3H, CH3), 2.08 – 2.03 (m, 4H, 2x CH2), 2.00 – 1.95 (m, 4H, 2x CH2), 1.68 (s, 3H, CH3), 1.62 (s, 3H, CH3), 1.60 (s, 
3H, CH3), 1.59 (s, 3H, CH3) ppm. 13C NMR (100 MHz, CDCl3):  = 208.8 (Cq), 136.4 (Cq), 135.0 (Cq), 131.1 (Cq), 124.0 (CH), 123.9 (t, 1JC,D 
= 23.1 Hz, C2H), 122.5 (CH), 43.7 (CH2), 39.7 (CH2), 39.6 (CH2), 29.9 (CH3), 26.7 (CH2), 26.5 (CH2), 25.6 (CH3), 22.4 (CH2), 17.6 (CH3), 
16.0 (CH3), 15.9 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 263 (5) [M]+, 248 (1), 220 (2), 205 (4), 193 (5), 178 (11), 162 (6), 135 (32), 125 
(24), 107 (42), 93 (27), 81 (36), 70 (100), 55 (13), 43 (99). IR (ATR): � ̃ = 2965 (m), 2917 (m), 2855 (m), 1716 (s), 1445 (m), 1359 (m), 
1158 (m) cm-1. UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 228 (1288) nm. 
General procedure for the synthesis of esters. A solution of diisopropylamine (1.05 eq., 0.75 M in abs. THF) was cooled to 0 °C and 
treated with n-butyl lithium (1.6 M in hexane, 1.05 eq.). The mixture was stirred for 1 h at 0 °C and then cooled to -78 °C. Slowly triethyl 
phoshonoacetate (1.0 eq.) was added and stirring was continued for 2 h at -78 °C. Compounds [9-2H]-1c and [13-2H]-1d (1.0 eq.) were added 
dropwise and the reaction mixture was stirred over night at room temperature. The reaction was hydrolyzed by addition of distilled water, 
followed by extraction with ethyl acetate. The combined organic layers were dried over MgSO4 and concentrated under reduced pressure. 
The corresponding esters were obtained as a mixture of 2E and 2Z diastereomers (4:1 for [10-2H]-3c, 11:1 for [14-2H]-3d) that were 
separated by repeated column chromatography with hexane/ethyl acetate (40:1). 
Ethyl (2E,6E)-[10-2H]-3,7,11-trimethyldodeca-2,6,10-trienoate (3c): Yield: (4.2 g, 15.9 mmol, 32%). Rf = 0.45 (hexane/EtOAc (20:1). 
GC (BPX-5): I = 1348. 1H NMR (400 MHz, CDCl3, TMS):  = 5.67 – 5.66 (m, 1H, CH), 5.11 – 5.07 (m, 1H, CH), 4.14 (q, 3JH,H = 7.1 Hz, 
2H, CH2), 2.17 – 2.16 (m, 3H, CH3), 2.07 – 2.04 (m, 4H, 2x CH2), 2.00 – 1.96 (m, 4H, 2x CH2), 1.68 (s, 3H, CH3), 1.60 (s, 6H, 2x CH3), 1.27 
(t, 3JH,H = 7.1 Hz, 3H, CH3) ppm. 13C NMR (100 MHz, CDCl3):  = 166.9 (Cq), 159.7 (Cq), 136.1 (Cq), 131.3 (Cq), 123.8 (t, 1JC,D = 23.2 Hz, 
C2H), 122.9 (CH), 115.6 (CH), 59.5 (CH2), 41.0 (CH2), 39.7 (CH2), 26.6 (CH2), 25.7 (CH2), 25.6 (CH3), 18.8 (CH3), 17.6 (CH3), 16.0 (CH3), 
14.3 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 265 (3) [M]+, 250 (1), 204 (3), 192 (3), 176 (3), 147 (5), 128 (37), 100 (12), 82 (42), 70 (100), 41 
(48). IR (ATR): � ̃ = 2977 (w), 2915 (w), 2855 (w), 1715 (m), 1648 (w), 1446 (w), 1371 (w), 1219 (m), 1141 (s), 1040 (w) cm-1. UV-Vis 
(CH2Cl2): max (, L mol-1 cm-1) = 230 (8914) nm. 
Ethyl (2Z,6E)-[10-2H]-3,7,11-trimethyldodeca-2,6,10-trienoate: Yield: (860 mg, 3.2 mmol, 7%). Rf = 0.47 (hexane/EtOAc (20:1). GC 
(BPX-5): I = 1809. 1H NMR (400 MHz, CDCl3, TMS):  = 5.66 – 5.65 (m, 1H, CH), 5.17 (tq, 3JH,H = 7.2 Hz, 4JH,H = 1.3 Hz, 1H, CH), 4.14 
(q, 3JH,H = 7.2 Hz, 2H, CH2), 2.67 – 2.63 (m, 2H, CH2), 2.21 – 2.15 (m, 2H, CH2), 2.07 – 2.04 (m, 2H, CH2), 1.99 – 1.96 (m, 2H, CH2), 1.89 
(d, 4JH,H = 1.4 Hz, 3H, CH3), 1.67 (s, 3H, CH3), 1.62 (s, 3H, CH3), 1.60 (s, 3H, CH3), 1.26 (t, 3JH,H = 7.2 Hz, 3H, CH3) ppm. 13C NMR (100 
MHz, CDCl3):  = 166.3 (Cq), 160.1 (Cq), 135.7 (Cq), 131.1 (Cq), 124.0 (t, 1JC,D = 23.7 Hz, C2H), 123.5 (CH), 116.2 (CH), 59.3 (CH2), 39.6 
(CH2), 33.4 (CH2), 26.7 (CH2), 26.5 (CH2), 25.6 (CH3), 25.3 (CH3), 17.6 (CH3), 15.9 (CH3), 14.3 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 265 
(9) [M]+, 250 (1), 221 (8), 204 (1) 192 (3), 176 (5), 149 (28), 128 (23) 121 (56), 109 (18), 91 (19), 82 (45), 70 (100), 53 (26), 41 (67). IR 
(ATR): � ̃ = 2977 (w), 2915 (w), 2855 (w), 1715 (m), 1648 (w), 1446 (w), 1371 (w), 1219 (m), 1141 (s), 1040 (w) cm-1. UV-Vis (CH2Cl2): 
max (, L mol-1 cm-1) = 230 (8914) nm. 
Ethyl (2E,6E,10E)-[14-2H]-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoate (3d): Yield: (1.0 g, 3.0 mmol, 46%). Rf = 0.46 
(hexane/EtOAc (20:1). GC (BPX-5): I = 2326. 1H NMR (400 MHz, CDCl3, TMS):  = 5.67 – 5.66 (m, 1H, CH), 5.12 – 5.08 (m, 2H, 2x CH), 
4.14 (q, 3JH,H = 7.1 Hz, 2H, CH2), 2.17 (s, 3H, CH3), 2.16 (s, 3H, CH3), 2.09 – 2.06 (m, 6H, 3x CH2), 2.04 – 1.95 (m, 6H, 3x CH2), 1.68 (s, 
3H, CH3), 1.60 (s, 6H, 2x CH3), 1.27 (t, 3JH,H = 7.1 Hz, 3H, CH3) ppm. 13C NMR (100 MHz, CDCl3):  = 166.9 (Cq), 159.7 (Cq), 136.1 (Cq), 
135.0 (Cq), 131.1 (Cq), 124.1 (CH), 122.9 (CH), 115.6 (CH), 59.4 (CH2), 41.0 (CH2), 39.7 (CH2), 39.6 (CH2), 26.6 (CH2), 26.5 (CH2), 26.0 
(CH2), 25.6 (CH3), 18.8 (CH3), 17.6 (CH3), 16.0 (CH3), 15.9 (CH3), 14.3 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 333 (7) [M]+, 318 (1), 288 
(4), 263 (2), 247 (2), 219 (2), 206 (4), 189 (12), 175 (7), 161 (7), 147 (12), 136 (24), 128 (45), 121 (43), 107 (21), 93 (27), 81 (47), 70 (100), 
53 (15), 41 (39). IR (ATR): � ̃ = 2966 (w), 2924 (w), 2855 (w), 1715 (m), 1648 (m), 1446 (w), 1379 (w), 1219 (m), 1142 (s), 1040 (w) cm-1. 
UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 229 (10069) nm. 
Ethyl (2Z,6E,10E)-[14-2H]-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoate: Yield: (83 mg, 0.25 mmol, 4%). Rf = 0.48 
(hexane/EtOAc (20:1). GC (BPX-5): I = 2281. 1H NMR (400 MHz, CDCl3, TMS):  = 5.66 – 5.65 (m, 1H, CH), 5.17 (tq, 3JH,H = 7.2 Hz, 
4JH,H = 1.1 Hz, 1H, CH), 5.13 – 5.09 (m, 1H, CH), 4.14 (q, 3JH,H = 7.2 Hz, 2H, CH2), 2.65 (t, 3JH,H = 7.5 Hz, 2H, CH2), 2.20 – 2.15 (m, 2H, 
CH2), 2.08 – 2.04 (m,4H, 2x CH2), 2.00 – 1.95 (m, 4H, 2x CH2), 1.89 (d, 4JH,H = 1.4 Hz, 3H, CH3), 1.68 (s, 3H, CH3), 1.62 (s, 3H, CH3), 1.60 
(s, 6H, 2x CH3), 1.27 (t, 3JH,H = 7.2 Hz, 3H, CH3) ppm. 13C NMR (100 MHz, CDCl3):  = 166.3 (Cq), 160.1 (Cq), 135.8 (Cq), 135.0 (Cq), 
131.1 (Cq), 124.2 (CH), 123.5 (CH), 59.4 (CH2), 39.7 (CH2), 33.4 (CH2), 26.8 (CH2), 26.7 (CH2), 26.6 (CH2), 25.6 (CH3), 25.4 (CH3), 17.6 
(CH3), 16.0 (2x CH3), 14.3 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 333 (5) [M]+, 318 (1), 290 (2), 263 (2), 248 (2), 233 (1), 219 (3), 206 (4), 
189 (20), 175 (8), 161 (7), 149 (31), 135 (18), 121 (55), 107 (20), 93 (26), 81 (31), 70 (100), 53 (16), 41 (44). IR (ATR): � ̃= 2967 (w), 2920 
(w), 2855 (w), 1716 (m), 1648 (w), 1445 (w), 1375 (w), 1238 (w), 1153 (s), 855 (w) cm-1. UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 230 
(8536) nm. 
General procedure for the synthesis of alcohols. The esters [10-2H]-3c and [14-2H]-3d (1.0 eq., 0.2 M in abs. Et2O) were cooled to -78 °C 
and a solution of DIBAL-H (2.0 eq., 1.0 M in hexane) was added dropwise. The reaction mixture was stirred for 2 h at -78 °C, hydrolysed 
with distilled water and extracted three times with Et2O. The combined organic layers were dried over MgSO4 and concentrated under 
reduced pressure. Column chromatography with hexane/ethyl acetate (5:1) yielded the desired alcohols [10-2H]-4c and [14-2H]-4d as 
colorless oils. 
(2E,6E)-[10-2H]-3,7,11-trimethyldodeca-2,6,10-trien-1-ol (4c): Yield: (2.6 g, 11.4 mmol, 72%). Rf = 0.25 (hexane/EtOAc (5:1). GC (BPX-
5): I = 1846. 1H NMR (400 MHz, CDCl3, TMS):  = 5.42 (tq, 3JH,H = 6.9 Hz, 4JH,H = 1.3 Hz, 1H, CH), 5.11 (tq, 3JH,H = 7.0 Hz, 4JH,H = 1.3 Hz, 
1H, CH), 4.15 (d, 3JH,H = 6.9 Hz, 2H, CH2), 2.15 – 1.96 (m, 8H, 4x CH2), 1.68 (s, 6H, 2x CH3), 1.60 (s, 6H, 2x CH3), 1.49 (br s, 1H, OH) 
ppm. 13C NMR (100 MHz, CDCl3):  = 139.7 (Cq), 135.3 (Cq), 131.2 (Cq), 123.9 (t, 1JC,D = 23.1 Hz, C2H), 123.7 (CH), 123.4 (CH), 59.3 
(CH2), 39.6 (CH2), 39.5 (CH2), 26.7 (CH2), 26.3 (CH2), 25.6 (CH3), 17.6 (CH3), 16.2 (CH3), 16.0 (CH3) ppm. MS (EI, 70 eV, MSTFA): m/z 
(%) = 295 (3) [M]+, 280 (2), 205 (7), 190 (14), 169 (12), 156 (19), 143 (29), 135 (31), 121 (16), 107 (29), 93 (46), 73 (100), 53 (12), 41 (40). 
IR (ATR): � ̃ = 3321 (br), 2965 (m), 2914 (s), 2854 (m), 1445 (s), 1377 (m), 998 (s) cm-1. UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 228 
(591) nm. 
(2E,6E,10E)-[14-2H]-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-ol (4d): Yield: (650 mg, 2.2 mmol, 75%). Rf = 0.25 
(hexane/EtOAc (5:1). GC (BPX-5): I = 2376. 1H NMR (400 MHz, CDCl3, TMS):  = 5.42 (tq, 3JH,H = 6.9 Hz, 4JH,H = 1.3 Hz, 1H, CH), 5.13 – 
5.09 (m, 2H, 2x CH), 4.15 (d, 3JH,H = 6.9 Hz, 2H, CH2), 2.13 – 1.95 (m, 12H, 6x CH2), 1.68 (s, 6H, 2x CH3), 1.60 (s, 9H, 3x CH3) ppm. 13C 
NMR (100 MHz, CDCl3):  = 139.8 (Cq), 135.4 (Cq), 135.0 (Cq), 131.1 (Cq), 124.2 (CH), 124.1 (t, 1JC,D = 23.2 Hz, C2H), 123.8 (CH), 123.3 
(CH), 59.4 (CH2), 39.7 (CH2), 39.6 (CH2), 39.5 (CH2), 26.7 (CH2), 26.6 (CH2), 26.3 (CH2), 25.6 (CH3), 17.6 (CH3), 16.3 (CH3), 16.0 (CH3), 
15.9 (CH3) ppm. MS (EI, 70 eV, MSTFA): m/z (%) = 363 (1) [M]+, 248 (1), 293 (1), 260 (1), 230 (2), 190 (3), 169 (5), 156 (9), 143 (12), 135 
(12), 121 (11), 107 (17), 93 (22), 81 (26), 70 (100), 53 (9), 41 (30). IR (ATR): � ̃ = 3314 (br), 2965 (m), 2916 (s), 2853 (m), 1667 (w), 1444 
(s), 1379 (m), 999 (s), 841 (w) cm-1. UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 227 (800) nm. 
General procedure for the synthesis of allyl bromides. To a cooled (0 °C) solution of the alcohols [2H9]-4a, [6-2H]-4b, and [10-2H]-4c (1.0 
eq., 1.4 M in abs. THF) was added PBr3 (0.4 eq.) dropwise. The mixture was stirred for 30 – 60 min at 0 °C and then poured onto ice-water. 
The aqueous phase was extracted three times with hexane. The combined organic layers were dried over MgSO4 and concentrated under 
reduced pressure. The allyl bromides [2H9]-5a, [6-2H]-5b, and [10-2H]-5c were obtained as yellow oils that were used in the next step without 
purification.  
Synthesis of (2E,6E,10E)-[14-2H]-1-chloro-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraene (5d). A solution of the alcohol [14-2H]-4d 
(1.0 eq., 0.25 M in abs. DMF) was treated with s-collidine (1.1 eq.) and LiCl (3.0 eq.). The mixture was cooled to 0 °C and MsCl (1.1 eq.) 
was added dropwise. The reaction was stirred over night at room temperature and quenched by pouring onto ice-water. After extraction with 
pentane, drying with MgSO4 and evaporation of the solvent the chloride [14-2H]-5d was obtained as pale yellow oil which was used in the 
next step without purification.  
General procedure for the synthesis of -ketoesters. The allyl bromides [6-2H]-5b and [10-2H]-5c (1.0 eq., 0.5 M in abs. acetone) were 
treated with ethyl acetoacetate (3.0 eq.) and K2CO3 (1.5 eq.). The mixture was stirred under reflux for 5 h and filtered after cooling to room 
temperature. The solvent was removed under reduced pressure and the residue purified by column chromatography with hexane/ethyl acetate 
(20:1) to give the desired esters [8-2H]-7b and [12-2H]-7c as pale yellow oils. 
Ethyl (E)-[8-2H]-2-acetyl-5,9-dimethyldeca-4,8-dienoate (7b): Yield: (14.5 g, 54.0 mmol, 76%, 2 steps). Rf = 0.19 (hexane/EtOAc (20:1). 
GC (BPX-5): I = 1793. 1H NMR (400 MHz, CDCl3, TMS):  = 5.04 (tq, 3JH,H = 7.3 Hz, 4JH,H = 1.3 Hz, 1H, CH), 4.18 (q, 3JH,H = 7.2 Hz, 2H, 
CH2), 3.44 (t, 3JH,H = 7.6 Hz, 1H, CH), 2.57 – 2.53 (m, 2H, CH2), 2.22 (s, 3H, CH3), 2.06 – 1.97 (m, 4H, 2x CH2), 1.67 (s, 3H, CH3), 1.63 (s, 
3H, CH3), 1.59 (s, 3H, CH3), 1.27 (s, 3JH,H = 7.2 Hz, 3H, CH3) ppm. 13C NMR (100 MHz, CDCl3):  = 203.0 (Cq), 169.5 (Cq), 138.3 (Cq), 
131.3 (Cq), 123.6 (t, 1JC,D = Hz, C2H), 119.6 (CH), 61.2 (CH2), 59.8 (CH), 39.6 (CH2), 29.2 (CH3), 26.9 (CH2), 26.3 (CH2), 25.5 (CH3), 17.6 
(CH3), 16.0 (CH3), 14.0 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 267 (5) [M]+, 249 (4), 224 (10), 197 (13), 178 (10), 155 (32), 137 (30), 123 
(80), 109 (76), 93 (20), 81 (48), 70 (82), 55 (12), 43 (100). IR (ATR): � ̃ = 2980 (w), 2914 (w), 2856 (w), 1740 (s), 1715 (s), 1446 (w), 1360 
(w), 1233 (m), 1145 (s), 1024 (m) cm-1. UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 228 (859) nm. 
Ethyl (4E,8E)-[12-2H]-2-acetyl-5,9,13-trimethyltetradeca-4,8,12-trienoate (7c): Yield: (2.5 g, 7.4 mmol, 58%, 2 steps). Rf = 0.85 
(hexane/EtOAc (5:1). GC (BPX-5): I = 2244. 1H NMR (400 MHz, CDCl3, TMS):  = 5.09 – 5.02 (m, 2H, 2x CH), 4.18 (q, 3JH,H = 7.2 Hz, 
2H, CH2), 3.44 (t, 3JH,H = 7.6 Hz, 1H, CH), 2.57 – 2.53 (m, 2H, CH2), 2.22 (s, 3H, CH3), 2.06 – 2.03 (m, 4H, 2x CH2), 2.00 – 1.94 (m, 4H, 2x 
CH2), 1.71 (s, 3H, CH3), 1.63 (s, 3H, CH3), 1.60 (s, 3H, CH3), 1.59 (s, 3H, CH3), 1.26 (t, 3JH,H = 7.2 Hz, 3H, CH3) ppm. 13C NMR (100 MHz, 
CDCl3):  = 203.0 (Cq), 169.6 (Cq), 138.4 (Cq), 135.2 (Cq), 131.1 (Cq), 124.0 (t, 1JC,D = 23.2 Hz, C2H), 123.8 (CH), 119.6 (CH), 61.2 (CH2), 
59.8 (CH), 39.7 (CH2), 29.1 (CH3), 26.9 (CH2), 26.6 (CH2), 26.5 (CH2), 25.6 (CH3), 17.6 (CH3), 16.1 (CH3), 15.9 (CH3), 14.1 (CH3) ppm. 
MS (EI, 70 eV): m/z (%) = 335 (5) [M]+, 317 (1), 290 (1), 274 (1), 247 (3), 232 (2), 210 (3), 197 (8), 173 (7), 155 (15), 136 (25), 123 (36), 
109 (30), 93 (22), 81 (45), 70 (100), 55 (12), 43 (78). IR (ATR): � ̃ = 2974 (w), 2914 (w), 2856 (w), 1715 (s), 1648 (m), 1445 (w), 1375 (w), 
1238 (w), 1154 (s), 855 (w) cm-1. UV-Vis (CH2Cl2): max (, L mol-1 cm-1) = 229 (10426) nm. 
Procedure for the synthesis of the diphosphate. The halide [14-2H]-5d (1.0 eq.) was added to a solution of (NBu4)3HP2O7 (1.5 eq., 0.5 M in 
abs. CH3CN). The reaction mixture was stirred over night at room temperature and then concentrated under reduced pressure. The residue 
was loaded onto a column containing ion exchange resin (DOWEX 50W-X8, NH4+ form). Elution with two column volumes of ion exchange 
buffer (0.03 M NH4HCO3 in 2% i-PrOH/H2O) and freeze drying yielded a yellowish solid. This material was dissolved in 0.05 M NH4HCO3 
and i-PrOH/CH3CN was added. The mixture was shaken until a white solid precipitated. After centrifugation the solution was transferred to a 
fresh flask and the solid again dissolved in 0.05 M NH4HCO3. The procedure was repeated twice. The collected solutions were pooled and 
freeze-dried to give the diphosphate [14-2H]-8d as colorless solid. 
Trisammonium (2E,6E,10E)-[14-2H]geranylgeranyl diphosphate (8d): Yield: (130 mg, 0.26 mmol, 30%, 2 steps). 1H NMR (400 MHz, 
2H2O, TMSP):  = 5.40 (t, 3JH,H = 6.6 Hz, 1H, CH), 5.12 – 5.07 (m, 2H, 2x CH), 4.46 – 4.42 (m, 2H, CH2), 2.09 – 1.92 (m, 12H, 6x CH2), 
1.73 (CH3), 1.62 (CH3), 1.58 (CH3), 1.55 (CH3), 1.54 (CH3) ppm. 13C NMR (100 MHz, 2H2O):  = 145.0 (Cq), 138.0 (Cq), 137.2 (Cq), 133.2 
(Cq), 127.2 (CH), 126.9 (CH), 122.5 (d, 3JC,P = 9.0 Hz, CH), 65.5 (d, 2JP,P = 3.9 Hz, CH2), 42.6 (CH2), 42.5 (CH2), 42.4 (CH2), 29.7 (CH2), 
29.6 (CH2), 29.4 (CH2), 28.2 (CH3), 20.2 (CH3), 18.9 (CH3), 18.6 (2x CH3) ppm. 31P NMR (162 MHz, 2H2O):  = -8.4 (d, 2JP,P = 19.2 Hz), -
9.9 (d, 2JP,P = 19.2 Hz) ppm. IR (ATR): � ̃ = 3023 (br), 2859 (m), 1442 (m), 1203 (m), 1161 (s), 1081 (s), 910 (s) cm-1. 
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Abstract: An uncharacterized terpene cyclase from Strepto-
myces pratensis was identified as (+)-(1(10)E,4E,6S,7R)-
germacradien-6-ol synthase. The enzyme product exists as
two interconvertible conformers, resulting in complex NMR
spectra. For the complete assignment of NMR data, all fifteen
(13C1)FPP isotopomers (FPP= farnesyl diphosphate) and
(13C15)FPP were synthesized and enzymatically converted.
The products were analyzed using various NMR techniques,
including 13C, 13C COSYexperiments. The (13C)FPP isotopom-
ers were also used to investigate the thermal rearrangement and
EI fragmentation of the enzyme product.
Terpenoids are structurally and functionally fascinating
natural products. The first identified compounds from bac-
teria, the earthy and musty odorants geosmin and 2-methyl-
isoborneol,[1] were isolated from streptomycetes in the 1960s,
while recent research has shown that terpenes are particularly
widespread in this taxon.[2] The biosynthesis of terpenes starts
from a linear oligoprenyl diphosphate that is converted by
a terpene cyclase in a reaction cascade via cationic inter-
mediates into a (poly)cyclic hydrocarbon or alcohol, which
usually has several contiguous stereocenters. Crystal struc-
tures of terpene cyclases[3] revealed that specific residues in
the active site bind a trinuclear (Mg2+)3 cluster that binds in
turn to the substrate’s diphosphate for ionization to a highly
reactive cation. Hydrophobic residues shape a contour to
force the substrate into a conformation for directed product
formation and exclude water from the cavity to prevent
quenching of immature intermediates. The products of
several bacterial terpene cyclases have been character-
ized.[3g,4]Additionally, our structure-based mechanistic under-
standing of bacterial terpene cyclases has been substantially
refined by quantum chemical calculations,[4s, 5] site-specific
mutations,[3g,h,4c,6] and isotope-labeling studies.[4b,g,q, 7] Herein,
we present a conformational analysis, the thermal rearrange-
ment, and EI-MS fragmentation (EI-MS= electron impact
mass spectrometry) of a sesquiterpene alcohol from Strepto-
myces pratensis by use of 13C-labeling techniques.
The genome of S. pratensis ATCC 33331 encodes five
terpene cyclases, four of which show close homology to the
synthases for geosmin,[4c] 2-methylisoborneol,[4f, g] 7-epi-a-
eudesmol,[4n] and epi-cubenol,[4l] in agreement with the
production of these terpenes by the bacterium.[2a] The gene
of the fifth uncharacterized terpene cyclase (accession
number ADW03055; exhibiting the aspartate-rich motif
86DDEYCD and the NSE triad 227NDLVSYHKE) was
cloned into the expression vector pYE-Express by homolo-
gous recombination in yeast.[4o] The purified protein con-
verted farnesyl diphosphate (FPP) into (1(10)E,4E)-germa-
cradien-6-ol (1), identified by GC–MS (Figure 1A), while
geranyl and geranylgeranyl diphosphate were not accepted.
Two of the Cope rearrangement products of 1 (2a and 2b)
were also observed as a result of the thermal impact of the GC
analysis (the mass spectra of 1, 2a, and 2b are shown in
Figure S1 in the Supporting Information). The 1H and
13C NMR spectra of 1 recorded in CDCl3 at room temper-
ature showed broad and poorly resolved signals (Figure S2).
In contrast, the NMR spectra at ¢50 8C and at 0 8C showed
two sets of sharp signals for the known conformers 1a and 1b
(as shown in Figure 1B by the “up/down” nomenclature for
the methyl group pointing upwards (U) or downwards (D)).[8]
The NMR data corresponded to reported, but incomplete,
data for (¢)-1 from Santolina rosmarinifolia.[8a] The optical
rotary power of [a]D
24
=+ 21.4 for the compound pointed
Figure 1. A) Total ion chromatogram of the sesquiterpene products
from the S. pratensis (1(10)E,4E,6S,7R)-germacradien-6-ol (1) synthase.
B) Structures of conformers 1a and 1b. U indicates that the methyl
group is pointing up, D that the methyl group points downwards.
[*] P. Rabe, L. Barra, J. Rinkel, Dr. R. Riclea, Dr. C. A. Citron,
T. A. Klapschinski, A. Janusko, Prof. Dr. J. S. Dickschat
Kekul¦-Institut fír Organische Chemie und Biochemie
Rheinische Friedrich-Wilhelms-Universitt Bonn
Gerhard-Domagk-Strasse 1, 53121 Bonn (Germany)
E-mail: dickschat@uni-bonn.de
Supporting information for this article is available on the WWW
under http://dx.doi.org/10.1002/anie.201507615.
.Angewandte
Communications
13448 Ó 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2015, 54, 13448 –13451
to the opposite enantiomer as in the plant ([a]D
20
=¢14.8),
establishing the terpene from Streptomyces pratensis as
(+)-(1(10)E,4E,6S,7R)-germacradien-6-ol. The absolute con-
figuration of the plant metabolite 1 was recently confirmed by
total synthesis.[9] Unlike the other terpene synthase products,
1 is not found in S. pratensis laboratory cultures (not shown).
The complex NMR spectra prevented a full assignment of
the 1H and 13C NMR signals to 1a and 1b, as in a previous
report.[8a] To overcome this problem, all fifteen (13C1)FPP
isotopomers were synthesized (Figures S3–6)[10] and con-
verted with germacradienol synthase. Each product was
extracted with (2H8)toluene and analyzed by
13C NMR
spectroscopy, resulting in two strong signals for the labeled
carbons of conformers 1a and 1b (Figure S7). These data
unambiguously established which 13C NMR signals of
1 belonged to which carbon center, but it was not possible
to assign which of the two 13C NMR signals observed in each
single experiment belonged to which conformer. Therefore,
completely labeled (13C15)FPP was synthesized and incubated
with germacradienol synthase and the product was analyzed
by 13C, 13C COSY NMR experiments.[11] This experiment
revealed two distinct sets of cross-peaks (Figure 2; for an
enlarged version see Figure S8) that allowed for an unambig-
uous assignment of all 30 carbon signals to each of the 15
carbon atoms of 1a and 1b (Table 1). The assignment of most
1H NMR resonance signals was possible from 1H, 1H COSY,
HSQC, and HMBC correlations (Figure 3) of the unlabeled
compound. For a few cases, the HSQC spectra of the relevant
(13C1)-1 isotopomers were very useful (Figure S9).
For structure elucidation of the two Cope rearrangement
products observed during GC–MS analysis, 1 was subjected to
a microwave reaction in toluene at 225 8C. The products were
separable by column chromatography and proved to be
identical to 2a and 2b in terms of their mass spectra and GC
retention times. Their structures were determined by one- and
two-dimensional NMR spectroscopy (Table 1), resulting in
their identification as shyobunol (2a) and 5,10-di-epi-shyo-
bunol (2b).[12] The relative configurations were determined
from key NOESY correlations (Figure 4A). The assignment
of NMR data was confirmed by Cope rearrangement of
(13C15)-1, obtained by enzymatic conversion of (
13C15)FPP, and
subsequent analysis of the product by 13C, 13C COSY NMR
experiments (Figure S10). From these experiments, two
distinct sets of cross-peaks were detected for 2a and 2b that
gave direct insights into the carbon–carbon connectivities.
The absolute configurations of 2a and 2b can be deduced
from the stereocenters at C-6 and C-7 of 1 that are not
affected by the Cope rearrangement, as is known for various
Figure 2. 13C, 13C COSY spectrum of (13C15)-1 obtained by enzymatic
conversion of (13C15)FPP. The two sets of cross-peaks for the con-
formers are shown in yellow (for 1a) and red (for 1b).
Table 1: NMR data of the conformers 1a and 1b of (1(10)E,4E,6S,7R)-germacradien-6-ol in (2H8)toluene recorded at ¢50 8C, and of 2a/2b in
(2H6)benzene at 25 8C.
[a]
1+2
C[a]
1a (DD)
1H 13C
1b (UD)
1H 13C
2a
1H 13C
2b
1H 13C
1 CH 4.80 (d, J=11.6, 1H) 129.0 4.87 (t, J=7.5, 1H) 121.5 5.78 (dd, J=17.5, 10.8, 1H) 150.3 5.85 (dd, J=17.6, 10.8, 1H) 150.2
2 CH2 2.17 (m, 1H)
1.95 (m, 1H)
24.8 2.24 (m, 1H)
1.89 (m, 1H)
24.6 4.98 (dd, J=17.5, 1.2, 1H, E)
4.94 (dd, J=10.8, 1.2, 1H, Z)
110.1 4.90 (dd, J=17.6, 0.8, 1H, E)
4.86 (dd, J=10.8, 0.8, 1H, Z)
110.4
3 CH2 2.04 (m, 1H)
2.00 (m, 1H)
39.2 2.09 (m, 1H)
1.94 (m, 1H)
37.5 5.02 (br s, 1H, Z)
4.91 (br s, 1H, E)
113.3 4.90 (br s, 1H)
4.70 (br s, 1H)
113.9
4 Cq – 131.8 – 132.0 – 146.8 – 145.5
5 CH 5.06 (d, J=7.0, 1H) 135.1 5.04 (d, J=8.5, 1H) 133.0 1.69 (d, J=1.7, 1H) 56.6 2.32 (d, J=6.8, 1H) 57.4
6 CH 4.54 (d, J=6.0, 1H) 68.5 4.55 (d, J=6.0, 1H) 68.4 3.81 (br s, 1H) 70.2 3.94 (m, 1H) 71.9
7 CH 0.75 (d, J=9.0, 1H) 49.7 0.66 (d, J=9.5, 1H) 52.5 0.74 (m, 1H) 49.8 1.54 (m, 1H) 44.6
8 CH2 1.95 (m, 2H)
1.39 (d, J=13.8, 1H)
30.7 1.80 (m, 1H)
1.30 (m, 1H)
25.6 1.63 (m, 1H)
1.49 (m, 1H)
21.1 1.56 (m, 2H) 22.3
9 CH2 2.44 (d, J=13.1, 1H)
1.62 (t, J=13.5, 1H)
36.1 2.14 (m, 1H)
1.79 (m, 1H)
41.8 1.48 (m, 1H)
1.29 (m, 1H)
41.1 1.53 (m, 1H)
1.25 (m, 1H)
33.7
10 Cq – 135.3 – 138.5 – 40.2 – 30.3
11 CH 1.78 (m, 1H) 32.0 1.73 (m, 1H) 32.6 1.68 (m, 1H) 29.4 1.88 (oct, J=6.8, 1H) 27.4
12 CH3 1.00 (d, J=6.0, 3H) 21.4 1.09 (d, J=6.3, 3H) 21.2 0.92 (d, J=6.8, 3H) 20.8 0.94 (d, J=6.8, 3H) 21.9
13 CH3 1.05 (d, J=6.5, 3H) 21.6 1.00 (d, J=6.0, 3H) 21.3 0.94 (d, J=6.9, 3H) 21.3 1.20 (d, J=6.6, 3H) 23.1
14 CH3 1.55 (s, 3H) 22.0 1.48 (s, 3H) 16.9 1.46 (s, 3H) 20.3 0.93 (s, 3H) 23.1
15 CH3 1.32 (s, 3H) 16.3 1.30 (s, 3H) 16.2 1.72 (s, 3H) 27.8 1.68 (s, 3H) 26.8
[a] Carbon numbering as shown in Figure 1. Chemical shifts d in ppm, multiplicity m (s=singlet, d=doublet, t= triplet, oct=octet, m=multiplet,
br=broad), coupling constants J are given in Hertz. Carbon assignments for 1 were deduced from incubation experiments with 13C-labeled FPP
isotopomers (see the main text).
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germacranes.[13] The bacterial shyobunol stereoisomers iso-
lated here are the enantiomers of plant compounds from
Acorus calamus,[12] in agreement with the fact that also
bacterial 1 is the optical antipode of a plant terpene. Whereas
2b arises from the reported conformer 1a,[8a] the formation of
2a is possible from the up/up conformer 1c (Figure 4B, UU).
Both rearrangement products are formed via chair-like
transition states, similar to the Cope rearrangements of
several other germacranes.[8b,14]
The relative configurations of 2a and 2b gave additional
support for the syn orientation of the hydroxy and isopropyl
groups in 1. In fact, the 13C NMR chemical shifts of 1 and its
anti stereoisomer kunzeaol are very similar (Table S11), and
the syn or anti orientation of the substituents in the con-
formationally flexible compounds 1 and kunzeaol[15] are
difficult to determine. However, the NOESY spectra of the
more rigid compounds 2a and 2b unambiguously proved the
syn arrangement of the hydroxy and the isopropyl groups,
thereby giving indirect evidence for the correct assignment of
the relative configuration of 1.
Since isotopically labeled compounds are very useful in
studying MS fragmentation mechanisms,[16] the products
obtained from all fifteen isotopomers of (13C)FPP with
germacradienol synthase were also subjected to GC/EI-MS
and GC/EI-MS-QTOF analysis. The observed fragment ion
patterns for the isotopomers of (13C)-1 (Figure S11) gave
direct insight into the fragmentation mechanism. Electron
impact ionization of 1 proceeds preferably with the loss of one
electron from an oxygen lone pair to yield the molecular ion
[M]+ (Figure 5A) that is observed at m/z= 222 for unlabeled
1 and at m/z= 223 for all (13C1)-1 isotopomers (Table S12).
Rearrangement of one hydrogen atom (rH) and inductive
cleavage (i) with the neutral loss of water yields the fragment
ion [M¢H2O]
+ that is detected at m/z= 204 for natural 1 and
at m/z= 205 for all (13C1)-1 isotopomers. A subsequent
a cleavage (a) with loss of the isopropyl group is the only
relevant mechanism that yields fragment ion [A]+. This is
evident from the observation of [A]+ atm/z= 161 in the mass
spectrum for unlabeled 1 as well as for all isotopomers that
contain 13C labeling within the isopropyl group, that is, for the
products obtained from (11-13C)FPP, (12-13C)FPP, and (13-
13C)FPP. All other (13C1)FPP isotopomers had a shifted
signal for [A]+ at m/z= 162 (Figure S11). This mechanism
was further supported by HRMS data for [A]+, which
established its molecular formula as C12H17
+ for all signals
at m/z= 161 or as 13C1
12C11H17
+ for all at m/z= 162
(Table S12), and byMS2 analysis showing the direct formation
of [A]+ from [M¢H2O]
+.
For the formation of the base peak [B]+ at m/z= 84, the
mechanism was shown to proceed by two a-cleavage reac-
tions with the loss of the neutral molecule 3-methylbut-1-ene
to a form a fragment ion at m/z= 152 and a third subsequent
a cleavage with the neutral loss of isoprene (Figure 5B). The
last step was confirmed by a shift of the signal for [B]+ to
m/z= 85 for all (13C1)-1 isotopomers in which the isotopic
labeling appears in the [B]+ forming portion, that is for
1 derived from (1-13C)FPP, (2-13C)FPP, (3-13C)FPP, (4-
13C)FPP, and (15-13C)FPP (Figure S11, Table S12). Further-
more, HRMS data established the molecular formulae for
molecular fragments with m/z= 84 (C5H8O
+) and m/z= 85
(13C1
12C4H8O
+). The formation of [B]+ as a daughter ion from
the fragment ion at m/z= 152 was investigated by MS2
analysis, but because of the low abundance of this ion this
experiment was inconclusive. The formation of [B]+ is thus
better described as a concerted process of three simultaneous
a fragmentations.
Figure 3. Key HMBC correlations that enabled the assignment of
1H NMR signals of unlabeled 1.
Figure 4. Cope rearrangement of 1. A) Key NOESY correlations for
determination of the relative configurations of 2a and 2b. B) Confor-
mations of 1 explaining the formation of 2a and 2b.
Figure 5. EI-MS fragmentation of 1. Mechanisms for the formation of
fragment ion [A]+ (m/z=161) and the base peak ion [B]+ (m/z=84).
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In summary we have characterized a bacterial terpene
cyclase from S. pratensis as (+)-(1(10)E,4E,6S,7R)-germacra-
dien-6-ol synthase. Only one closely related homologue with
99.4% identical sites is found in Streptomyces sp.
PAMC26508. As is typical for germacranes, 1 exists in
different well-defined conformers that are observable by
NMR at low temperatures. Extensive labeling experiments
using synthetic 13C-labeled FPP isotopomers enabled a full
assignment of 1H and 13C NMR data of 1, which had until this
point not been possible for 1 and related germacranes as
a result of their complex NMR spectra.[8] A thermal
rearrangement of 1 via chair-like transition states yielded
two products whose absolute configurations were deduced
from the absolute configuration of 1, while the relative
configurations of the rearrangement products reconfirmed
that 1 is different from its epimer kunzeaol. Using 13C-labeled
FPP isotopomers, we have also laid the groundwork for
analyses of EI-MS fragmentation patterns of sesquiterpenes,
and we present a first showcase study here. Future experi-
ments in our laboratories will include the usage of the FPP
isotopomers to address various other intricate problems of
sesquiterpene chemistry.
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Strains and culture conditions, cloning and homologous recombination 
The bacterium Streptomyces pratensis ATCC 33331 was obtained from the Deutsche 
Sammlung von Mikroorganismen und Zellkulturen (DSMZ, Braunschweig, Germany). The 
strain was cultured on medium Gym 65 (Glucose 4.0 g, Yeast extract 4.0 g, Malt extract 4.0 
g, 1L water, pH 7.2) for 5 d at 28°C. The terpene cyclase gene of Streptomyces pratensis 
ATCC 33331 (accession number ADW03055) was amplified from genomic DNA using the 
primers PR024f_ADW03055 (sequence is given below) and PR024r_ADW03055. The 
obtained PCR product was used as a template in a second PCR with elongated primers 
containing homology arms (PR023f_ADW03055 and PR023r_ADW03055, homology arms 
are underlined) for homologous recombination with the linearized (HindIII and EcoRI 
digestion) vector pYE-Express[1] in S. cerevisiae FY834. Transformation of S. cerevisiae with 
the PCR product and the linearized vector pYE-Express for homologous recombination was 
carried out using the LiOAc/SS carrier DNA protocol.[2] The transformed cells were plated on 
SM-URA agar plates and grown for three days at 28 °C. Plasmid DNA was isolated from the 
grown yeast using the kit Zymoprep Yeast Plasmid Miniprep II (Zymo Research, Irvine, 
USA), shuttled into E. coli BL 21 cells by electroporation and confirmed by sequencing. 
PR024f_ADW03055: ATGACCTCCCAAGCTTCAGC 
PR024r_ADW03055: CTAGTCCTTCAGCAGCGTCC 
PR023f_ADW03055: GGCAGCCATATGGCTAGCATGACTGGTGGAATGACCTCCCAAGCTTCAGC 
PR023r_ADW03055: TCTCAGTGGTGGTGGTGGTGGTGCTCGAGTCTAGTCCTTCAGCAGCGTCC 
 
Incubation experiments of purified enzyme with FPP and isolation of products 
E. coli BL 21 transformants were inoculated in a 2YT liquid preculture (tryptone 16 g, yeast 
extract 10 g, NaCl 5 g, water 1 L, pH 7.2) containing kanamycin (50 mg/L) overnight. E. coli 
BL 21 transformants from the preculture were inoculated in large scale 2YT liquid cultures (8 
x 1 L) containing kanamycin (50 mg/L). Cells were grown to an OD600 = 0.5 at 37 °C and 160 
rpm, followed by cooling of the cultures to 18 °C for 30 minutes. IPTG (0.4 mM) was added 
and the culture was incubated at 18 °C and 160 rpm overnight. E. coli cells were harvested 
by centrifugation at 4 °C and 3600 rpm for 60 min. The pellets were resuspended in 2 x 10 
mL lysis buffer (20 mM Na2HPO4, 0.5 M NaCl, 20 mM imidazole, 1 mM MgCl2, pH 7.0) for 
each 1 L culture. Cell disruption was done by ultra-sonication on ice for 6 x 60 sec. The 
soluble enzyme fractions were harvested at 4 °C and 11000 rpm by repeated centrifugation 
(2 x 10 min). Protein purification was performed by Ni2+-NTA affinity chromatography with 
Ni2+-NTA superflow (Novagen) using binding buffer (20 mM Na2HPO4, 0.5 M NaCl, 20 mM 
imidazole, 1 mM MgCl2, pH 7.0) and elution buffer (20 mM Na2HPO4, 0.5 M NaCl, 500 mM 
imidazole, 1 mM MgCl2, pH 7.0). All wash and elution fraction were checked by SDS-PAGE. 
Incubation experiments were performed with the pure protein fractions (160 mL) and 
incubation buffer (100 mL, 50 mM Tris∙HCl, 10 mM MgCl2, 20 % glycerin, pH 7.0) containing 
FPP (100 mg, 0.5 mg/mL) at 28 °C overnight. The reaction mixture was extracted with 3 x 
100 mL pentane. The combined organic layers were dried with MgSO4 and concentrated 
under reduced pressure. Column chromatography on silica gel of the crude product (30 mg) 
with pentane/diethyl ether (5:1) yielded the pure sesquiterpene (15 mg) for structure 
elucidation by NMR. 
 
GC-MS and GC-MS-QTOF analysis 
GC-MS analyses were carried out with a 7890B gas chromatograph connected to a 5977A 
inert mass detector (Agilent) fitted with a HP5-MS fused silica capillary column (30 m, 0.25 
mm i. d., 0.50 m film). Instrumental parameters were (1) inlet pressure, 77.1 kPa, He 23.3 
mL min-1, (2) injection volume, 1-2 L, (3) transfer line, 250 °C, and (4) electron energy 70 
eV. The GC was programmed as follows: 5 min at 50 °C increasing at 10 °C min-1 to 320 °C, 
and operated in split mode (50:1, 60 s valve time). The carrier gas was He at 1 mL min-1. 
Retention indices (I) were determined from a homologous series of n-alkanes (C8-C40). 
HRMS analyses were carried out with a 7890B gas chromatograph connected to a 7200 
accurate-mass Q-TOF mass detector (Agilent) eqipped with a HP5-MS fused silica capillary 
column (30 m, 0.25 mm i. d., 0.50 m film). Instrumental parameters were (1) inlet pressure, 
83.2 kPa, He 24.6 mL min-1, (2) injection volume, 1 L, (3) transfer line, 250 °C, and (4) 
electron energy 70 eV. The GC was programmed for HR-MS as follows: 5 min at 50 °C 
increasing at 10 °C min-1 to 320 °C, and operated in split mode (50:1-100:1, 60 s valve time). 
The carrier gas was He at 1 mL min-1.For targeted MS/MS the instrumental parameters were 
for (1) collison cell: collison gas flow 1 mL min-1 N2, collison energy: 10 V or 20 V and (2) 
MS1 scan resolution mode: narrow. 
 
NMR spectroscopy 
NMR spectra of synthetic compounds and isolated natural products were recorded on a 
Bruker DRX-400 (400 MHz), AV III-400 (400 MHz) or AV Avance DMX-500 (500 MHz) 
spectrometer, and were referenced against solvent signals (1H NMR: (2H)chloroform  = 7.26 
ppm, (2H6)benzene  = 7.16 ppm, (2H8)toluene  = 2.08 ppm; 13C NMR: (2H)chloroform  = 
77.16 ppm, (2H6)benzene  = 128.06 ppm, (2H8)toluene  = 20.43 ppm). All temperature-
dependent NMR analyses with the natural product were performed at -50 °C, 0 °C and 25 °C. 
 
(+)-(1(10)E,4E,6S,7R)-germacradien-6-ol (1):  
TLC (cyclohexane/ethyl acetate 5:1): Rf = 0.35. GC (HP 5): I = 1694 (literature (HP 5): I = 
1697).[3] [D20= + 21.4 (CH2Cl2); MS (EI, 70 eV): m/z (%) = 222 (6), 207 (6), 204 (9), 189 (6), 
179 (4), 161 (35), 151 (5), 147 (6), 140 (8), 138 (9), 137 (16), 136 (11), 133 (11), 123 (17), 
121 (31), 119 (23), 111 (11), 109 (38), 108 (11), 107 (26), 105 (34), 97 (15), 95 (27), 93 (34), 
91 (33), 84 (100), 83 (54), 81 (66), 79 (33), 77 (25), 69 (33), 68 (24), 67 (45), 55 (66), 53 
(29), 43 (34), 41 (78), 39 (30). HRMS (TOF): obs. m/z (calcd., formula) = 222.1974 
(222.1978, C15H26O+, [M]+), 207.1740 (207.1743, C14H23O+, [M-CH3]+), 204.1875 (204.1873, 
C15H24+, [M-H2O]+). IR (diamond ATR): 𝜈 = 3388 (br m), 2918 (s), 2867 (m), 2853 (m), 1663 
(w), 1473 (m), 1446 (m), 1383 (m), 1366 (m), 1304 (w), 1248 (w), 1061 (m), 1014 (m), 982 
(w), 847 (m), 675 (w), 551 (w), 507 (w), 493 (w) cm-1. 
1H and 13C NMR data of both conformers are summarized in Table 1 of main text. 
 
 
 
 Figure 1. A) Cyclisation mechanism of FPP cyclisation to 1. EI-MS spectra of B) the enzyme 
product (1(10)E,4E,6S,7R)-germacradien-6-ol (1) and of its Cope rearrangement products C) 
shyobunol (2a) and D) 5,10-di-epi-shyobunol (2b). 
 Figure 2. A) Recorded 1H-NMR spectra of (1(10)E,4E,6S,7R)-germacradien-6-ol (1) at 
298 K, 273 K and 223 K and B) 13C-NMR spectra of (1(10)E,4E,6S,7R)-germacradien-6-ol 
(1) at 298 K and 223 K. 
General synthetic methods 
Chemicals were purchased from Acros Organics (Geel, Belgium) or Sigma Aldrich Chemie 
GmbH (Steinheim, Germany) and used without purification. All non-aqueous reactions were 
performed under an inert atmosphere (N2 and Ar) in flame-dried flasks. Solvents were 
purified by distillation and dried according to standard methods. Thin-layer chromatography 
was performed with 0.2 mm precoated plastic sheets Polygram Sil G/UV254 (Machery-
Nagel). Column chromatography was carried out using Merck silica gel 60 (70-200 mesh). 
 
Synthesis of all fifteen isotopomers of (13C1)FPP and of (13C15)FPP 
The synthesis of most 13C-labeled isotopomers of FPP (with 13C labeling at C-1, C-2, C-3, 
C-4, C-5, C-6, C-7, C-8, C-9, and C-10, and for completely labeled (13C15)FPP) was 
performed via a previously reported strategy (for FPPs with labeling at other carbons vide 
infra).[4] Briefly, acetone (3a) was used in a Horner-Wadsworth-Emmons reaction with 
triethylphosphonoacetate to yield ethyl 3-methylbut-2-enoate (4a, Figure 3 of SI). A DIBAL-H 
reduction yielded prenol (5a) that was converted into the corresponding bromide (6a) with 
PBr3 (or into the chloride with MsCl, LiCl and collidine). The bromide or chloride was used for 
the alkylation of ethyl acetoacetate under basic conditions (K2CO3) to give the -keto ester 
7a, that reacted upon saponification under spontaneous decarboxylation to sulcatone (3b), 
the analog of acetone elongated by one terpenoid isoprene unit. After a second round of this 
cycle, geranyl acetone (3c) was obtained that was further converted into farnesyl bromide or 
chloride (6c) and then with (Bu4N)3P2O7H into FPP (8). For introduction of labeling the 
commercially available appropriate building blocks (13C3)acetone, triethyl (1-13C)phosphono-
acetate, triethyl (2-13C)phosphonoacetate, triethyl (13C2)phosphonoacetate, ethyl (1,2-13C2)-
acetoacetate, ethyl (3-13C)acetoacetate, ethyl (4-13C)acetoacetate, and ethyl 
(13C4)acetoacetate were used (note that the seemingly more appropriate building blocks ethyl 
(2-13C)acetoacetate and ethyl (2,3,4-13C3)acetoacetate are more expensive than ethyl 
(1,2-13C2)acetoacetate or not commercially available, respectively). All compounds along the 
route are known and the NMR data matched previously reported data,[5-12] only the data for 
the portions influenced by the introduced 13C-labeling deviated due to additional C,C- and 
C,H-couplings for which all coupling constants that could be determined are summarized in 
Tables 1 – 8 of SI. 
 
 
Figure 3. Synthesis of 13C-labeled isotopomers of FPP. 
 Table 1. Specific aspects of 13C-NMR data of the 13C-labeled isotopomers of 4a – 4c. All other 13C-NMR data matched those reported for the 
unlabeled compounds.[5,11,12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] C-1 C-2 C-3 C-4 C-5 C-6 C-7 C-8 C-9 C-10 C-11 C-12 C-13 C-14 C-15 C-1’ C-2’ 
                  
(1-13C)-4a 166.8* 116.2 
d 
1J=75.9 
156.4 
d 
2J=2.2 
27.5 
d 
3J=7.6 
20.3 
d 
3J=1.4 
          59.5 
d 
2J=2.3 
14.4 
d 
3J=2.2 
(2-13C)-4a 166.8 
d 
1J=75.8 
116.2* 156.4 
d 
1J=72.2 
27.5 
d 
2J=4.0 
             
(13C5)-4a 166.8* 
dddd 
1J=75.5 
2J=1.9 
3J=7.6 
3J=1.9 
116.2* 
dddd 
1J=73.9 
1J=73.9 
2J=4.0 
2J=4.0 
156.4* 
dddd 
1J=72.3 
1J=40.3 
1J=40.3 
2J=2.2 
27.5* 
dddd 
1J=40.7 
2J=3.7 
2J=3.7 
3J=3.7 
20.3* 
ddd 
1J=40.1 
J=3.3 
J=1.0 
          59.5 
dd 
2J=1.6 
3J=1.6 
14.4 
d 
3J=2.3 
(1-13C)-4b 167.0* 115.8 
d 
1J=75.7 
159.9 
d 
2J=2.1 
41.1 
d 
3J=7.2 
           59.6 
d 
2J=2.4 
14.4 
d 
3J=2.2 
(2-13C)-4b 167.0 
d 
1J=75.6 
115.8* 159.9 
d 
1J=72.3 
41.1 
d 
2J=3.5 
26.2 
d 
3J=3.0 
          59.6 
d 
3J=1.5 
 
(3-13C)-4b 167.0 
d 
2J=1.9 
115.8 
d 
1J=71.8 
159.9* 41.1 
d 
1J=39.9 
26.2 
d 
2J=2.2 
123.2 
d 
3J=3.6 
   18.9 
d 
1J=40.1 
       
(4-13C)-4b 167.0 
d 
3J=7.1 
 
115.8 
d 
2J=3.3 
159.9 
d 
1J=40.0 
41.1* 26.2 
d 
1J=33.4 
123.2 
d 
2J=1.5 
132.6 
d 
3J=3.7 
  18.9 
d 
1J=2.7 
       
(5-13C)-4b  115.8 
d 
3J=2.9 
159.9 
d 
2J=2.1 
41.1 
d 
1J=33.4 
26.2* 123.2 
d 
1J=44.2 
 25.8 
d 
3J=4.7 
17.8 
d 
3J=3.7 
18.9 
d 
3J=1.5 
       
(6-13C)-4b   159.9 
d 
3J=3.4 
41.1 
d 
2J=1.6 
26.3 
d 
1J=44.1 
123.2* 132.6 
d 
1J=73.9 
25.8 
d 
2J=3.2 
17.8 
d 
2J=1.9 
        
(10-13C)-4b 167.0 
d 
3J=1.4 
 159.9 
d 
1J=40.0 
41.1 
d 
2J=2.7 
26.2 
d 
3J=1.5 
    18.9*        
(13C10)-4b 167.0* 
dddd 
1J=75.8 
3J=7.1 
2J=1.7 
2J=1.7 
115.8* 
dd 
1J=73.8 
1J=73.8 
 
159.9* 
ddd 
1J=72.5 
1J=38.2 
1J=38.2 
41.1* 
dd 
1J=36.4 
1J=36.5 
26.3* 
dd 
1J=34.7 
1J=43.6 
123.2* 
dd 
1J=74.0 
1J=44.0 
132.6* 
dddd 
1J=42.3 
1J=42.3 
1J=74.6 
J=3.5 
25.8* 
d 
1J=42.6 
 
17.8* 
d 
1J=42.3 
18.9* 
d 
1J=40.3 
     59.6 
dd 
2J=1.6 
3J=1.6 
14.5 
d 
3J=2.1 
(1-13C)-4c 167.0* 115.8 
d 
1J=75.8 
159.9 
d 
2J=2.0 
41.1 
d 
3J=7.0 
          18.9 
d 
3J=1.4 
59.6 
d 
2J=2.3 
14.5 
d 
3J=2.3 
(2-13C)-4c 167.0 
d 
1J=75.7 
115.8* 159.9 
d 
1J=72.0 
41.1 
d 
2J=3.4 
26.1 
d 
3J=2.9 
          59.6 
d 
3J=1.4 
 
(3-13C)-4c 167.0 
d 
2J=1.9 
115.8 
d 
1J=71.7 
159.9* 41.1 
d 
1J=40.1 
26.1 
d 
2J=2.2 
            
(4-13C)-4c 167.0 
d 
3J=7.0 
115.8 
d 
2J=3.3 
159.9 
d 
1J=40.1 
41.1* 26.1 
d 
1J=33.2 
123.0 
d 
2J=1.6 
136.3 
d 
3J=3.8 
          
(5-13C)-4c  115.8 
d 
3J=2.9 
159.9 
d 
2J=2.1 
41.1 
d 
1J=33.6 
26.1* 123.0 
d 
1J=44.0 
 39.8 
d 
3J=4.5 
     16.1 
d 
3J=3.9 
   
(6-13C)-4c   159.9 
d 
3J=3.2 
41.1 
d 
2J=1.6 
26.1 
d 
1J=67.9 
123.0* 136.3 
d 
1J=73.6 
39.8 
d 
2J=2.6 
26.8 
d 
3J=3.0 
        
(7-13C)-4c    41.1 
d 
3J=3.6 
 
 
123.0 
d 
1J=73.5 
136.3* 39.8 
d 
1J=42.5 
26.8 
d 
2J=2.3 
124.4 
d 
3J=3.8 
   16.1 
d 
1J=42.2 
   
(8-13C)-4c     26.1 
d 
3J=4.4 
123.0 
d 
2J=2.6 
136.3 
d 
1J=42.7 
39.8* 
 
26.8 
d 
1J=33.7 
124.4 
d 
2J=1.6 
131.5 
d 
3J=3.7 
  16.1 
d 
2J=3.9 
   
(9-13C)-4c      123.0 
d 
3J=3.0 
136.3 
d 
2J=2.1 
39.8 
d 
1J=33.4 
26.8* 
 
124.4 
d 
1J=44.2 
 
 
25.8 
d 
3J=4.5 
17.8 
d 
3J=3.5 
16.1 
d 
3J=1.2 
   
(10-13C)-4c       136.3 
d 
3J=3.3 
39.8 
d 
2J=1.6 
26.8 
d 
1J=44.0 
124.4* 131.5 
d 
1J=73.7 
25.8 
d 
2J=3.2 
17.8 
d 
2J=2.2 
    
(14-13C)-4c     26.1 
d 
3J=3.9 
123.0 
d 
2J=1.8 
136.3 
d 
1J=42.3 
39.8 
d 
2J=3.6 
26.8 
d 
3J=1.4 
    16.1*    
(15-13C)-4c 167.0 
d 
3J=1.4 
 159.9 
d 
1J=40.1 
41.1 
d 
2J=2.6 
26.1 
d 
3J=1.4 
         18.9*   
(13C15)-4c 167.0* 
dddd 
1J=75.6 
3J=7.1 
2J=1.7 
2J=1.7 
115.8* 
dd 
1J=72.2 
1J=75.5 
159.9* 
ddd 
1J=72.0 
1J=39.5 
1J=39.5 
41.1* 
dd 
1J=36.4 
1J=36.4 
26.1* 
dd 
1J=35.6 
1J=43.3 
123.0* 
dd 
1J=73.9 
1J=44.0 
136.3* 
ddd 
1J=73.8 
1J=40.8 
1J=40.8 
39.8* 
dd 
1J=34.8 
1J=40.8 
26.8* 
dd 
1J=34.8 
1J=43.0 
124.3* 
dd 
1J=44.4 
1J=72.6 
131.5* 
dddd 
1J=73.8 
1J=42.3 
1J=42.3 
J=3.5 
25.8* 
d 
1J=42.7 
17.8* 
d 
1J=42.1 
16.1* 
d 
1J=42.2 
18.9* 
d 
1J=40.0 
59.6 
dd 
2J=1.7 
3J=1.7 
14.5 
d 
3J=2.2 
[a] Coupling constants nJ are C,C-couplings via n bonds and given in Hertz (d = doublet, n.d. = not determinable due to signal overlappings). 
Asterisks indicate 13C-labeled carbons. 
 Table 2. Specific aspects of 1H-NMR data of the 13C-labeled isotopomers of 4a – 4c. All other 1H-NMR data matched those reported for the 
unlabeled compounds.[5,11,12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] H-2 H-4 H-5 H-6 H-8 H-9 H-10 H-12 H-13 H-14 H-15 H-1’ H-2’ 
              
(1-13C)-4a   1.88 
d 
4J=0.9 
        4.14 
d 
3J=3.1 
 
(2-13C)-4a 5.66 
d 
1J=159.7 
2.16 
d 
3J=4.5 
1.88 
d 
3J=5.9 
          
(13C5)-4a 5.67 
d 
1J=153.0 
2.14 
d 
1J=128.0 
1.86 
d 
1J=126.8 
          
(1-13C)-4b            4.14 
d 
3J=3.1 
 
(2-13C)-4b 5.65 
d 
1J=159.3 
            
(3-13C)-4b       2.14 
d 
2J=1.0 
      
(4-13C)-4b  2.15 
d 
1J=128.5 
           
(5-13C)-4b   2.15 
d 
1J=128.5 
          
(6-13C)-4b    5.07 
d 
1J=150.9 
1.60 
d 
3J=4.3 
1.68 
d 
3J=5.5 
       
(10-13C)-4b 5.66 
d 
3J=8.0 
     2.15 
d 
1J=127.7 
      
(13C10)-4b 5.66 
d 
1J=159.3 
2.15 
d 
1J=128.5 
2.15 
d 
1J=128.5 
5.07 
d 
1J=150.7 
1.60 
d 
1J=125.2 
1.68 
d 
1J=125.5 
2.15 
d 
1J=128.5 
    4.14 
d 
3J=3.0 
 
(1-13C)-4c            4.14 
d 
3J=3.0 
 
(2-13C)-4c 5.66 
d 
1J=159.3 
         2.16 
d 
3J=4.7 
  
(3-13C)-4c              
(4-13C)-4c  2.16 
d 
1J=128.8 
           
(5-13C)-4c   n.d.           
(6-13C)-4c    5.09 
d 
1J=150.8 
         
(7-13C)-4c              
(8-13C)-4c     1.98 
d 
1J=120.4 
        
(9-13C)-4c      n.d.        
(10-13C)-4c       5.09 
d 
1J=150.0 
1.67 
d 
3J=5.9 
     
(14-13C)-4c          1.60 
d 
1J=125.6 
   
(15-13C)-4c 5.65 
d 
3J=8.2 
         2.17 
d 
1J=127.6 
  
(13C15)-4c 5.66 
d 
1J=159.4 
2.16 
d 
1J=127.2 
2.16 
d 
1J=127.2 
5.09 
d 
1J=149.8 
1.98 
d 
1J=123.6 
2.05 
d 
1J=128.4 
5.09 
d 
1J=150.6 
1.68 
d 
1J=124.8 
1.60 
d 
1J=125.5 
1.60 
d 
1J=125.5 
2.17 
d 
1J=127.7 
4.14 
d 
3J=3.0 
 
[a] Compound numbers refer to Figure 1. Coupling constants nJ are C,H-couplings via n bonds and given in Hertz (d = doublet, n.d. = not 
determinable due to signal overlappings). 
 Table 3. Specific aspects of 13C-NMR data of the 13C-labeled isotopomers of 5a – 5c. All other 13C-NMR data matched those reported for the 
unlabeled compounds.[7,10,12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] C-1 C-2 C-3 C-4 C-5 C-6 C-7 C-8 C-9 C-10 C-11 C-12 C-13 C-14 C-15 
                
(1-13C)-5a 59.5* 123.7 
d 
1J=47.6 
136.6 
d 
2J=1.6 
25.9 
d 
3J=5.1 
17.9 
d 
3J=4.1 
          
(2-13C)-5a 59.5 
d 
1J=47.8 
123.7* 136.5 
d 
1J=72.6 
25.9 
d 
2J=2.9 
17.9 
d 
2J=1.6 
          
(13C5)-5a 59.5* 
dddd 
1J=47.6 
2J=1.6 
3J=4.1 
3J=5.1 
123.7* 
dddd 
1J=47.6 
1J=72.7 
2J=2.9 
2J=1.6 
136.5* 
dddd 
1J=73.0 
1J=41.4 
1J=42.5 
2J=1.6 
25.9* 
d 
1J=42.4 
 
17.9* 
dddd 
1J=41.4 
3J=4.1 
2J=5.9 
2J=1.6 
          
(1-13C)-5b 59.5* 123.4 
d 
1J=47.5 
139.9 
d 
2J=1.2 
39.7 
d 
3J=4.8 
     16.4 
d 
3J=4.2 
     
(2-13C)-5b 59.5 
d 
1J=47.5 
123.4* 139.9 
d 
1J=72.4 
39.7 
d 
2J=2.5 
26.5 
d 
3J=3.0 
          
(3-13C)-5b 59.5 
d 
2J=1.6 
123.4 
d 
1J=72.7 
139.9* 39.7 
d 
1J=41.9 
26.5 
d 
2J=2.2 
124.0 
d 
3J=3.8 
   16.4 
d 
1J=41.3 
     
(4-13C)-5b 59.5 
d 
3J=4.8 
123.4 
d 
2J=2.4 
139.9 
d 
1J=41.7 
39.7* 
 
26.5 
d 
1J=33.6 
124.0 
d 
2J=1.6 
131.8 
d 
3J=3.6 
 
 
 16.4 
d 
2J=3.5 
     
(5-13C)-5b  
 
123.4 
d 
3J=3.0 
139.9 
d 
2J=2.2 
39.7 
d 
1J=33.6 
26.5* 124.0 
d 
1J=44.0 
 25.8 
d 
3J=4.5 
17.8 
d 
3J=3.8 
16.4 
d 
3J=1.4 
     
(6-13C)-5b   139.9 
d 
3J=3.5 
39.7 
d 
2J=1.6 
26.5 
d 
1J=44.0 
124.0* 131.9 
d 
1J=73.6 
25.8 
d 
2J=3.2 
17.8 
d 
2J=1.7 
      
(7-13C)-5b    39.7 
d 
3J=3.7 
 124.0 
d 
1J=73.7 
131.9* 25.8 
d 
1J=43.1 
17.8 
d 
1J=42.1 
      
(10-13C)-5b 59.5 
d 
3J=4.3 
123.4 
d 
2J=1.6 
139.9 
d 
1J=41.7 
39.7 
d 
2J=3.5 
26.5 
d 
3J=1.5 
    16.4*      
(13C10)-5b 59.5* 
dddd 
1J=47.5 
3J=4.6 
3J=4.6 
2J=1.2 
123.4* 
dd 
1J=72.5 
1J=47.5 
139.9* 
ddd 
1J=41.7 
1J=41.7 
1J=72.6 
 
39.7* 
dd 
1J=33.6 
1J=41.7 
 
 
26.5* 
dd 
1J=34.5 
1J=43.8 
 
124.0* 
dd 
1J=73.7 
1J=44.0 
 
131.9* 
dddd 
1J=42.5 
1J=42.5 
1J=73.7 
2J=3.7 
25.8* 
d 
1J=42.9 
 
17.8* 
d 
1J=42.2 
 
16.4* 
d 
1J=41.6 
 
     
(1-13C)-5c 59.6* 123.5 
d 
1J=47.4 
140.0 
d 
2J=1.2 
39.7 
d 
3J=4.7 
          16.4 
d 
3J=4.2 
(2-13C)-5c 59.6 
d 
1J=47.4 
123.5* 140.0 
d 
1J=73.0 
39.7 
d 
2J=2.4 
26.4 
d 
3J=3.1 
         16.4 
d 
2J=1.5 
(3-13C)-5c 59.6 
d 
2J=1.3 
123.5 
d 
1J=72.7 
140.0* 39.7 
d 
1J=41.8 
26.4 
d 
2J=2.2 
123.9 
d 
3J=3.5 
        16.4 
d 
1J=41.7 
(4-13C)-5c 59.6 
d 
3J=4.8 
123.5 
d 
2J=2.3 
140.0 
d 
1J=41.8 
39.7* 
 
26.4 
d 
1J=33.5 
123.9 
d 
2J=1.6 
135.5 
d 
3J=3.6 
        
(5-13C)-5c  123.5 
d 
2J=3.0 
 
 
39.7 
d 
1J=34.5 
26.5* 
 
123.9 
d 
1J=44.0 
 
 
39.8 
d 
3J=3.5 
     16.2 
d 
3J=3.7 
16.4 
d 
3J=1.5 
(6-13C)-5c   
 
140.0 
d 
3J=3.6 
 
39.7 
d 
2J=1.6 
26.4 
d 
1J=44.0 
123.9* 135.5 
d 
1J=73.7 
39.8 
d 
2J=2.6 
26.9 
d 
3J=3.1 
      
(7-13C)-5c    39.7 
d 
3J=3.5 
 123.9 
d 
1J=73.4 
135.5* 
 
39.8 
d 
1J=42.4 
26.9 
d 
2J=2.1 
124.4 
d 
3J=3.7 
   16.2 
d 
1J=42.4 
 
(8-13C)-5c     26.4 
d 
3J=4.4 
123.9 
d 
2J=2.6 
135.5 
d 
1J=42.1 
39.8* 26.8 
d 
1J=33.7 
124.4 
d 
2J=1.6 
131.5 
d 
3J=3.6 
  16.2 
d 
2J=3.7 
 
(9-13C)-5c      123.9 
d 
3J=2.9 
135.5 
d 
2J=2.1 
39.8 
d 
1J=34.2 
26.8* 124.4 
d 
1J=44.1 
 
 
25.8 
d 
3J=4.7 
17.8 
d 
3J=3.7 
16.2 
d 
3J=1.4 
 
(10-13C)-5c       135.5 
d 
3J=3.5 
39.8 
d 
2J=1.7 
26.9 
d 
1J=44.1 
124.4* 131.5 
d 
1J=73.7 
25.8 
d 
2J=3.2 
17.8 
d 
2J=2.0 
  
(11-13C)-5c        39.8 
d 
3J=3.7 
 124.4 
d 
1J=73.7 
131.5* 25.8 
d 
1J=43.1 
17.8 
d 
1J=42.2 
  
(12-13C)-5c         26.9 
d 
3J=4.6 
124.4 
d 
2J=3.1 
131.5 
d 
1J=43.1 
25.8* 17.8 
d 
2J=4.5 
  
(13-13C)-5c         26.9 
d 
3J=3.6 
124.4 
d 
2J=2.0 
131.5 
d 
1J=42.2 
25.8 
d 
2J=4.5 
17.8*   
(14-13C)-5c     26.4 
d 
3J=1.5 
123.9 
d 
2J=1.8 
135.5 
d 
1J=42.2 
39.8 
d 
2J=3.8 
26.9 
d 
3J=1.5 
    16.2*  
(15-13C)-5c 59.6 
d 
3J=4.3 
123.5 
d 
2J=1.7 
140.0 
d 
1J=41.7 
39.7 
d 
2J=3.5 
26.4 
d 
3J=1.6 
         16.4* 
(13C15)-5c 59.6* 
dddd 
1J=47.4 
1J=4.6 
1J=4.6 
1J=1.3 
123.5* 
dd 
1J=47.6 
1J=72.9 
140.0* 
ddd 
1J=72.6 
1J=41.8 
1J=41.8 
39.7* 
dd 
1J=36.6 
1J=36.6 
 
26.4* 
dd 
1J=43.5 
1J=36.5 
123.9* 
dd 
1J=44.0 
1J=73.7 
 
135.5* 
ddd 
1J=73.6 
1J=42.2 
1J=42.2 
39.8* 
dd 
1J=38.0 
1J=41.0 
26.9* 
dd 
1J=40.0 
1J=40.0 
124.4* 
dd 
1J=42.0 
1J=73.0 
 
131.5* 
ddd 
1J=73.6 
1J=42.3 
1J=42.3 
25.8* 
d 
1J=42.8 
17.8* 
d 
1J=42.0 
 
16.2* 
d 
1J=42.3 
16.4* 
d 
1J=41.7 
[a] Coupling constants nJ are C,C-couplings via n bonds and given in Hertz (d = doublet, n.d. = not determinable due to signal overlappings). 
Asterisks indicate 13C-labeled carbons. 
 Table 4. Specific aspects of 1H-NMR data of the 13C-labeled isotopomers of 5a – 5c. All other 1H-NMR data matched those reported for the 
unlabeled compounds.[6,10,12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] H-1 H-2 H-4 H-5 H-6 H-8 H-9 H-10 H-12 H-13 H-14 H-15 
             
(1-13C)-5a 4.14 
d 
1J=141.8 
           
(2-13C)-5a 4.14 
d 
2J=3.7 
5.40 
d 
1J=153.1 
1.74 
d 
3J=5.8 
1.68 
d 
3J=4.6 
        
(13C5)-5a 4.12 
d 
1J=141.5 
5.41 
d 
1J=153.2 
1.74 
dddd 
1J=125.7 
2J=5.4 
3J=5.4 
3J=5.4 
1.68 
d 
1J=125.7 
2J=5.1 
3J=5.1 
3J=5.1 
        
(1-13C)-5b 4.15 
d 
1J=141.6 
           
(2-13C)-5b 4.15 
d 
2J=4.0 
5.41 
d 
1J=153.4 
          
(3-13C)-5b 4.15 
d 
3J=5.1 
           
(4-13C)-5b   2.03 
d 
1J=127.6
 
         
(5-13C)-5b    2.10 
d 
1J=127.9 
        
(6-13C)-5b     5.10 
d 
1J=150.3 
1.60 
d 
3J=4.58 
      
(10-13C)-5b        1.68 
d 
1J=125.9 
    
(13C10)-5b 4.15 
d 
1J=142.0 
5.41 
d 
1J=153.1 
2.03 
d 
1J=126.3 
2.10 
d 
1J=127.9 
5.09 
d 
1J=150.5 
1.60 
d 
1J=125.2 
1.68 
d 
1J=126.0 
1.68 
d 
1J=126.0 
    
(1-13C)-5c 4.15 
d 
1J=142.5 
           
(2-13C)-5c 4.15 
d 
2J=4.0 
5.42 
d 
1J=153.2 
          
(3-13C)-5c 4.15 
d 
3J=4.9 
           
(4-13C)-5c  
 
 
5.42 
d 
3J=6.5 
          
(5-13C)-5c    n.d.         
(6-13C)-5c     5.10 
d 
1J=150.2 
       
(7-13C)-5c           1.60 
d 
2J=5.5 
 
(8-13C)-5c      1.98 
d 
1J=130 
      
(9-13C)-5c       2.05 
d 
1J=126.8 
     
(10-13C)-5c        5.10 
d 
1J=150.1 
    
(11-13C)-5c        n.d. n.d. n.d.   
(12-13C)-5c         1.68 
d 
1J=125.2 
   
(13-13C)-5c          1.60 
d 
1J=125.1 
  
(14-13C)-5c           1.60 
d 
1J=125.4 
 
(15-13C)-5c  5.42 
d 
3J=7.1 
         1.68 
d 
1J=126.1 
(13C15)-5c 4.15 
d 
1J=141.9 
5.42 
d 
1J=153.5 
  5.10 
d 
1J=149.9 
  5.10 
d 
1J=149.9 
1.68 
d 
1J=125.6 
1.60 
d 
1J=125.0 
1.60 
d 
1J=125.0 
1.68 
d 
1J=125.6 
[a] Coupling constants nJ are C,H-couplings via n bonds and given in Hertz (d = doublet, n.d. = not determinable due to signal overlappings).
 Table 5. Specific aspects of 13C-NMR data of the 13C-labeled isotopomers of 7a and 7b. All other 13C-NMR data matched those reported for the 
unlabeled compounds.[8,12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] via X= C-1 C-2 C-3 C-4 C-5 C-6 C-7 C-8 C-9 C-10 C-11 C-12 C-13 C-1’ C-2’ C-3’ 
                  
(2-13C)-7a Br 29.2 
d 
1J=41.8 
203.2* 60.0 
d 
1J=37.4 
27.1 
d 
2J=1.3 
119.9 
d 
3J=2.6 
        169.6 
d 
2J=1.6 
  
(1’,3-13C2)-7a Br 29.2 
d 
2J=12.8 
203.2 
dd 
1J=37.2 
2J=1.6 
60.0* 
d 
1J=56.2 
27.1 
dd 
1J=33.7 
2J=1.5 
119.9 
dd 
2J=1.3 
3J=2.7 
134.9 
d 
3J=3.6 
       169.6* 
d 
1J=56.1 
61.4 
d 
2J=2.4 
14.2 
d 
3J=2.1 
(4-13C)-7a Br  203.2 
d 
2J=1.4 
60.0 
d 
1J=33.8 
27.1* 119.9 
d 
1J=44.3 
 
 
25.9 
d 
3J=4.8 
17.9 
d 
3J=3.8 
     169.7 
d 
2J=1.6 
  
(5-13C)-7a Br  203.2 
d 
3J=2.7 
60.0 
d 
2J=1.0 
27.1 
d 
1J=44.6 
119.9* 134.9 
d 
1J=74.1 
25.9 
d 
2J=3.5 
17.9 
d 
2J=1.9 
     169.6 
d 
3J=2.7 
  
(13C9)-7a 
in 
(2H6)benzene 
Br 28.6* 
dd 
1J=42.0 
2J=13.1 
201.4* 
dd 
1J=37.2 
1J=42.0 
60.0* 
ddd 
1J=35.7 
1J=35.7 
1J=56.0 
27.3* 
dd 
1J=33.8 
1J=44.3 
120.8* 
dd 
1J=44.4 
1J=74.2 
134.3* 
dddd 
1J=72.2 
1J=42.7 
1J=42.7 
3J=3.6 
25.8* 
dddd 
1J=42.9 
2J=4.2 
2J=4.2 
3J=4.2 
17.7* 
dddd 
1J=42.1 
3J=4.2 
2J=4.2 
2J=1.8 
     169.5* 
d 
1J=56.3 
61.0 
d 
2J=2.4 
14.0 
d 
3J=2.0 
 
(2-13C)-7b Br 29.2 
d 
1J=41.8  
203.2* 60.0 
d 
1J=37.2 
27.0 
d 
2J=1.2 
119.8 
d 
3J=2.6 
        169.6 
d 
2J=1.6  
  
(1’,3-13C2)-7b Br 29.2 
d 
3J=12.7 
203.2 
dd 
1J=37.3 
2J=1.4 
60.0* 
d 
1J=56.0 
27.0 
dd 
1J=33.7 
2J=1.4 
119.8 
dd 
2J=2.8 
3J=1.1 
138.5 
d 
3J=3.5 
 
       169.6* 
d 
1J=56.0 
 
61.2 
d 
2J=2.4 
14.1 
d 
3J=2.0 
(4-13C)-7b Br  203.2 
d 
2J=1.1 
60.0 
d 
1J=33.6 
27.0* 119.8 
d 
1J=44.4 
 39.8 
d 
3J=4.3 
     16.2 
d 
3J=4.0 
   
(5-13C)-7b Br  203.2 
d 
3J=2.7 
60.0 
d 
2J=1.2 
27.0 
d 
1J=44.2 
119.8* 138.5 
d 
1J=74.0 
39.8 
d 
2J=3.0 
26.6 
d 
3J=3.0 
    16.2 
d 
2J=1.6 
169.6 
d 
3J=2.6 
  
(6-13C)-7b    60.0 
d 
3J=3.5 
 119.8 
d 
1J=73.9 
138.5* 39.8 
d 
1J=42.2 
26.6 
d 
2J=2.2 
124.1 
d 
3J=3.4 
   16.2 
d 
1J=42.2 
   
(7-13C)-7b Br    27.0 
d 
3J=4.5 
119.8 
d 
2J=2.9 
138.5 
d 
1J=42.4 
39.8* 
 
26.6 
d 
1J=33.8 
124.1 
d 
2J=1.5 
131.7 
d 
3J=3.6 
  16.2 
d 
2J=3.6 
   
(8-13C)-7b Br     119.8 
d 
3J=3.1 
138.5 
d 
2J=2.1 
39.8 
d 
1J=33.6 
26.6* 124.1 
d 
1J=44.2 
 
 
25.8 
d 
3J=4.8 
17.8 
d 
3J=3.6 
16.2 
d 
3J=1.1 
   
(9-13C)-7b Br      138.5 
d 
3J=3.2 
39.8 
d 
2J=1.6 
26.6 
d 
1J=44.1 
124.1* 131.7 
d 
1J=73.7 
25.8 
d 
2J=3.2 
17.8 
d 
2J=1.9 
    
(13-13C)-7b Br    27.0 
d 
3J=4.0 
119.8 
d 
2J=1.7 
138.5 
d 
1J=42.1 
39.8 
d 
2J=3.6 
26.6 
d 
3J=1.4 
    16.2*    
(13C14)-7b 
in 
(2H6)benzene 
Br 28.7* 
dd 
1J=42.0 
2J=13.3 
201.4* 
dd 
1J=37.2 
1J=42.0 
60.0* 
ddddd 
1J=56.3 
1J=37.3 
1J=34.1 
2J=13.0 
3J=3.4 
27.1* 
dd 
1J=44.1 
1J=34.1 
 
120.8* 
dd 
1J=44.3 
1J=74.3 
138.0* 
ddd 
1J=31.8 
1J=31.8 
1J=74.1 
40.1* 
dd 
1J=33.7 
1J=41.9 
26.8* 
dd 
1J=44.1 
1J=34.1 
124.6* 
dd 
1J=43.7 
1J=74.2 
131.3* 
dd 
1J=74.3 
1J=42.6 
25.8* 
d 
1J=43.2 
17.7* 
d 
1J=42.2 
 
16.1* 
d 
1J=42.2 
169.6* 
d 
1J=56.3 
61.0 
d 
2J=2.4 
14.1 
d 
1J=2.0 
[a] Coupling constants nJ are C,C-couplings via n bonds and given in Hertz (d = doublet, n.d. = not determinable due to signal overlappings). 
Asterisks indicate 13C-labeled carbons. 
 Table 6. Specific aspects of 1H-NMR data of the 13C-labeled isotopomers of 7a and 7b. All other 1H-NMR data matched those reported for the 
unlabeled compounds.[8,12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] via X= H-1 H-3 H-4 H-5 H-7 H-8 H-9 H-11 H-12 H-13 H-2’ H-3’ 
              
(2-13C)-7a Br 2.21 
d 
2J=6.1 
3.42 
d 
2J=6.4 
          
(1’,3-13C2)-7a Br 2.21 
d 
3J=1.1 
3.42 
d 
1J=131.6 
        4.18 
d 
J=3.2 
 
(4-13C)-7a Br  3.42 
d 
2J=4.3 
2.53 
d 
1J=130.4 
         
(5-13C)-7a Br  3.42 
d 
3J=3.2 
 5.02 
d 
1J=152.5 
1.67 
d 
3J=5.9 
1.62 
d 
3J=4.9 
      
(13C9)-7a 
in 
(2H6)benzene 
 
Br 1.87 
ddd 
1J=127.8 
J=6.1 
J=1.2 
3.27 
d 
1J=131.1 
 
2.62 
d 
1J=130.1 
5.10 
d 
1J=151.5 
1.55 
d 
1J=125.8 
 
1.49 
d 
1J=125.6 
    4.18 
dd 
J=3.3 
J=0.7 
 
(2-13C)-7b Br 2.22 
d 
2J=6.1 
3.43 
d 
2J=6.0 
          
(1’,3-13C2)-7b Br 2.22 
d 
2J=1.0 
3.43 
dd 
1J=131.8 
2J=6.0 
          
(4-13C)-7b Br  3.43 
t 
2J=4.3 
2.52 
d 
1J=150.5 
         
(5-13C)-7b Br  3.43 
d 
3J=3.0 
 5.04 
d 
1J=152.3 
     1.63 
d 
3J=5.1 
  
(6-13C)-7b Br          1.62 
d 
2J=6.0 
  
(7-13C)-7b Br     1.98 
d 
1J=120.4 
    1.63 
d 
3J=3.9 
  
(8-13C)-7b Br      2.04 
d 
1J=125.1 
      
(9-13C)-7b Br       5.04 
d 
1J=150.4 
1.67 
d 
3J=6.0 
1.58 
d 
3J=5.0 
   
(13-13C)-7b Br          125.5 
d 
1J=125.5 
  
(13C14)-7b 
in 
(2H6)benzene 
Br 1.87 
ddd 
1J=127.3 
2J=6.0 
3J=1.2 
3.28 
d 
1J=130.2 
2.63 
d 
1J=130.1 
5.14 
d 
1J=151.7 
1.97 
d 
1J=125.3 
2.07 
d 
1J=124.5 
5.12 
d 
1J=30.2 
   3.88 
dd 
3J=3.3 
4J=1.0 
 
[a] Coupling constants nJ are C,H-couplings via n bonds and given in Hertz (d = doublet, n.d. = not determinable due to signal overlappings).
 Table 7. Specific aspects of 13C-NMR data of the 13C-labeled isotopomers of 3b and 3c. All other 13C-NMR data matched those reported for the 
unlabeled compounds.[9,12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] C-1 C-2 C-3 C-4 C-5 C-6 C-7 C-8 C-9 C-10 C-11 C-12 C-13 
              
(1-13C)-3b 30.0* 
 
209.0 
d 
1J=40.9 
43.9 
d 
2J=14.0 
22.7 
d 
3J=0.8 
         
(2-13C)-3b 30.0 
d 
1J=40.0 
209.0* 43.9 
d 
1J=39.0 
22.7 
d 
2J=1.8 
122.8 
d 
3J=3.5 
        
(3-13C)-3b 30.2 
d 
2J=14.0 
209.2 
d 
1J=39.2 
44.1* 
 
22.8 
d 
1J=34.8 
122.8 
d 
2J=1.7 
133.0 
d 
3J=3.7 
       
(4-13C)-3b 30.0 
d 
3J=0.8 
209.2 
d 
2J=1.9  
43.9 
d 
1J=34.7 
22.7* 
s 
 
122.8 
d 
1J=44.4 
 25.8 
d 
3J=4.7 
17.8 
d 
3J=3.8 
     
(5-13C)-3b  209.0 
d 
3J=3.2 
43.6 
d 
2J=1.6 
22.7 
d 
1J=44.1 
122.8* 132.9 
d 
1J=73.9 
25.8 
d 
2J=3.2 
17.8 
d 
2J=1.9 
     
(13C8)-3b 30.0* 
dd 
1J=40.0 
2J=14.0 
209.0* 
dd 
1J=39.5 
1J=39.5 
43.9* 
ddd 
1J=36.7 
1J=36.7 
2J=14.0 
22.7* 
dd 
1J=34.7 
1J=44.4 
122.8* 
dd 
1J=44.2 
1J=74.0 
132.9* 
dddd 
1J=42.6 
1J=42.6 
1J=74.0 
3J=3.6 
25.8* 
dddd 
1J=43.0 
3J=4.0 
3J=4.0 
2J=4.0 
17.8* 
d 
1J=42.0 
     
(1-13C)-3c 30.1* 208.8 
d 
1J=40.1 
43.9 
d 
2J=14.1 
           
(2-13C)-3c 30.1 
d 
1J=40.1 
208.8* 43.9 
d 
1J=39.1 
22.5 
d 
2J=1.7 
122.6 
d 
3J=3.3 
        
(3-13C)-3c 30.1 
d 
2J=13.8 
208.8 
d 
1J=39.5 
43.9* 22.6 
d 
1J=34.7 
122.7 
d 
2J=1.5 
136.5 
d 
3J=3.7 
       
(4-13C)-3c 30.1 
d 
3J=0.6 
208.8 
d 
2J=1.8 
43.9 
d 
1J=34.8 
22.5* 122.6 
d 
1J=44.0 
 39.8 
d 
3J=4.5 
     16.1 
d 
3J=3.9 
(5-13C)-3c  208.8 
d 
3J=3.3 
43.9 
d 
2J=1.7 
22.6 
d 
1J=44.3 
122.6* 136.5 
d 
1J=74.0 
39.8 
d 
2J=2.6 
26.7 
d 
3J=3.0 
    16.1 
d 
2J=1.8 
(6-13C)-3c   43.9 
d 
3J=3.6 
 122.6 
d 
1J=73.7 
136.5* 39.8 
d 
1J=42.8 
26.7 
d 
2J=2.2 
124.3 
d 
3J=3.6 
   16.1 
d 
1J=42.2 
(7-13C)-3c[b]      136.5 
d 
1J=42.8 
39.8* 
 
26.7 
d 
1J=33.7 
     
(8-13C)-3c     122.6 
d 
3J=3.0 
136.5 
d 
2J=2.2 
39.8 
d 
1J=33.7 
26.7* 124.3 
d 
1J=44.2 
 25.8 
d 
3J=4.6 
17.8 
d 
3J=3.7 
16.1 
d 
3J=1.4 
(9-13C)-3c      136.5 
d 
3J=3.6 
39.8 
d 
2J=1.6 
26.7 
d 
1J=44.1 
124.3* 131.5 
d 
1J=73.7 
25.8 
d 
2J=3.1 
17.8 
d 
2J=1.9 
 
(13-13C)-3c    22.6 
d 
3J=4.0 
122.6 
d 
2J=1.8 
136.5 
d 
1J=42.2 
39.8 
d 
2J=3.7 
26.7 
d 
3J=1.5 
    16.1* 
(13C15)-3c 30.1* 
dd 
1J=40.0 
1J=14.0 
208.8* 
dddd 
1J=40.0 
1J=40.0 
2J=1.8 
3J=3.4 
 
43.9* 
dddd 
1J=38.3 
1J=34.9 
2J=14.0 
3J=3.4 
22.6* 
dd 
1J=34.7 
1J=44.0 
122.6* 
dd 
1J=73.7 
1J=44.1 
 
136.5* 
dddddd 
1J=74.0 
1J=42.4 
1J=42.4 
2J=2.2 
3J=3.6 
3J=3.6 
39.8* 
dd 
1J=42.2 
1J=34.1 
26.7* 
dd 
1J=34.9 
1J=43.3 
124.3* 
dddddd 
1J=73.7 
1J=44.2 
2J=1.9 
2J=1.9 
2J=3.4 
3J=3.4 
131.5* 
dddd 
1J=73.6 
1J=42.6 
1J=42.6 
3J=3.6 
25.8* 
dddd 
1J=43.0 
2J=3.3 
2J=4.3 
3J=4.3 
17.8* 
dddd 
1J=42.2 
2J=2.1 
2J=4.3 
3J=4.3 
16.1* 
ddddd 
1J=42.2 
2J=1.6 
2J=3.5 
3J=1.6 
3J=3.5 
[a] Coupling constants nJ are C,C-couplings via n bonds and given in Hertz (d = doublet, n.d. = not determinable due to signal overlappings). 
Asterisks indicate 13C-labeled carbons. [b] Not recorded, data inferred from coupling constants observed for (6-13C)- and (8-13C)-FPP. 
 Table 8. Specific aspects of 1H-NMR data of the 13C-labeled isotopomers of 3b and 3c. All other 13C-NMR data matched those reported for the 
unlabeled compounds.[9,12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] H-1 H-3 H-4 H-5 H-7 H-8 H-9 H-11 H-12 H-13 
           
(1-13C)-3b 2.13 
d 
1J=127.1 
         
(2-13C)-3b 2.13 
d 
2J=5.8 
         
(3-13C)-3b  2.44 
d 
1J=125.5 
        
(4-13C)-3b   2.24 
d 
1J=128.1 
       
(5-13C)-3b    5.06 
d 
1J=151.1 
1.61 
d 
3J=5.0 
1.67 
d 
3J=6.0 
    
(13C8)-3b 2.12 
dd 
1J=127.0 
2J=5.8 
3J=0.8 
2.44 
d 
1J=125.1 
2.24 
d 
1J=128.1 
5.05 
d 
1J=151.1 
1.61 
d 
1J=125.4 
1.67 
d 
1J=125.4 
    
(1-13C)-3c 2.12 
d 
1J=127.1 
         
(2-13C)-3c 2.13 
d 
2J=5.8 
2.45 
d 
2J=5.2 
        
(3-13C)-3c 2.13 
d 
3J=1.2 
2.45 
d 
1J=129.0 
        
(4-13C)-3c   n.d.        
(5-13C)-3c    5.07 
d 
1J=151.1 
    1.61 
d 
3J=5.0 
 
(6-13C)-3c           
(7-13C)-3c     1.97 
d 
1J=129.2 
    1.61 
d 
3J=3.9 
(8-13C)-3c      2.05 
d 
1J=127.4 
    
(9-13C)-3c       5.06 
d 
1J=150.1 
1.67 
d 
3J=5.5 
1.58 
d 
3J=4.9 
 
(13-13C)-3c          1.60 
d 
1J=126.1 
(13C15)-3c 2.13 
dd 
1J=127.0 
2J=5.7 
2.45 
d 
1J=125.4 
2.26 
d 
1J=127.4 
5.07 
d 
1J=150.4 
1.97 
d 
1J=130.6 
2.05 
d 
1J=126 
5.07 
d 
1J=150.4 
1.67 
d 
1J=125.1 
1.59 
d 
1J=125.1 
1.61 
d 
1J=125.1 
[a] Coupling constants nJ are C,H-couplings via n bonds and given in Hertz (d = doublet, n.d. = not determinable due to signal overlappings).
 Table 9. Specific aspects of 13C-NMR data of the 13C-labeled isotopomers of 8. All other 13C-NMR data matched those reported for the unlabeled 
compound.[12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] C-1 C-2 C-3 C-4 C-5 C-6 C-7 C-8 C-9 C-10 C-11 C-12 C-13 C-14 C-15 
                
(1-13C)-8 
in 2H2O 
65.2* 122.5 
d 
1J=50.0 
 41.5 
d 
3J=4.6 
          18.3 
d 
3J=4.1 
(2-13C)-8 
in 2H2O 
 122.4* 145.6 
d 
1J=72.4 
41.6 
d 
2J=2.7 
28.4 
d 
3J=3.1 
         18.4 
d 
2J=1.6 
(3-13C)-8 
in 2H2O 
 122.6 
d 
1J=72.2 
145.0* 41.6 
d 
1J=41.6 
28.4 
d 
2J=2.1 
126.9 
d 
3J=3.6 
        18.3 
d 
1J=41.4 
(4-13C)-8 
in 2H2O 
  145.3 
d 
1J=41.8 
41.5* 28.3 
d 
1J=35.0 
         18.3 
d 
2J=2.0 
(5-13C)-8 
in 2H2O 
 122.3 
d 
3J=2.7 
145.7 
d 
2J=1.8 
41.6 
d 
1J=33.5 
28.4* 127.0 
d 
1J=43.4 
 41.6 
d 
3J=4.2 
     18.0 
d 
3J=3.4 
18.4 
d 
3J=1.3 
(6-13C)-8 
in 2H2O 
     126.5*          
(7-13C)-8 
in 2H2O 
      138.8*         
(8-13C)-8 
in 2H2O 
    28.6 
d 
3J=5.0 
126.8 
d 
2J=2.0 
138.3 
d 
1J=42.6 
41.7* 28.7 
d 
1J=42.8 
127.0 
d 
2J=1.2 
134.4 
d 
3J=3.1 
  17.9 
d 
2J=3.0 
 
(9-13C)-8 
in 2H2O 
      139.4 
d 
2J=1.8 
41.5 
d 
1J=33.7 
28.5* 127.2 
d 
1J=41.0 
 27.6 
d 
3J=4.6 
19.7 
d 
3J=3.5 
  
(10-13C)-8 
in 2H2O 
      138.9 
d 
3J=3.2 
 28.7 
d 
1J=42.4 
127.2* 
s 
135.4 
d 
1J=72.5 
27.7 
d 
2J=3.2 
19.8 
d 
2J=1.9 
  
(11-13C)-8 
in 2H2O 
       41.8 
d 
3J=3.6 
 127.0 
d 
1J=73.1 
134.4* 
s 
27.7 
d 
1J=42.9 
19.8 
d 
1J=42.0 
  
(12-13C)-8 
in 2H2O 
        
 
28.8 
d 
3J=4.6 
127.1 
d 
2J=3.0 
134.8 
d 
1J=41.9 
27.7*    
(13-13C)-8 
in 2H2O 
        28.8 
d 
3J=3.5 
126.9 
d 
2J=2.0 
134.0 
d 
1J=42.2 
27.7 
d 
2J=2.0 
19.6* 
s 
  
(14-13C)-8 
in 2H2O 
    28.3 
d 
3J=3.0 
126.8 
d 
2J=1.5 
 41.5 
d 
2J=2.3 
28.5 
d 
3J=3.5 
    17.9*  
(15-13C)-8 
in 2H2O 
  144.9 
d 
1J=41.6 
41.8 
d 
2J=3.4 
          18.4* 
(13C15)-8 
in 2H2O 
65.2 
d 
1J=49.2 
122.5 
dd 
1J=72.6 
1J=50.0 
145.4 
ddd 
1J=72.6 
1J=41.7 
1J=41.7 
41.5 
dd 
1J=38.0 
1J=38.0 
28.4 
dd 
1J=42.5 
1J=37.0 
126.7 
dd 
1J=71.9 
1J=43.3 
139.3 
ddd 
1J=72.0 
1J=41.7 
1J=41.7 
41.4 
dd 
1J=38.0 
1J=38.0 
28.6 
dd 
1J=42.5 
1J=37.0 
127.1 
dd 
1J=71.9 
1J=43.3 
135.1 
dddd 
1J=72.0 
1J=41.8 
1J=41.8 
3J=3.4 
27.5 
d 
1J=42.2 
19.6 
d 
1J=41.8 
17.9 
d 
1J=41.6 
18.3 
d 
1J=41.6 
[a] Coupling constants nJ are C,C-couplings via n bonds and given in Hertz (d = doublet, n.d. = not determinable due to signal overlappings). 
Asterisks indicate 13C-labeled carbons. 
 Table 10. Specific aspects of 1H-NMR data of the 13C-labeled isotopomers of 8. All other 1H-NMR data matched those reported for the unlabeled 
compound.[12] NMR data were recorded in CDCl3 unless otherwise noted. 
Compound[a] H-1 H-2 H-4 H-5 H-6 H-8 H-9 H-10 H-12 H-13 H-14 H-15 
             
(1-13C)-8 
in 2H2O 
4.46 
d 
1J=145.7 
           
(2-13C)-8 
in 2H2O 
4.48 
d 
2J=3.6 
5.45 
d 
1J=156.7 
         1.73 
d 
3J=4.7 
(3-13C)-8 
in 2H2O 
            
(4-13C)-8 
in 2H2O 
  n.d.          
(5-13C)-8 
in 2H2O 
   2.12 
d 
1J=126.7 
        
(6-13C)-8 
in 2H2O 
    5.24 
d 
1J=150.0 
       
(7-13C)-8 
in 2H2O 
            
(8-13C)-8 
in 2H2O 
     2.00 
d 
1J=127.0 
    1.62 
d 
3J=3.1 
 
(9-13C)-8 
in 2H2O 
      2.11 
d 
1J=126.0 
     
(10-13C)-8 
in 2H2O 
       5.14 
d 
1J=149.3 
    
(11-13C)-8 
in 2H2O 
        1.68 
d 
2J=6.2 
1.62 
d 
2J=6.3 
  
(12-13C)-8 
in 2H2O 
        1.68 
d 
1J=125.1 
   
(13-13C)-8 
in 2H2O 
         1.62 
d 
1J=126.0 
  
(14-13C)-8 
in 2H2O 
          1.60 
d 
1J=125.4 
 
(15-13C)-8 
in 2H2O 
           1.71 
d 
1J=125.6 
(13C15)-8 
in 2H2O 
4.48 
d 
1J=145.6 
5.48 
d 
1J=156.1 
2.14 
d 
1J=124.6 
2.11 
d 
1J=126.5 
5.19 
d 
1J=151.9 
2.02 
d 
1J=127.0 
2.11 
d 
1J=126.5 
5.19 
d 
1J=151.9 
1.68 
d 
1J=125.2 
1.62 
d 
1J=125.4 
1.63 
d 
1J=125.4 
1.72 
d 
1J=125.5 
[a] Coupling constants nJ are C,H-couplings via n bonds and given in Hertz (d = doublet, n.d. = not determinable due to signal overlappings). 
Synthesis of (15-13C)FPP 
The synthesis of (15-13C)FPP was performed via the route shown in Figure 4 of SI with 
usage of (13C)methyl iodide that is much cheaper than ethyl (4-13C)acetoacetate that would 
be required for a synthesis via the strategy shown in Figure 3 of SI. Ethyl acetate was treated 
with LDA to form the ester enolate that was alkylated with freshly prepared geranyl bromide 
(6b, prepared from geraniol 5b with PBr3) to yield the ester 9. DIBAL-H reduction to the 
alcohol 10 was followed by IBX oxidation to the aldehyde 11 that was used in a Grignard 
reaction with freshly prepared (13C)methylmagnesium iodide to yield the alcohol 12. IBX 
oxidation afforded (1-13C)geranyl acetone (3c) that was converted into (1-13C)FPP through 
the methods shown in Figure 1 of SI. 
 
 
Figure 4. Alternative synthesis of (1-13C)geranyl acetone (3c). 
 
Synthesis of ethyl (E)-5,9-dimethyldeca-4,8-dienoate (9) 
According to a literature procedure[13] to a cooled solution (0°C) of geraniol (5b) (3.09 g, 20 
mmol, 1.0 eq., 0.35 M in abs. THF) was added PBr3 (2.17 g, 8 mmol, 0.4 eq.) dropwise. The 
reaction mixture was stirred for 45 min at 0 °C and then poured into ice-water. The aqueous 
phase was extracted three times with EtOAc. The combined organic layers were dried with 
MgSO4 and concentrated under reduced pressure to yield analytically pure geranyl bromide 
(6b). In a second flask a solution of diisopropylamine (4.14 g, 41 mmol, 2.05 eq.) in abs. THF 
(50 mL) was cooled to 0 °C and treated with n-butyllithium (1.6 M in hexane, 25.6 mL, 
41 mmol, 2.05 eq.). The reaction mixture was stirred for 1 h at 0 °C. In a third flask ethyl 
acetate (3.61 g, 41 mmol, 2.05 eq.) was dissolved in abs. THF (150 mL), CuI (15.23 g, 80 
mmol, 4.0 eq.) was added, and the mixture was cooled to -110 °C. The freshly prepared LDA 
from flask 2 was cannulated to flask 3 with stirring at -110 °C. The reaction mixture was 
warmed to -50 °C and further stirred for 1.5 h. The freshly prepared geranyl bromide (6b) in 
abs. THF (20 mL) was added dropwise and the reaction was stirred for another 2 h at -30 °C. 
The reaction mixture was then hydrolyzed by the addition of a saturated aqueous NH4Cl 
solution (200 mL), followed by extraction with ethyl acetate (3 x 200 mL). The combined 
organic layers were dried over MgSO4 and concentrated under reduced pressure. The 
residue was purified by column chromatography with hexane/ethyl acetate (20:1) to give the 
desired ester 9 (3.25g, 14.5 mmol, 73%) as colorless oil. 
TLC (hexane/ethyl acetate 20:1): Rf = 0.35. 1H-NMR (400 MHz, CDCl3, TMS):  = 5.11-5.03 
(m, 2H, 2xCH), 4.10 (q, 2H, 3JH,H = 7.13 Hz, 1JC,H = 147.1 Hz, CH2), 2.30 (m, 4H, 2xCH2), 
2.00 (m, 4H, 2xCH2), 1.65 (d, 3H, 4JH,H = 1.2 Hz, 1xCH3), 1.60 (d, 3H, 4JH,H = 1.1 Hz, 1xCH3), 
1.57 (d, 3H, 4JH,H = 1.0 Hz, 1xCH3), 1.24 (t, 3H, 3JH,H = 7.2 Hz) ppm. 13C-NMR (100 MHz, 
CDCl3):  = 173.5 (CO), 136.7 (Cq), 131.5 (Cq), 124.3 (CH), 122.5 (CH), 60.3 (CH2), 39.8 
(CH2), 34.6 (CH2), 26.7 (CH2), 25.8 (CH3), 23.7 (CH2), 17.8 (CH3), 16.1 (CH3), 14.4 (CH3) 
ppm. GC (HP 5): I = 1554. MS (EI, 70 eV): m/z (%) = 224 (5) [M]+, 181 (89), 155 (10), 123 
(26), 135 (33), 123 (10), 109 (68), 93 (13), 81 (52), 69 (100), 55 (12), 41 (33). 
 
Synthesis of (E)-5,9-dimethyldeca-4,8-dien-1-ol (10) 
The ester 9 (3.2 g, 14.3 mmol, 1.0 eq.) was dissolved in dry diethyl ether (70 mL) and the 
solution was cooled to -78 °C. A solution of DIBAL-H (2.2 eq., 1.0 M in hexane, 31.4 mmol, 
31.4 mL) was added dropwise. The reaction mixture was stirred for 1 h at -78 °C, followed by 
hydrolysis with a saturated aqueous sodium potassium tartrate solution. The aqueous layer 
was extracted three times with diethyl ether (100 mL). The combined organic layers were 
dried with MgSO4 and concentrated under reduced pressure. Column chromatography with 
hexane/ethyl acetate (5:1) yielded the desired alcohol 10 (2.47 g, 13.6 mmol, 95%) as 
colorless oil. 
TLC (hexane/ethyl acetate 5:1): Rf = 0.25. 1H-NMR (400 MHz, CDCl3, TMS):  = 5.16-5.10 
(m, 1H, 1xCH), 5.10-5.05 (m, 1H, 1xCH), 3.62 (t, 2H, 3JH,H = 6.5 Hz, CH2), 2.09-1.95 (m, 8H, 
4xCH2), 1.67 (d, 3H, 4JH,H = 1.2 Hz, 1xCH3), 1.60 (s, 3H, 1xCH3), 1.59 (s, 3H, 1xCH3) ppm. 
13C-NMR (100 MHz, CDCl3):  = 135.9 (Cq), 131.5 (Cq), 124.4 (CH), 123.9 (CH), 62.8 (CH2), 
39.8 (CH2), 32.9 (CH2), 26.8 (CH2), 25.8 (CH3), 24.4 (CH2), 17.8 (CH3), 16.1 (CH3) ppm. GC 
(HP 5): I = 1437. MS (EI, 70 eV): m/z (%) = 182 (4) [M]+, 147 (9), 139 (60), 123 (26), 109 
(10), 95 (79), 81 (14), 69 (100), 55 (19), 41 (38). 
 
Synthesis of (E)-5,9-dimethyldeca-4,8-dienal (11) 
The alcohol 10 (2.2 g, 12.1 mmol, 1.0 eq.) was dissolved in abs. DMSO (60 mL) and IBX 
(4.15 g, 14.7 mmol, 1.2 eq.) was added in one portion. The reaction mixture was stirred for 2 
h at room temperature, hydrolyzed with water (200 mL) and extracted three times with ethyl 
acetate (200 mL). The organic phase was washed twice with saturated aqueous NaHCO3 
solution. The combined organic layers were dried with MgSO4 and concentrated under 
reduced pressure. Column chromatography with cyclohexane/ethyl acetate (10:1) yielded the 
desired aldehyde (11) (1.93 g, 11.1 mmol, 92%) as pale yellow oil. 
TLC (hexane/ethyl acetate 5:1): Rf = 0.63. 1H-NMR (400 MHz, CDCl3, TMS):  = 9.74 (t, 1H, 
3JH,H = 1.7 Hz, 1xCH), 5.12-5.02 (m, 2H, 2xCH), 2.47-2.42 (m, 2H, 1xCH2), 2.35-2.28 (m, 2H, 
1xCH2), 2.08-1.94 (m, 4H, 2xCH2), 1.66 (d, 3H, 4JH,H = 1.1 Hz, 1xCH3), 1.61 (m, 3H, 1xCH3), 
1.59 (s, 3H, 1xCH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 202.7 (CHO), 136.9 (Cq), 131.6 
(Cq), 124.2 (CH), 122.1 (CH), 44.1 (CH2), 39.7 (CH2), 26.7 (CH2), 25.8 (CH3), 21.0 (CH2), 
17.8 (CH3), 16.1 (CH3) ppm. GC (HP 5): I = 1376. MS (EI, 70 eV): m/z (%) = 180 (3) [M]+, 
162 (2), 147 (6), 137 (21), 121 (8), 109 (6), 93 (28), 81 (9), 69 (100), 55 (23), 41 (34). 
 
Synthesis of (1-13C)-(E)-6,10-dimethylundeca-5,9-dien-2-ol (12) 
Mg (106 mg, 5.75 mmol, 1.0 eq.) was covered with dry Et2O (1 mL) in a flame-dried flask and 
(13C)MeI (797 mg, 5.75 mmol, 1.0 eq.) in abs. Et2O (5.2 mL) was added dropwise. After 
consumption of the Mg the aldehyde 11 (936 mg, 5.75 mmol, 1.0 eq.) was added dropwise at 
0 °C and the reaction mixture was stirred overnight. The reaction mixture was hydrolyzed 
with saturated aqueous NH4Cl solution (50 mL) and extracted three times with ethyl acetate 
(100 mL). The combined organic layers were dried with MgSO4 and concentrated under 
reduced pressure. Column chromatography on silica gel with cyclohexane/ethyl acetate (8:1) 
yielded the desired alcohol 12 (824 mg, 4.2 mmol, 73%) as pale yellow oil. 
TLC (cyclohexane/ethyl acetate 3:1): Rf = 0.39. 1H-NMR (400 MHz, CDCl3, TMS):  = 5.16-
5.10 (m, 1H, 1xCH), 5.10-5.04 (m, 1H, 1xCH), 3.78 (qtd, 1H, 1xCH, 3JH,H = 6.2 Hz, 3JH,H = 6.2 
Hz, 2JC,H = 1.0 Hz), 2.15-1.95 (m, 6H, 3xCH2), 1.67 (d, 3H, 4JH,H = 1.0 Hz, 1xCH3), 1.61 (d, 
3H, 4JH,H = 1.0 Hz, 1xCH3), 1.59 (s, 3H, 1xCH3), 1.55-1.41 (m, 2H, 1xCH2), 1.17 (dd, 3H, 3JH,H 
= 6.11 Hz, 1JC,H = 124.9 Hz, 1xCH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 135.7 (Cq), 131.5 
(Cq), 124.4 (CH), 124.1 (CH), 68.0 (d, 1JC,C = 38.5 Hz, CH), 39.8 (CH2), 39.3 (CH2), 26.8 
(CH2), 25.8 (CH3), 24.5 (d, 3JC,C = 2.6 Hz, CH2), 23.6 (13CH3), 17.8 (CH3), 16.1 (CH3) ppm. 
GC (HP 5): I = 1460. MS (EI, 70 eV): m/z (%) = 197 (3) [M]+, 179 (5), 164 (7), 154 (38), 123 
(30), 110 (89), 95 (19), 82 (28), 69 (100), 55 (33), 46 (35), 41 (83). 
 
Synthesis of (1-13C)geranylacetone (3c) 
The alcohol 12 (610 mg, 3.1 mmol, 1.0 eq.) was dissolved in abs. DMSO (15 mL) and IBX 
(962 mg, 3.41 mmol, 1.1 eq.) was added in one portion. The reaction mixture was stirred 
overnight at room temperature, hydrolyzed with water (50 mL) and extracted three times with 
diethyl ether (100 mL). The organic phase was washed twice with saturated aqueous 
NaHCO3 solution. The combined organic layers were dried with MgSO4 and concentrated 
under reduced pressure. Column chromatography with cyclohexane/ethyl acetate (5:1) 
yielded the desired methyl ketone 3c (559 mg, 2.87 mmol, 93 %) as pale yellow oil. 
NMR data are presented in Tables 1 and 2 of SI. 
Synthesis of (14-13C)FPP 
Due to the high costs of ethyl (4-13C)acetoacetate the synthesis of (14-13C)FPP was also 
performed via an alternative route (Figure 5 of SI). The allyl alcohol 13 was converted into 
ethyl 5-methylhex-4-enoate (14) via a Claisen orthoester rearrangement. The ester 14 was 
then converted into the Weinreb amide 15 via a standard method, followed by a reaction with 
freshly prepared (13C)methylmagnesium iodide to yield the methyl ketone 3b that was further 
converted into (14-13C)FPP using the strategy presented in Figure 1 of SI. 
 
 
Figure 5. Alternative synthesis of (1-13C)-6-methyl-5-hepten-2-one (3b). 
 
Synthesis of ethyl 5-methylhex-4-enoate (14) 
According to a literature procedure[14] a solution of 1,1-dimethylallyl alcohol (13) (2.0 g, 23.3 
mmol, 1.0 eq.), triethyl orthoacetate (37.8 g, 233 mmol, 10 eq.) and cyclohexanecarboxylic 
acid (297 mg, 2.32 mmol, 0.1 eq.) was stirred under reflux conditions for 3 h. The reaction 
mixture was then cooled to room temperature and extracted three times with diethyl ether 
(100 mL). The combined organic layers were washed with 10 % aqueous HCl, saturated 
aqueous NaHCO3 solution, water and brine (each 100 mL). The organic layer was dried with 
MgSO4 and concentrated under reduced pressure. The residue was purified by silica gel 
column chromatography using hexane/ethyl acetate (30:1) as eluent to afford the 
corresponding ester 14 (6.67 g, 17.1 mmol, 74%).  
1H-NMR (400 MHz, CDCl3):  = 5.08-5.02 (m, 1H, CH), 4.08 (q, 3JH,H = 7.1 Hz, 2H, CH2), 
2.28-2.25 (m, 4H, 2xCH2), 1.65 (d, 4JH,H = 0.9 Hz, 3H, CH3,), 1.58 (s, 3H, CH3), 1.25 (t, 3JH,H = 
7.1 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, CDCl3):  = 173.5 (CO), 133.0 (Cq), 122.6 (CH), 
60.2 (CH2), 34.6 (CH2), 25.7 (CH3), 23.7 (CH2), 17.7 (CH3), 14.3 (CH3) ppm. GC (HP-5): I = 
1093. MS (EI, 70 eV): m/z (%) = 156 (77), 141 (1), 127 (6), 111 (25), 101 (11), 95 (6), 88 
(22), 85 (56), 82 (100), 73 (6), 69 (83), 60 (15), 55 (21), 41 (31). 
 
Synthesis of N-methoxy-N,5-dimethylhex-4-enamide (15) 
According to a literature procedure[15] to a solution of ester 14 (2.58 g, 16.5 mmol, 1 eq.) in 
dry THF (30 mL) and N,O-dimethylhydroxylamide hydrochloride (3.03 g, 49.6 mmol, 3 eq.) 
was slowly added a freshly prepared solution of iPrMgCl in THF (66.1 mL, 66.1 mmol, 1.0 M, 
4 eq.) at -20 °C. The mixture was stirred for 30 min at -10 °C and then hydrolyzed with NH4Cl 
solution (20 wt % in H2O, 100 mL), followed by three times extraction with diethyl ether (100 
mL). The combined organic layers were dried with MgSO4 and concentrated under reduced 
pressure. The resulting residue was purified by flash column chromatography to afford the 
desired Weinreb amide 15 (2.37 g, 13.9 mmol, 84%).  
 
1H-NMR (400 MHz, CDCl3):  = 5.14 (tqq, 3JH,H = 7.2 Hz, 4JH,H = 1.5 Hz, 4JH,H = 1.4 Hz, 1H, 
CH), 3.65 (s, 3H, OCH3), 3.15 (s, 3H, NCH3), 2.41 (t, 3JH,H = 7.6 Hz, 2H, CH2), 2.28 (dt, 3JH,H 
= 7.2 Hz, 3JH,H = 7.6 Hz, 2H, CH2), 1.66 (d, 4JH,H = 1.1 Hz, 3H, CH3), 1.60 (s, 3H, CH3) ppm. 
13C-NMR (100 MHz, CDCl3):  = 174.4 (CO), 132.7 (Cq), 123.2 (CH), 61.3 (CH3), 32.2 (CH2), 
25.7 (2xCH3), 23.3 (CH2), 17.7 (CH3) ppm. GC (HP-5): I= 1297. MS (EI, 70 eV): m/z (%) = 
171 (31), 140 (12), 111 (25), 103 (19), 98 (10), 83 (50), 79 (3), 73 (7), 69 (100), 61 (69), 55 
(33), 41 (36). 
 
Synthesis of (1-13C)-6-methyl-5-hepten-2-one (3b) 
To a stirred solution of amide 15 (2.46 g, 13.5 mmol, 1.0 eq.) in dry THF (100 mL) at 0 °C, 
was added dropwise a solution of freshly prepared 13CH3MgI (33.0 mmol, 33 mL, 2.5 eq., 1.0 
M in Et2O). After 2 h stirring at 0 °C, the reaction mixture was hydrolyzed by dropwise 
addition of 1 M HCl (30 mL). The layers were separated and the aqueous layer was extracted 
three times with Et2O (50 mL). The combined organic layers were dried with MgSO4, filtered 
and concentrated under reduced pressure. The resulting residue was purified by flash 
column chromatography using hexane/EtOAc (15:1-7:1) as eluent to give the ketone 3b as 
colorless oil (1.33g, 10.5 mmol, 79%).  
NMR data are presented in Tables 1 and 2 of SI. 
Synthesis of (11-13C)FPP, (12-13C)FPP and (13-13C)FPP 
For the synthesis of (12-13C)FPP and (13-13C)FPP with a stereoselective labeling at the 
terminal (E)- or (Z)-methyl groups the strategy shown in Figure 1 is inappropriate. The 
synthetic route that was used instead to prepare these compounds (Figure 6 of SI) 
proceeded via an intermediate that could also be used to prepare (11-13C)FPP in just a few 
steps that was therefore also not made via the route of Figure 1 of SI. 
 
Figure 6. Alternative synthesis of A) (11-13C)-5c, B) (12-13C)-5c and C) (13-13C)-5c. 
Briefly, for the synthesis of (11-13C)FPP alcohol 16[16] was converted into the iodide 17 with 
I2, PPh3 and imidazole, followed by conversion into the Wittig salt 18. A Wittig reaction with 
(2-13C)acetone resulted in 19 that was deprotected with TBAF to yield (11-13C)-5c. The 
transformation into (11-13C)FPP was performed as shown in Figure 1. 
Labeling of the terminal methyl groups was introduced via a HWE reaction of aldehyde 20[16] 
with (1-13C)- and (3-13C)triethylphosphonopropionate, made from commercially available (1-
13C)triethylphosphonoacetate and methyl iodide respectively triethylphosphonoacetate and 
(13C)methyl iodide.[17] The esters 21 were reduced to alcohol 23 using DIBAL-H and further 
defunctionalized via reduction of the mesylate with LiAlH4[18] to 19. Both isotopomers were 
deprotected with TBAF to give (12-13C)- and (13-13C)-5c which were converted into the 
corresponding diphosphates 8 (Figure 1 of SI). 
 
Synthesis of tert-butyl(((2E,6E)-10-iodo-3,7-dimethyldeca-2,6-dien-1-yl)oxy)diphenylsilane 
(17) 
As described in the literature,[19] PPh3 (2.38 g, 9.1 mmol, 1.2 eq.) was dissolved in abs. 
CH2Cl2 (40 mL) and added imidazole (640 mg, 9.1 mmol, 1.2 eq.). After that alcohol 16 
(3.30 g, 7.6 mmol, 1.0 eq.), which was synthesized via a literature-known procedure starting 
from farnesol,[16] was added dropwise. After addition of I2 (2.30 g, 9.1 mmol, 1.2 eq.), the 
mixture was stirred 2 h at room temperature, concentrated under reduced pressure and 
purified by column chromatography [cyclohexane/ethyl acetate (20:1)] to give iodide 17 
(3.40 g, 6.2 mmol, 82%) as a colorless oil. 
TLC (hexane/ethyl acetate 20:1): Rf = 0.90. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.74-7.68 
(m, 4H, CH), 7.45-7.35 (m, 6H, CH), 5.43-5.36 (m, 1H, CH), 5.22-5.15 (m, 1H, CH), 4.23 (d, 
3J = 6.2 Hz, 2H, CH2), 3.14 (t, 3J = 7.0 Hz, 2H, CH2), 2.14-1.97 (m, 6H, 3xCH2), 1.95-1.86 (m, 
2H, CH2), 1.60 (s, 3H, CH3), 1.45 (s, 3H, CH3), 1.06 (s, 9H, 3xCH3) ppm. 13C-NMR (101 MHz, 
CDCl3):  = 137.0 (Cq), 135.8 (4xCH), 134.2 (2xCq), 133.2 (Cq), 129.6 (2xCH), 127.7 (4xCH), 
125.7 (CH), 124.4 (CH), 61.3 (CH2), 40.2 (CH2), 39.5 (CH2), 31.7 (CH2), 27.0 (3xCH3), 26.4 
(CH2), 19.3 (Cq), 16.5 (CH3), 16.0 (CH3), 6.8 (CH2) ppm. 
 
Synthesis of ((4E,8E)-10-((tert-butyldiphenylsilyl)oxy)-4,8-dimethyldeca-4,8-dien-1-yl)-
triphenylphosphonium iodide (18) 
The iodide 17 (3.40 g, 6.2 mmol, 1.0 eq.) and PPh3 (2.00 g, 7.4 mmol, 1.2 eq.) were 
dissolved in abs. toluene (30 mL) and heated for 16 h under reflux conditions. The mixture 
was concentrated under reduced pressure. Column chromatography [CH2Cl2/MeOH (20:1)] 
yielded the Wittig salt 18 (2.10 g, 2.3 mmol, 42%) as a yellow gel. 
TLC (CH2Cl2/MeOH 10:1): Rf = 0.52. 1H-NMR (300 MHz, CD2Cl2, TMS):  = 7.89-7.64 (m, 
19H, 19xCH), 7.43-7.32 (m, 6H, 6xCH), 5.37 (tq, 3J = 6.4 Hz, 4J = 1.2 Hz, 1H, CH), 5.19 (t, 3J 
= 6.9 Hz, 1H, CH), 4.19 (d, 3J = 6.4 Hz, 2H, CH2), 3.44-3.31 (m, CH2), 2.27 (t, 3J = 7.1 Hz, 
2H, CH2), 2.14-2.03 (m, 2H, CH2), 2.03-1.93 (m, 2H, CH2), 1.85-1.69 (m, 2H, CH2), 1.50 (s, 
3H, CH3), 1.45 (s, 3H, CH3), 1.02 (s, 9H, 3xCH3) ppm. 13C-NMR (75 MHz, CD2Cl2):  = 137.5 
(Cq), 135.8 (4xCH), 135.6 (d, JC,P = 3.0 Hz, 3xCH), 134.3 (2xC), 133.9 (d, JC,P = 10.0 Hz, 
6xCH), 132.9 (Cq), 130.8 (d, JC,P = 12.6 Hz, 6xCH), 129.8 (2xCH), 127.9 (4xCH), 127.2 (CH), 
124.2 (CH), 118.3 (d, 1JC,P = 86.3 Hz, 3xCq), 61.3 (CH2), 39.9 (d, JC,P = 15.8 Hz, CH2), 39.6 
(CH2), 26.9 (3xCH3), 26.7 (CH2), 22.5 (d, JC,P = 51.2 Hz, CH2), 20.8 (d, JC,P = 4.0 Hz, CH2), 
19.3 (Cq), 16.4 (CH3), 15.8 (CH3) ppm. 
 
Synthesis of (11-13C)tert-butyldiphenyl(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)-
oxy)silane (19) 
Wittig salt 18 (2.10 g, 2.3 mmol, 1.0 eq.) was dissolved in abs. THF (20 mL) and cooled to 
0 °C. A solution of n-butyllithium (1.6 M in hexane, 1.6 mL, 2.5 mmol, 1.1 eq.) was added 
dropwise and the mixture was stirred for 90 min at 0 °C. After cooling to -78 °C, (2-
13C)acetone (133 mg, 2.3 mmol, 1.0 eq.) was added slowly and stirring was continued over 
night at constant temperature. The reaction was quenched with H2O (20 mL) and the mixture 
was extracted three times with Et2O. The combined organic layers were dried over MgSO4, 
concentrated under reduced pressure and purified by column chromatography 
[cyclohexane/ethyl acetate (20:1)] to give the protected farnesol 19 (0.57 g, 1.2 mmol, 54%) 
as colorless oil. 
TLC (hexane/ethyl acetate 20:1): Rf = 0.69. 1H-NMR (300 MHz, CDCl3, TMS):  = 7.74-7.67 
(m, 4H, 4xCH), 7.46-7.34 (m, 6H, 6xCH), 5.40 (tq, 3J = 6.3 Hz, 4J = 1.1 Hz, 1H, CH), 5.17-
5.06 (m, 2H, 2xCH), 4.23 (d, 3J = 6.3 Hz, 2H, CH2), 2.14-2.04 (m, 4H, 2xCH2), 2.03-1.94 (m, 
4H, 2xCH2), 1.69 (d, 2JC,H = 6.2 Hz, 3H, CH3), 1.61 (s, 3H, CH3), 1.60 (d, 2JC,H = 4.2 Hz, 3H, 
CH3), 1.45 (s, 3H, CH3), 1.05 (s, 9H, 3xCH3) ppm. 13C-NMR (75 MHz, CDCl3):  = 137.2 (Cq), 
135.8 (4xCH), 135.3 (Cq), 134.3 (2xCq), 131.4 (13Cq), 129.6 (2xCH), 127.7 (4xCH), 124.5 (d, 
1JC,C = 73.8 Hz, CH), 124.2 (CH), 124.1 (CH), 61.3 (CH2), 39.9 (d, 2JC,C = 3.6 Hz, CH2), 39.7 
(CH2), 27.0 (3xCH3), 26.9 (CH2), 26.5 (CH2), 25.9 (d, 1JC,C = 43.1 Hz, CH3), 19.3 (Cq), 17.8 (d, 
1JC,C = 42.2 Hz, CH3), 16.5 (CH3), 16.2 (CH3) ppm. GC (HP 5): I = 3045. MS (EI, 70 eV): m/z 
(%) = 405 (4), 404 (11), 326 (3), 205 (4), 204 (12), 201 (15), 200 (53), 199 (100), 197 (8), 188 
(4), 181 (7), 176 (4), 135 (18), 121 (4), 110 (3), 105 (2), 93 (3), 81 (4), 77 (7), 70 (19), 42 (5), 
41 (5). 
 
Synthesis of (11-13C)farnesol (5c) 
The oxysilane (11-13C)-19 (570 mg, 1.24 mmol, 1.0 eq.) was dissolved in abs. THF (10 mL) 
and cooled to 0 °C. A solution of TBAF in THF (1.0 m, 1.5 mL, 1.5 mmol, 1.2 eq.) was added 
dropwise. The reaction mixture was stirred for 2.5 h at 0 °C, diluted with H2O (10 mL) and 
extracted three times with Et2O. After drying of the combined organic layers over MgSO4 and 
concentration of the solution under reduced pressure, column chromatography 
[cyclohexane/ethyl acetate (8:1)] yielded the desired alcohol (11-13C)-5c as colorless liquid. 
NMR data are presented in Tables 3 and 4 of SI. 
 
Synthesis of (1-13C)- and (2-(13C)methyl)-(2E,6E,10E)-12-((tert-butyldiphenylsilyl)oxy)-2,6,10-
trimethyldodeca-2,6,10-trien-1-ol (23) 
A suspension of 60% NaH in mineral oil (542 mg, 13.6 mmol, 2.0 eq.) was suspended in abs. 
THF (35 mL) and cooled to 0 °C. After that, (1-13C)triethyl phosphonopropionate, prepared 
from (1-13C)triethyl phosphonoacetate by methylation with methyl iodide (vide infra) and 
contaminated with inseparable starting material and (1-13C)-2-methyl-
triethylphosphonopropionate, (2.92 g) was added dropwise and the reaction mixture was 
stirred for 1 h at 0 °C, cooled to -78 °C and aldehyde 20 (2.95 g, 6.8 mmol, 1.0 eq., 
synthesized according to ref. 16) was added slowly. The reaction was stirred at -78 °C for 
19 h, warmed to room temperature und quenched with H2O (40 mL). The mixture was 
extracted with Et2O (three times), the organic layers were dried with MgSO4 and 
concentrated under reduced pressure. Column chromatography gave a mixture of the two 
diastereomeric esters (E)- and (Z)-(1-13C)-21 and (1-13C)-22 as colorless oil that was 
inseparable by column chromatorgaphy and used directly in the next step. 
The mixture of esters (E)- and (Z)-(1-13C)-21 and (1-13C)-22 (3.40 g) was dissolved in THF 
(65 mL) and cooled to -78 °C. A 1 M solution of DIBAL-H in hexane (15.7 mL, 15.7 mmol) 
was added slowly and cooling was removed. The reaction mixture was stirred for 3 h and 
hydrolysed by addition of saturated aqueous Na-K-tartrate solution (70 mL). The mixture was 
extracted four times with Et2O (100 mL), the organic layers were washed with Na-K-tartrate 
solution, dried with MgSO4 and concentrated under reduced pressure. Repeated column 
chromatography gave the desired pure alcohol (1-13C)-23 (1.12 g, 2.3 mmol, 35% over two 
steps) as colorless oil. 
TLC (hexane/ethyl acetate 3:1): Rf = 0.44. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.74-7.68 
(m, 4H, 4xCH), 7.45-7.35 (m, 6H, 6xCH), 5.43-5.35 (m, 2H, 2xCH), 5.13 (tq, 3J = 6.7 Hz, 4J = 
1.2 Hz, 1H, CH), 4.23 (d, 3J = 6.3 Hz, 2H, CH2), 3.99 (d, 1JC,H = 141.5 Hz, 2H, CH2), 2.18-
1.96 (m, 8H, 4xCH2), 1.67 (d, 3JC,H = 4.2 Hz, 3H, CH3), 1.61 (s, 3H, CH3), 1.44 (s, 3H, CH3), 
1.05 (s, 9H, 3xCH3) ppm. 13C-NMR (101 MHz, CDCl3):  = 137.1 (Cq), 135.8 (4xCH), 134.9 
(Cq), 134.8 (d, 1JC,C = 45.8 Hz, Cq), 134.2 (2xCq), 129.6 (2xCH), 127.7 (4xCH), 126.2 (d, 2JC,C 
= 3.5 Hz, CH), 124.5 (CH), 124.2 (CH), 69.2 (13CH2), 61.3 (CH2), 39.6 (CH2), 39.4 (CH2), 27.0 
(3xCH3), 26.4 (CH2), 26.3 (d, 3JC,C = 4.8 Hz, CH2), 19.3 (Cq), 16.5 (CH3), 16.2 (CH3), 13.8 (d, 
2JC,C = 4.5 Hz, CH3) ppm. 
The synthesis of (2-(13C)methyl)-23 was performed in a similar way, only unlabeled triethyl 
phosphonoacetate was methylated with (13C)methyl iodide in the preparation of (3-13C)triethyl 
phosphonopropionate (25, vide infra). Yield: 1.15 g, 2.41 mmol (23% over two steps). 
1H-NMR (400 MHz, CDCl3, TMS):  = 7.74-7.67 (m, 4H, 4xCH), 7.45-7.35 (m, 6H, 6xCH), 
5.44-5.36 (m, 2H, 2xCH), 5.14 (tq, 3J = 6.7 Hz, 4J = 1.1 Hz, 1H, CH), 4.23 (d, 3J = 6.3 Hz, 2H, 
CH2), 3.99 (d, 3JC,H = 2.8 Hz, 2H, CH2), 2.19-1.95 (m, 8H, 4xCH2), 1.67 (d, 1JC,H = 126.1 Hz, 
3H, CH3), 1.62 (s, 3H, CH3), 1.45 (s, 3H, CH3), 1.41 (br s, 1H, OH), 1.05 (s, 9H, 3xCH3) ppm. 
13C-NMR (101 MHz, CDCl3):  = 137.1 (Cq), 135.8 (4xCH), 134.9 (Cq), 134.8 (d, 1JC,C = 
43.2 Hz, Cq), 134.2 (2xCq), 129.6 (2xCH), 127.7 (4xCH), 126.2 (d, 2JC,C = 1.6 Hz, CH), 124.4 
(CH), 124.2 (CH), 69.1 (d, 2JC,C = 4.5 Hz, CH2), 61.3 (CH2), 39.6 (CH2), 39.4 (CH2), 27.0 
(3xCH3), 26.4 (CH2), 26.4 (d, 3JC,C = 3.5 Hz, CH2), 19.3 (Cq), 16.5 (CH3), 16.2 (CH3), 13.8 
(13CH3) ppm. 
Synthesis of (12-13C)- and (13-13C)tert-butyldiphenyl(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-
trien-1-yl)oxy)silane (19) 
Following a known procedure,[18] alcohol (1-13C)-23 (1100 mg, 2.31 mmol, 1.0 eq.) was 
dissolved in CH2Cl2 (70 mL) and cooled to 0 °C. To the solution was added Et3N (467 mg, 
4.61 mmol, 2.0 eq.), DMAP (564 mg, 4.61 mmol, 2.0 eq.) and slowly MsCl (529 mg, 
4.61 mmol, 2.0 eq.). After stirring 1 h at 0 °C, another portion of Et3N (2.0 eq) and MsCl 
(2.0 eq) was added. After additional 40 min, the reaction mixture was stirred 2 h at room 
temperature, poured into ice water (100 mL) and was extracted six times with hexane. The 
combined organic layers were sequentially washed with 5%-HCl solution and saturated 
aqueous solutions of NaHCO3 and NaCl. After drying over MgSO4, solvent was removed 
under reduced pressure to give the crude mesylate as yellowish oil. This material was used 
without further purification and added slowly to a suspension of LiAlH4 (1.60 g, 42.1 mmol, 
18.3 eq.) in THF (380 mL). The reaction mixture was stirred for 2 h at room temperature and 
quenched by slow addition of ethyl acetate (saturated with H2O, 200 mL). After stirring over 
night, saturated aqueous NH4Cl solution (300 mL) was added, the suspension was filtered 
and extracted four times with hexane. The combined organic layers were dried with MgSO4 
and concentrated under reduced pressure. Column chromatography [cyclohexane/ethyl 
acetate (20:1)] gave the protected farnesol (12-13C)-19 (545 mg, 1.18 mmol, 51%) as 
colorless oil. 
TLC (hexane/ethyl acetate 20:1): Rf = 0.69. 1H-NMR (400 MHz, CDCl3, TMS):  = 7.73-7.67 
(m, 4H, 4xCH), 7.45-7.34 (m, 6H, 6xCH), 5.39 (tq, 3J = 6.3 Hz, 4J = 1.2 Hz, 1H, CH), 5.16-
5.06 (m, 2H, 2xCH), 4.23 (d, 3J = 6.3 Hz, 2H, CH2), 2.13-2.03 (m, 4H, 2xCH2), 2.03-1.95 (m, 
4H, 2xCH2), 1.67 (dq, 1JC,H = 125.1 Hz, 4J = 1.0 Hz, 3H, CH3), 1.62-1.59 (m, 6H, 2xCH3), 1.45 
(s, 3H, CH3), 1.05 (s, 9H, 3xCH3) ppm. 13C-NMR (101 MHz, CDCl3):  = 137.2 (Cq), 135.8 
(4xCH), 135.3 (Cq), 134.3 (2xCq), 131.4 (d, 1JC,C = 43.1 Hz, Cq), 129.6 (2xCH), 127.7 (4xCH), 
124.5 (d, 2JC,C = 3.1 Hz, CH), 124.2 (CH), 124.1 (CH), 61.3 (CH2), 39.9 (CH2), 39.7 (CH2), 
27.0 (3xCH3), 26.9 (d, 3JC,C = 4.6 Hz, CH2), 26.5 (CH2), 25.9 (13CH3), 19.3 (Cq), 17.9 (d, 2JC,C 
= 4.5 Hz, CH3), 16.5 (CH3), 16.2 (CH3) ppm. GC (HP 5): I = 3029. MS (EI, 70 eV): m/z (%) = 
405 (5), 404 (17), 326 (3), 251 (3), 205 (6), 204 (20), 201 (26), 200 (82), 199 (100), 197 (16), 
188 (8), 183 (7), 181 (13), 176 (8), 161 (3), 137 (8), 135 (29), 123 (4), 121 (10), 119 (3), 110 
(6), 107 (3), 105 (5), 95 (3), 93 (4), 91 (3), 81 (7), 77 (12), 70 (33), 68 (6), 67 (5), 55 (3), 42 
(10), 41 (10). 
For the synthesis of (13-13C)-19 the same procedure starting from (2-(13C)methyl)-23 was 
used. Yield: 398 mg, 0.86 mmol (36%). 
1H-NMR (400 MHz, CDCl3, TMS):  = 7.73-7.67 (m, 4H, 4xCH), 7.45-7.35 (m, 6H, 6xCH), 
5.40 (tq, 3J = 6.3 Hz, 4J = 1.2 Hz, 1H, CH), 5.16-5.06 (m, 2H, 2xCH), 4.23 (d, 3J = 6.3 Hz, 2H, 
CH2), 2.13-2.03 (m, 4H, 2xCH2), 2.03-1.95 (m, 4H, 2xCH2), 1.69 (d, 3JC,H = 3.9 Hz, 3H, CH3), 
1.61 (s, 3H, CH3), 1.60 (d, 1JC,H = 129.3 Hz, 3H, CH3), 1.45 (s, 3H, CH3), 1.05 (s, 9H, 3xCH3) 
ppm. 13C-NMR (101 MHz, CDCl3):  = 137.2 (Cq), 135.8 (4xCH), 135.3 (Cq), 134.3 (2xCq), 
131.4 (d, 1JC,C = 42.2 Hz, Cq), 129.6 (2xCH), 127.7 (4xCH), 124.5 (d, 2JC,C = 2.0 Hz, CH), 
124.2 (CH), 124.1 (CH), 61.3 (CH2), 39.9 (CH2), 39.7 (CH2), 27.0 (3xCH3), 26.9 (d, 3JC,C = 
3.6 Hz, CH2), 26.5 (CH2), 25.9 (d, 2JC,C = 4.5 Hz, CH3), 19.3 (Cq), 17.9 (13CH3), 16.5 (CH3), 
16.2 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 404 (5), 199 (100), 181 (3), 135 (6), 77 (3), 70 (9), 
42 (3), 41 (3). 
Synthesis of (12-13C)- and (13-13C)farnesol (5c) 
The oxysilanes (12-13C)-19 (527 mg, 1.14 mmol) and (13-13C)-19 (398 mg, 0.86 mmol) were 
converted into farnesols (12-13C)-5c (218 mg, 0.98 mmol, 86%) and (13-13C)-5c (160 mg, 
0.72 mmol, 83%) with TBAF following the same procedure as described above for (11-13C)-
19. NMR data for both isotopomers are presented in Tables 3 and 4. 
Synthesis of (1-13C)- and (3-13C)triethylphosphonopropionate (25) 
According to the literature,[17] a suspension of 60% NaH in mineral oil (658 mg, 16.45 mmol, 
1.03 eq.) was suspended in abs. THF (9 mL) and cooled to 0 °C. After that a solution of (1-
13C)triethylphosphonoacetate 24 (3.60 g, 16.0 mmol, 1.00 eq.) in dry THF (9 mL) was added 
slowly during a period of 20 min. The reaction was stirred at room temperature for 2.5 h, 
cooled to -5 °C and added a solution of MeI (2.39 g, 16.87 mmol, 1.06 eq.) in abs. THF 
(9 mL) during 10 min. The mixture was stirred for additional 1 h at room temperature, 
quenched by addition of H2O (14 mL) and extracted four times with CH2Cl2. The combined 
organic layers were dried over MgSO4 and concentrated under reduced pressure to give an 
inseparable mixture of the starting material (1-13C)-24 and the two methylation products 
(1-13C)-25 and (1-13C)-26 (2.94 g) as a yellow, biphasic oil. 
Analytical data for main compound (1-13C)-25 in the mixture are: 1H-NMR (500 MHz, CDCl3, 
TMS):  = 4.25-4.10 (m, 6H, 3xCH2), 3.01 (ddq, 2JH,P = 23.4 Hz, 2JH,C = 7.7 Hz, 3JH,H = 7.4 Hz, 
1H, CHMe), 1.48-1.39 (m, 3H, CH3), 1.36-1.23 (m, 9H, 3xCH3) ppm. 13C-NMR (126 MHz, 
CDCl3):  = 169.9 (d, 2JC,P = 4.7 Hz, 13CO), 62.8 (d, 2JC,P = 6.6 Hz, 2xCH2), 61.5 (d, 2JC,C = 
2.6 Hz, CH2), 39.5 (dd, 1JC,P = 133.4 Hz, 1JC,C = 57.1 Hz, CH), 16.6-16.4 (m, 2xCH3), 14.2 (d, 
3JC,C = 2.0 Hz, CH3), 11.8 (dd, 2JC,P = 6.3 Hz, 2JC,C = 1.9 Hz, CH3) ppm. 31P-NMR (203 MHz, 
CDCl3):  = 23.8 (d, 2JC,P = 4.7 Hz) ppm. GC (HP 5): I = 1428. MS (EI, 70 eV): m/z (%) = 239 
(10), 212 (17), 210 (9), 194 (70), 193 (13), 166 (84), 165 (34), 164 (9), 155 (41), 139 (16), 
138 (85), 137 (32), 136 (15), 127 (37), 120 (13), 111 (38), 109 (100), 103 (34), 99 (54), 92 
(18), 91 (32), 82 (20), 81 (65), 75 (20), 65 (27), 57 (30), 56 (29), 45 (22), 43 (7). 
(3-13C)Triethylphosphonopropionate (25) was synthesized with the same procedure using 
triethylphosphonoacetate and (13C)methyl iodide.  
Analytical data for main compound (3-13C)-25 in the mixture are: 1H-NMR (400 MHz, CDCl3, 
TMS):  = 4.21-4.04 (m, 6H, 3xCH2), 3.02-2.89 (m, 1H, CHMe), 1.59-1.49 (m, 3H, CH3), 
1.31-1.17 (m, 9H, 3xCH3) ppm. 13C-NMR (101 MHz, CDCl3):  = 169.7 (d, 2JC,P = 4.6 Hz, 
CO), 62.6 (d, 2JC,P = 6.7 Hz, 2xCH2), 61.4 (CH2), 39.4 (dd, 1JC,P = 133.5 Hz, 1JC,C = 32.5 Hz, 
CH), 16.5-16.3 (m, 2xCH3), 14.1 (CH3), 11.7 (d, 2JC,P = 6.3 Hz, 13CH3) ppm. 31P-NMR 
(203 MHz, CDCl3):  = 24.3 (d, 2JC,P = 6.3 Hz) ppm. GC (HP 5): I = 1430. MS (EI, 70 eV): m/z 
(%) = 239 (9), 212 (26), 210 (13), 194 (89), 193 (18), 167 (40), 166 (98), 165 (18), 155 (42), 
138 (100), 137 (33), 127 (31), 110 (42), 109 (51), 103 (27), 99 (41), 81 (41), 75 (14), 65 (14), 
57 (14), 44 (14). 
 
Incubation experiments of purified enzyme with (13C)FPPs. 
For each incubation a 0.5 L 2YT liquid culture (containing kanamycin (50 mg/L)) of E. coli BL 
21 transformants was inoculated. The cultivation and protein isolation conditions are 
performed as reported above. Each pure protein fraction from 0.5 L 2YT liquid culture was 
concentrated with a Vivaspin20 concentration tube (MWCO 30000, Sartorius Stedim, 
Göttingen) for 0.5 to 1.5 h at 6000 rpm to 2 mL enzyme fraction. Incubation experiments 
were performed with the pure protein (2 mL) and incubation buffer (2 mL, 50 mM Tris∙HCl, 10 
mM MgCl2, 20 % glycerin, pH 7.0) containing the (13C)FPP (3 mg, 1.5 mg/mL) at 28 °C 
overnight. The reaction mixture was extracted with 0.6 mL (2H8)toluene and directly 
measured by NMR. 
 
 Figure 7. A) 13C-NMR spectrum of unlabelled 1(10)E,4E,6S,7R)-germacradien-6-ol (1), and NMR spectra of isotopomers of (13C1)-1 obtained from 
B) (1-13C)FPP, C) (2-13C)FPP, D) (3-13C)FPP, E) (4-13C)FPP and F) (5-13C)FPP. Blue circles indicate 13C-labeled carbons and asterisks indicate 
signals of 13C-labelled carbons for the two conformers of 1 observed in each experiment. Spectra were recorded in (2H8)toluene. 
 Figure 7. A) 13C-NMR spectrum of unlabelled 1(10)E,4E,6S,7R)-germacradien-6-ol (1), and NMR spectra of isotopomers of (13C1)-1 obtained from 
G) (6-13C)FPP (one signal observed as a shoulder of a solvent signal (shown in the box), H) (7-13C)FPP, I) (8-13C)FPP, J) (9-13C)FPP and K) (10-
13C)FPP. Blue circles indicate 13C-labeled carbons and asterisks indicate signals of 13C-labelled carbons for the two conformers of 1 observed in 
each experiment. Spectra were recorded in (2H8)toluene. 
 Figure 7. A) 13C-NMR spectrum of unlabelled 1(10)E,4E,6S,7R)-germacradien-6-ol (1), and NMR spectra of isotopomers of (13C1)-1 obtained from 
L) (11-13C)FPP, M) (12-13C)FPP, N) (13-13C)FPP, O) (14-13C)FPP and P) (15-13C)FPP. Blue circles indicate 13C-labeled carbons and asterisks 
indicate signals of 13C-labelled carbons for the two conformers of 1 observed in each experiment. Spectra were recorded in (2H8)toluene. 
 Figure 8. 13C,13C-COSY NMR spectrum of (13C15)-1 obtained by enzymatic conversion of (13C15)FPP with germacradienol synthase recorded in 
(2H8)toluene (S = solvent signals). The two sets of crosspeaks for the conformers are shown in yellow (for 1a) and red (for 1b) and numbers next to 
crosspeaks indicate which carbons are coupling (e. g. 1/2 in yellow is a crosspeak for coupling of C-1 with C-2 of conformer 1a) 
 Figure 9. HSQC spectrum of (2-13C1)-(1(10)E,4E,6S,7R)-germacradien-6-ol (1) recorded in 
(2H8)toluene at 223K. Blue circles indicate 13C-labeled carbons. 
 
 Figure 9 (continued). HSQC spectrum of (3-13C1)-(1(10)E,4E,6S,7R)-germacradien-6-ol (1) 
recorded in (2H8)toluene at 223K. Blue circles indicate 13C-labeled carbons. 
 
 
 Figure 9 (continued). HSQC spectrum of (8-13C1)-(1(10)E,4E,6S,7R)-germacradien-6-ol (1) 
recorded in (2H8)toluene at 223K. Blue circles indicate 13C-labeled carbons. 
 Figure 9 (continued). HSQC spectrum of (9-13C1)-(1(10)E,4E,6S,7R)-germacradien-6-ol (1) 
recorded in (2H8)toluene at 223K. Blue circles indicate 13C-labeled carbons. 
 
 Figure 9 (continued). HSQC spectrum of (11-13C1)-(1(10)E,4E,6S,7R)-germacradien-6-ol 
(1) recorded in (2H8)toluene at 223K. Blue circles indicate 13C-labeled carbons. 
Cope rearrangement  
The Cope rearrangement from 6.8 mg of (+)-(1(10)E,4E,6S,7R)-germacradien-6-ol was 
performed at 225°C for 20 h in (2H8)toluene in a CEM Discover microwave reactor. After 
cooling to room temperature the solvent was evaporated under reduced pressure. Column 
chromatography with pentane/diethyl ether (10:1) yielded the products 2a (2 mg, 29%) and 
2b (1.8 mg, 26%). 
2a:  
TLC (cyclohexane/ethyl acetate 2:1): Rf = 0.85. GC (HP 5): I = 1521. MS (EI, 70 eV): m/z (%) 
= 222 (3), 207 (4), 204 (4), 189 (10), 179 (6), 161 (32), 137 (10), 136 (27), 133 (11), 123 (33), 
121 (64), 119 (20), 109 (43), 108 (25), 107 (40), 105 (32), 95 (43), 93 (80), 91 (50), 83 (45), 
81 (100), 79 (48), 77 (37), 71 (22), 69 (51), 67 (64), 57 (25), 55 (70), 53 (33), 43 (72), 41 
(98), 39 (35). HRMS (TOF): m/z = 222.1975 (calcd. 222.1978, C15H26O+). IR (diamond ATR): 𝜈 = 3357 (br m), 3060 (w), 2956 (m), 2927 (m), 2869 (w), 1636 (w), 1601 (w), 1520 (s), 1483 
(m), 1348 (s), 1217 (w), 1162 (w), 1108 (w), 1016 (w), 1003 (w), 965 (w), 906 (m), 873 (m), 
850 (s), 820 (m), 748 (m), 723 (m), 704 (m), 638 (w), 555 (w) cm-1. 
2b:  
TLC (cyclohexane/ethyl acetate 2:1): Rf = 0.79. GC (HP 5): I = 1526. MS (EI, 70 eV): m/z (%) 
= 222 (1), 207 (6), 189 (6), 179 (6), 161 (26), 137 (14), 136 (24), 123 (39), 121 (40), 119 (20), 
109 (60), 107 (37), 105 (30), 95 (46), 93 (79), 91 (48), 83 (42), 81 (89), 79 (52), 77 (39), 71 
(19), 69 (51), 67 (66), 57 (24), 55 (63), 53 (34), 43 (70), 41 (100), 39 (36). HRMS (TOF): m/z 
= 222.1967 (calcd. 222.1978). IR (diamond ATR): 𝜈 = 3447 (br w), 3079 (w), 2955 (s), 2925 
(s), 2869 (m), 1730 (w), 1673 (w), 1510 (m), 1378 (m), 1259 (m), 1085 (m), 1014 (s), 951 (w), 
894 (s), 799 (s) cm-1. 
1H and 13C NMR data of both Cope rearrangement products are summarized in Table 1 of 
main text. 
 
Cope rearrangement of (13C15)-(1(10)E,4E,6S,7R)-germacradien-6-ol: 
The NMR sample of (13C15)-(1(10)E,4E,6S,7R)-germacradien-6-ol in (2H8)toluene was heated 
to 225°C for 16 h in a CEM Discover microwave reactor. After cooling to room temperature 
the product was immediately measured on NMR. The 13C,13C-COSY NMR spectrum of the 
mixture of (13C15)-2a and (13C15)-2b is presented in Figure 10 of SI. 
  
Figure 10. 13C,13C-COSY NMR spectrum of (13C15)-2a and (13C15)-2b obtained after COPE rearrangement of (13C15)-1 in (2H8)toluene after 
microwave reaction at 225°C. Bold lines in the structures of 2a and 2b show contiguous 13C-spin systems. Crosspeaks of 2a are shown in red and 
crosspeaks of 2b are in yellow. 
Table 11. Compared 13C-NMR data sets of (1(10)E,4E,6S,7R)-germacradien-6-ol (1) and its 
stereoisomer kunzeaol (anti-1) measured in (2H)chloroform.  
1 
(this work)[a] 
1 
(Baran et al.)[20] 
1 
(Blaney et al.)[21] 
anti-1 
(Kunzeaol, 
Ro et al.) [22] 
anti-1 
(Kunzeaol, 
Wyllie et al.)[23] 
anti-1 
(Kunzeaol, 
Szafranek et al.)[24] 
138.9 138.8  (-0.1) 138.9  138.7 (-0.2) 138.4 (-0.5) 138.9  
135.8 135.8  135.7 (-0.1) 135.7 (-0.1) 135.3 (-0.4)   
133.5 133.8 (+0.3) 133.5  133.6 (+0.1) 133.8 (+0.3) 133.6 (+0.1) 
133.4 133.4  133.3 (-0.1) 133.2 (-0.2) 132.3 (-1.1) 132.4 (-1.0) 
133.2 133.0 (-0.2) 133.0 (-0.2) 132.9 (-0.3) 132.2 (-1.0)   
131.3 131.6 (+0.3) 131.4 (+0.1) 131.5 (+0.2) 131.7 (+0.3) 131.5 (+0.2) 
128.8 128.9 (+0.1) 128.7 (-0.1) 128.8  128.5 (-0.3) 128.8  
121.4 121.5 (+0.1) 121.3 (-0.1) 121.3 (-0.1) 121.1 (-0.3) 121.4  
68.9 69.0 (+0.1) 68.8 (-0.1) 68.8 (-0.1) 68.5 (-0.4) 68.8 (-0.1) 
68.8   68.6 (-0.2) -  -    
52.2 52.3 (+0.1) 52.2  52.2  51.9 (-0.3) 52.2  
49.4 49.5 (+0.1) 49.3 (-0.1) 49.4  49.2 (-0.2) 49.4  
41.4 41.5 (+0.1) 41.3 (-0.1) 41.4  41.2 (-0.2) 41.4  
39.1 39.2 (+0.1) 39.0 (-0.1) 39.1  38.8 (-0.3) 39.1  
37.2 37.3 (+0.1) 37.2  37.1 (-0.1) 36.9 (-0.3) 37.1 (-0.1) 
35.8 35.9 (+0.1) 35.7 (-0.1) 35.8  35.6 (-0.2) 35.8  
32.2 32.3 (+0.1) 32.1 (-0.1) 32.2  31.9 (-0.3) 32.2  
31.8 31.9 (+0.1) 31.7 (-0.1) 31.7 (-0.1) 31.5 (-0.3) 31.7 (-0.1) 
30.3 30.2 (-0.1) 30.3  30.1 (-0.2) 29.9 (-0.4) 30.1 (-0.2) 
25.3 25.2 (-0.1) 25.2 (-0.1) 25.0 (-0.3) 24.9 (-0.4) 25.1 (-0.2) 
24.6 24.7 (+0.1) -        
24.3 24.4 (+0.1) 24.3  24.3  24.3  24.3  
22.1 22.1  22.1  21.9 (-0.2) 21.7 (-0.4) 22.0 (-0.1) 
21.5 21.5  21.5  21.3 (-0.2) 20 (-1.5) 21.1 (-0.4) 
21.3 21.4 (+0.1) 21.3  21.2 (-0.1) 20 (-1.3) 21.1 (-0.2) 
21.2 21.3 (+0.1) 21.2  21.1 (-0.1)     
21.0 21.1 (+0.1) 21.0  21.0      
17.1 17.1  17.0 (-0.1) 16.9 (-0.2) 16.7 (-0.4) 16.9 (-0.2) 
16.5 16.5  16.5        
16.4   16.4  16.3 (-0.1) 16.2 (-0.2) 16.4  
[a] All signals are given in ppm. Deviations of reported 13C-NMR shifts from data measured in 
this work are shown in brackets. 
  
Figure 11. EI mass spectra of (1(10)E,4E,6S,7R)-germacradien-6-ol (1). A) Unlabeled 1, B) 
(6-13C)-1 obtained from (1-13C)FPP, C) (5-13C)-1 obtained from (2-13C)FPP. Blue circles 
indicate 13C-labeled carbons. 
  
Figure 11 (continued). EI mass spectra of (1(10)E,4E,6S,7R)-germacradien-6-ol (1). 
D) (4-13C)-1 obtained from (3-13C)FPP, E) (3-13C)-1 obtained from (4-13C)FPP, F) (2-13C)-1 
obtained from (5-13C)FPP. Blue circles indicate 13C-labeled carbons. 
  
Figure 11 (continued). EI mass spectra of (1(10)E,4E,6S,7R)-germacradien-6-ol (1). 
G) (1-13C)-1 obtained from (6-13C)FPP, H) (10-13C)-1 obtained from (7-13C)FPP, I) (9-13C)-1 
obtained from (8-13C)FPP. Blue circles indicate 13C-labeled carbons. 
 
  
Figure 11 (continued). EI mass spectra of (1(10)E,4E,6S,7R)-germacradien-6-ol (1). 
J) (8-13C)-1 obtained from (9-13C)FPP, K) (7-13C)-1 obtained from (10-13C)FPP, L) (11-13C)-1 
obtained from (11-13C)FPP. Blue circles indicate 13C-labeled carbons. 
 
  
Figure 11 (continued). EI mass spectra of (1(10)E,4E,6S,7R)-germacradien-6-ol (1). 
M) (12-13C)-1 obtained from (12-13C)FPP, N) (13-13C)-1 obtained from (13-13C)FPP, 
O) (14-13C)-1 obtained from (14-13C)FPP. Blue circles indicate 13C-labeled carbons. 
  
Figure 11 (continued). EI mass spectra of (1(10)E,4E,6S,7R)-germacradien-6-ol (1). 
P) (15-13C)-1 obtained from (15-13C)FPP, Q) (13C15)-1 obtained from (13C15)FPP. Blue circles 
indicate 13C-labeled carbons. 
  
Table 12. Molecular and fragment ions of 1 observed in the EI mass spectra after enzymatic 
conversion of FPP, all fifteen (13C)FPP isotopomers, and (13C15)FPP. The structures of 
fragment ions [A]+ and [B]+ are shown in Figure 5 of main text. 
Compd. Product [M]+ [M-H2O]+ [A]+ [A]+ (HR-MS)[a] [B]+ [B]+ (HR-MS)[b] 
        
FPP 1 222 204 161 161.1336 84 84.0574 
(1-13C)FPP (6-13C)-1 223 205 162 162.1354 85 85.0599 
(2-13C)FPP (5-13C)-1 223 205 162 162.1357 85 85.0601 
(3-13C)FPP (4-13C)-1 223 205 162 162.1362 85 85.0606 
(4-13C)FPP (3-13C)-1 223 205 162 162.1356 85 85.0601 
(5-13C)FPP (2-13C)-1 223 205 162 162.1359 84 84.0567 
(6-13C)FPP (1-13C)-1 223 205 162 162.1357 84 84.0568 
(7-13C)FPP (10-13C)-1 223 205 162 162.1356 84 84.0565 
(8-13C)FPP (9-13C)-1 223 205 162 162.1356 84 84.0566 
(9-13C)FPP (8-13C)-1 223 205 162 162.1355 84 84.0567 
(10-13C)FPP (7-13C)-1 223 205 162 162.1358 84 84.0565 
(11-13C)FPP (11-13C)-1 223 205 161 161.1321 84 84.0565 
(12-13C)FPP (12-13C)-1 223 205 161 161.1320 84 84.0567 
(13-13C)FPP (13-13C)-1 223 205 161 161.1323 84 84.0568 
(14-13C)FPP (14-13C)-1 223 205 162 162.1358 84 84.0567 
(15-13C)FPP (15-13C)-1 223 205 162 162.1357 85 85.0602 
(13C15)FPP (13C15)-1 237 219 173 173.1728 89 89.0738 
[a] Calculated masses for [A]+: 161.1325 (C12H17+), 162.1358 (13C112C11H17+), 173.1727 (13C12H17+). [b] Calculated masses for 
[B]+: 84.0570 (C5H8O+), 85.0603 (13C112C4H17O+), 89.0737 (13C5H8O+). 
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A method for investigating the stereochemical
course of terpene cyclisations†
Patrick Rabe, Jan Rinkel, Tim A. Klapschinski, Lena Barra and Jeroen S. Dickschat*
Three sesquiterpene cyclases from Streptomyces scabei 87.22, Streptomyces venezuelae ATCC 10712
and Streptomyces clavuligerus ATCC 27064 were characterised and their products were identified as
(−)-neomeranol B, (+)-isodauc-8-en-11-ol and (+)-intermedeol, respectively. The stereochemical
courses of the terpene cyclisations were investigated by use of various 13C-labelled FPP isotopomers.
A quick and easy test was developed that allows to distinguish reprotonations of olefinic double bonds
in neutral intermediates from the two stereoheterotopic faces. The method makes use of incubating
13C-FPP isotopomers labelled at the reprotonated carbon in deuterium oxide and subsequent HSQC ana-
lysis of the product. A 1,7-cyclisation towards (+)-isodauc-8-en-11-ol was followed by use of (1,7-13C2)-
FPP. Surprisingly, the (+)-isodauc-8-en-11-ol also accepted (2Z,6E)-FPP resulting in the same product
profile as obtained from (2E,6E)-FPP.
Introduction
Terpenes are a structurally diverse class of natural products
which are present in all kingdoms of life. Their biosynthesis
proceeds via the linear precursors geranyl diphosphate (mono-
terpenes, C10), farnesyl diphosphate (sesquiterpenes, C15) or
geranylgeranyl diphosphate (diterpenes, C20) that are con-
verted into (poly)cyclic terpene hydrocarbons or alcohols by
terpene cyclases. As crystallographic data reveal,1–8 class 1
enzymes exhibit, despite an overall low sequence conservation,
a highly conserved α-helical fold, and in their active sites the
highly conserved aspartate-rich motif (DDXX(X)(D,E)) near
position 90 and approximately 130 residues downstream the
NSE triad (NDXXSXX(R,K)(E,D)) for binding of a trinuclear
Mg2+ cluster. The substrate binds in turn with its diphosphate
moiety to the Mg2+ cations for formation of a highly reactive
allyl cation. A reaction cascade involving cyclisations, carbon
backbone rearrangements, hydride migrations and a terminal
deprotonation or nucleophilic attack of water yields a terpene
hydrocarbon or alcohol.9,10 The recently obtained crystal struc-
ture of selina-4(15),7(11)-diene synthase from Streptomyces
pristinaespiralis in combination with site-specific mutations
demonstrated the additional involvement of a highly con-
served arginine (pyrophosphate sensor) that is part of an
effector triad located at the helix G break, in most bacterial
enzymes exactly 46 residues upstream of the NSE triad, and a
RY dimer near the enzyme’s C-terminus that are both impor-
tant for substrate recognition.8 Cationic intermediates along
the cyclisation cascade can be stabilised by cation–pi-inter-
actions with aromatic residues.4,5,7,8,11 To date, the products of
nearly 50 bacterial type I terpene synthases have been
characterized,11–31 and the functions of many enzymes can be
delineated from their high sequence identity to these known
enzymes. This work has resulted in the assignment of a func-
tion to nearly half of the ca. 600 presumptive terpene cyclases
encoded in the genomes of sequenced bacteria, while the
other half of these enzymes still awaits functional characteris-
ation. Here we present the molecular cloning and expression
of three bacterial terpene cyclases and structure elucidation of
the products made by these enzymes. Furthermore, the
enzyme mechanisms were investigated by isotopic labelling
experiments.
Results and discussion
The gene of an unidentified terpene synthase from Strepto-
myces scabiei 87.22 (WP_013004899) was cloned into the
expression vector pYE-Express by homologous recombination
in yeast.26 The His-tagged recombinant protein was expressed
in E. coli, purified by Ni-NTA chromatography and incubated
with oligoprenyl diphosphates for functional characterisation.
While GPP and GGPP were not accepted as substrates, FPP
†Electronic supplementary information (ESI) available: Strains, culture con-
ditions, gene cloning and expression conditions, details of incubation experi-
ments and synthesis of (1,7-13C2)FPP including spectroscopic data, and gas
chromatograms, mass spectra and NMR spectra of terpene cyclase products. See
DOI: 10.1039/c5ob01998b
Kekulé-Institut für Organische Chemie und Biochemie, Rheinische Friedrich-
Wilhelms-Universität Bonn, Gerhard-Domagk-Straße 1, 53121 Bonn, Germany.
E-mail: dickschat@uni-bonn.de
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conversion yielded a product with an EI mass spectrum that
was not included in our mass spectral libraries (Fig. 1a of
ESI†). EI-MS-QTOF analysis pointed to a sesquiterpene alcohol
(m/z = 222.1970, calc. for C15H26O
+: 222.1978). The compound
was purified from an enzymatic conversion of 80 mg FPP,
yielding 4.1 mg of the pure sesquiterpene alcohol, and its
structure was determined by one- and two-dimensional NMR
spectroscopy (Table 1).
The 13C-NMR and 13C-DEPT135-NMR spectra of 1 exhibited
fifteen carbon signals (four methyl, five methylene, two
methine, one oxygenated methine and three quarternary
carbons). The absence of signals for sp2 carbons suggested a
tricyclic ring system. The signals for the corresponding
protons for each carbon were assigned by heteronuclear single
quantum correlation (HSQC) spectroscopy. 1H,1H-correlation
spectroscopy (COSY) revealed two contiguous spin systems
(C-5-6-7-8-9 and C-1-2-3, Fig. 2a). The 1H-NMR signals for all
four methyl groups appeared as singlets revealing their attach-
ment to quarternary carbons. The highfield shifts of the
protons attached to C-6 and C-7 (δ = 0.48 and 0.52 ppm)
suggested the presence of a cyclopropane ring. Heteronuclear
multiple bond correlation (HMBC) spectroscopy showed cross
peaks from C-12 and C-13 to C-6, C-7 and C-11, from C-14 to
C-1, C-4, C-8, C-9 and C-10, and from C-15 to C-3, C-4, C-5 and
C-10. These and all other HMBC correlations (including C-6 to
C-5, C-7 and C-8; C-10 to C-2 and C-1 to C-3) were in agreement
with the structure of 1. The relative configuration was deter-
mined by nuclear Overhauser spectroscopy (NOESY, Fig. 2a).
Key correlations were observed between H-12, H-6 and H-7,
indicating the cis-orientation of H-6 and H-7. Correlations
between both bridgehead methyl groups H-14 and H-15 sup-
ported the cis-fused 7-5 ring system. Further diagnostic cross-
peaks were observed between H-5 and H-13 and between
H-6 and H-15, resulting in a fully assigned relative
stereochemistry. The optical rotary power was determined as
[α]24D = −10.2 (c = 0.082, CH2Cl2).
The sesquiterpene alcohol 1 (neomeranol B) is a new
natural product with a neomerane-type carbon backbone as
previously described for neomeranol (2), a compound that was
isolated from the green alga Neomeris annulata and has
cytotoxic activity against brine shrimp.32,33 A series of oxidised
neomeranes was recently isolated from Valeriana officinalis.34
Compound 1 is also present in headspace extracts of
Streptomyces scabiei 87.22 (Fig. 2 of ESI†), demonstrating that
the neomeranol B synthase is expressed under laboratory
culture conditions.
Table 1 NMR data of (−)-neomeranol B (1), (+)-isodauc-8-en-11-ol (3) and (+)-intermedeol (4) in (2H6)benzene
1 Ca 1H (δ, m, J, int)b 13C (δ)c 3 Ca 1H (δ, m, J, int)b 13C (δ)c 4 Ca 1H (δ, m, J, int)b 13C (δ)c
1a 1.78 (dt, 3J = 9.4,
2J = 12.5, 1H)
35.7 (CH2) 1 — 42.5 (Cq) 1a 1.22 (m, 1H) 41.7 (CH2)
1b 1.09 (m, 1H) 1b 0.98 (m, 1H)
2a 1.63 (m, 1H) 19.2 (CH2) 2a 1.33 (m, 1H) 41.9 (CH2) 2 1.33 (m, 2H) 22.5 (CH2)
2b 1.65 (m, 1H) 2b 1.20 (m, 1H)
3a 2.49 (m, 1H) 34.9 (CH2) 3a 1.55 (m, 1H) 27.5 (CH2) 3a 1.58 (m, 1H) 43.8 (CH2)
3b 1.46 (m, 1H) 3b 1.50 (m, 1H) 3b 1.17 (m, 1H)
4 — 52.3 (Cq) 4 2.13 (dt,
3J = 11.4,
3J = 9.2, 1 H)
53.55 (CH) 4 — 71.3 (Cq)
5 3.19 (d, 3J = 9.1, 1H) 69.5 (CH) 5 1.71 (dt, 3J = 12.5,
3J = 2.2, 1 H)
57.4 (CH) 5 1.38 (m, 1H) 49.1 (CH)
6 0.48 (dd, 3J = 9.5,
3J = 9.2, 1H)
31.2 (CH) 6a 1.43 (ddt, 2J = 13.5,
3J = 11.8, 3J = 2.4, 1 H)
23.9 (CH2) 6a 1.81 (m, 1H) 23.9 (CH2)
6b 2.31 (ddt, 2J = 13.5,
3J = 5.6, 3J = 2.4, 1 H)
6b 1.63 (m, 1H)
7 0.52 (dt, 3J = 9.5,
3J = 6.2, 1H)
27.9 (CH) 7a 2.03 (m, 1H) 36.5 (CH2) 7 2.34 (br, 1H) 39.8 (CH)
7b 1.97 (m, 1H)
8a 1.03 (m, 1H) 20.5 (CH2) 8 — 139.4 (Cq) 8a 2.15 (dtt,
3J = 12.6,
3J = 1.8, 1H)
23.1 (CH2)
8b 1.51 (m, 1H) 8b 1.27 (m, 1H)
9a 1.37 (m, 1H) 37.3 (CH2) 9 5.48 (m, 1H) 123.3 (CH) 9a 1.42 (m, 1H) 40.7 (CH2)
9b 1.42 (m, 1H) 9b 1.05 (m, 1H)
10 — 46.1 (Cq) 10a 1.86 (m, 1H) 42.9 (CH2) 10 — 35.4 (Cq)
10b 2.07 (m, 1H)
11 — 19.3 (Cq) 11 — 73.7 (Cq) 11 — 146.9 (Cq)
12 0.95 (s, 3H) 29.0 (CH3) 12 1.06 (s, 3H) 27.7 (CH3) 12 1.78 (dt,
4J = 0.7,
4J = 0.6, 3H)
23.0 (CH3)
13 1.02 (s, 3H) 15.2 (CH3) 13 1.02 (s, 3H) 32.4 (CH3) 13 5.08 (dm,
2J = 9.4,
4J = 0.7, 2 H)
111.4 (CH2)
14 0.87 (d, 4J = 0.8, 3H) 28.0 (CH3) 14 1.75 (m, 3H) 27.3 (CH3) 14 0.79 (t,
4J = 0.8, 3H) 18.6 (CH3)
15 1.04 (s, 3H) 15.2 (CH3) 15 0.85 (s, 3H) 19.4 (CH3) 15 0.98 (d,
4J = 0.7, 3H) 22.7 (CH3)
a Carbon numbering as in Fig. 1. b Chemical shifts δ in ppm, multiplicity m (s = singlet, d = doublet, t = triplet, m = multiplet, br = broad),
coupling constants J are given in Hertz (spectra of 1 and 3 recorded at 500 MHz, spectra of 4 recorded at 600 MHz). c Chemical shifts δ in ppm
and assignment of carbons by 13C-DEPT135 spectroscopy. For NMR data of 3 in (2H)chloroform cf. Table 1 of ESI.
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Using the same approach a terpene synthase from Strepto-
myces venezuelae ATCC 10712 (CCA53839) also yielded an
unknown sesquiterpene alcohol (EI-MS-QTOF: m/z = 222.1973,
the EI mass spectrum is shown in Fig. 1b of ESI†) from FPP,
while GPP and GGPP were not accepted. The enzymatic conver-
sion of 90 mg FPP followed by purification via column
chromatography yielded 12 mg of the pure compound 3. Its
13C-NMR and 13C-DEPT135 spectra showed fifteen carbon
signals for four methyl, five methylene, three methine and
three quarternary carbons (Table 1). One of the quarternary
carbons (δ = 73.7 ppm) carried the alcohol function, while the
signals of two carbons appeared in the olefinic region, indicat-
ing a bicyclic system. HSQC allowed for a correlation of the
1H signals with the 13C signals, while the 1H,1H-COSY
spectrum revealed two spin systems (C-9-10 and C-2-3-4-5-6-7,
Fig. 2b). HMBC connectivities from C-4 to C-11, C-12 and C-13
indicated the 1-hydroxy-1-methylethyl moiety, while further
key HMBC correlations from C-5 to C-3, C-4, C-6, C-7, C-11 and
C-15, and from C-14 to C-7, C-8, C-9 and C-10 explained the
bicyclo[5.3.0]decene system. The relative configuration was
determined by NOESY (Fig. 2b) that showed diagnostic corre-
lations between H-15 and H-12, and between H-5, H-4 and
H-13, in agreement with a trans-fused ring system and the
cis-orientation of H-4 and H-5. The optical rotary power was
determined as [α]22D = +19.4 (c = 0.505, CH2Cl2). In summary,
compound 3 was identified as the new natural product
(+)-isodauc-8-en-11-ol.
Recently, Ikeda and coworkers reported on the production
of (+)-dauca-8,11-diene by the same terpene cyclase during
heterologous expression in Streptomyces avermitilis.29 This
compound was observed as a minor product (3%) of the
purified recombinant enzyme in the conversion of FPP (Fig. 3a
of ESI†). In agreement with this finding only the sesquiterpene
alcohol 3, but not dauca-8,11-diene is present in headspace
extracts of S. venezuelae ATCC 10712 (Fig. 3b of ESI†).35 In
conclusion, the function of the sesquiterpene cyclase from
S. venezuelae must be reassigned as (+)-isodauc-8-en-11-ol
synthase.
The incubation of FPP with a third terpene cyclase from S.
clavuligerus ATCC 27064 (WP_003955204) yielded a sesquiter-
pene alcohol, whereas GPP and GGPP were not converted by
the enzyme. Its EI mass spectrum (Fig. 1c of ESI†) and all
NMR data were in agreement with literature data for inter-
medeol (4) (Tables 1 and 2 of ESI†).36,37 The absolute configur-
ation was determined as (+)-(4S,5S,7R,10S)-4 based on the
measured optical rotary power of [α]25D = +11.9 (c = 0.50,
CH2Cl2) in comparison to reported data for (+)-4 of [α]
22
D =
+18.0 (c = 2.80, CHCl3).
36 The sesquiterpene alcohol 4 is also
found in the volatiles fraction of S. clavuligerus ATCC 27064
(Fig. 4 of ESI†).
The biosynthetic mechanisms of the three characterised
bacterial sesquiterpene cyclases were investigated by isotopic
labelling experiments. For the biosynthesis of 2 a pathway
via cyclisation of FPP to the (E,E)-germacradienyl cation (5) fol-
lowed by deprotonation to bicyclogermacrene (6) was proposed
(Scheme 1a).32 Several types of halogenases including
vanadium-dependent chloroperoxidases or FADH2-dependent
halogenases provide Hal+ equivalents in the biosynthesis of
halogenated natural products.38,39 The halogenation of 6 with
an electrophilic bromine species to the cationic intermediate
8 may initiate a second cyclisation with attack of water, either
in a concerted process or via a cyclopropylcarbinyl cation as
discussed for the biosynthesis of avermitilol,40 to yield 2. For
the biosynthesis of 1 a very similar cyclisation cascade can be
assumed in which the electrophile “Br+” is substituted by a
proton. Such a cyclisation cascade via the neutral intermediate
6 can be catalysed by a single terpene cyclase, while the bio-
synthesis of 2 likely requires two enzymes: a terpene cyclase
for the formation of 6 from FPP and a halogenase for the
conversion of 6 into 2. The pathway for the formation of 1 by
the terpene cyclase from S. scabiei via the neutral intermediate
6 is supported by its occurrence as a trace compound in
enzyme incubations of FPP (Fig. 2a of ESI†).
The protonation of 6 at C-1 was evident from incubations of
(6-13C)FPP31 in water and in deuterium oxide followed by
direct 13C-NMR analysis of the product that was simply
extracted with (2H6)benzene, resulting in a strongly enhanced
singlet for C-1 of 1 in the incubation experiment in water and
a triplet due to 2H,13C-coupling in the experiment in deuter-
ium oxide (Fig. 3a and b). The stereochemical course of the
protonation was followed by HSQC analysis of the two
obtained samples. While (1-13C)-1 gave two distinct crosspeaks
for coupling of C-1 with the two directly bound diastereotopic
Fig. 2 Key HMBC (single headed arrows) and NOESY correlations
(double headed arrows) for (a) neomeranol B (1) and (b) isodauc-8-en-
11-ol (3). Contiguous 1H-spin systems are shown in bold.
Fig. 1 Structures of neomeranol B (1), neomeranol (2), isodauc-8-en-
11-ol (3) and (+)-intermedeol (4).
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protons at δH = 1.09 and 1.78 ppm, only one crosspeak at δH =
1.78 ppm was observed for (1-13C,1-2H)-1 obtained from the
incubation of FPP in deuterium oxide (Fig. 3c). Thus, the
proton at δH = 1.09 was substituted by deuterium, which is cis-
oriented to Me-14, as was established by NOESY with the
unlabelled compound (this hydrogen shows a crosspeak with
the neighbouring methyl group (H-14), while the second
proton at C-1 shows a crosspeak to H-5, next to the hydroxy
function; Fig. 12 of ESI†). In summary, this experiment
revealed a strict stereochemical course for the reprotonation of
the neutral intermediate 6 to yield 1 with a cis-orientation of
the introduced hydrogen and Me-14. Because of the unknown
absolute configuration of 1 it remains unknown whether this
corresponds to a Re or a Si face attack to intermediate 6.
A model for the biosynthesis of (4S,5S,7R,10S)-4 starts with
a 1,10-cyclisation of FPP to the germacradienyl cation (5) that
forms germacrene A (9) upon loss of a proton (Scheme 1b).
Reprotonation at C-1 initiates a second cyclisation and sub-
sequent attack of water to yield 4. This suggested mechanism
was studied using the same approach as described above for
the neomeranol B synthase, i.e. via the incubation of (6-13C)-
FPP with the intermedeol synthase in water and in deuterium
oxide. NMR analysis of the extracted product resulted in a
strongly enhanced singlet (incubation in water) or triplet for
the 13C-labelled carbon due to 2H,13C-coupling (incubation in
deuterium oxide), thereby proving the reprotonation at C-1
(Fig. 4a and b). The stereochemistry of the protonation step
was again evident from HSQC analysis of both samples, reveal-
ing that the crosspeak at δH = 0.98 ppm (pro-R proton as
evident from the NOESY spectrum, Fig. 26 of ESI†) is retained
in the deuterated sample, while the crosspeak at δH =
1.22 ppm (pro-S proton) is lost (Fig. 4c). Here, reprotonation of
the neutral intermediate 9 from the Si face can be concluded,
since the absolute configuration of 4 is known.
A biosynthetic proposal for the formation of 3 includes the
initial isomerisation of FPP to NPP that may react in a zipper
mechanism in two concerted 1,7- and 6,10-cyclisations with
Scheme 1 Proposed biosynthesis of (a) neomeranols 1 and 2, (b)
(+)-(4S,5S,7R,10S)-intermedeol (4) and isodauc-8-en-11-ol (3). Red
circles indicate 13C-labelled carbons.
Fig. 3 Incubation experiments with (6-13C)FPP and the neomeranol B
synthase in water and in deuterium oxide. Red circles indicate 13C-
labelled carbons.
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concomittant attack of water at C-11 (Scheme 1c). Experi-
mental evidence for this mechanism was obtained by incu-
bation of (1,7-13C2)FPP (for synthesis cf. Fig. 5 of ESI†) with
the purified recombinant isodauc-8-en-11-ol synthase that gave
two doublets for 1JC,C-coupling in the
13C-NMR spectrum with
a coupling constant of 35.0 Hz and a strong roof effect (Fig. 5).
The biosynthesis of related sesquiterpenoids from
Ferula jaeshkeana was suggested by Dev et al. in 1973 to
proceed via (2Z,6E)-FPP.41 Although the generally accepted
mechanism for the biosynthesis of sesquiterpenes with an
initial 1,6- or 1,7-cyclisation proceeds via NPP, the possibility
of an enzymatic conversion of (2Z,6E)-FPP by the isodauc-8-en-
11-ol synthase was tested. (2Z,6E)-FPP7 was indeed accepted as
substrate and converted into the same main product 3 and all
minor side products as observed from (2E,6E)-FPP (Fig. 3c of
ESI†). In previous work the conversion of (2Z,6E)-FPP was also
demonstrated for tobacco 5-epi-aristolochene synthase42,43 and
δ-cadinene synthase from cotton,44 but in contrast to our find-
ings for the isodauc-8-en-11-ol synthase these experiments
yielded different product spectra as obtained from (2E,6E)-FPP.
Whether the results presented here mean that (2Z,6E)-FPP is a
true intermediate in the biosynthesis of 3 that may itself be
formed from (2E,6E)-FPP via NPP (Scheme 1c),45 or just fits
with a similar conformation as NPP into the enzyme’s active
site and is thus transformed, is a question that will be difficult
to address experimentally.
Finally, the stereochemical course of all three bacterial ses-
quiterpene cyclases in terms of the fate of the terminal E- and
Z methyl groups (C-12 and C-13) of FPP was investigated by
incubation experiments with (13-13C)FPP (red circles in
Scheme 1). As was followed by 13C-NMR spectroscopy (Fig. 6)
the isotopic labelling from (13-13C)FPP showed up at C-13 (δ =
15.2 ppm), but not at C-12 of 1 (δ = 29.0 ppm) in the incu-
bation experiment with neomeranol B synthase, while the
enzymatic conversion of (13-13C)FPP with intermedeol
synthase produced 4 with specific introduction of labelling
into C-12 (δ = 23.0 ppm) and not C-13 (δ = 111.4 ppm; a very
small peak is visible here that likely originates from a small
contamination (<1%) of synthetic (13-13C)FPP with (12-13C)-
FPP). Finally, the incubation of (13-13C)FPP with the isodauc-
8-en-11-ol synthase resulted in a specific labelling at C-13 (δ =
32.4 ppm), but not at C-12 of 3 (δ = 27.7 ppm). In conclusion,
all three enzymes revealed a very strict stereochemical course.
Fig. 5 Incubation of (1,7-13C2)FPP with isodauc-8-en-11-ol synthase.
The two doublets in the 13C-NMR spectrum show a strong roof effect.
Red circles indicate 13C-labelled carbons.
Fig. 4 Incubation experiments with (6-13C)FPP and the intermedeol
synthase in water and in deuterium oxide. Red circles indicate 13C-
labelled carbons.
Fig. 6 Results (13C-NMR spectra) obtained from incubation experi-
ments with (13-13C)FPP. The corresponding isotopic labellings are
shown in Scheme 1.
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Conclusions
We have characterised the enzyme products of three bacterial
terpene cyclases as (−)-neomeranol B (1), (+)-isodauc-8-en-11-
ol (3) and (+)-intermedeol (4). The compounds 1 and 3 have
been isolated from natural sources for the first time. The
terpene cyclisations of FPP to 1 and 4 proceed via the neutral
intermediates bicyclogermacrene and germacrene A, that are
reprotonated for further conversion into the final products. We
provide here a fast and easy method to investigate the stereo-
chemical courses, i.e. to distinguish reprotonations from the
two stereochemically different faces of an olefinic double
bond, by using a 13C-FPP isotopomer with labelling at the
reprotonated carbon for incubations in deuterium oxide. A
simple HSQC spectrum in combination with NOESY analysis
of the unlabelled enzyme product gives then information
about the stereochemical course. Furthermore, we have investi-
gated the stereochemical courses of terpene cyclisations with
respect to the fate of the stereochemically different E- and Z
methyl groups of FPP (C-12 and C-13) by usage of (13-13C)FPP.
A similar experiment using deuterium labels has previously
been performed, inter alea, with the epi-isozizaene synthase
from Streptomyces coelicolor A3(2).46 As demonstrated here and
in previous work from our and other groups isotopic labellings
are very useful for structure elucidations and mechanistic
biosynthetic investigations.28,31,47–52 We will continue to
investigate interesting aspects of terpene cyclisations via this
approach.
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Strains and culture conditions, cloning and homologous recombination 
The bacteria Streptomyces clavuligerus ATCC 27064, Streptomyces scabiei 87.22 and 
Streptomyces venezuelae ATCC 10712 were obtained from the Deutsche Sammlung von 
Mikroorganismen und Zellkulturen (DSMZ, Braunschweig, Germany). Genomic DNA was 
isolated from cells grown in Gym 65 liquid culture (glucose: 4.0 g, yeast extract: 4.0 g, malt 
extract: 4.0 g, water: 1 L, pH 7.2). The genes of the terpene synthases were amplified from 
genomic DNA using the primers as shown in Table 1. The obtained PCR product was used 
as a template in a second PCR with elongated primers containing homology arms (Table 1, 
homology arms are underlined) for homologous recombination with the linearised (HindIII 
and EcoRI double digest) vector pYE-Express1 in S. cerevisiae FY834. Transformation of S. 
cerevisiae with the PCR product and the linearised vector pYE-Express for homologous 
recombination was carried out using the LiOAc/SS carrier DNA protocol.2 The transformed 
cells were plated on SM-URA2 agar plates and grown for three days at 28 °C. Plasmid DNA 
was isolated from the grown yeast using the kit Zymoprep Yeast Plasmid Miniprep II (Zymo 
Research, Irvine, USA), shuttled into E. coli BL 21 cells by electroporation and confirmed by 
sequencing. 
 
Table 1 Primers for cloning of terpene cyclase genes into pYE-Express by homologous recombination in yeast. 
Primer Terpene 
synthase 
Sequence 
PR016f_ZP06775814 intermedeol ATGAATCCCCGGATGACACA 
PR016r_ZP06775814 intermedeol CTATCCGGACGCGGTCCGCG 
MY021f_ZP06775814 intermedeol GGCAGCCATATGGCTAGCATGACTGGTGGAATGAATCCCCGGATGACACA 
MY021r_ZP06775814 intermedeol TCTCAGTGGTGGTGGTGGTGGTGCTCGAGTCTATCCGGACGCGGTCCGCG 
PR026f_CCA53839 isodaucen-11-ol ATGACAGTGCGTGCCGTCGA 
PR026r_CCA53839 isodaucen-11-ol TCATGCGCTTCCTGCGGAGG 
PR025f_CCA53839 isodaucen-11-ol GGCAGCCATATGGCTAGCATGACTGGTGGAATGACAGTGCGTGCCGTCGA 
PR025r_CCA53839 isodaucen-11-ol TCTCAGTGGTGGTGGTGGTGGTGCTCGAGTTCATGCGCTTCCTGCGGAGG 
PR063f_YP003492893 neomeranol B GTGGCGGACACCTTCCAGAT 
PR063r_YP003492893 neomeranol B TCAGGCGGCGCACCGGTATC 
PR062f_YP003492893 neomeranol B GGCAGCCATATGGCTAGCATGACTGGTGGAGTGGCGGACACCTTCCAGAT 
PR062r_YP003492893 neomeranol B TCTCAGTGGTGGTGGTGGTGGTGCTCGAGTTCAGGCGGCGCACCGGTATC 
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Incubation experiments of purified enzyme with FPP and isolation of products 
E. coli BL 21 transformants were inoculated in a 2YT liquid preculture (tryptone: 16 g, yeast 
extract: 10 g, NaCl: 5 g, water: 1 L, pH 7.2) containing kanamycin (50 mg/L) overnight. E. coli 
BL 21 transformants from the preculture were inoculated in large scale 2YT liquid cultures (6-
8 x 1 L) containing kanamycin (50 mg/L). Cells were grown to an OD600 = 0.4 at 37 °C and 
160 rpm, followed by cooling of the cultures to 18 °C for 30 minutes. IPTG (0.4 mM) was 
added and the culture was incubated at 18 °C and 160 rpm overnight. E. coli cells were 
harvested by centrifugation at 4 °C and 3600 rpm for 60 min. The pellets were resuspended 
in 2 x 10 mL lysis buffer (20 mM Na2HPO4, 0.5 M NaCl, 20 mM imidazole, 1 mM MgCl2, pH 
7.0) for each 1 L culture. Cell disruption was done by ultra-sonication on ice for 6 x 60 sec. 
The soluble enzyme fractions were harvested at 4 °C and 8000 rpm by repeated 
centrifugation (2 x 10 min). Protein purification was performed by Ni2+-NTA affinity 
chromatography with Ni2+-NTA superflow (Novagen) using binding buffer (20 mM Na2HPO4, 
0.5 M NaCl, 20 mM imidazole, 1 mM MgCl2, pH 7.0) and elution buffer (20 mM Na2HPO4, 0.5 
M NaCl, 500 mM imidazole, 1 mM MgCl2, pH 7.0). All wash and elution fraction were checked 
by SDS-PAGE. Incubation experiments were performed with the pure protein fractions (80-
160 mL) and incubation buffer (100 mL, 50 mM Tris∙HCl, 10 mM MgCl2, 20 % glycerin, pH 
7.0) containing FPP (50-80 mg, 0.4-0.6 mg/mL) at 28 °C overnight. The reaction mixture was 
extracted with 3 x 100 mL pentane. The combined organic layers were dried with MgSO4 and 
concentrated under reduced pressure. Column chromatography on silica gel of the crude 
products with pentane/diethyl ether (5:1) yielded the pure sesquiterpene alcohols for 
structure elucidation by NMR. 
Neomeranol B (1). Yield: 4.1 mg. HRMS (TOF): obs. m/z (calcd., formula) = 222.1970 
(222.1978, C15H26O+, [M]+). GC (HP5-MS): I = 1607. MS (EI, 70 eV): m/z (%) = 222 (0.3) 
[M]+, 204 (2), 189 (3), 161 (4), 137 (5), 123 (4), 109 (24), 97 (35), 85(100), 69 (18), 55 (20), 
41 (18). IR (diamond ATR): 𝜈 = 3385 (br m), 2953 (s), 2923 (s), 2891 (m), 2873 (m), 1725 
(w), 1453 (m), 1378 (m), 1298 (w), 1261 (w), 1164 (w), 1136 (w), 1019 (s), 1002 (s), 951 (w), 
827 (w), 804 (w), 712 (w), 600 (w), 529 (w) cm-1. []D24 = -10.2 (CH2Cl2, c = 0.082). 
Intermedeol (4). Yield: 9.6 mg. HRMS (TOF): obs. m/z (calcd., formula) = 222.1970 
(222.1978, C15H26O+, [M]+). GC (HP5-MS): I = 1664. MS (EI, 70 eV): m/z (%) = 222 (3) [M]+, 
204 (100), 189 (95), 175 (17), 161 (94), 147 (34), 133 (38), 122 (46), 107 (46), 107 (45), 93 
(45), 81 (65), 71 (30), 55 (26), 43 (34). IR (diamond ATR): 𝜈 = 3438 (br m), 3085 (w), 2969 
(m), 2929 (s), 2867 (m), 2850 (m), 1738 (w), 1638 (w), 1452 (m), 1381 (m), 1229 (w), 1168 
(w), 1095 (m), 1064 (w), 931 (w), 907 (m), 887 (m), 803 (w), 575 (w), 527 (w) cm-1. []D25 = 
+11.9 (CH2Cl2, c = 0.50). 
Isodauc-8-en-11-ol (3). Yield: 11.8 mg. HRMS (TOF): obs. m/z (calcd., formula) = 222.1973 
(222.1978, C15H26O+, [M]+). GC (HP5-MS): I = 1669. MS (EI, 70 eV): m/z (%) = 222 (x) [M]+, 
204 (35), 189 (14), 163 (18), 161 (16) 149 (41), 135 (16), 121 (27), 107 (41), 95 (77), 81 (44), 
67 (29), 59 (100), 55 (20), 42 (32). IR (diamond ATR): 𝜈 = 3364 (br m), 2966 (m), 2923 (m), 
2886 (m), 1738 (w), 1454 (w), 1440 (w), 1383 (m), 1364 (m), 1147 (s), 945 (m), 928 (m), 883 
(s), 840 (m), 802 (m), 660 (w), 587 (w), 519 (w), 476 (w) cm-1. []D22 = +19.4 (CH2Cl2, c = 
0.505). 
NMR data of all natural products are presented in Table 1 of main text. 
 
Incubation experiments of purified enzyme with 13C-labelled FPPs. 
For each incubation a 0.5 L 2YT liquid culture (containing kanamycin (50 mg/L)) of E. coli BL 
21 transformants was inoculated from an overnight preculture. Cells were grown to an OD600 
= 0.4 at 37 °C and 160 rpm, followed by cooling of the cultures to 18 °C for 30 minutes. IPTG 
(0.4 mM) was added and the culture was incubated at 18 °C and 160 rpm overnight. E. coli 
cells were harvested by centrifugation at 4 °C and 8000 rpm for 10 min. The pellets were 
resuspended in 10 mL lysis buffer (20 mM Na2HPO4, 0.5 M NaCl, 20 mM imidazole, 1 mM 
MgCl2, pH 7.0) and lysed by ultra-sonication on ice for 5 x 30 sec. The soluble enzyme 
fractions were harvested at 4°C and 11000 rpm by centrifugation (1 x 10 min). Protein 
purification was performed by Ni2+-NTA affinity chromatography with Ni2+-NTA superflow 
(Novagen) using binding buffer (20 mM Na2HPO4, 0.5 M NaCl, 20 mM imidazole, 1 mM MgCl2, 
pH 7.0) and elution buffer (20 mM Na2HPO4, 0.5 M NaCl, 500 mM imidazole, 1 mM MgCl2, pH 
7.0). Each pure protein fraction (checked by SDS) was concentrated with a Vivaspin20 
concentration tube (MWCO 30000, Sartorius Stedim, Göttingen) for 1.5 h at 6000 rpm to 2 
mL enzyme fraction. Incubation experiments were performed with the pure protein (2 mL) 
and incubation buffer (2 mL, 50 mM Tris∙HCl, 10 mM MgCl2, 20 % glycerin, pH 7.0) containing 
the 13C-labelled FPP (3 mg, 1.5 mg/mL) at 28 °C overnight. The reaction mixture was 
extracted with 0.6 mL (2H6)benzene and directly measured by NMR. 
The protein purifications of intermedeol synthase and neomeranol B synthase in D2O were 
performed by Ni2+-NTA affinity chromatography with Ni2+-NTA superflow (Novagen) using 
binding buffer (20 mM Na2HPO4, 0.5 M NaCl, 20 mM imidazole, 1 mM MgCl2, pH 7.0 in D2O) 
and elution buffer (20 mM Na2HPO4, 0.5 M NaCl, 500 mM imidazole, 1 mM MgCl2, pH 7.0 in 
D2O). Each pure protein fraction (checked by SDS) was concentrated with a Vivaspin20 
concentration tube (MWCO 30000, Sartorius Stedim, Göttingen) for 1.5 at 6000 rpm to 2 mL 
enzyme fraction. Incubation experiments were performed with the pure protein (2 mL) and 
D2O (2 mL) containing the (6-13C)FPP (3 mg, 1.5 mg/mL) at 28 °C overnight. The reaction 
mixture was extracted with 0.6 mL (2H6)benzene and directly measured by NMR. 
 
Incubation experiments of purified isodaucen-11-ol synthase with (2Z,6E)FPP 
For the incubation experiment of isodaucen-11-ol synthase with the substrate analogue 
(2Z,6E)FPP a 0.5 L 2YT liquid culture (containing kanamycin (50 mg/L)) of E. coli BL 21 
transformants was inoculated. The cultivation and protein isolation conditions are performed 
as reported above. The pure protein fraction of isodaucen-11-ol synthase was used for an 
incubation experiment with the pure protein (2 mL) and incubation buffer (2 mL, 50 mM 
Tris∙HCl, 10 mM MgCl2, 20 % glycerin, pH 7.0) containing the (2Z,6E)FPP3 (0.6 mg, 0.3 
mg/mL) at 28 °C overnight. The reaction mixture was extracted with 0.5 mL nhexane
 
and 
directly injected in GC/MS. 
 
GC-/MS and GC/Q-TOF analysis 
GC-MS analyses were carried out with a 7890B gas chromatograph connected to a 5977A 
inert mass detector (Agilent) fitted with a HP5-MS fused silica capillary column (30 m, 0.25 
mm i. d., 0.50 m film). Instrumental parameters were (1) inlet pressure, 77.1 kPa, He 23.3 
mL min-1, (2) injection volume, 1-2 L, (3) transfer line, 250 °C, and (4) electron energy 70 
eV. The GC was programmed as follows: 5 min at 50 °C increasing at 10 °C min-1 to 320 °C, 
and operated in split mode (50:1, 60 s valve time). The carrier gas was He at 1 mL min-1. 
Retention indices (I) were determined from a homologous series of n-alkanes (C8-C40). 
HRMS analyses were carried out with a 7890B gas chromatograph connected to a 7200 
accurate-mass Q-TOF mass detector (Agilent) eqipped with a HP5-MS fused silica capillary 
column (30 m, 0.25 mm i. d., 0.50 m film). Instrumental parameters were (1) inlet pressure, 
83.2 kPa, He 24.6 mL min-1, (2) injection volume, 1 L, (3) transfer line, 250 °C, and (4) 
electron energy 70 eV. The GC was programmed for HR-MS as follows: 5 min at 50 °C 
increasing at 10 °C min-1 to 320 °C, and operated in split mode (50:1-100:1, 60 s valve time). 
The carrier gas was He at 1 mL min-1. 
 
CLSA headspace sampling 
The volatiles released by Streptomyces scabiei 87.22, Streptomyces venezuelae ATCC 
10712 and Streptomyces clavuligerus ATCC 27064 were trapped by use of the CLSA 
(closed-loop stripping analysis) technique after cultivation of Streptomyces scabiei 87.22 on 
medium Gym 65 (glucose: 4.0 g, yeast extract: 4.0 g, malt extract: 4.0 g, water: 1 L, pH 7.2) 
and Streptomyces venezuelae ATCC 10712 on medium SFM (mannitol: 20.0 g, soya flour: 
20.0 g, water: 1 L, pH 7.2) for 3 d at 28°C as reported previously.4 
 Fig. 1 EI-MS spectra of a) neomeranol B (1), b) isodauc-8-en-11-ol (3) and c) intermedeol 
(4). 
 Fig. 2 Total ion chromatograms of a) a hexane extract of an incubation experiment of 
neomeranol B synthase with FPP at pH 7.0 and b) of a CLSA headspace extract of wildtype 
Streptomyces scabiei 87.224 on medium SFM demonstrating the production of 1. The slighly 
deviating retention times for one and the same compound in the three samples are due to 
usage of different GCs, but retention indices matched. 
 Fig. 3 Total ion chromatograms a) of a hexane extract of an incubation experiment of 
isodauc-8-en-11-ol synthase with (2E,6E)-FPP at pH 7.0, b) of a CLSA headspace extract of 
wildtype S. venezuelae ATCC 107124 on medium Gym 65 demonstrating the production of 3, 
and c) of an hexane extract of an incubation experiment of isodauc-8-en-11-ol synthase with 
(2Z,6E)-FPP at pH 7.0. The slighly deviating retention times for one and the same compound 
in the three samples are due to usage of different GCs, but retention indices matched. 
Table 2 Comparison of measured and reported NMR data of intermedeol (4) in 
(2H)chloroform, confirming the identity of isolated 4 and intermedeol. 
4 (this study, 100 MHz)[a] 4 (de Groot et al., 50 MHz)5 4 (San Feliciano et al., 50 MHz)6 
146.9 146.6 146.8 
110.8 110.7 110.7 
72.1 72.0 71.9 
49.2 49.1 49.1 
43.6 43.4 43.5 
41.4 41.3 41.4 
40.4 40.2 40.4 
39.3 39.2 39.4 
35.3 35.2 35.2 
23.5 23.4 23.5 
22.8 22.7 22.7 
22.7 22.7 22.7 
22.3 22.2 22.3 
20.2 20.1 20.1 
18.5 18.4 18.4 
[a] All signals are given in ppm. Deviations of reported 13C-NMR shifts from data measured in 
this work are shown in brackets. 
 Fig. 4 Total ion chromatogram of a CLSA headspace extract of wildtype Streptomyces 
clavuligerus ATCC 270644 on medium SFM demonstrating the production of 4. 
Fig. 5 Synthesis of (1,7-13C2)FPP. 
 
 
General synthetic methods 
Chemicals were purchased from Acros Organics (Geel, Belgium) or Sigma Aldrich Chemie 
GmbH (Steinheim, Germany) and used without purification. All non-aqueous reactions were 
performed under an inert atmosphere (N2 or Ar) in flame-dried flasks. Solvents were purified 
by distillation and dried according to standard methods. Thin-layer chromatography was 
performed with 0.2 mm precoated plastic sheets Polygram Sil G/UV254 (Machery-Nagel). 
Column chromatography was carried out using Merck silica gel 60 (70-200 mesh). NMR 
spectra of synthetic compounds and isolated natural products were recorded on a Bruker 
DRX-400 (400 MHz), AV III-400 (400 MHz) or AV Avance DMX-500 (500 MHz) spectrometer, 
and were referenced against solvent signals (1H NMR: (2H)chloroform  = 7.26 ppm, 
(2H6)benzene  = 7.16 ppm, 13C NMR: (2H)chloroform  = 77.16 ppm, (2H6)benzene  = 
128.06 ppm). 
Synthesis of ethyl (1,7-13C2)-(6E)-3,7,11-trimethyldodeca-2,6,10-trienoate (SI-2) 
A solution of diisopropylamine (95 mg, 0.93 mmol, 1.1 eq.) in abs. THF (5 mL) was cooled to 
0 °C and treated with n-butyl lithium (59.4 L, 0.93 mmol, 1.6 M in hexane, 1.1 eq.). It was 
stirred for 30 min at 0 °C and then the reaction was cooled to -78 °C. Slowly (1-13C)triethyl 
phoshonoacetate (210 mg, 0.93 mmol, 1.1 eq.) was added and stirring was continued for 2 h 
at -78 °C. (6-13C)Geranylacetone7 (SI-1) (164 mg, 0.84 mmol, 1.0 eq.) was added dropwise 
at -78°C and the reaction mixture was stirred over night at room temperature. The reaction 
was hydrolyzed by addition of distilled water, followed by extraction with ethyl acetate. The 
combined organic layers were dried over MgSO4 and concentrated under reduced pressure. 
Column chromatography on silica gel with cyclohexane/ethyl acetate (45:1) resulted in a 
mixture of diastereoisomers SI-2 (E/Z : 4/1; 92 mg, 0.35 mmol, 41%). 
1H-NMR (400 MHz, CDCl3):  = 5.68-5.62 (m, 1H, CH), 5.12-5.05 (m, 2H, 2xCH), 4.14 (dq, 
3JH,H = 7.1 Hz, 3JC,H = 3.0 Hz, 2H, CH2), 2.19-2.15 (m, 7H, 2xCH2 + CH3), 2.09-2.02 (m, 2H, 
1xCH2), 2.01-1.94 (m, 2H, 1xCH2), 1.27 (t, 3JH,H = 7.1 Hz, 3H, CH3), 1.68 (s, 3H, CH3), 1.60 
(br, 3H, CH3), 1.59 (s, 3H, CH3) ppm.13C-NMR (100 MHz, CDCl3):  = 167. 0 (13Cq), 159.9 (d, 
2JC,C = 2.0 Hz, Cq), 136.3 (13Cq), 131.5 (Cq), 124.4 (d, 3JC,C = 3.7 Hz, CH), 123.0 (d, 1JC,C = 
73.6 Hz, CH), 115.7 (d, 1JC,C = 75.7 Hz, CH), 59.6 (d, 2JC,C = 2.3 Hz, CH2), 41.1 (dd, 3JC,C = 
7.0 Hz, 3JC,C = 3.6 Hz, CH2), 39.8 (d, 1JC,C = 42.6 Hz, CH2), 26.8 (d, 2JC,C = 2.3 Hz, CH2), 26.1 
(CH2), 25.8 (CH3), 18.9 (d, 3JC,C = 1.5 Hz, CH3), 17.8 (CH3), 16.1 (d, 1JC,C = 42.1 Hz, CH3), 
14.5 (d, 3JC,C = 2.2 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 266 (11) [M]+, 251 (4), 221 (18), 
205 (8), 192 (12), 177 (14), 148 (20), 137 (39), 129 (100), 122 (87), 101 (45), 82 (91), 69 
(99), 54 (18), 41 (93). 
 
Synthesis of (1,7-13C2)-(2E,6E)-farnesol (SI-3) 
The mixture of diastereoisomers SI-2 (92 mg, 0.34 mmol, 1.0 eq.) in abs. THF (3.5 mL) was 
cooled to -78 °C and a solution of DIBAL-H (0.75 mmol, 0.75 mL 2.2 eq., 1.0 M in hexane) 
was added dropwise. The reaction mixture was stirred for 2 h at -78 °C. It was hydrolyzed 
with saturated potassium sodium tartrate solution in water and extracted three times with 
diethyl ether. The combined organic layers were dried over MgSO4 and concentrated under 
reduced pressure. Repeated column chromatography with cyclohexane/ethyl acetate (9:1) 
yielded in the alcohols (1,7-13C2)-(2E,6E)-farnesol (30 mg, 0.14 mmol, 41%) and (1,7-13C2)-
(2Z,6E)-farnesol (SI-3) (13 mg, 0.06 mmol, 17%) as colorless oils. 
1H-NMR (400 MHz, CDCl3):  = 5.42 (tdq, 3JH,H = 6.9 Hz, 2JC,H = 1.3 Hz, 4JH,H = 1.3 Hz, 1H, 
CH), 5.14-5.06 (m, 2H, 2xCH), 4.15 (dd, 1JC,H = 142.2 Hz, 3JH,H = 6.9 Hz, 2H, CH2), 2.16-1.94 
(m, 8H, 4xCH2), 1.68 (s, 6H, 2xCH3), 1.60 (s, 3H, 1xCH3), 1.60 (d, 2JC,H = 5.9 Hz, 3H, 1xCH3) 
ppm.13C-NMR (100 MHz, CDCl3):  = 140.0 (d, 2JC,C = 1.3 Hz, Cq), 133.5 (13Cq), 131.5 (Cq), 
124.4 (d, 3JC,C = 3.4 Hz, CH), 123.9 (d, 1JC,C = 73.5 Hz, CH), 123.5 (d, 1JC,C = 47.1 Hz, CH), 
59.6 (13CH2), 39.8 (d, 1JC,C = 42.7 Hz, CH2), 39.7 (cd, 3JC,C = 4.7 Hz, 3JC,C = 3.6 Hz, CH2), 
26.9 (d, 2JC,C = 2.2 Hz, CH2), 26.4 (CH2), 25.8 (CH3), 17.8 (CH3), 16.4 (d, 3JC,C = 4.3 Hz, 
CH3), 16.2 (d, 1JC,C = 42.4 Hz, CH3) ppm. MS (EI, 70 eV): m/z (%) = 224 (5) [M]+, 206 (6), 192 
(14), 181 (10), 163 (20), 137 (77), 124 (63), 110 (56), 94 (93), 82 (100), 69 (98), 55 (38), 41 
(99). 
 
Synthesis of (1,7-13C2)-(2E,6E)-farnesyl diphosphate (FPP) 
A solution of (1,7-13C2)-(2E,6E)-farnesol (SI-3) (30 mg, 0.14 mmol, 1.0 eq.) in abs. THF (0.4 
mL) was treated with PBr3 (15 mg, 0.056 mmol, 5.3 L, 0.4 eq.) at 0°C. The reaction was 
stirred for 30 min at 0°C and quenched by pouring into ice-water. After extraction with 
pentane the combined organic layers were dried with MgSO4. The solvent was removed 
under reduced pressure and the pale yellow oil was subsequently added to a solution of 
(nBu4)3HP2O7 (190 mg, 0.21 mmol, 1.5 eq.) in abs. CH3CN (0.8 mL). The reaction mixture 
was stirred over night at room temperature and then concentrated under reduced pressure. 
The yellow oil was loaded onto a column containing ion exchange resin (DOWEX 50W-X8, 
NH4+ form). Elution with two column volumes of ion exchange buffer (0.03 M NH4HCO3 in 
2% iPrOH/H2O) and freeze drying yielded a yellowish solid. This material was dissolved in 
0.05 M NH4HCO3 and iPrOH/CH3CN (1/1) was added. The mixture was shaken until a white 
solid precipitated. After centrifugation the solution was transferred to a fresh flask and the 
solid again dissolved in 0.05 M NH4HCO3. The procedure was repeated twice. The solvent 
was pooled and concentrated under reduced pressure and again resolved in 5 mL H2O. 
Freeze-drying give (1,7-13C2)FPP (54 mg, 0.12 mmol, 85%) as pale yellow solid. 
1H-NMR (400 MHz, CDCl3):  = 5.46 (br, 1H, CH), 5.24-5.14 (m, 2H, 2xCH), 4.46 (d, 
1JC,H=147.9, 2H, CH2), 2.15-1.95 (m, 8H, 4xCH2), 1.73 (br, 3H,CH3), 1.68 (s, 3H,CH3), 1.62 
(d, 3H,CH3), 1.62 (s, 3H,CH3).13C-NMR (100 MHz, CDCl3):  = 145.6 (d, 2JC,C = 1.7 Hz, Cq), 
138.4 (13Cq), 134.4 (Cq), 127.0 (CH), 126.9 (d, 3JC,C = 3.4 Hz, CH), 122.4 (dd, 1JC,C = 50.7 Hz, 
3JC,P = 1.8 Hz, CH), 65.2 (br, 13Cq), 41.6 (dd, 3JC,C = 4.0 Hz, 3JC,C = 4.2 Hz, CH2), 41.5 (d, 1JC,C 
= 42.7 Hz, CH2), 28.7 (d, 3JC,C = 1.6 Hz, CH2), 28.4 (CH2), 27.7 (CH3), 19.8 (CH3), 18.5 (d, 
3JC,C = 4.2 Hz, CH3), 18.0 (d, 1JC,C = 42.2 Hz, CH3) ppm. 
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Abstract: The biosynthetic gene cluster for the antiplasmodial
natural product siphonazole was identified by using a combi-
nation of genome mining, imaging, and expression studies in
the natural producer Herpetosiphon sp. B060. The siphonazole
backbone is assembled from an unusual starter unit from the
shikimate pathway that is extended by the action of polyketide
synthases and non-ribosomal peptide synthetases with unusual
domain structures, including several split modules and a large
number of duplicated domains and domains predicted to be
inactive. Product release proceeds through decarboxylation
and dehydration independent of the thioesterase SphJ and
yields the diene terminus of siphonazole. High variation in
terms of codon-usage within the gene cluster, together with the
dislocated domain organization, suggest a recent emergence in
evolutionary terms.
For decades natural products have played major roles as
biological probes, inspiration for organic chemists and, most
prominently, an important source of therapeutic com-
pounds.[1, 2] But natural product research currently struggles
with two dilemmas. On the one hand, the development of
resistance renders many drugs useless, while on the other
hand, the development of innovative drugs has been dead-
locked over the last two decades, since doubts have arisen
concerning the usefulness of natural products as a basis for
new leads. One reason is that known compounds are
frequently re-isolated in bioactivity-based screening
approaches. A still promising approach for today is offered
by so far poorly studied groups of organisms, for example,
microorganisms associated with insects or from marine
habitats, or the diverse group of gliding bacteria that usually
exhibit complex life cycles and harbor great potential to
produce bioactive compounds.[3–7] Herein, we report on the
discovery of the siphonazole biosynthetic gene cluster from
Herpetosiphon sp. B060, a strain that we isolated from a soil
sample from the intertidal zone, through a combination of
genome mining, expression analysis, and imaging mass
spectrometry (IMS). The gene cluster shows a mosaic-like
structure, combines parts from the shikimate pathway and
polyketide and non-ribosomal peptide biosynthesis,[8] and
makes use of an unusual termination mechanism that was
studied in detail.
Siphonazole was isolated from Herpetosiphon sp. B060
and its structure elucidated a decade ago,[8] and strategies for
its total synthesis have also been developed,[9, 10] but details of
the biosynthesis, including the timing and the corresponding
gene cluster, are unknown. Besides expression analysis, an
interesting and fast method to follow the production of
a natural product is offered by imaging mass spectrometry
(IMS), which can be directly performed on an agar-plate
culture. To investigate product distribution and to identify the
siphonazole biosynthetic gene cluster, IMS analysis of Her-
petosiphon sp. B060 grown on agar was performed (Fig-
ure 1a). Siphonazole production was specifically detected at
the outer edge of the swarming colonies, that is, only in young
cells. Hence, it was shown that this method can be successfully
used to investigate strains for which no genetic tools exist.
The draft genome ofHerpetosiphon sp. B060 was screened
for polyketide synthase (PKS) and nonribosomal peptide
synthetase (NRPS) sequences, resulting in two contigs that
encoded gene clusters for hybrid PKS/NRPS metabolites.
One of these gene clusters showed high similarity to a pathway
present in the related strainHerpetosiphon aurantiacus, which
does not produce siphonazole. Furthermore, prediction of the
adenylation (A) domain substrate specificities for this cluster
pointed to the incorporation of ornithine, asparagine, and
leucine, but none of these amino acids correlated to the
structure of siphonazole (Scheme 1), which is assembled from
a methylated 3,4-dihydroxybenzoate starter unit, one glycine
and two threonines, three intact acetate units, and C2 of
a fourth acetate (Figure S1 in the Supporting Information).[8]
The second candidate PKS/NRPS gene cluster contained
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A domains predicted to be specific for glycine and threonine
activation, as expected for siphonazole. Furthermore, oxida-
tion domains were identified within the NRPS modules,
which are required for oxazole ring formation. Expression
level analysis for the cluster genes sphA and sphB revealed
strong expression in young cells, with a maximum at day two
(Figure 1b), which is in line with the results of IMS analysis.
A fosmid library of Herpetosiphon sp. B060 genomic
DNA was generated and screened with primers designed for
specific parts of the cluster, resulting in the identification of
three fosmids carrying partial cluster information. DNA
sequencing of the three fosmids yielded large parts of the
cluster sequence, and the gaps were closed by PCR amplifi-
cation of genomic DNA, finally yielding the putative biosyn-
thetic gene cluster for siphonazole biosynthesis (Figure 2).
The hybrid NRPS/trans-AT PKS cluster consists of ten genes,
sphA to sphJ, and spans 50 kb in total (Table S1 in the
Supporting Information). RT-PCR with primer pairs covering
the end of one gene and the start of the downstream following
one revealed that sphA and sphB, as well as sphC to sphJ, are
transcriptionally coupled units (Figure S2).
The core of the siphonazole biosynthetic gene cluster
consists of twelve modules, including four NRPS and eight
trans-AT PKS modules. Further, the O-methyltransferase
SphB, a C-terminal hydrolase domain of SphH, and the
aldolase SphI are integral parts of the cluster (Figure 2). The
activities of these enzymes/domains, as well as activation of
the starter unit, were analyzed in detail (see the Supporting
Information).
Feeding experiments with (1-13C)acetate revealed that the
last acetate is decarboxylated after its incorporation.[8] The
last module shows the unusual domain organization KS-
ACP0-DH0-KR-ACP-HYD, with a C-terminal hydrolase that
is unique to the siphonazole cluster. A bioinformatic analysis
of the discrete thioesterase (TE) SphJ reveals that this
enzyme may have a proof-reading function to release mis-
primed substrates from ACPs of the siphonazole pathway
instead of being responsible for product release. To inves-
tigate how the domains of the last module participate in the
processing of the fourth incorporated malonyl-CoA unit, and
which domains of this module are relevant for product off-
loading, possibly together with the discrete TE SphJ, the C-
terminal part of SphH (ACP-HYD, referred to as SphHCterm)
and SphJ were heterologously expressed in E. coli and
purified (Figures S21,S22). Since the natural substrate in its
bound state with the ACP of SphHCterm is difficult to obtain,
enzyme incubation experiments were performed with short
substrate mimics that were synthesized starting from 3-
hydroxyhex-4-enoic acid (3).[11] The acid was transformed
into the respective N-acetylcysteamine thioester (SNAC
ester) 1 by using EDC as a coupling reagent (Scheme 2). As
Figure 1. a) IMS analysis of an actively growing agar-plate culture of
Herpetosiphon sp. B060. The detected ions m/z 464 and m/z 486
correspond to siphonazole [M+H]+ and the sodium adduct [M+Na]+.
The culture was inoculated in the area indicated by the black line. The
red lines indicate the area of the swarming colony, in which the cells
are 2–3 days old. b) Time course of the expression of the siphonazole
genes sphA and sphB.
Scheme 1. The structure of siphonazole.
Figure 2. The biosynthetic gene cluster and a biosynthetic model for
the assembly of siphonazole. A: adenylation domain, ACP: acyl carrier
protein, AT-OR: acyltransferase–oxidoreductase, C: condensation
domain, CYC: cyclisation domain, DAHP: 3-deoxy-d-arabinoheptuloso-
nate-7-phosphate synthase, DH: dehydratase, HYD: hydrolase, KR: ke-
toreductase, KS: ketosynthase, MT: methyltransferase, OX: oxidation
domain, PCP: peptidyl carrier protein, TE: thioesterase. Domains that
are predicted through bioinformatics to be inactive are indicated by
the index 0.
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a side product of this reaction the SNAC ester of sorbic acid
(2) was isolated. Furthermore, for investigation of the enzyme
mechanism, the isotopically labelled compound (2-13C,2,2-
2H2)-1 was synthesized through aldol addition of (2-
13C,2,2-
2H3)acetic acid to (E)-crotonaldehyde and conversion into the
SNAC ester.
The synthetic substrate analogues were incubated with
different enzyme preparations, and the production of penta-
diene, which is formed analogously to the natural product
siphonazole, was detected by capturing the volatiles from the
incubation reaction on a solid-phase microextraction (SPME)
fiber followed by GC/MS analysis.[12] Incubation of 1 with
SphHCterm and SphJ resulted in a strong production of
pentadiene (4 ; Table 1 and Figure S14), which is in line with
a mechanism of initial hydrolysis of the thioester 1 to the acid
3 by SphJ, followed by a decarboxylation and dehydration by
SphH (Scheme 3a), but this experiment does not always allow
exclusion of the possibility that only one of the enzymes
participates in the reaction. Therefore, the thioester 1was also
incubated with either SphJ or SphHCterm alone, and indeed
incubation of 1 with SphJ did not result in the production of 4
(only traces were detected, as in the control experiment
without enzyme), while incubation with SphHCterm alone
resulted in the formation of 4 in similar amounts to those
observed following incubation with both enzymes. These data
call into question the involvement of the TE SphJ in the
termination mechanism of siphonazole biosynthesis and
further support a sole proof-reading function for this
enzyme, while suggesting that product release, decarboxyla-
tion, and dehydration are all catalyzed by SphHCterm.
The question of which of these three reactions occurs first
was investigated through incubation experiments with sub-
strates (2-13C,2,2-2H2)-1, 2, and 3. If thioester hydrolysis were
first, then the subsequent steps of dehydration and decarbox-
ylation could be a concerted process (Scheme 3b). This was
studied by using the isotopically labelled substrate (2-13C,2,2-
2H2)-1, which may first be hydrolyzed to the free acid (2-
13C,2,2-2H2)-3. Protonation of the hydroxy function in (2-
13C,2,2-2H2)-3 and elimination of water could induce sponta-
neous decarboxylation, and in this mechanism, both deute-
rium atoms and the 13C-labelling should be retained in the
product (1-13C,1,1-2H2)-4. As shown in an incubation experi-
ment with SphHCterm and (2-
13C,2,2-2H2)-1, this was the case
(Figure S15; a mass spectrum of the obtained (1-13C,1,1-2H2)-4
is shown in in Figure S16). The results of this labelling
experiment also speak against a mechanism in which the
dehydration of 1 to 2 is the first step, because this would
require the loss of one deuterium from Ca. Furthermore,
incubation of 2 with neither SphHCterm, SphJ, nor both yielded
4 (Table 1 and Figure S17), which is in agreement with the
function of SphJas proof-reading TE. If ester hydrolysis is the
first step, then substrate 3 should be converted into 4 by
SphHCterm, as was experimentally observed (Table 1 and
Figure S18), but similar amounts of 4 were detected in the
control experiment without enzyme, thus suggesting that
SphHCterm only catalyzes the thioester hydrolysis, while the
decarboxylation–dehydration of 3 to 4 is likely a spontaneous
reaction in water. However, it cannot be excluded that
catalysis by SphHCterm is required for conversion of the natural
substrate.
Siphonazole was tested for its biological activity. Cyto-
toxic activity was observed, but the effect (the mean IC50
value against a panel of 36 cancer cell lines was 5.90 mgmL@1,
12.74 mm) was too weak for further evaluation as an anti-
cancer agent. At non-cytotoxic concentrations, no antiviral
activity was observed (tested: coxsackie virus B3, influenza
virus A, herpes simplex virus type 1). Antibacterial or anti-
Table 1: Results from incubation experiments with substrates 1–3, (2–
13C,2,2-2H2)-1, and different enzyme combinations.
Substrate SphHCterm + SphJ SphJ SphHCterm Control
1 + @ + @
(2-13C,2,2-2H2)-1 n.d. n.d. + @
2 @ @ @ @
3 n.d. n.d. + +
+ : pentadiene production, @: no pentadiene production, n.d.: not
determined
Scheme 3. Possible mechanisms for product release in siphonazole
biosynthesis. a) Thioester hydrolysis by SphJ and dehydration/decar-
boxylation by SphHCterm. b) Initial dehydration by SphHCterm followed by
thioester hydrolysis and decarboxylation by the same enzyme. c) Thio-
ester hydrolysis by SphHCterm followed by spontaneous/concerted
dehydration and decarboxylation.
Scheme 2. Synthesis of substrate analogues 1–3 used for the in vitro
incubation experiments. a) EDC, DMAP, HSNAC, 70% of 1 and 4% of
2 ; b) nBuLi (1 equiv), LDA (1 equiv);, then (E)-crotonaldehyde, 85%;
c) DCC, DMAP, HSNAC, 47%. EDC=1-ethyl-3-(3-dimethylaminopro-
pyl)carbodiimide, DMAP=4-dimethylaminopyridine, HSNAC=N-ace-
tylcystamine, LDA= lithium diisopropylamide, DCC=N,N’-dicyclohex-
ylcarbodiimide.
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fungal effects were not observed. Instead, siphonazole
showed activity against Plasmodium falciparum (IC50 :
0.59 mgmL@1, 1.27 mm ; Table S2).
The siphonazole biosynthetic gene cluster shows many
idiosyncrasies, which is typical for trans-AT PKSs and hints at
recombination events through horizontal gene transfer. Until
now, most approaches to mutate a cluster in a target-oriented
way have remained ineffective. Herpetosiphon sp. B060 is an
example where nature has relatively recently performed
recombinatorial biosynthesis, and obtained a natural prod-
uct—the desired output for synthetic biology. Future inves-
tigation of the siphonazole cluster might provide new insight
into this field to create “unnatural natural products”.
Furthermore, new tools for synthetic biology are desirable.
The investigated thioester hydrolysis, which is a prerequisite
for the terminal, presumably spontaneous decarboxylation–
dehydration of the released molecule, by SphHCterm represents
such a novel functionality within PKS systems. A similar
terminal alkene moiety was observed in the biosynthesis of
the anticancer compound curacin A.[13] However, in cura-
cin A biosynthesis, a sulfotransferase encoded in the terminal
module first transfers a sulfonate group to the b-hxdroxy
group, making it a better leaving group. The subsequent
decarboxylative elimination is catalyzed by a TE. By contrast,
in siphonazole biosynthesis, SphHCterm is sufficient, and the
simplified substrate mimic used indicates promiscuity of this
enzyme, which could be used in further transformations. The
promising antiplasmodial activity of siphonazole will be
subject of future investigations, since additional economically
priced treatment options are still needed to achieve reduc-
tions in the Plasmodium falciparum malaria burden.[14]
In this report, a work flow is illustrated that allows one to
link a metabolite of interest directly to its biosynthetic gene
cluster. Such approaches are needed to speed up gene cluster
identification, even when only draft genomes are available.
This holds especially true for organisms that are not
genetically accessible. Using a mass spectrometry based
technology such as IMS, which was established to observe
the chemical output and metabolic exchange between an
organism and the environment directly on agar plates,[15,16]
facilitates the linking of a metabolite to its biosynthetic gene
cluster. Increasing sequencing efforts make clear the discrep-
ancy between computationally identified biosynthetic gene
clusters and known metabolites, and this resource should be
made use of. New microorganisms, preferably from under-
investigated ecological niches, should be domesticated, as
recently shown for the teixobactin producer,[17] and metage-
nomics approaches should be intensified to create a basis for
identifying gene loci for new lead compounds. Then, a mass
spectrometry based analysis in combination with expression
profiles should enable the prompt linking of genes and
metabolites.
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Siphonazole biosynthetic gene cluster  
All individual domains were screened for the presence of signature motifs that are known to 
be required for catalytic activity (Figures S3 – S8). This analysis revealed that several KS 
domains (KS5, KS7 and KS9 and ACPs (ACP61 and ACP121), and the dehydratase domain 
DH12 are likely inactive because of critical mutations.[18-20] Therefore, modules 3, 5 and 6 
merely pass on the intermediate without elongation, while the product of module 12 is likely 
an ACP-bound 3-hydroxy intermediate and not an enoyl-S-ACP. The three KRs identified in 
the siphonazole gene cluster are all regarded as active, even though the conserved 
asparagine of KR12 is replaced by a cysteine residue (Figure S6). However, this is also the 
case in the first PksM-KR from Bacillus subtilis, which has been reported as functional.[21] In 
silico prediction of the substrate specificities for the four A domains pointed to the group of 
hydrophobic-aromatic substrates for the loading A domain (A1), while the domains A4 and 
A8 have identical sequences and were predicted to activate threonine, and the substrate of 
A10 was tentatively identified as glycine. In the NRPS modules 4 and 8 no C domains are 
found, but instead two pairs of cyclisation (Cyc) domains are present that usually catalyze 
the formation of heterocycles from serine, threonine or cysteine residues.[22] The unusual 
arrangement of tandem Cyc domains has its precedence in the biosynthesis of vibriobactin 
and leinamycin, in which the first domain is responsible for heterocyclisation and the second 
one substitutes for a regular C domain for peptide bond formation.[23,24] A similar mechanism 
can be assumed for siphonazole biosynthesis. Modules 4 and 8 also contain tandem 
oxidation (Ox) domains for the conversion of initially formed oxazoline/thiazoline into 
oxazole/thiazole rings. As exemplified for epothilone biosynthesis,[25] one such domain is 
sufficient for this transformation. Indeed, analysis of the signature motifs revealed that the 
second Ox domains of modules 4 and 8 both lack the NADPH-binding site,[26] indicating that 
these are non-functional due to impaired cofactor binding. Another peculiarity of modules 4 
and 8 is the 98% identity of their nucleotide sequences over a range of 4,750 bp, suggesting 
either a duplication event or a double integration into the cluster. Furthermore, the GC-
content of these modules is much higher (68%) than the average over the whole gene cluster 
(53%), which also points to their recent acquisition and integration into a hypothetical 
parental gene cluster. This hypothesis is also reflected by the non-functional modules 5, 7 
and 9 surround modules 4 and 8, representing a mosaic-like architecture that is also 
frequently seen in other trans-AT PKS clusters that generally seem to develop by extensive 
horizontal gene transfers.[27] The trans-AT domain SphA of the siphonazole cluster is 
predicted to load malonyl-CoA onto the ACP domains of the PKS modules 2, 6, 11 and 12 
(Figure S3), in agreement with the results from feeding experiments with labelled acetate.[9] 
The C-terminal part of SphA contains an oxidoreductase domain, but the catalytic histidine is 
replaced by tyrosine, suggesting the oxidoreductase as non-functional. 
Off-loading of the nascent molecule is done by the action of a thioesterase (TE). In the 
present cluster sphJ encodes a free-standing TE which contains the conserved G-x-S-x-G 
motif and shows highest identity to TEs from Bacillus species. SphJ also shows the motif for 
proof-reading TEs (Figure S8) that have the function to edit miss-primed domains and 
thereby ensure the loading of the correct substrate. Hence, the TE domain may not be 
involved in substrate off-loading, but another mechanism may be relevant for siphonazole, as 
will be discussed later. In addition to the described proteins forming the PKS/NRPS core of 
the biosynthetic gene cluster, the O-methyltransferase (O-MT) SphB, a C-terminal hydrolase 
domain of SphH, and the aldolase SphI are integral parts of the cluster (Figure 2). 
 
In silico analysis of SphI revealed its homology to 3-deoxy-D-arabino-heptulosonate 7-
phosphate (DAHP) synthases, enzymes catalyzing the condensation of 
phosphoenolpyruvate (PEP) and erythrose 4-phosphate (E4P) to yield chorismate.[28] SphI 
showed 54% identity to a hypothetical aldolase from an unclassified bacterium (accession 
number: PRJNA192319), and ensures the precursor supply from the versatile shikimate 
pathway, as was shown for other metabolites using shikimate pathway derived starter units 
such as the glycopeptide antibiotic balhimycin.[29] Heterologous expression of sphI in E. coli 
and incubation of the purified protein (Figure S9) with E4P and PEP yielded DAHP. Optimal 
conditions were pH7 and 30°C, while addition of EDTA abolished enzyme activity, revealing 
SphI to be a metallo-enzyme (Figure S10). The kinetic properties of SphI were determined 
under optimal conditions using Mn2+ as co-factor (KM 377.9 ±20.8 µM; kcat 0.0088 ±0.0003 s-
1). 
 
SphB showed homology to S-adenosylmethionine (SAM)-dependent O-MTs with highest 
identity (65%) to a SAM-dependent MT from Paenibacillus sonchi (accession number: 
WP_039835538). The three conserved motifs that participate in SAM-binding were identified 
within the protein sequence (Figure S11). For siphonazole either 3,4-dihydroxybenzoic acid 
(protocatechuic acid) or its 4’-O-methyl derivative isovanillic acid may act as the biosynthetic 
starter unit. Feeding experiments with (methyl-13C)methionine identified SAM as the methyl 
group donor.[9] The methylation of the 4’-hydroxyl group by SphB was verified by protein 
expression in E. coli and incubation of the purified enzyme with protocatechuic acid and 
SAM. HPLC and UV/Vis analysis revealed formation of the product isovanillic acid (Figure 
S12). The optimal enzyme conditions were determined to be 45 °C and pH8 with kinetic 
parameters of KM 1.325 µM and kcat of 1.54 min-1. 
 
As discussed above, the amino acid sequence of the loading domain A1 pointed to the 
group of hydrophobic-aromatic substrates, but its precise specificity could not be predicted 
with certainty. Hence, the activity of A1 was tested towards the candidate substrates 
protocatechuic acid and isovanillic acid, as well as selected amino acids in vitro by an ATP-
PPi exchange assay. Therefore, N-terminal parts of SphC were heterologously expressed in 
E. coli. Interestingly, only protocatechuic acid, but not isovanillic acid, was accepted as a 
substrate (Figure S13). Furthermore, the tridomain A1-PCP1-PCP12 yielded a ten-fold higher 
exchange rate than the didomain A1-PCP1, while the single A1 domain was inactive. These 
data point to activation and loading of protocatechuic acid by the A1 domain and implicate a 
post-loading methylation by SphB. 
 
 
General material and methods 
 
Imaging mass spectrometry 
Thin layer ISP2 agar plates were prepared. ISP2 media was prepared as described. Briefly, 
yeast extract 4 g, malt extract 10 g, dextrose 4 g, and agar 20 g, were added to 1 L of 
deionized water. For S. coelicolor growth, an aqueous suspension of spores was spotted 
onto the agar. For gliding bacteria the inoculum consisted of a part (0.5x0.5 cm) of a pre-
grown plate placed upside down on the ISP2 medium. The bacterial colonies were allowed to 
form for the times indicated in the paper. Incubation was performed at 28°C. A photograph of 
the colonies was taken before they were subjected to further sample preparation for IMS. 
Afterwards, a region of agar was cut, laid on top of a cleaned and washed MALDI target 
plate, and covered by sprinkling the matrix consisting of a 1:1 mixture of α-cyano-4-
hydroxycinnamic acid and 2,5-dihydroxybenzoic acid on top of the culture using a 20 µm 
sieve. Once the sample was completely covered with matrix, it was dried in a 37 °C oven. 
The matrix is required for the ionization of the molecules present along the surface of the 
sample. At the same time, the matrix effectively fixes the organisms in place when applied. 
The natural product IMS was performed as described earlier28. Briefly, the Bruker MSP 96 
anchor plate containing the sample was inserted into a Microflex Bruker Daltonics mass 
spectrometer outfitted with Compass 1.2 software suite (Consists of FlexImaging 2.0, 
FlexControl 3.0, and FlexAnalysis 3.0). A photomicrograph of the colonies to be imaged by 
mass spectrometry was loaded onto the Fleximaging command window. Three teach points 
were selected in order to align the background image with the sample target plate, before the 
sample was run in positive mode. After data acquisition, the data was analyzed using the 
FlexImaging software. The resulting mass spectra were filtered manually and individual 
colors were assigned to the specific masses. 
 
Genomic mining and expression analysis 
Fosmid library. Chromosomal DNA derived from a liquid culture of Herpetosiphon spec. 
B060 was used for the construction of a fosmid library construction using pCC1FOS 
(Epicenter, Madison, USA). The genomic library was constructed according to 
manufacturer’s instructions. The resulting colonies with an average insert length of 36 kb 
were generated and transferred into 96-well microtiter plates. For long term storage at -80 °C 
the fosmid cultures were mixed with an equal volume of 100 % glycerol. 
Genome sequencing. Genomic DNA for sequencing was isolated with the Qiagen DNeasy 
Blood & Tissue Kit according to the manufacturer’s protocol. The resulting DNA with a 
concentration of ~400 ng/µL was submitted to 454 whole genome sequencing on a Roche 
GS FLX Titanium sequencer. The output was 158,535,259 bp which were assembled to 
1,663 contigs. The average contig size was 7,809 bp with the largest contig stretching over 
121,725 bp. 
Genomic mining. A local Blast database was set up containing all the contigs obtained by 
sequencing. In previous work three fosmids were found to carry NRPS or PKS parts. DNA 
sequences of subclones from theses fosmids as well as end sequences of the inserts were 
used as queries for Blast analysis. In that way identified contigs were subsequently analyzed 
more profound manually. Genes were annotated and the therefrom encoded proteins were 
analyzed in respect to siphonazole biosynthesis. In this analysis further all contigs showing 
homology to PKS and NRPS coding sequences were included. In silico prediction of A 
domain specificity was performed using NRPSpredictor.[30] 
Gap closure. To close the initially remaining gaps in the putative biosynthetic gene cluster, 
specific primers were designed and used for PCRs using genomic DNA of Herpetosiphon 
spec. B060 as template. The resulting amplificates were subjected to Sanger sequencing, 
and the obtained sequence information was aligned with the existing one. In addition specific 
primers were designed and used for direct sequencing using the corresponding fosmid as 
template. 
 
 
Molecular cloning 
SphB. The primer pair OMt-fwd-BamHI and OMt-rev-HindIII, was used to amplify the sphB-
gene, whereby each primer carried the sequence for the desired restriction site for 
subsequent cloning into the expression vector pET28. In brief, the target sequence was 
amplified using fosmid DNA as template. The gel purified fragment was ligated into the 
cloning vector pGEM-T (Promega), and the resulting construct was transferred to CaCl2-
competent E. coli XL1 Blue cells. The identity of the fragment was verified by sequencing, 
before it was restricted from the construct using BamHI and HindIII. The restricted fragment 
was gel-purified and ligated into likewise restricted pET28. The resulting construct (pET28_ 
SphB) was subsequently transferred in CaCl2-competent E. coli BL21 cells.  
However, the protein precipitated rapidly when exposed to low temperatures. Therefore, 
purification had to be carried out at room temperature and the following assays were 
performed directly afterwards to avoid activity loss. 
SphC. For the expression of the SphC A domain several constructs were created, i.e. the 
single A domain (primer pair: sphC-A-fwd and sphC-A-rev), the A-PCP1 didomain (primer 
pair: sphC-A-fwd and sphC-A+ACP1), and the A-PCP1-PCP12 tridomain (primer pair: sphC-
A-fwd and sphC-A+ACP1&2). For all the constructs the targeted DNA-fragment was 
amplified by PCR using Pfu-polymerase, directly cloned into pET151, and transferred to E. 
coli Top10 cells. Then, the constructs were verified by sequencing, and positive ones were 
transferred in CaCl2-competent E. coli BL21* cells. 
SphI. Primers showing homology to the 5’ start region (sphI-fwd) and the 3’ end region (sphI-
rev) of the sphI-gene have been designed carrying 5’-prime overhangs for subsequent 
cloning into the vector pET151 (Invitrogen). PCR using Pfu-polymerase (Promega) in 
combination with these primers yielded an amplificate of 736 bps. This was cloned into 
pET151, and transferred into E. coli cells. The identity of the final construct (pET151_SphI) 
was verified by Sanger sequencing.  
SphH. To amplify the coding sequence of the SphHCterm, the primer pair SphH_end_fw and 
SphH_end_dn was designed. Forward primer contains a 3' single strand end (CAAC) 
overhang which is identical to the 5' end of TOPO®–charged vector. pCC1FOS containing 
the complete siphonazole gene cluster was used as template for amplification of the target 
gene. Using Pfu-polymerase in the PCR reaction resulted in a blunt-ended fragment. The 
amplified fragment with the correct size of 1378 bp was extracted from the agarose gel. The 
yielded DNA was cloned into the pET-TOPO® vector by topoisomerase cloning. The ready 
construct of pET151 harboring SphHCterm was transferred to Top 10 chemically competent E. 
coli cells. The grown colonies on LB medium supplied with ampicillin were picked and 
inoculated in 3 mL liquid medium. Subsequently, plasmids were isolated from these cultures 
and subjected to sequencing. The accurate construct (pET151-SphHCterm) was transferred to 
the expression host E. coli BAP1. 
SphJ. The primer pair, SphJ-topo-Up and SphJ-topo-Down was used to amplify the SphJ- 
coding sequence. The resulting fragment (736 bp) was cloned in pET151 and used to 
transform E. coli XL1-Blue. The positive colony containing the accurate construct with the 
exact nucleotide sequence of sphJ, as deduced form the restriction pattern and the 
sequencing result, was selected for further experiments. The resulting construct 
pET151_SphJ was isolated from the corresponding colony and used to transform the 
expression host E. coli BL21 star. 
Protein expression 
A single colony of the respective cells, i.e. E. coli BL21 or E. coli BAP1, containing the 
desired construct was inoculated in 10 mL LB medium supplemented with the appropriate 
antibiotic. After 16 h this culture was used for inoculation of 1 L LB medium at 37°C on a 
shaker. Once the cells reached an OD600 of ~0.4–0.6 the flask was cooled down to 16°C and 
protein expression was induced by adding IPTG (final concentration 0.4–0.5 mM); further 
incubation was performed at 16°C over night. Cells were harvested by centrifugation (4,000 
rpm, 20 min, 4°C) and resuspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole, pH 8). After disruption of the cells by sonification and subsequent centrifugation 
(8,500 rpm, 20 min, 4°C) the supernatant was applied to Ni-NTA columns (equilibrated in 
lysis buffer). To increase the binding efficiency, the flow-through was re-loaded on the 
column at least three times. The column was washed twice with 2.5 ml washing buffers (50 
mM NaH2PO4, 300 mM NaCl, pH 8) with 30 and 50 mM imidazole, respectively. 
Subsequently, the elution of the protein was performed in five elution steps using 500 µl 
elution buffer (50 mM NaH2PO4, 300 mM NaCl, pH 8) with 100, 150, 200, 300 and 300 mM 
imidazole, respectively. All collected fractions were analyzed by SDS-PAGE. 
Heterologous expression and purification of SphB. 
SphB was expressed in good amounts with an N-terminal his-tag and purified from BL21 E. 
coli cells (Figure S19). The visible band between 20 and 30 kDa is in accordance with the 
calculated mass of 28.95 kDa. Elution fractions 3 – 5 were pooled and used for subsequent 
assays. The soluble protein precipitated rapidly when exposed to low temperatures or during 
concentration procedures. Therefore, purification had to be carried out at room temperature 
and assays performed directly afterwards to avoid loss of activity. 
Heterologous expression and purification of the SphC A domain. 
The constructs were based on pET151 cloning vector and BL21 star™ expression cells were 
used. Using these constructs it was possible to generate soluble proteins (Figure S20). 
 
 
Heterologous expression and purification of SphI. 
After optimization, the strain containing the (pET151-SphI) construct was incubated at 16°C 
and induced with 0.4 mM IPTG at an OD600 of 0.5 (Figure S9). The His-tagged protein (41.3 
kDa) was purified by affinity chromatography using higher concentrations of imidazole in 
washing and elution steps. 
Heterologous expression and purification of SphHCterm. 
Heterologous expression of SphHCterm in the apo- as well as in the holo-form was performed 
in E.coli BL21 or E.coli BAP1, respectively. The desired proteins were overexpressed and 
purified from 1 L cultures. A prominent band corresponding to SphHCterm with the expected 
size of 53.5 kDa was enriched during purification (Figure S21). 
Heterologous expression and purification of SphJ. 
Expression and purification of recombinant SphJ was accomplished in an analogous way to 
SphHCterm expression. Analytic SDS-PAGE revealed a band in the elution fractions 
corresponding to the expected size of 31.2 kDa (Figure S22).  
 
Protein assays 
SphB-activity was observed by an in vitro methylation assay in 50 mM Tris-HCl buffer, pH 
7.5. Reagents and protein solution were always prepared freshly and used directly. A typical 
reaction mixture (100 µL final volume) consisted of: SphB 25 µM, protocatechuic acid 
(substrate) 1 mM, S-adenosylmethionine 500 µM, MgCl2 10 mM, and 50 mM Tris/HCl (pH 
7.5). Incubation was performed at 30°C. HPLC analysis of the methylation assay was carried 
out on a Merck-Hitachi system consisting of a D-6000A interface with an L-6200A Intelligent 
Pump, a Rheodyne 7725i injection system and an L-4500A diode array detector. Column 
was a Waters XTerra™ C18 (5 µm, 4.6 x 250 mm). The complete reaction mix was injected 
without further preparation and separated using a gradient of 0.1% TFA and acetonitrile as 
liquid phase in the following setup. Solvent A: H20 with 0.1% TFA, solvent B: acetonitrile, 
gradient: from 90% A, 10% B in 20 min to 40% A, 60% B, with a flow rate of 1 mL/min. 
SphC-activity was measured using an ATP-PPi exchange assay. The assay used is based 
on the consumption of γ-18O4-labelled ATP and the formation of 16O4-ATP by an excess of 
unlabeled PPi.[31] In brief, 200 nM purified A domain (solved in 20 mM Tris-HCl (pH 7.5), 5% 
glycerol, 1mM DTT) was incubated with 1 mM γ-18O4-ATP, 1mM substrate, 5 mM MgCl2 and 
5 mM PPi in a reaction volume of 6 µL for 30 min at room temperature. The assay was 
stopped by the addition of 6 µL 9-aminoacridine in acetone (10 mg/mL). The subsequent 
analysis was performed by MALDI-TOF-MS. Therefore, the ratio of γ-16O4-ATP (m/z=506) 
and the sum of all ATP species, including unlabeled, partially labeled, fully labeled 
(m/z=514), and monosodium-coordinated ions (m/z 506, 508, 510, 512, 514, 528, 530, 532, 
534, and 536, respectively) was determined. The percent exchange was normalized with the 
following modifier: % exchange = (100/0.833) x 16O/(18O+16O). 
SphI-activity was analyzed using a continuous spectrophotometric method. A typical reaction 
mixture consisted of the freshly purified enzyme, PEP (80 µM), erythrose-4-phosphate (350 
µM), and MnSO4 (100 µM) in 50 mM BTP buffer (pH 7). The sample was incubated in a 
quartz cuvette and the absorption was observed at 232 nm using a LAMBDA 40 UV/Vis 
Spectrophotometer (Perkin Elmer). One unit of enzyme activity was defined as consumption 
of 1 µmol PEP per minute.[32] To get metal-free SphI, the enzyme was pre-treated with EDTA 
for 10 minutes prior reaction. The reaction was started by adding pre-treated SphI to the 
reaction mixture. The latter was supplemented with different divalent cations, i.e. Mg²⁺, Zn²⁺, 
Cu²⁺, and Cd²⁺, and Mn²⁺ (100 µM). Enzyme activity was monitored at room temperature as 
described before. To determine the effect of temperature on the enzymatic activity of SphI, 
the assay was incubated for 10 min at the respective temperature between 10°-70° C. 
Reactions were started by SphI-addition. To investigate the pH dependence of SphI, the pH 
of the buffer used was varied between pH 5-9. Further, the beforehand determined optimal 
conditions were used for kinetic studies of SphI. The concentration of E4P was varied 
(between 0.025 – 1 mM), whereas the PEP concentration was kept constantly (80 µM). The 
reaction mixtures containing 100 µM MnCl2 were initiated by adding freshly purified enzyme 
and incubation was performed at 30° C. To determine Km, Vmax and Kcat various E4P 
concentrations (0.025-1.0 mM) and steady concentration of PEP (80 µM) were used. The 
values were calculated using double-reciprocal plots (software: Graf Pad Prism 5). 
 
Anti-plasmodial assay 
Antiplasmodial activity was determined against the NF54 strain of Plasmodium falciparum, 
using a modified [3H] hypoxanthine incorporation assay.[33] Briefly, infected human 
erythrocytes were exposed to serial drug dilutions in microtiter plates for 48 h at 37 °C in a 
gas mixture with reduced oxygen and elevated CO2. [3H] hypoxanthine was added to each 
well and after further incubation for 24 h the wells were harvested on glass fiber filters and 
counted in a liquid scintillation counter. From the sigmoidal inhibition curve the IC50 value was 
calculated. Chloroquine was used as positive control in each test series. 
 
General synthetic methods. Chemicals were obtained from Acros Organics (Geel, Belgium) 
or Sigma Aldrich Chemie GmbH (Steinheim, Germany) and used without purification. All 
reactions were performed under argon atmosphere in dried reaction vessels. Solvents were 
purified by distillation and dried according to standard methods. Thin-layer chromatography 
was performed with 0.2 mm precoated plastic sheets Polygram® Sil G/UV254 (Machery-
Nagel). Column chromatography was carried out using Merck silica gel 60 (70-200 mesh). 1H 
NMR and 13C NMR spectra were recorded on Bruker Avance DMX-500 (500 MHz), Bruker 
Avance DPX-400 (400 MHz) spectrometers, and were referenced against solvent signals (1H 
NMR: (2H)dichloromethane δ = 5.32 ppm; 13C NMR: (2H)dichloromethane δ = 53.84 ppm). 
GC-MS analyses of synthetic compounds were carried out with a 7890B gas chromatograph 
connected to a 5977A inert mass detector (Agilent) fitted with a HP5-MS fused silica capillary 
column (30 m, 0.25 mm i. d., 0.25 µm film). Instrumental parameters were (1) inlet pressure, 
77.1 kPa, He 23.3 mL min-1, (2) injection volume, 1 µL, (3) transfer line, 250 °C, and (4) 
electron energy 70 eV. The GC was programmed as follows: 5 min at 50 °C increasing at 10 
°C min-1 to 320 °C, and operated in split mode (50:1, 60 s valve time). The carrier gas was 
He at 1 mL min-1. Retention indices (I) were determined from a homologous series of n-
alkanes (C8-C38). 
 
 
Synthesis of (E)-S-(2-acetamidoethyl) 3-hydroxyhex-4-enethioate (1).  
 
Acid 3 (105 mg, 0.81 mmol, 1 eq) was dissolved in 3 mL absolute DCM and HSNAC (115 
mg, 0.97 mmol, 1.2 eq) was added. Afterwards EDC.HCl (186 mg, 0.97 mmol, 1.2 eq) and 
DMAP (22 mg, 0.18 mmol, 0.2 eq) were added and the reaction was stirred for 1h at room 
temperature. The solvent was removed under reduced pressure and the crude material was 
purified by HPLC (KNAUER Eurospher II 100-5 C18A; 5 µm; 250 x 16 mm, MeCN/H2O, v/v 
20:80, Rt = 6.02 min). Thioester 1 (142 mg, 0.62 mmol, 70%) was obtained as a colorless 
liquid. As a side product, the SNAC ester of sorbic acid (2) was isolated (6 mg, 0.03 mmol, 
4%). 
Analytical data for 1: 1H-NMR (400 MHz, [2H2]-DCM): δ = 5.88 (s br, 1H, NH), 5.73 (dqd, 
3J(H,H) = 15.3 Hz, 3J(H,H) = 6.5 Hz, 4J(H,H) = 1.1 Hz, 1H, CH), 5.49 (ddq, 3J(H,H) = 15.3 Hz, 
3J(H,H) = 6.3 Hz, 4J(H,H) = 1.6 Hz, 1H, CH), 4.51 (dt, 3J(H,H) = 6.2 Hz, 3J(H,H) = 6.3 Hz, 1H, 
CH), 3.39 (m, 2H, CH2), 3.02 (m, 2H, CH2), 2.75 (d, 3J(H,H) = 6.3 Hz, 2H, CH2), 2.60 (s br, 
1H, OH), 1.91 (s, 3H, CH3), 1.69 (m, 3H, CH3) ppm. 13C-NMR (100 MHz, [2H2]-DCM): δ = 
198.8 (s, Cq), 170.5 (s, Cq), 132.4 (s, CH), 127.7 (s, CH), 69.9 (s, CH), 51.6 (s, CH2), 39.5 (s, 
CH2), 29.3 (s, CH2), 23.3 (s, CH3), 17.8 (s, CH3) ppm. IR (ATR): ṽ = 3433, 3269, 3087, 2945, 
2856, 1684, 1618, 1556, 1431, 1299, 1120, 1054, 924, 867, 763, 628, 609 cm-1. HR MS 
(ESI+): calcd. for C10H17NNaO3S+ [M-Na+] 254.0821, found 254.0821. 
Analytical data for 2: 1H-NMR (400 MHz, [2H2]-DCM): δ = 7.21 (dd, 3J(H,H) = 10.4 Hz, 3J(H,H) 
= 15.2 Hz, 1H, CH), 6.26 (dq, 3J(H,H) = 6.5 Hz, 3J(H,H) = 15.0 Hz, 1H, CH), 6.18 (dd, 3J(H,H) 
= 10.5 Hz, 3J(H,H) = 15.0 Hz, 1H, CH), 6.10 (d, 3J(H,H) = 15.2 Hz, 1H, CH), 5.88 (s br, 1H, 
NH), 3.40 (dt, 3J(H,H) = 6.3 Hz, 3J(H,H) = 6.4 Hz, 2H, CH2), 3.07 (t, 3J(H,H) = 6.4 Hz, 2H, 
CH2), 1.90 (s, 3H, CH3), 1.87 (d, 3J(H,H) = 6.3 Hz, 3H, CH3) ppm. 13C-NMR (100 MHz, [2H2]-
DCM): δ = 190.4 (Cq), 170.4 (Cq), 142.5 (CH), 142.1 (CH), 130.0 (CH), 126.2 (CH), 40.2 
(CH2), 29.0 (CH2), 23.5 (CH3), 19.2 (CH3) ppm. MS (EI, 70 eV): m/z (%) = 213 (<1), 185 (4), 
154 (4), 127 (7), 95 (100), 67 (41), 43 (32). GC (HP-5MS): I = 1939. 
 
Synthesis of [(2-13C,2,2-2H2)-(E)-3-hydroxyhex-4-enoic acid ((2-13C,2,2-2H2)-3)[1] 
 
(2-13C,2,2,2-2H3)acetic acid (0.10 g, 1.56 mmol, 1 eq) was dissolved in 1.5 mL of absolute 
THF and cooled to -78°C under argon atmosphere. n-butyllithium (1.6M in hexane, 0.98 mL, 
1.56 mmol, 1 eq) was added dropwise by use of a syringe pump. The reaction was stirred for 
1h at -78°C and then warmed to 0°C. Freshly prepared LDA solution (2M in THF, 0.94 mL, 
1.87 mmol, 1.2 eq) was added dropwise and after stirring for 10 minutes the reaction was 
warmed to 45°C for 1h. After cooling to -78°C, crotonaldehyde (0.13 g, 1.87 mmol, 1.2 eq) 
was added dropwise as a THF solution (10M). After stirring for 2h at -78°C the reaction was 
quenched with water, warmed to room temperature and acidified with 2M HCl. The aqueous 
phase was extracted three times with ethyl acetate and the combined organic phases were 
dried over MgSO4. The solvent was removed under reduced pressure and the product 
isolated as colorless, waxy oil (0.37g, 2.84 mmol, 85%).  
1H-NMR (400 MHz, C2H2Cl2): δ = 5.75 (dq, 3J(H,H) = 15.3 Hz, 3J(H,H) = 6.5 Hz, 1H, CH), 
5.52 (m, 1H, CH), 4.47 (d, 3J(H,H) = 6.3 Hz, 1H, CH), 1.70 (d, 3J(H,H) = 6.5 Hz, 3H, CH3) 
ppm. 13C-NMR (100 MHz, C2H2Cl2): δ = 176.9 (d, 1J(C,C) = 54.1 Hz, Cq), 132.0 (CH), 128.2 
(d, J(C,C) = 3.3 Hz, CH), 69.1 (d, 1J(C,C) = 37.7 Hz, CH), 41.2 (quin, 1J(C,2H) = 19.8 Hz, 
C2H2), 17.8 (CH3) ppm. IR (ATR): ṽ = 3430 (br), 3015, 2970, 2920, 2641, 1736, 1712, 1438, 
1367, 1258, 1229, 1217, 1130, 1073, 1010, 963, 920, 826, 798, 764, 660, 566, 517, 490 cm-
1
. HR MS (ESI-): calcd. for 13CC52H2H7O3- [M-H]- 132.0716, found 132.0730. 
 
Synthesis of (2-13C,2,2-2H2)-(E)-S-(2-acetamidoethyl) 3-hydroxyhex-4-enethioate ((2-
13C,2,2-2H2)-1). 
 
(2-13C,2,2-2H2)-3 (85 mg, 0.64 mmol, 1 eq) was dissolved in 2 mL absolute DCM and HSNAC 
(91 mg, 0.77 mmol, 1.2 eq) was added. Afterwards DCC (158 mg, 0.77 mmol, 1.2 eq) and 
DMAP (16 mg, 0.13 mmol, 0.2 eq) were added and the reaction was stirred for 1h at room 
temperature. After filtration the solvent was removed under reduced pressure and the crude 
material was purified by HPLC (KNAUER Eurospher II 100-5 C18A; 5 µm; 250 x 16 mm, 
MeCN/H2O, v/v 20:80, Rt = 6.02 min). The product 1 (70 mg, 0.3 mmol, 47%) was obtained 
as a colorless liquid.   
1H-NMR (400 MHz, C2H2Cl2): δ = 5.97 (s br, 1H, NH), 5.76 (dddq, 3J(H,H) = 15.3 Hz, 3J(H,H) 
= 6.5 Hz, 4J(H,C) = 1.1 Hz, 4J(H,H) = 1.1 Hz, 1H, CH), 5.53 (dddq, 3J(H,H) = 15.3 Hz, 4J(H,H) 
= 1.6 Hz, 4J(H,C) = 2.2 Hz, 3J(H,H) = 6.3 Hz, 1H, CH), 4.53 (d, 3J(H,H) = 6.3 Hz, 1H, CH), 
3.43 (m, 2H, CH2), 3.05 (m, 2H, CH2), 1.95 (s, 3H, CH3), 1.72 (m, 3H, CH3) ppm. 13C-NMR 
(100 MHz, C2H2Cl2): δ = 198.8 (Cq), 170.6 (Cq), 132.4 (CH), 127.7 (d, 3J(C,C) = 3.3 Hz, CH), 
69.8 (d, 1J(H,H) = 36.5 Hz, CH), 51.0 (quin, 1J(C,2H) = 19.8 Hz, CH2), 39.5 (CH2), 29.2 (CH2), 
23.3 (CH3), 17.8 (CH3) ppm. Degree of deuteration: 84 %. IR (ATR): ṽ = 3434, 3270, 3086, 
2968, 2943, 2855, 1680, 1621, 1555, 1374, 1300, 1268, 1237, 1202, 1142, 1085, 1032, 
1006, 971, 939, 892, 848, 763, 752, 731, 634, 543, 505, 479 cm-1. HR MS (ESI+): calcd. for 
13CC92H2H15NNaO3S+ [M-Na+] 257.0980, found 257.0982. 
 
SPME sampling. Substrate mimics 1, 2, 3 and [2-13C,2-2H2]-1 (c=0.09 mg/µL) were 
incubated with the respective enzymes for 1h at 30°C in a closed reaction tube furnished with 
a septum. The SPME assembly needle (df = 75 µm, Carboxen/Polydimethylsiloxane, fused 
silica, 24Ga, 3pk) was placed through the septum above the reaction headspace for the 
complete reaction time and was directly analyzed by GC-MS. The GC-MS parameters were 
as follows: 7890B gas chromatograph connected to a 5977A inert mass detector (Agilent) 
fitted with a HP5-MS fused silica capillary column (30 m, 0.25 mm i. d., 0.25 µm film). 
Instrumental parameters were (1) inlet pressure, 77.1 kPa, He 23.3 mL min-1, (2) transfer 
line, 250 °C, and (3) electron energy 70 eV. The GC was programmed as follows: 5 min at 25 
°C increasing at 1 °C min-1 to 30 °C, followed by increasing at 10 °C min-1 to 80 °C and 
operated in split mode (10:1 or 100:1, 60 s valve time). The carrier gas was He at 1 mL min-1. 
  
 
Figure S1. Molecular structure of siphonazole and its deduced building blocks. 
Origins of building blocks are marked according to feeding experiments. 
 
 Figure S2. Test PCRs for RNA expression analysis. 
A) Schematic representation of PCR probes; B) PCR from isolated mRNA from days 1, 2, 3, 
4 and 7 with primer pair gap1; M, marker; C) PCRs from fosmid DNA; D) RT-PCR from RNA; 
In C and D the fragments are loaded in alphabetical order; The white arrow highlights the 
missing amplificate of the intergenic region between sphB and sphC. This finding suggests 
that two transcriptionally coupled units exist, i.e. sphA-sphB, and sphC-sphJ. 
  
 SphA G H S V  G 90 
BaeE G H S L  G 87 
PksE G H S L  G 92 
DfnA G H S L  G 89 
ChiA G H S L  G 89 
 
 
SphA Q T Q Y T Q 60 G A F H 193 
BaeE Q T Q F T Q 56 G A F H 191 
PksE Q T Q Y T Q 61 G A F H 196 
DfnA K T Q F T Q 58 G A F H 192 
ChiA Q T Q Y T Q 58 G A F H 192 
 
Figure S3. Multiple sequence alignment of the acyltransferase SphA. 
Residues corresponding to the consensus motifs are coloured yellow; reference sequences 
were taken from the biosynthesis of bacillaene (BaeE, YP_001421287), difficidin (DfnA, 
YP_001421800) and similar proteins from Paenibacillus mucilaginosus (PksE, 
YP_004640302) and Pseudomonas fluorescens (ChiA, AAM12912). 
  
Motif 1 
Motif 2 Motif 3 
  
KS2 G P (X)7 C S S 17  H G T G T 302  G H 341 
KS3 G P (X)7 C S S 17
5 
 H G T G T 303  G H 344 
KS5 G P (X)7 C S S 17  A A T G S 303  G H 340 
KS6 G P (X)7 C S S 17  H G T G T 305  G H 343 
KS7 G P (X)7 C S S 17  Q G T G T 302  G H 341 
KS9 G P (X)7 C S S 17  A A N G T 304  G H 342 
KS11 G P (X)7 C S S 17  H G T G T 300  G H 344 
KS12 G P (X)7 C S S 17  H G T G T 302  G H 340 
 
Figure S4. Multiple sequence alignment of the KS domains. 
Highly conserved residues are coloured yellow; residues of the catalytic triad are coloured 
green; deviations in the catalytic core are printed in red. The numbering corresponds to the 
module in which the domains are located. 
  
Motif 1 Motif 2 Motif 3 
 ACP1 E L G F  D S V 32 
ACP12 E L G F  D S V 32 
ACP2 E F G L  D S I 32 
ACP5 I Y G I  N S Q 32 
ACP6 E Y G F  D A I 32 
ACP62 E Y G F  D S V 32 
ACP7 N Y G I  D S V 32 
ACP9 R Y G F  N S L 32 
ACP10 N Y G F  D S I 32 
ACP11 S Y G V  D S V 32 
ACP12 E Y G L  D A P 32 
ACP122 N Y G V  D S L 32 
 
 
PCP3 A Y G L  D S  I 32 
PCP4 S A G A  T S  L 30 
PCP42 S A G A  T S  L 30 
PCP8 S A G A  T S  L 30 
PCP82 S A G A  T S  L 30 
 
 
Figure S5. Multiple sequence alignment of the ACP and PCP domains 
Residues corresponding to the consensus motifs are coloured yellow; the essential serine 
moiety is coloured green; deviations in this location are printed in red. 
  
 KR2 G L  G G V G L L C A 1889 
KR11 G K  G A L G A I F A 166 
KR12 G A  G N V G F K L C 504 
A.var. G T  S A V G T E I A 1220 
PksM G A  G Y I G E A W S 1540 
H.che. G L  G K I G L A L A 1125 
 
KR2 K [23]  S [12]  Y G Y A N 2024 
KR11 K [23]  S [12]  Y A Y A N 297 
KR12 K [23]  S [12]  Y A A G C 639 
A.var. K [23]  S [14]  Y A A A N 1373 
PksM K [23]  S [12]  Y A S G C 1675 
H.che. K [23]  S [12]  Y A A A N 1347 
 
Figure S6. Multiple sequence alignment of the KR domains  
Residues corresponding to the consensus motif are highlighted in yellow; catalytic 
residues are highlighted in green, deviations in these locations are printed in red; 
reference sequences were taken from similar proteins from Anabaena variabilis (A.var., 
YP_324485), Bacillus subtilis (PksM, P40872) and Hahella chejuensis (H.che., 
YP_434161). 
  
Catalytic Core 
 
NADPH-binding motif 
DH2 H R W E G Q A L L P 40 
DH11 H I V Q G Q R V L P 40 
DH12 Y Q V A D S Q R L P 43 
SorB H R V L D M H L L P 33 
Ery chain A H V V G G R T L V P 42 
Beggiatoa H V V G S Q K T L P 39 
 
Figure S7. Multiple sequence alignment of the DH domains  
Residues corresponding to the consensus motif are coloured yellow; catalytic residues 
are coloured green, deviations in these locations are printed in red; reference 
sequences were taken from the biosynthesis of sorangicin (SorB, ADN68477), 
erythromycin (Ery chain A, 3EL6_A) and a similar protein from Beggiatoa sp. SS 
(Beggiatoa, ZP_01997443). 
 
 
 
 
Figure S8. Multiple sequence alignment of the thioesterase SphJ with the sequence of type 
II TEs associated with bacterial PKSs, NRPSs.  
Residues corresponding to the consensus motif are coloured yellow; catalytic residues are 
coloured green; the hydrolase signature sequence (G-X-S-X-G) of SphJ matches to the 
conserved seqence of type II TEs (G-H-S-M-G), while while the Met residue in the signature 
sequence of SphJ and TE PikAV are replaced by Leu. Reference sequences were taken 
from the biosynthesis of rifamycin (A.mediterranei, AAG52991), gramicidin (B. brevis, 
AAA58717) and pikromycin (S. venezuelae, AAC69333).[36] 
  
F G H S L G 89 
L G H S M G 97 
F G H S M G 96 
F G H S L G 101 
S G P H 199 
P G D H 212 
P G G H 214 
S G G H 215 
SphJ 
GrsT 
RifR 
PikAV 
 Figure S9. SDS-PAGEs of a typical SphI purification by affinity-chromatography on a Ni-NTA 
column  
FT: flow through; W1 and W2, (washing steps with 50 and 100 mM imidazole, respectively); 
E1–E5, elution fractions; M, marker; P: pellet. The black arrow indicates SphI (calculated 
mass of 41.3 kDa). 
 
 
Figure S10. A) pH dependency; B) metal requirements of SphI  
The enzymatic activity was determined between pH 5-9. The mean value of two independent 
enzyme purifications is given; error bar indicates standard deviation. 
Disappearance of PEP in the reaction mixture containing 80 µM PEP, 350 µM E4P, 
100 µM MnSO4 and BTP buffer (pH 5-9) were observed by adding SphI at room 
temperature and the values were recorded 30 minutes after reaction start. 100% 
activity are equivalent to a consumption of 80 µM PEP in 30 minutes. To investigate 
the metal dependence of SphI, the reaction was started by adding SphI to the mixture 
(80 µM PEP, 350 µM E4P, EDTA 100 µM or divalent cations, 50 mM BTP buffer; pH 
7). Divalent cations tested: Cd²⁺, Cu²⁺, Mg²⁺, Mn²⁺ and Zn²⁺ (100 µM).   
E5   E4     E3    E2    E1   M    W2    W1    FT    P 
     
60 kDA 
50 
40 
Motif1 (VIL)-(LV)-(DE)-(IV)-G-(GC)-G-(TP)-G 
Motif2 (PG)-(QT)-(FYA)-D-A-(IVY)-(FI)-(CVL) 
Motif3 L-L-(RK)-P-G-G-(RIL)-(LI)-(LFIV)-(IL) 
 
SphB M L E I G T F T G 72 N Y F D F  V Y I 142 
N. punct. T L E V G V F T G 72 E T F D F  A F I 142 
R. brookii T L D I G V F T G 72 E T F D F  A F I 142 
B. cereus V L E V G T F T G 76 N I F D F  I F I 146 
 
 
SphB L V  R P G G I I G  I 168 
N. punct. L L  R P G G L I A  I 168 
R. brookii L I  R S G G L I A  V 168 
B. cereus L I  R P G G I V A  V 172 
 
Figure S11. Signature motifs and multiple sequence alignment of SphB.  
Residues corresponding to the consensus motifs are coloured yellow; reference sequences 
were taken from similar proteins from Nostoc punctiforme (N. punct., YP_001867016), 
Raphidiopsis brookii D9 (R. brookii, ZP_06306391) and Bacillus cereus BGSC 6E1 (B. 
cereus, EEK53069). 
Motif 1 Motif 2 
Motif 3 
 Figure S12. Methylation activity of SphB 
A) Time course of a methylation assay. The grey peak represents the substrate 
protocatechuic acid and the red peak the product isovanillic acid, respectively. B) Optimal 
temperature of SphB. C) pH dependency of SphB.  
  
 Figure S13. Results of the ATP-PPi exchange assay 
The best conversion was set to 100%. The first six rows show the result for the tridomain 
A1-PCP1-PCP12, while the next rows show the result for the didomain A1-PCP1. IVA, 
isovanillic acid; PC, protocatechuic acid. 
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 Figure S14. Extracted ion chromatograms of the base peak ion of pentadiene 4 (m/z 67) for 
in vitro experiments with substrate mimic 1. The relative intensities for experiments A – D are 
directly comparable.  
 Figure S15. Extracted ion chromatograms of the base peak ion of labelled pentadiene 
(1-13C,1,1-2H2)-4 (m/z 70) of in vitro experiments with substrate mimic (2-13C,2,2-2H2)-1. The 
relative intensities for experiments A and B are directly comparable. 
  
 Figure S16. Mass spectrum of A) 1,3-pentadiene 4 and B) of labelled pentadiene 
(1-13C,1,1-2H2)-4 obtained by incubation of (2-13C,2,2-2H2)-1 with SphHCterm (B). 
  
 Figure S17. Extracted ion chromatograms of the base peak ion of pentadiene 4 (m/z 67) for 
in vitro experiments with substrate mimic 2. The relative intensities for experiments A – D are 
directly comparable. 
 
 Figure S18. Extracted ion chromatograms of the base peak ion of pentadiene 4 (m/z 67) for 
in vitro experiments with substrate mimic 3. The relative intensities for experiments A and B 
are directly comparable. 
  
 Figure S19. SDS-PAGE of a typical purification of SphB by affinity-
chromatography on Ni-NTA column. 
Protein gel shows fraction from the purification; Ft, flow through; W1, wash1 (20 mM 
imidazole); W2, wash2 (40 mM imidazole); E1 – E5, elution fractions with 100 to 300 
mM imidazole; M, size marker. Black arrow indicates SphB (calculated mass of 28.9 kDa). 
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Figure S20. SDS-PAGE of a typical purification of SphC by affinity-
chromatography on Ni-NTA column. 
Protein gel shows fraction from the purification; W1, wash1 (20 mM imidazole); W2, 
wash2 (40 mM imidazole); E1 – E5, elution fractions with 100 to 300 mM imidazole; 
M, marker. Black arrow indicates calculated mass of 58,1 kDa for the SphC.  
 
 
Figure S21. SDS-PAGE of a typical purification of SphHCterm by affinity-chromatography on a 
Ni-NTA column. 
FT, flow through; W1 and W2, (washing steps with 30 and 50 mM imidazole, respectively); 
E1–E5, elution fractions (100-350 mM imidazole) once at 100 mM, once at 150 mM, once at 
200 mM, and twice at 300 mM).; M, marker. Black arrow indicates calculated mass of 53.5 
kDa for the SphH Hyd-ACP. 
 
P       M     W1   W2    E1     E2     E3    E4    E5 
     
60 kDA 
50 
40 
E5       E4     E3      E2      E1     M    W2      W1      FT 
     
60 kDA 
 
50 
 
40 
 Figure S22. SDS-PAGE of a typical purification of SphJ by affinity-chromatography on a Ni-
NTA column.  
FT, flow through; W1 and W2, (washing steps with 30 and 50 mM imidazole, respectively); 
E1–E5, elution fractions (100-350 mM imidazole); M, marker. The black arrow indicates the 
calculated mass of 31.2 kDa for the SphJ. 
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Table S1. Predicted functionalities of the proteins encoded in the siphonazole biosynthetic 
gene cluster 
Gene Sizea Highest homologyb Identityc Predicted domainsd 
sphA 762 malonyl CoA-ACP transacylase [Pelosinus fermentans] 
389/765 
(51%) 
trans-AT-OR 
 
sphB 221 SAM-dependent methyltransferase  [Paenibacillus sonchi] 
144/220 
(65%) 
O-methyltransferase 
 
sphC 5451 hypothetical protein [Fischerella sp. PCC 9339] 
135/339 
(40%) 
A-ACP-ACP-KS-DH-KR-
ACP-KS-PCP-Cyc-Cyc- A-
PCP-PCP-Ox-Ox-KS 
sphD 2089 beta-ketoacyl synthase [Clostridium] cellulolyticum] 
719/1951 
(37%) 
ACP-KS-ACP-ACP-KS-
ACP 
sphE 2693 hypothetical protein  [Paenibacillus polymyxa] 
662/2120 
(31%) 
Cyc-Cyc-A-PCP-PCP- 
Ox-Ox-KS-ACP 
sphF 2059 
mixed polyketide synthase/non-
ribosomal peptide synthetase, 
partial [Streptomyces avermitilis] 
862/2013 
(43%) C-A-ACP-KS-DH 
sphG 1186 hypothetical protein, partial [Clostridium] cellulolyticum] 
479/1031 
(46%) KR-ACP-KS-ACP 
sphH 1228 
putative Carboxyl esterase 
[Xenorhabdus bovienii str. 
oregonense] 
270/915 
(30%) DH-KR-ACP-Hydrolase 
sphI 348 hypothetical protein [Atribacteria bacterium JGI 0000059-I14] 
183/342 
(54%) Aldolase 
sphJ 243 MULTISPECIES: thioesterase [Bacillus] 
100/231 
(43%) TE 
a
 The size of the proteins is given in amino acids. b BLASTp results for the amino acid sequences from 
the siphonazole biosynthetic gene cluster. c The numbers of amino acids identical to the highest 
homologue are given. d Column five shows the predicted protein functions. 
 
Table S2. Antiprotozoal activities of siphonazole. 
Parasite 
Siphonazole Reference drug1 
IC50 (µg/mL) IC50 (µM) IC50 (µg/mL) IC50 (µM) 
 
T. brucei rhodesiense 
 
5.36 
 
11.57 
 
0.0013 
 
0.0032 
Trypanosoma cruzi 22.40 48.36 0.30 1.15 
Leishmania donovani 28.40 61.32 0.14 0.34 
Plasmodium falciparum 0.59 1.27 0.04 0.11 
Cytotoxicity (L6 cells) 23.80 51.38 0.01 0.02 
 
1
 (melarsoprol, benznidazole, miltefosine, chloroquine, podophyllotoxin) 
 
  
Table S3. mRNA screening primers. 
Primer Sequence (5’–3’) 
A-fwd  
A-rev 
GCGAGGCATACCATGAAAGG 
CCTGCTTCTGTGATCCTTG 
B-fwd 
B-rev 
CAGGCTCGTCATGTCGATAC 
TTCTGGTGGCGTTTGCATGG 
C-fwd 
C-rev 
TTGGTGATGGCTTGACTCTC 
CGGGCTTGGTTGGTAAACAG 
D-fwd 
D-rev 
TGGCGTAATTCAGCCACGTC 
GCAATCGCGGTTAAATCAGG 
E-fwd 
E-rev 
TTCAGGAACTGCGCTTGATG 
GCAGTCGCGAATGGTTGGTG 
F-fwd 
F-rev 
AATCCCGCCCACCCAGATTC 
AATGCCATGCCGACGCTAAG 
G-fwd 
G-rev 
GGAGCAGGTTGGCATCTACG 
GTTTCAGGCACCATCCCTTG 
H-fwd 
H-rev 
TTGTTATTTGAGCGCCACCC 
AACGCTGACTATCAGCAACC 
I-fwd 
I-rev 
TTCTGCGCGAGCAAGAAGCC 
CTTTGGCAACGCCCACAATG 
J-fwd 
J-rev 
CCGACAACTCAATCCCAATG 
TCAAGCAGCGGCTCTTGACG 
 
Table S4. Primers for protein expression constructs 
Primer Sequence (5’–3’) 
OMt-fwd-BamHI 
OMt-rev-HindIII 
GCGGATCCATGGCAAAGGCATCATTGAAC 
CGAAGCTTGTTATTTGCGAATAACGAGAG 
SphI-fwd 
SphI-rev 
CACCATGATCGTAACGATAGAGC 
CTAACTGACCACAAGTGC 
SphH_end_fw 
SphH_end_dn 
CACCTTGTATGGCTATATTCTTGG 
CTAGACAAGCGTTGACATTA 
SphJ-topo-Up 
SphJ-topo-Down 
CACCATGGCAAGCTTGATCAAG 
CTATTCGTCAACTATGCTAATC 
sphC-A-fwd  
sphC-A-rev  
sphC-A+ACP1 
sphC-A+ACP1&2 
CACCATGGTGCAACAAGATTTAC 
CTAATCAATTTTGCCATTGGGAAG  
CTAAAGGGCGCTGGCCAAATC 
CTACAATGCCAGCGCAAGATC 
 
  
Table S5. Bacterial strains and plasmids used in this study 
Organism Genotype of interest Provider 
XL1-Blue E. coli 
recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F´ proAB 
lacIqZ∆M15 Tn10 (Tetr) 
Stratagene (La 
Jolla, CA,USA) 
BL21  E. coli 
F- ompT gal dcm Ion hsdSb (rB- 
mB-) λ(DE3 [lac lacUV5-T7 gene1 
ind 1 sam7 nin5]) 
Invitrogen Life      
Technologies      
Corporation 
(Germany) 
BAP1 E. coli BL21(DE3) ∆prpRBCD::T7psfp-T7pprpE 
Pfeifer et al., 
2001[36] 
TOP10 E. coli 
F- mcrA ∆(mrr-hsdRMS-mcrBC) 
Φ80lacZ∆M15 ∆lacΧ74 recA1 
araD139 ∆(ara-leu)7697 galU 
galK rpsL (StrR) endA1 nupG) 
Invitrogen Life      
Technologies      
Corporation 
(Germany) 
pET28a(+) kanR, His tag cds (6xHis) Merck KGaA (Germany) 
pET151/D-TOPO ampR, His tag cds (6xHis) 
Invitrogen Life 
Technologies 
Corporation 
(Germany) 
pET28_SphB sphB 
This study 
 
pET151_SphC sphC (N-terminal A domain) This study 
pET151_SphC 
_ACP1 sphC (A + ACP1 domains) This study 
pET151_SphC 
_ACP1&2 sphC (A + ACP1+ACP12 domains) This study 
pET151_SphI sphI This study 
pET151_SphHCterm sphH (C-terminal part) This study 
pET151_SphJ sphJ This study 
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Sceptrin – Enantioselective Synthesis of a Tetrasubstituted all-
trans Cyclobutane Key Intermediate
Lena Barra[a] and Jeroen S. Dickschat*[a]
Abstract: The asymmetric synthesis of both enantiomers of
tetrasubstituted all-trans dimethyl 3,4-diacetylcyclobutane-1,2-
dicarboxylate with high enantiomeric purity (>98 % ee) using a
valine-derived chiral auxiliary in a diastereoselective photodi-
merization is reported. The absolute configuration was assigned
Introduction
The cyclobutane ring is a widespread structural motif that
occurs in all classes of natural products including terpenes,
alkaloids, fatty acids, nucleosides and polyketides.[1] Particularly
intriguing are cyclobutane-centred symmetric (or pseudo-sym-
metric) natural products that are presumably formed by an in-
termolecular [2+2] cycloaddition of two identical (or structurally
related) monomers that can usually result in a variety of regio-
and stereoisomers. Well-known examples are the pseudo-sym-
metric all-trans compound anisumic acid (1) from the Chinese
medicinal plant Clausena anisum-olens (Rutaceae)[2] and scep-
trin (2), which was isolated in 1981 by Faulkner and Clardy and
co-workers from the marine sponge Agelas sceptrum (Fig-
ure 1).[3] This dimer of hymenidin (3) belongs to a large group
of marine pyrrole-imidazole alkaloids that exhibit remarkable
structural architectures and a broad spectrum of bioactivities,[4]
including anti-microbial, anti-muscarinic and anti-histaminic ac-
tivities, and inhibition of the cell motility of cancer cell lines
without showing cytotoxicity at the effective concentrations.[5]
Besides 2, a series of related compounds can be isolated from
different Agelas species, such as ageliferin (4),[6] which can be
rationalized as the [4+2] cycloadduct of 3, and nakamuric acid
(5),[7] for which the absolute configuration was recently clari-
fied.[8] From a synthetic point of view, these chiral natural prod-
ucts are challenging targets because methods for the asymmet-
ric construction of cyclobutane scaffolds are limited.[9] The first
total synthesis of (rac)-2 was reported in 2004 and proceeded
via the tetrasubstituted all-trans cyclobutane (rac)-6 as a key
intermediate that was transformed into (rac)-2 in 12 linear
steps.[10] A subsequent enantioselective synthesis of (+)-6 gave
[a] Kekulé-Institute of Organic Chemistry and Biochemistry,
Rheinische Friedrich Wilhelms University of Bonn,
Gerhard-Domagk-Straße 1, 53121 Bonn, Germany
E-mail: dickschat@uni-bonn.de
https://www.chemie.uni-bonn.de/oc/forschung/arbeitsgruppen/
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Supporting information and ORCID(s) from the author(s) for this article are
available on the WWW under https://doi.org/10.1002/ejoc.201700882.
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by single-crystal X-ray diffraction analysis. Because this cyclo-
butane is a key intermediate in the total synthesis of (–)-scep-
trin and ageliferin, our findings strengthen the recently revised
absolute configurations of these pyrrole-imidazole alkaloids.
access to natural (–)-2 and confirmed the initially assigned ab-
solute configuration,[11] but a more recent synthetic route start-
ing from L-glutamic acid resulted in a revision of the absolute
configuration for sceptrin and, consequently, for the key inter-
mediate (+)-6 of the first enantioselective approach towards
sceptrin.[12] Here we describe an alternative procedure for the
synthesis of both enantiomers of 6 from L- or D-valine that con-
firms the recently revised absolute configuration of sceptrin.
Figure 1. Structures of anisumic acid (1), sceptrin (2), hymenidin (3), ageliferin
(4), nakamuric acid (5) and of the synthetic key intermediate (+)-6 towards
sceptrin and ageliferin.
Results and Discussion
For the enantioselective synthesis of 6, L-valinol (7) and levulinic
acid (8) were converted into the bicyclic lactam 9, which is a
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known intermediate in the total synthesis of (–)-grandisol
(Scheme 1A).[13] Introduction of an α,-unsaturation by Grieco
elimination yielded the enone 10, a compound that was previ-
ously applied in face-selective cyclopropanation reactions.[14]
UV irradiation of 10 at 250 nm in dichloromethane resulted in
the formation of two products in yields of 15 % and 8 % that
were tentatively identified as [2+2] dimerization products by
GC–MS (Table 1).
Scheme 1. Synthesis of photodimers: A) synthesis of monomer 10 from
valinol and subsequent irradiation to photodimers 11 and B) representation
of all possible photodimers with their point groups given in parentheses.
Table 1. Optimization of the reaction conditions for the photodimerization of
10.[a]
λ [nm] Solvent Additive Time [h] Yield [%]
11b 11c 11d
250 DCM – 24 15 n.d. 8
250 MeCN – 24 19 n.d. 10
250 neat – 48 0 0 0
350 MeCN – 48 0 0 0
350 MeCN acetophenone 12 37 5 32
350 MeCN benzophenone 48 0 0 0
350 MeCN acetone 48 0 0 0
[a] DCM = dichloromethane, MeCN = acetonitrile, n.d. = not determined.
During optimization of the reaction conditions, moderately
increased yields were obtained in acetonitrile, whereas neat
conditions did not give any [2+2] cycloadducts, even after pro-
longed reaction times. Changing to a wavelength of 350 nm
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did not yield any photodimerization products, but with the ad-
dition of acetophenone as photosensitizer significantly im-
proved yields could be obtained, even with reduced reaction
times, and also minor quantities (5 %) of a third product were
obtained. When applied under the same conditions, benzo-
phenone and acetone proved to be ineffective as photosensitiz-
ers.
The structures of the three compounds obtained under the
optimized reaction conditions were elucidated by the following
rationale. In theory, the photodimerization of 10 can lead to six
isomers, namely three head-to-head connected isomers 11a–
c and three head-to-tail cycloadducts 11d–f (Scheme 1B, the
symmetry properties of the molecules discussed in the follow-
ing section are summarized in Tables S1 and S2 in the Support-
ing Information). Among the head-to-head compounds the cis-
syn-cis stereoisomer 11a exhibits C1 symmetry, whereas the two
cis-anti-cis stereoisomers 11b and 11c both represent the point
group C2. Analogously, the head-to-tail isomer 11d is of C1 sym-
metry, whereas 11e and 11f belong to the C2 point group. The
main product of the photodimerization shows 10 signals in its
13C NMR spectrum, in agreement with one of the C2-symmetric
structures. The acid-catalysed cleavage of this product in meth-
anol resulted in (+)-6 (Scheme 2A), the reported intermediate
in the synthesis of sceptrin, which can only be formed from
11b with epimerization of both methyl ketones or from 11c
with epimerization of both methyl ester groups to yield the
Scheme 2. Methanolysis of photodimers: A) acid-catalyzed cleavage of photo-
dimers 11b and 11d, B) further possible methanolysis products from head-
to-tail photodimers and C) from head-to-head photodimers with their point
groups given in parentheses.
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thermodynamically most stable all-trans cyclobutane. Epimeri-
zation of the methyl ketones was assumed to be faster than
epimerization of the methyl esters, thereby favouring the struc-
ture of 11b for the main product. Indeed, the cleavage in
(2H4)methanol with
2H2SO4 proceeded with H/D exchange of
only the cyclobutane hydrogens at the α positions with respect
to the methyl ketones and not the methyl esters (Figure 2, for
incorporation rates, 13C NMR and HSQC spectra see Table S3
and Figures S1–S3 in the Supporting Information). The structure
of 11b is further supported by X-ray diffraction analysis, with
the crystallographic data of its lysis product pointing to a
(1R,2R,3S,4S) configuration for (+)-6 (Figure 3).
Figure 2. Result of the H/D exchange experiment. A) 1H NMR spectrum of 6
(700 MHz, C6D6) and B)
1H NMR spectrum of (2H14)-6 (700 MHz, C6D6).
Figure 3. X-ray structures of 11b and its cleavage product (+)-6. ORTEP repre-
sentations of A) 11b and B) (1R,2R,3S,4S)-6 (crystallographic data are given
in Tables S4 and S5 in the Supporting Information).
Starting from D-valinol, ent-(–)-6 was obtained by the same
route. Both enantiomers were isolated with high enantiomeric
purity (>98 % ee), as revealed by HPLC analysis on a homochiral
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stationary phase (Figure 4). The delineated structure of 11b is
also supported by 2D NMR spectroscopy, including 1H,1H COSY,
HSQC, HMBC and NOESY, but many of the observed correlations
are also in line with the other C2-symmetric isomers. This was
also a major problem in the identification of the other two
photodimers.
Figure 4. Analysis of the enantiomeric excess of 6 by HPLC on a chiral station-
ary phase. A) Mixture of (+)- and (–)-6, B) (+)-6 obtained from the cleavage
of (+)-11b, C) (–)-6 obtained from the cleavage of (–)-11b and D) (–)-6 ob-
tained from the cleavage of (+)-11c.
The second most abundant photodimerization product from
10 exhibits 20 signals in its 13C NMR spectrum, which points to
one of the two possible structures of C1 symmetry (11a or 11d).
Methanolysis of this product yielded two achiral or chiral race-
mic products, as indicated by a missing optical rotation. One of
these products reveals six and the other one nine signals in
their 13C NMR spectra, requiring the presence of symmetric ele-
ments in both cases. Taking epimerizations (preferably at the
methyl ketones) into account, the only possible structures for
the minor product with nine 13C NMR signals are the achiral
compounds 12b or 12c (see Table S2 in the Supporting Infor-
mation). For all the other stereoisomers of 12 with either Ci or
C2v symmetry, six carbon signals are expected, whereas none
of the stereoisomers of 6 that could potentially arise from a
head-to-head isomer such as 11a has the correct symmetry
properties to explain the observed 13C NMR spectrum. The
product 12b was finally identified, because two sets of signals
for the diastereotopic methyl ester functions and coinciding sig-
nals for the enantiotopic methyl ketones are observed, whereas
12c would require two sets of signals for the methyl ketones
and just one for the methyl esters. The major product of this
methanolysis is likely to be 12a, and the initial mixture of these
two products pointed to the structure of 11d for the second
photodimer of 10. The formation of 12b shows again the pref-
erential epimerization of the methyl ketone functions, whereas
the hypothetical isomerization of one methyl ester group would
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produce 12c. No formation of the all-trans cyclobutane 12e was
observed, which also demonstrates the difficulties associated
with the epimerization of the methyl ester groups under the
applied reaction conditions.
The third minor product of the photodimerization of 10 ex-
hibits 10 signals in the 13C NMR spectrum, in agreement with
the structures of 11c, 11e or 11f. Methanolysis resulted in
(–)-6, which is only explainable from the second C2-symmetric
head-to-head dimer 11c, again requiring epimerization of both
methyl ketones.
Conclusions
An alternative approach to the synthesis of both pure enantio-
mers of the tetrasubstituted all-trans cyclobutane 6 in five steps
and 19 % overall yield has been developed. The stereoinforma-
tion is transferred from valinol, guiding a diastereoselective
photodimerization that yields three products with interesting
stereochemical properties. Also, their methanolysis with poten-
tial epimerization of the methyl ketones is a peculiar and intel-
lectually challenging stereochemical problem. As outlined, the
cyclobutane (+)-6 is a key intermediate in the total synthesis of
the pyrrole-imidazole alkaloid sceptrin (2) that serves itself as a
precursor for the synthesis of the related natural products ageli-
ferin (4) and nakamuric acid (5).[15] In the work presented here,
the absolute configuration of (+)-6 was re-examined, including
by X-ray diffraction analysis, which confirmed the recently re-
vised absolute configurations of this compound and all the nat-
ural products that were synthetically obtained from it. The effi-
cient enantioselective approach to both enantiomers of 6 from
cheap L- and D-valinol may be of use for the total synthesis of
other cyclobutane natural products.
Experimental Section
General Synthetic Methods: All chemicals were obtained from
Acros Organics (Geel, Belgium), Sigma Aldrich Chemie GmbH (Stein-
heim, Germany) or TCI Deutschland GmbH (Eschborn, Germany). All
solvents were purified by distillation. Whenever necessary, reactions
were carried out under inert atmosphere (Ar) using vacuum-heated
flasks and dried solvents (dried according to standard protocols).
TLC was performed on 0.20 mm silica plates (Polygram SIL G/UV254)
obtained from Macherey–Nagel (Düren, Germany). Column chroma-
tography was performed on Merck silica gel (0.040–0.063 Mesh).
NMR spectra were recorded with Bruker AV I (400 MHz), AV III HD
Prodigy (500 MHz) and AV III HD Cryo (700 MHz) spectrometers,
and were referenced against CDCl3 (δ = 7.26 ppm), C6D6 (δ =
7.16 ppm) and [D3]DMSO (δ = 2.50 ppm) for
1H NMR, and CDCl3
(δ = 77.01 ppm), C6D6 (δ = 128.06 ppm) and [D6]DMSO (δ =
39.52 ppm) for 13C NMR spectroscopy. The multiplicities are speci-
fied as follows: singlet (s), doublet (d), triplet (t), quartet (q), septet
(sept.), multiplet (m). GC–MS analyses were carried out with an
Agilent HP7890B gas chromatograph connected to a HP5977A mass
detector fitted with a HP-5MS silica capillary column (30 m, 0.25 mm
i.d., 0.50 µm film). The GC–MS conditions were as follows: 1) inlet
pressure: 77.1 kPa, He flow 23.3 mL/min; 2) injection volume: 1 µL;
3) injection mode: split 50:1, valve time 60 s; 4) oven temperature
ramp: 5 min at 50 °C increasing at 10 °C/min to 320 °C; 5) carrier
gas He at 1 mL/min; 6) transfer line: 250 °C; 7) electron energy:
70 eV. Retention indices (I) were determined from a homologous
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series of n-alkanes (C8–C40). Optical rotary powers were recorded
with a P8000 Polarimeter (Krüss). UV/Vis spectra were recorded with
a Cary 100 UV/Vis spectrometer (Agilent). IR spectra were recorded
with an Alpha FT-IR spectrometer from Bruker. The intensities of the
signals are specified as follows: strong (s), medium (m), weak (w),
broad (br).
(3S,7aR)-3-Isopropyl-7a-methyltetrahydropyrrolo[2,1-b]oxazol-
5(6H)-one [(+)-9]: L-Valinol (7.20 g, 69.8 mmol, 1.0 equiv.) and
levulinic acid (8.11 g, 69.8 mmol, 1.0 equiv.) were dissolved in tolu-
ene (400 mL) and p-toluenesulfonic acid (0.60 g, 3.49 mmol,
0.05 equiv.) was added. The reaction mixture was heated at reflux
for 16 h using a Dean–Stark trap. After completion of the reaction
the mixture was concentrated and washed with NaHCO3 (sat. aque-
ous solution). The organic phase was dried with MgSO4 and the
solvent was removed under reduced pressure. The crude product
was purified by column chromatography on silica gel (cyclohexane/
ethyl acetate, 3:1) and (+)-9 (12.0 g, 65.6 mmol, 94 %) was isolated
as a colourless oil. [α]D
21 = +84.2 (c = 1, acetone). Rf = 0.2. GC (HP-
5MS): I = 1379. 1H NMR (400 MHz, CDCl3): δ = 4.14 (dd,
2JH,H = 8.7,
3JH,H = 7.3 Hz, 1 H, CHH), 3.85 (dd,
2JH,H = 8.7,
3JH,H = 6.1 Hz, 1 H,
CHH), 3.59 (ddd, 3JH,H = 6.3,
3JH,H = 7.3,
3JH,H = 10.4 Hz, 1 H, CH),
2.73 (ddd, 2JH,H = 17.0,
3JH,H = 9.8,
3JH,H = 9.8 Hz, 1 H, CHH), 2.46
(ddd, 2JH,H = 17.0,
3JH,H = 7.0,
3JH,H = 5.6 Hz, 1 H, CHH), 2.20–2.12
(m, 2 H, CH2), 1.73–1.61 (m, 1 H, CH), 1.47 (s, 3 H, CH3), 1.03 (d,
3JH,H = 6.7 Hz, 3 H, CH3), 0.88 (d,
3JH,H = 6.7 Hz, 3 H, CH3) ppm.
13C
NMR (100 MHz, CDCl3): δ = 179.0 (Cq), 100.0 (Cq), 71.1 (CH2), 61.8
(CH), 34.2 (CH2), 33.6 (CH), 33.1 (CH2), 25.1 (CH3), 20.6 (CH3), 19.2
(CH3) ppm. IR (ATR): ν˜ = 2959 (w), 2931 (w), 2872 (w), 1704 (s), 1466
(w), 1347 (s), 1247 (w), 1190 (w), 1020 (m), 879 (m) cm–1. MS (EI,
70 eV): m/z (%) = 183 (32), 168 (87), 154 (18), 140 (100), 126 (19),
112 (32), 100 (46), 82 (55), 69 (23), 55 (24), 43 (30). HRMS (ESI): calcd.
for C10H17NNaO2
+ 206.1151; found 206.1151 [M + Na]+.
(3R,7aS)-3-Isopropyl-7a-methyltetrahydropyrrolo[2,1-b]oxazol-
5(6H)-one [(–)-9]: Lactam (–)-9 was synthesized analogously from
D-valinol (5.00 g, 48.5 mmol). Yield: 8.08 g (44.1 mmol, 91 %). All
recorded spectroscopic data, with the exception of the optical
rotary power, were identical to those for (+)-9. [α]D
21 = –81.9 (c = 1,
acetone).
(3S,7aR)-3-Isopropyl-7a-methyl-2,3-dihydropyrrolo[2,1-b]ox-
azol-5(7aH)-one [(+)-10]: Diisopropylamine (0.61 g, 6.00 mmol,
2.2 equiv.) was dissolved in dry THF (15 mL) under Ar and cooled
to 0 °C. A solution of n-butyllithium (1.6 M in hexane, 3.80 mL,
6.00 mmol, 2.2 equiv.) was added dropwise and the mixture was
stirred for 30 min and afterwards cooled to –78 °C. A solution of
(+)-9 (0.50 g, 2.73 mmol, 1.0 equiv.) in dry THF (1 mL) was added
dropwise and the mixture was stirred for 2 h, followed by dropwise
addition of a cooled solution (–78 °C) of PhSeBr (0.77 g, 3.28 mmol,
1.2 equiv.) in dry THF (10 mL). The mixture was warmed to room
temperature and stirred overnight, quenched with water and ex-
tracted with EtOAc. The combined organic phases were dried with
MgSO4 and the solvent was removed under reduced pressure. The
crude selenylation product and pyridine (0.54 g, 6.82 mmol,
2.5 equiv.) were dissolved in DCM (15 mL) and cooled to 0 °C. A
35 % aqueous H2O2 solution (0.80 mL, 8.18 mmol, 3.0 equiv.) was
added dropwise and the mixture was stirred for 3 h. After comple-
tion of the reaction the mixture was quenched with 1 M HCl solu-
tion. The organic phase was washed with water and brine and dried
with MgSO4. After removal of the solvent under reduced pressure,
the crude product was purified by column chromatography on silica
gel (petroleum ether/diethyl ether, 3:1) and (+)-10 was obtained as
a pale-yellow solid, which was repeatedly washed with cold pent-
ane until a colourless product was obtained (0.34 g, 1.86 mmol,
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68 %). [α]D
21 = +48.6 (c = 1, acetone). Rf = 0.2. GC (HP-5MS): I = 1320.
M.p. 49–51 °C. 1H NMR (500 MHz, C6D6): δ = 6.37 (d,
3JH,H = 5.8 Hz,
1 H, CH), 5.64 (d, 3JH,H = 5.8 Hz, 1 H, CH), 3.88 (dd,
2JH,H = 8.8,
3JH,H =
7.3 Hz, 1 H, CHH), 3.64 (dd, 2JH,H = 8.8,
3JH,H = 6.0 Hz, 1 H, CHH),
3.44 (ddd, 3JH,H = 10.1,
3JH,H = 7.2,
3JH,H = 6.3 Hz, 1 H, CH), 1.45
(dsept., 3JH,H = 10.1,
3JH,H = 6.6 Hz, 1 H, CH), 1.17 (s, 3 H, CH3), 1.10
(d, 3JH,H = 6.6 Hz, 3 H, CH3), 0.58 (d,
3JH,H = 6.6 Hz, 3 H, CH3) ppm.
13C NMR (125 MHz, C6D6): δ = 177.6 (Cq), 150.6 (CH), 127.9 (CH),
100.4 (Cq), 73.7 (CH2), 62.7 (CH), 33.2 (CH), 22.3 (CH3), 20.8 (CH3),
19.2 (CH3) ppm. IR (ATR): ν˜ = 3089 (w), 2959 (w), 2930 (w), 2875 (w),
1708 (s), 1671 (m), 1320 (s), 1105 (s), 1011 (m), 892 (s), 833 (m) cm–1.
UV/Vis (MeCN): λmax [log (ε/M
–1 cm–1)] = 245 [3.187] nm. MS (EI,
70 eV): m/z (%) = 181 (6), 166 (49), 151 (60), 138 (100), 124 (11),
110 (54), 96 (27), 80 (11), 59 (17), 53 (11), 41 (16). HRMS (ESI): calcd.
for C10H15NNaO2
+ 204.0995; found 204.0999 [M + Na]+.
(3R,7aS)-3-Isopropyl-7a-methyl-2,3-dihydropyrrolo[2,1-b]-
oxazol-5(7aH)-one [(–)-10]: Compound (–)-10 was synthesized
analogously from (–)-9 (5.00 g, 27.3 mmol). Yield: 3.26 g (18.0 mmol,
66 %). All recorded spectroscopic data, with the exception of the
optical rotary power, were identical to those for (+)-10. [α]D
21 = –49.3
(c = 1, acetone).
General procedure for the photochemical dimerization of 10:
Enone 10 was dissolved at a concentration of 0.1 M in freshly de-
gassed solvent according to Table 1 and irradiated by use of a Ray-
onet RPR-200 photoreactor. When utilized, photosensitizers were
added (5 equiv.) directly to 10. When irradiation with λ = 250 nm
was conducted, reaction vessels made of fused silica glass were
used. The reaction progress was monitored by GC and carried out
until all starting material was consumed or after no product forma-
tion was detected after 48 h. The solvent was removed under re-
duced pressure and the crude products were directly subjected to
HPLC separation [system: Fa. KNAUER GmbH (Berlin, Germany), two
pumps S-1800, assistant 6000 with feedpump S-100 (10 mL pump-
head) and electronic injection valve (6 port), UV/Vis detector S-2550
(190–900 nm); column: KNAUER Eurospher II 100-5 C18P, 5 µm,
250 × 20 mm; solvent: MeCN/H2O (45:55); flow rate: 24.0 mL/min].
Fractions containing the target compound were pooled and the
solvent was removed by lyophilization. For the different tested reac-
tion conditions, see Table 1.
Photodimers (+)-11b, (+)-11d and (+)-11c: Enone (+)-10 (0.20 g,
1.10 mmol, 1.0 equiv.) was dissolved in freshly degassed dry MeCN
(10 mL) and acetophenone (0.66 g, 5.52 mmol, 5.0 equiv.) was
added. The solution was irradiated with λ = 350 nm until all starting
material was consumed (12 h). The solvent was removed under
reduced pressure and the crude product mixture was purified by
HPLC. After lyophilization (+)-11b (74.0 mg, 0.20 mmol, 37 %), (+)-
11d (64 mg, 0.18 mmol, 32 %) and (+)-11c (10 mg, 0.03 mmol, 5 %)
were isolated as colourless solids.
Analytical data for (+)-11b: [α]D
21 = +193.6 (c = 1, MeOH). GC (HP-
5MS): I = 2642. M.p. 196–198 °C. 1H NMR (400 MHz, C6D6): δ = 3.99–
3.89 (m, 2 H, 2 CHH), 3.58–3.51 (m, 4 H, 2 CHH, 2 CH), 3.57–3.48 (m,
2 H, 2 CH), 3.31 (m, 2 H, 2 CH), 2.99 (m, 2 H, 2 CH), 1.39–1.27 (m, 2
H, 2 CH), 1.08 (s, 6 H, 2 CH3), 1.07 (d,
3JH,H = 6.7 Hz, 6 H, 2 CH3),
0.57 (d, 3JH,H = 6.6 Hz, 6 H, 2 CH3) ppm.
13C NMR (100 MHz, C6D6):
δ = 176.9 (2 Cq), 97.8 (2 Cq), 73.0 (2 CH2), 61.0 (2 CH), 46.1 (2 CH),
42.2 (2 CH), 34.5 (2 CH), 25.5 (2 CH3), 20.9 (2 CH3), 19.0 (2 CH3) ppm.
IR (ATR): ν˜ = 2957 (w), 2940 (w), 2875 (w), 1703 (s), 1466 (w), 1352
(s), 1227 (w) 1148 (w), 1047 (w), 1007 (m), 899 (w), 769 (m), 609
(w) cm–1. MS (EI, 70 eV): m/z (%) = 362 (7), 347 (100), 319 (25), 291
(4), 279 (8), 261 (3), 236 (3), 219 (2), 207 (9), 193 (8), 182 (12), 166
(17), 151 (46), 138 (33), 128 (54), 108 (44), 96 (32), 80 (20), 69 (45),
55 (16), 43 (52). HRMS (ESI): calcd. for C20H31N2O4
+ 363.2278; found
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363.2278 [M + H]+. Optical rotary power of (–)-11b: [α]D
21 = –184.2
(c = 1, MeOH).
Analytical data for (+)-11d: [α]D
21 = +89.0 (c = 1, acetone). GC (HP-
5MS): I = 2690. M.p. 189–192 °C. 1H NMR (500 MHz, C6D6): δ = 3.87
(dd, 2JH,H = 8.5,
3JH,H = 7.6 Hz, 1 H, CHH), 3.79 (dd,
2JH,H = 8.2,
3JH,H =
8.2 Hz, 1 H, CHH), 3.67 (ddd, 3JH,H = 10.8,
3JH,H = 7.2,
3JH,H = 7.0 Hz,
1 H, CH), 3.56 (m, 1 H, CH), 3.53 (m, 1 H, CHH), 3.46 (ddd, 3JH,H =
10.2, 3JH,H = 7.1,
3JH,H = 7.1 Hz, 1 H, CH), 3.36 (dd,
2JH,H = 8.5,
3JH,H =
6.9 Hz, 1 H, CHH), 3.00 (m, 1 H, CH), 2.99 (m, 1 H, CH), 2.63 (m, 1 H,
CH), 1.43–1.30 (m, 2 H, 2 CH), 1.23 (s, 3 H, CH3), 1.15 (d,
3JH,H =
6.6 Hz, 3 H, CH3), 1.07 (d,
3JH,H = 6.6 Hz, 3 H, CH3), 1.05 (s, 3 H, CH3),
0.57 (d, 3JH,H = 6.6 Hz, 3 H, CH3), 0.56 (d,
3JH,H = 6.6 Hz, 3 H,
CH3) ppm.
13C NMR (125 MHz, C6D6): δ = 182.0 (Cq), 178.2 (Cq),
100.8 (Cq), 97.9 (Cq), 72.6 (CH2), 69.0 (CH2), 64.0 (CH), 61.9 (CH), 45.7
(CH), 44.9 (CH), 44.1 (CH), 41.4 (CH), 34.4 (CH), 34.1 (CH), 25.9 (CH3),
21.2 (CH3), 20.9 (CH3), 20.4 (CH3), 19.0 (CH3), 18.9 (CH3) ppm. IR
(ATR): ν˜ = 2924 (w), 2903 (w), 2868 (w), 1694 (s), 1463 (w), 1329 (m),
1138 (w), 1030 (w), 873 (w), 751 (w) cm–1. MS (EI, 70 eV): m/z (%) =
362 (23), 347 (100), 319 (60), 279 (11), 236 (21), 220 (3), 207 (7), 182
(20), 166 (7), 151 (72), 138 (21), 128 (45), 126 (44), 108 (21), 96 (23),
84 (12), 69 (21), 56 (7), 43 (21). HRMS (ESI): calcd. for C20H30N2NaO4
+
385.2098; found 385.2098 [M + Na]+. Optical rotary power of
(–)-11d: [α]D
21 = –91.5 (c = 0.6, acetone).
Analytical data for (+)-11c: [α]D
21 = +5.2 (c = 1, acetone). GC (HP-
5MS): I = 2738. M.p. 192–193 °C. 1H NMR (500 MHz, [D6]DMSO): δ =
4.10 (dd, 2JH,H = 8.4,
3JH,H = 8.4 Hz, 2 H, 2 CHH), 3.76 (dd,
2JH,H =
8.4, 3JH,H = 6.9 Hz, 2 H, 2 CHH), 3.50 (ddd,
3JH,H = 10.7,
3JH,H = 7.5,
3JH,H = 7.5 Hz, 2 H, 2 CH), 3.04 (m, 2 H, 2 CH), 2.98 (m, 2 H, 2 CH),
1.76–1.64 (m, 2 H, 2 CH), 1.50 (s, 6 H, 2 CH3), 0.98 (d,
3JH,H = 6.6 Hz,
6 H, 2 CH3), 0.85 (d,
3JH,H = 6.6 Hz, 6 H, 2 CH3) ppm.
13C NMR
(125 MHz, [D6]DMSO): δ = 181.2 (2 Cq), 100.3 (2 Cq), 68.0 (2 CH2),
63.8 (2 CH), 42.6 (2 CH), 42.1 (2 CH), 32.8 (2 CH), 20.9 (2 CH3), 19.3
(2 CH3), 18.8 (2 CH3) ppm. IR (ATR): ν˜ = 2963 (w), 2951 (w), 2872
(w), 1718 (s), 1459 (w), 1296 (m), 1280 (m), 1181 (m), 1071 (w), 999
(w), 986 (w), 863 (s), 695 (w) cm–1. MS (EI, 70 eV): m/z (%) = 362
(21), 347 (27), 319 (40), 295 (5), 279 (5), 235 (13), 182 (9), 151 (100),
138 (19), 128 (60), 108 (60), 96 (20), 84 (10), 69 (16), 56 (6), 43 (20).
HRMS (ESI): calcd. for C20H30N2NaO4
+ 385.2098; found 385.2098 [M
+ Na]+.
Dimethyl (1R,2R,3S,4S)-3,4-Diacetylcyclobutane-1,2-dicarboxyl-
ate [(+)-6]: Photodimerization product (+)-11b (62.0 mg,
0.17 mmol, 1.0 equiv.) was dissolved in MeOH (10 mL) and conc.
H2SO4 (1 mL) was added carefully. The reaction mixture was heated
at 70 °C for 6 h. After completion of the reaction, the mixture was
diluted with EtOAc and washed with water. The organic phase was
dried with MgSO4 and the solvent was removed under reduced
pressure. The crude product was purified by column chromatogra-
phy on silica gel (petroleum ether/diethyl ether, 1:1) and (+)-6
(34.0 mg, 0.13 mmol, 78 %, 98 % ee, Figure 4) was isolated as a
colourless solid. [α]D
21 = +30.3 (c = 1, CHCl3). Rf = 0.3. GC (HP-5MS):
I = 1663. M.p. 76–78 °C. 1H NMR (500 MHz, CDCl3): δ = 3.75 (s, 6 H,
2 CH3), 3.51 (dd, J = 9.5, 2.4 Hz, 2 H, 2 CH), 3.40 (dd, J = 9.5, 2.4 Hz,
2 H, 2 CH), 2.20 (s, 6 H, 2 CH3) ppm.
13C NMR (125 MHz, CDCl3): δ =
205.0 (Cq) , 171.8 (Cq) , 52.7 (CH3) , 46.6 (CH), 39.1 (CH), 27.9
(CH3) ppm. IR (ATR): ν˜ = 2964 (w), 2922 (w), 2903 (w), 2865 (w), 1695
(s), 1461 (w), 1347 (m), 1168 (m), 1114 (m), 874 (w), 773 (w), 683
(w) cm–1. MS (EI, 70 eV): m/z (%) = 256 (3), 241 (7), 224 (33), 213
(19), 196 (1), 182 (21), 171 (10), 164 (5), 153 (25), 140 (22), 123 (12),
111 (26), 95 (14), 85 (6), 59 (11), 43 (100). HRMS (ESI): calcd. for
C12H16NaO6
+ 279.0839; found 279.0839 [M + Na]+.
Dimethyl (1S,2S,3R,4R)-3,4-Diacetylcyclobutane-1,2-dicarboxyl-
ate [(–)-6]: Compound (–)-6 was synthesized by acidic cleavage of
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either (+)-11c (yield: 8.00 mg, 0.03 mmol, 71 %, 98 % ee, Figure 4)
or (–)-11b (yield: 12.0 mg, 0.05 mmol, 78 %, 98 % ee, Figure 4) fol-
lowing the same procedure as used for (+)-6. All recorded spectro-
scopic data, with the exception of the optical rotary power, were
identical to those for (+)-6. [α]D
21 = –30.0 (c = 1, CHCl3).
Dimethyl (1R,2R,3S,4S)-2,4-Diacetylcyclobutane-1,3-dicarboxyl-
ate (12a) and Dimethyl (1r,2R,3s,4S)-2,4-Diacetylcyclobutane-
1,3-dicarboxylate (12b): Photodimerization product (+)-11d
(36.0 mg, 0.10 mmol, 1.0 equiv.) was dissolved in MeOH (3 mL) and
conc. H2SO4 (0.3 mL) was added carefully. The reaction mixture was
heated at 70 °C for 16 h. After complete reaction, the mixture was
diluted with EtOAc and washed with water. The organic phase was
dried with MgSO4 and the solvent was removed under reduced
pressure. The crude product was purified by column chromatogra-
phy on silica gel (petroleum ether/diethyl ether, 1:2) and 12a
(9.00 mg, 0.035 mmol, 35 %) and 12b (4.00 mg, 0.016 mmol, 16 %)
were isolated as colourless solids.
Analytical data for 12a: Rf = 0.3. GC (HP-5MS): I = 1729. M.p. 77–
78 °C. 1H NMR (500 MHz, CDCl3): δ = 3.84–3.77 (m, 2 H, 2 CH), 3.73–
3.67 (m, 2 H, 2 CH), 3.69 (s, 6 H, 2 CH3), 2.20 (s, 6 H, 2 CH3) ppm.
13C NMR (125 MHz, CDCl3): δ = 205.7 (2 Cq), 171.8 (2 Cq), 52.5 (2
CH3), 47.2 (2 CH), 40.4 (2 CH), 29.4 (2 CH3) ppm. IR (ATR): ν˜ = 3005
(w), 2954 (w), 2921 (w), 2851 (w), 1722 (s), 1706 (s), 1440 (m), 1358
(m), 1298 (w), 1233 (s), 1193 (s), 1073 (m), 1038 (w), 982 (w), 953
(w), 935 (w), 797 (m), 724 (w), 661 (w), 510 (w) cm–1. MS (EI, 70 eV):
m/z (%) = 256 (3), 241 (9), 225 (22), 214 (9), 209 (3), 196 (10), 182
(26), 171 (19), 155 (6), 150 (43), 140 (35), 139 (35), 123 (20), 111 (25),
95 (14), 79 (2), 69 (2), 59 (4), 43 (100). HRMS (ESI): calcd. for
C12H16NaO6
+ 279.0839; found 279.0839 [M + Na]+.
Analytical data for 12b: Rf = 0.2. GC (HP-5MS): I = 1689. M.p. 99–
101 °C. 1H NMR (500 MHz, CDCl3): δ = 4.06 (dd,
3JH,H = 10.0,
3JH,H =
10.0 Hz, 1 H, CH), 3.78 (s, 3 H, CH3), 3.67 (s, 3 H, CH3), 3.67 (dd,
3JH,H = 9.0,
3JH,H = 9.0 Hz, 1 H, CH), 3.40 (dd,
3JH,H = 9.5,
3JH,H =
9.5 Hz, 2 H, 2 CH), 2.13 (s, 6 H, 2 CH3) ppm.
13C NMR (125 MHz,
CDCl3): δ = 204.6 (2 Cq), 172.9 (Cq), 172.0 (Cq), 52.7 (CH3), 52.4 (CH3),
46.4 (2 CH), 42.9 (CH), 41.4 (CH), 27.5 (2 CH3) ppm. IR (ATR): ν˜ =
3003 (w), 2942 (w), 2919 (w), 2851 (w), 1717 (s), 1706 (s), 1441 (m),
1378 (w), 1358 (w), 1282 (s), 1184 (m), 1158 (s), 1132 (s), 1054 (m),
1040 (w), 996 (w), 934 (m), 806 (w), 589 (w), 486 (w) cm–1. MS (EI,
70 eV): m/z (%) = 256 (<1), 241 (9), 224 (56), 214 (3), 209 (4), 193
(12), 181 (15), 171 (12), 165 (4), 155 (4), 150 (40), 139 (30), 123 (12),
111 (25), 95 (13), 85 (9), 59 (5), 59 (12), 43 (100). HRMS (ESI): calcd.
for C12H16NaO6
+ 279.0839; found 279.0839 [M + Na]+.
(2H6)Dimethyl (1R,2R,3S,4S)-(
2H8)-3,4-Diacetylcyclobutane-1,2-
dicarboxylate [(2H14)-6]: Photodimer (+)-11b (19.0 mg, 0.05 mmol)
was dissolved in (2H4)methanol (3 mL) and (
2H2)sulfuric acid (98 %
in D2O, 0.3 mL) was added carefully. The reaction was heated for
16 h at 70 °C, diluted with D2O (10 mL) and extracted with DCM.
The organic phase was dried with MgSO4 and the solvent was re-
moved under reduced pressure to yield (2H14)-6 (11.0 mg,
0.04 mmol, 78 %). GC (HP-5MS): I = 1650. MS (EI, 70 eV): m/z (%) =
270 (3), 252 (7), 235 (33), 224 (17), 216 (5), 206 (4), 200 (4), 188 (5),
180 (5), 172 (3), 161 (10), 155 (9), 146 (11), 116 (41), 100 (8), 62
(8), 46 (100). For the NMR spectroscopic data, see Table S1 in the
Supporting Information.
Analysis of the Enantiomeric Excess of 6: The enantiomeric ex-
cesses of (+)- and (–)-6 obtained from acidic cleavage of either (+)-
11b, (–)-11b or (+)-11c were analysed by HPLC using the following
conditions: system: Fa. Knauer GmbH (Berlin, Germany), HPG-pump
P6.1L, oven CT 2.1, photodiode array detector DAD 6.1L (190–
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1020 nm); column: DAICEL Chiralpak IB; 5 µm, 4.6 mm × 250 mm;
solvent: n-hexane/2-propanol (85:15); flow rate: 1.0 mL/min; pres-
sure: 42 bar; temperature: 25 °C.
CCDC 1552548 [for (+)-11b], and 1552549 [for (+)-6] contain the
supplementary crystallographic data for this paper. These data can
be obtained free of charge from The Cambridge Crystallographic
Data Centre.
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1. SYMMETRY PROPERTIES OF PHOTODIMERS AND HYDROLYSIS 
PRODUCTS 
 
Table S1. Symmetry properties of photodimers. 
Dimer Point group Expected no. of 13C-NMR signals Hydrolysis product(s)[a] 
11a C1 20 6c (6b, 6e) 
11b C2 10 6d (6a, 6) 
11c C2 10 ent-6d (ent-6a, ent-6) 
11d C1 20 12a (12b) 
11e C2 10 12d (12c, 12e) 
11f C2 10 12d (12c, 12e) 
[a] Initial hydrolysis product plus products formed by epimerisation(s) at -carbons of methyl 
ketones (in brackets). 
 
Table S2. Symmetry properties of hydrolysis products. 
Compound Point group Expected no. of 13C-NMR signals Equivalent groups[a] 
6 C2 6 esters, ketones 
12a Ci 6 esters, ketones 
12b Cs 9 ketones 
12c Cs 9 esters 
12d C2v 6 esters, ketones 
12e C2v 6 esters, ketones 
6a C1 12 – 
6b C1 12 – 
6c Cs 6 esters, ketones 
6d C2 6 esters, ketones 
6e Cs 6 esters, ketones 
[a] Superimposable by symmetry operation and magnetically equivalent in NMR. 
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2. LABELING STUDY 
 
Table S3. NMR data of 6 and (2H14)-6. 
C[a] 13C () of 
6[b] 
1H (, m, J) 
of 6 
13C (, m, J) of (2H14)-6[b] 1H (, m) 
of (2H14)-6 
1  171.7 (Cq) − 171.7 (s) − 
2 39.3 (CH) 3.46 (m) 39.2 (s) 3.45 (s) 
3 46.8 (CH) 3.39 (m) CH (8%): 46.7 (s) 
CD (92%): 46.3 (t, 1JC,D = 21.4) 
− 
4 203.8 (Cq) − 203.9 (s) − 
5 27.2 (CH3) 1.78 (s) CHD2 (18%): 26.8 (quin, 1JC,D = 19.5) 
CD3 (82%): 26.5 (sept, 1JC,D = 19.6) 
− 
6  51.9 (CH3) 3.23 (s) 51.1 (sept, 1JC,D = 22.4) − 
[a] Carbon numbering as shown in Figure S1. [b] 13C NMR data (175 MHz) recorded in C6D6. 
Chemical shifts  in ppm, multiplicities m, coupling constants J are given in Hertz, differing 
degree of deuteration given in % by peak integration, assignment of carbons by 13C DEPT 
135 and HSQC spectroscopy. [c] 1H NMR data (700 MHz) recorded in C6D6. Chemical shifts 
 in ppm, multiplicities m, coupling constants J are given in Hertz. 
 
 
Figure S1. Structure of (2H14)-6 and carbon numbering for 6. 
5 
 
 
Figure S2. Comparison of 13C NMR data of 6 and (2H14)-6 (175 MHz, C6D6). 
6 
 
 
Figure S3. HSQC spectrum of (2H14)-6. 
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3. CRYSTALLOGRAPHIC DATA 
For both (+)-6 and (+)-11b clear colorless needles were obtained from slow 
evaporation of a concentrated solution in C6D6. The data collections were performed 
on a Bruker D8-Venture diffractometer ((Bruker CMOS-Photon100 detector)) 
equipped with a low temperature device (Oxford Cryostream 800er series, Oxford 
Cryosystems, 100K) using Cu Kα radiation (λ = 1.54178 Å, monochromated by a 
HELIOS multilayer optics). Intensities were measured by fine-slicing ω- and φ-scans 
and corrected for background, polarization and Lorentz effects. A semi-empirical 
(mulabs) absorption correction1 was carried out on both data sets. The structures 
were solved by a dual-space method (SHELXT-2014)2 and refined by full-matrix least 
squares on F2 (SHELXL-2014).3 All non-hydrogen atoms were refined anisotropically. 
Hydrogen atoms at carbon were placed in calculated positions and refined 
isotropically using a riding model. CCDC-1552549 {(+)-6} and CCDC-1552548 {(+)-
11b} contain the supplementary data for these structures. These data can be 
obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing 
data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic 
Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033. 
 
Table S4. Details of X-ray crystal structure determination of (+)-6. 
Crystal habitus clear colorless 
needle 
/mm-1 0.919 
Device type Bruker D8-Venture F(000) 272.0 
Empirical 
formula 
C12H16O6 Crystal size/mm3 0.18 x 0.08 x 0.04 
Moiety formula C12H16O6 Absorption correction empirical 
Formula weight 256.25 Tmin; Tmax 0.4435; 0.7535 
Temperature/K 100 Radiation CuK ( = 1.54178) 
Crystal system monoclinic 2 range for data collection/° 10.806 to 135.464 
Space group P21 Completeness to theta 0.998 
a/Å 5.0361(3) Index ranges -6≤h≤6,-18≤k≤18,-10≤1≤9 
b/ Å 15.3716(9) Reflections collected 9291 
c/ Å 8.4503(5) Independent reflections 2269 [Rint = 0.0793, Rsigma = 
0.0615] 
/° 90 Data/restrain/parameters 2269/1/167 
/° 104.335(4) Goodness-of-fit F2 1.054 
/° 90 Final R indexes [I>=2 (l)] R1 = 0.0401, wR2 = 0.0920 
Volume/ Å3 633.79(7) Final R indexes [all data] R1 = 0.0484, wR2 = 0.0968 
Z 2 Largest diff. peak/hole / eÅ-3 0.20/-0.30 
calc [g/cm3] 1.343 Flack parameter 0.12(16) 
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Table S5. Details of X-ray crystal structure determination of (+)-11b. 
Crystal habitus clear colorless 
needle 
/mm-1 0.693 
Device type Bruker D8-
Venture 
F(000) 392.0 
Empirical 
formula 
C20H30N2O4 Crystal size/mm3 0.3 x 0.15 x 0.1 
Moiety formula C20H30N2O4 Absorption correction empirical 
Formula weight 362.46 Tmin; Tmax 0.4153; 0.7536 
Temperature/K 122.99 Radiation CuK ( = 1.54178) 
Crystal system monoclinic 2 range for data collection/° 7.236 to 135.444 
Space group P21 Completeness to theta 1.000 
a/Å 12.3155(12) Index ranges -14≤h≤14,-7≤k≤6,-14≤1≤14 
b/ Å 6.4811(6) Reflections collected 26213 
c/ Å 12.3723(11) Independent reflections 3443 [Rint = 0.0817, Rsigma = 0.0448] 
/° 90 Data/restrain/parameters 3443/2/242 
/° 99.081(6) Goodness-of-fit F2 1.048 
/° 90 Final R indexes [I>=2 (l)] R1 = 0.0457, wR2 = 0.1071 
Volume/ Å3 975.16(16) Final R indexes [all data] R1 = 0.0534, wR2 = 0.1141 
Z 2 Largest diff. peak/hole / eÅ-3 0.18/-0.28 
calc [g/cm3] 1.234 Flack parameter 0.3(3) 
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4. NMR SPECTRA OF SYNTHETIC COMPOUNDS 
 
Figure S4. 1H NMR spectrum of 9 (400 MHz, CDCl3). 
10 
 
 
Figure S5. 13C NMR spectrum of 9 (100 MHz, CDCl3). 
11 
 
 
Figure S6. 13C DEPT 135 spectrum of 9 (100 MHz, CDCl3). 
12 
 
 
Figure S7. 1H NMR of 10 (500 MHz, C6D6). 
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Figure S8. 13C NMR spectrum of 10 (125 MHz, C6D6). 
14 
 
 
Figure S9. 13C DEPT 135 spectrum of 10 (125 MHz, C6D6). 
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Figure S10. 1H NMR spectrum of 11b (400 MHz, C6D6).  
16 
 
 
Figure S11. 13C NMR spectrum of 11b (125 MHz, C6D6). 
17 
 
 
Figure S1. 13C DEPT 135 spectrum of 11b (125 MHz, C6D6). 
18 
 
 
Figure S2. 1H,1H-COSY NMR spectrum of 11b (500 MHz, C6D6). 
19 
 
 
Figure S3. HMBC spectrum of 11b (C6D6). 
20 
 
 
Figure S4. HSCQ spectrum of 11b (C6D6). 
21 
 
 
Figure S5. NOESY spectrum of 11b (C6D6). 
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Figure S6. 1H NMR spectrum of 11d (500 MHz, C6D6). 
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Figure S18. 13C NMR spectrum of 11d (125 MHz, C6D6). 
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Figure S19.13C DEPT 135 spectrum of 11d (125 MHz, C6D6).  
25 
 
 
Figure S7. 1H,1H-COSY spectrum of 11d (C6D6). 
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Figure S8. HMBC spectrum of 11d (C6D6). 
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Figure S9. HSQC spectrum of 11d (C6D6).
28 
 
 
Figure S10. NOESY spectrum of 11d (C6D6). 
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Figure S11. 1H NMR spectrum of 11c (500 MHz, d6-DMSO). 
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Figure S12. 13C NMR spectrum of 11c (125 MHz, d6-DMSO). 
31 
 
 
Figure S13. 13C DEPT 135 spectrum of 11c (125 MHz, d6-DMSO).  
32 
 
 
Figure S14. 1H,1H-COSY spectrum of 11c (500 MHz, d6-DMSO). 
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Figure S28. HMBC spectrum of 11c (d6-DMSO). 
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Figure S29. HSQC spectrum of 11c (d6-DMSO). 
35 
 
-
 
Figure S15. NOESY spectrum of 11c (d6-DMSO). 
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Figure S16. 1H NMR spectrum of 12a (500 MHz, CDCl3). 
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Figure S17. 13C NMR spectrum of 12a (125 MHz, CDCl3). 
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Figure S18. 13C DEPT 135 spectrum of 12a (125 MHz, CDCl3). 
39 
 
 
Figure S19. 1H,1H COSY spectrum of 12a (500 MHz, CDCl3). 
40 
 
 
Figure S20. HMBC spectrum of 12a (CDCl3). 
41 
 
 
Figure S21. HSQC spectrum of 12a (CDCl3). 
42 
 
 
Figure S22. NOESY spectrum of 12a (CDCl3). 
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Figure S38. 1H NMR spectrum of 12b (500 MHz, CDCl3). 
44 
 
 
Figure S39. 13C NMR spectrum of 12b (125 MHz, CDCl3).  
45 
 
 
Figure S23. 13C DEPT 135 spectrum of 12b (125 MHz, CDCl3). 
46 
 
 
Figure S24. 1H,1H-COSY spectrum of 12b (500 MHz, CDCl3). 
47 
 
 
Figure S25. HMBC spectrum of 12b (CDCl3). 
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Figure S26. HSQC spectrum of 12b (CDCl3). 
49 
 
 
Figure S27. NOESY spectrum of 12b (CDCl3). 
50 
 
 
Figure S28. 1H NMR spectrum of 6 (500 MHz, CDCl3). 
51 
 
 
Figure S29. 13C NMR spectrum of 6 (125 MHz, CDCl3). 
52 
 
 
Figure S30. 13C DEPT 135 spectrum of 6 (125 MHz, CDCl3). 
53 
 
 
Figure S48. 1H,1H-COSY spectrum of 6 (500 MHz, CDCl3). 
54 
 
 
Figure S49. HMBC spectrum of 6 (CDCl3). 
55 
 
 
Figure S31. HSQC spectrum of 6 (CDCl3). 
56 
 
 
Figure S32. NOESY spectrum of 6 (CDCl3). 
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Summary 
The cumulative doctoral thesis “Studies on the Biosynthesis and Structure 
Elucidation of Terpene Natural Products by Isotopic Labeling Experiments” deals with 
the application of stable isotopes for structure elucidation and biosynthesis studies of 
terpenoids from microorganisms. Additionally, analytic and synthetic studies on 
volatile natural products were conducted.  
A highly sensitive method for the identification of terpenes from fungal organisms, 
based on in vivo incorporation of 13C-labeled biosynthetic precursors was developed. 
This method was successfully applied for the identification of pogostol from the 
endophytic fungus Geniculosporium, of harzianone from the biocontrol fungus 
Trichoderma and of hypodoratoxide from the mycophilic fungus Hypomyces 
odoratus. The results gave additional insights into the biosynthesis of these 
metabolites. Isotopically labeled substrates were also designed, synthesized and 
utilized for in vitro experiments with recombinant enzymes from bacterial sources.  
Additionally, two studies on volatile metabolites from microorganisms were 
conducted. Nineteen recently genome sequenced actinomycetes were investigated 
and the chemical analysis was correlated to genome sequencing data. The volatiles 
of five sponge-associated fungi were analyzed and a series of bioactive metabolites, 
like the quorum sensing inhibitor protoanemonin, a highly phytotoxic lactone and 
algicidal phloroglucinol derivates were identified. 
During studies towards the total synthesis of the sesquiterpene koraiol, an 
enantioselective approach for the synthesis of a pseudosymmetric, tetrasubstituted 
all-trans cyclobutane was developed. The method makes use of a chiral auxiliary in a 
diastereoselective photodimerization. The obtained cyclobutane derivative is a key 
intermediate in the total synthesis of the highly bioactive sponge-derived metabolite 
sceptrin.    
